Drug Expenditure in Canada, 1985 to 2011 pic Spending and Health Workforce

Drug Expenditure in Canada, 1985 to 2011 pic Spending and Health Workforce
pic
pic
pic
Drug Expenditure in Canada, 1985 to 2011
Spending and Health Workforce
Our Vision
Better data. Better decisions.
Healthier Canadians.
Our Mandate
To lead the development and
maintenance of comprehensive
and integrated health information
that enables sound policy and
effective health system management
that improve health and health care.
Our Values
Respect, Integrity, Collaboration,
Excellence, Innovation
Table of Contents
Executive Summary ...................................................................................................................... v
Introduction ................................................................................................................................... 1
National Drug Expenditure Overview ............................................................................................ 3
The Share of Drugs in Total Health Expenditure .................................................................... 3
Total Drug Expenditure ........................................................................................................... 6
Total Drug Expenditure per Capita.......................................................................................... 7
Drug Expenditure: Prescribed and Non-Prescribed Drugs ..................................................... 8
Prescribed Drug Expenditure by Source of Finance ............................................................. 10
Drug Expenditure in the Provinces and Territories ..................................................................... 17
The Share of Drugs in Total Health Expenditure .................................................................. 18
Total Drug Expenditure by Source of Finance ...................................................................... 20
Total Drug Expenditure per Capita by Source of Finance..................................................... 21
Drug Expenditure by Type of Drug and by Source of Finance.............................................. 22
International Comparisons .......................................................................................................... 29
Comparability of Health Expenditure Across Countries ........................................................ 29
Share of Drugs in Total Health Expenditure.......................................................................... 29
Share of Public Expenditure in Total Expenditure on Drugs ................................................. 32
Share of Drugs in Public Expenditure on Health ................................................................... 33
Factors Affecting Drug Expenditure in Canada ........................................................................... 35
Methodological Notes ................................................................................................................. 39
Background ........................................................................................................................... 39
Data Limitations .................................................................................................................... 43
Collection and Non-Response .............................................................................................. 45
Sources of Data .................................................................................................................... 52
Series A—Expenditure on Drugs by Type, by Source of Finance and as a Share of
Public, Private and Total Health Expenditure, Canada, 1985 to 2011 ........................................ 55
Series B—Expenditure on Drugs by Type, by Source of Finance and as a Share of
Public, Private and Total Health Expenditure, by Province/Territory, 1985 to 2011 ................... 61
Series C—International Comparisons ....................................................................................... 115
Appendix A—Comparison of Provincial and Territorial Drug Subsidy Programs ...................... 121
References................................................................................................................................ 143
Drug Expenditure in Canada, 1985 to 2011
List of Figures
ii
Figure 1
Total Drug Expenditure as a Percentage of Total Health Expenditure,
Canada, 1985 to 2011 ............................................................................................... 3
Figure 2
Annual Growth Rate for Total Drug Expenditure and Total Health
Expenditure, Canada, 1985 to 2011 .......................................................................... 4
Figure 3
Total Health Expenditure, by Use of Funds, Canada, 2011....................................... 5
Figure 4
Total Drug Expenditure, Canada, 1985 to 2011 ........................................................ 6
Figure 5
Total Drug Expenditure per Capita, Current and Constant Dollars, Canada,
1985 to 2011 .............................................................................................................. 7
Figure 6
Total Drug Expenditure, by Type (Prescribed and Non-Prescribed), Canada,
1985 to 2011 .............................................................................................................. 9
Figure 7
Total Drug Expenditure, by Source of Finance and Type of Expenditure,
Canada, 2011 .......................................................................................................... 10
Figure 8
Prescribed Drug Expenditure, by Source of Finance, Canada, 1985 to 2011 ......... 11
Figure 9
Annual Growth Rate for Prescribed Drug Expenditure, by Source of Finance,
Canada, 1985 to 2011 ............................................................................................. 12
Figure 10
Prescribed Drug Expenditure, by Private-Sector Source of Finance, Canada,
1988 to 2011 ............................................................................................................ 14
Figure 11
Drug Expenditure as a Percentage of Total Health Expenditure, by Province/
Territory and Canada, 1985 and 2011 ..................................................................... 19
Figure 12
Percentage of Total Drug Expenditure by Source of Finance, by Province/
Territory and Canada, 2011 ..................................................................................... 20
Figure 13
Total Drug Expenditure per Capita, by Type and by Source of Finance,
by Province/Territory and Canada, 2011 ................................................................. 21
Figure 14
Annual Growth Rate for Public- and Private-Sector Prescribed and
Non-Prescribed Drug Expenditure per Capita, by Province/Territory
and Canada, 2011 ................................................................................................... 23
Figure 15
Average Annual Growth Rate for Prescribed Drug Expenditure per Capita,
by Source of Finance, by Province/Territory and Canada, Between
1985 and 2011 ......................................................................................................... 24
Figure 16
Public-Sector Prescribed Drug Expenditure as a Percentage of Total
Prescribed Drug Expenditure, by Province/Territory, 1985 to 2011......................... 25
Figure 17
Drug Expenditure per Capita, Selected OECD Comparator Countries,
1985 to 2009 ............................................................................................................ 31
Figure 18
Composition of Total Health Expenditure, by Source of Finance ............................ 40
Figure 19
Patented Medicine Price Index (PMPI), Consumer Price Index (CPI) and
Industrial Product Price Index (IPPI), 1985 to 2011 (1987 = 100) ........................... 45
Drug Expenditure in Canada, 1985 to 2011
List of Tables
Table 1
Distribution of Prescribed Drug Expenditure, by Source of Finance, Canada,
1988 and 2011 .......................................................................................................... 13
Table 2
Drug Expenditure Summary, by Province/Territory and Canada, 2011 .................... 17
Table 3
Total Expenditure on Pharmaceutical Goods per Capita and as a Percentage
of Total Health Expenditure, Selected OECD Comparator Countries, 2009 ............. 30
Table 4
Public Expenditure on Pharmaceutical Goods per Capita and as a Percentage
of Total Expenditure on Pharmaceutical Goods, Selected OECD Comparator
Countries, 2009 ......................................................................................................... 33
Table 5
Public Expenditure on Pharmaceutical Goods per Capita and as a
Percentage of Public-Sector Health Expenditure, Selected OECD
Comparator Countries, 2009 ..................................................................................... 34
Table 6
Provincial/Territorial Government Drug Expenditure Data ........................................ 46
Table 7
Comparison of Provincial and Territorial Drug Subsidy Programs as
of December 2011 ................................................................................................... 122
iii
Drug Expenditure in Canada, 1985 to 2011
Executive Summary
Total expenditure on drugsi in Canada was $29.6 billionii in 2009, and is forecast to have reached
$32.0 billion in 2011. Between 1985 and 2009, the share of drugs in total health expenditure
increased from 9.5% to 16.2%. It is forecast to have slightly decreased to 16.0% in 2011.
Since 1997, among major categories of health expenditure, drugs have accounted for
the second-largest share, after hospitals.1
At the national level, 2010 and 2011 forecast data indicates that
• The share of drugs in total health expenditure is forecast to have stabilized in 2010 and 2011
at 16.0%.
• Total drug expenditure is forecast to have reached $30.8 billion in 2010 and $32.0 billion in 2011,
representing annual increases of 4.2% and 4.0%, respectively.
• Total drug expenditure per capita in Canada is expected to have reached $903 in 2010 and
$929 in 2011, representing annual rates of increase of 3.0% and 2.8%, respectively.
• The share of prescribed drugs in total drug expenditure is forecast to have reached 84.3% in
2010 and 84.8% in 2011.
• Expenditure on prescribed drugs is expected to have reached $26.0 billion in 2010 and
$27.2 billion in 2011, representing growth rates of 4.7% in both years.
• Expenditure on non-prescribed drugs is forecast to have reached $4.8 billion in 2010 and
$4.9 billion in 2011, representing increases of 1.7% and 0.5%, respectively.
• Public-sector expenditure on prescribed drugs is forecast to have reached $11.8 billion
in 2010 and $12.1 billion in 2011, representing annual growth rates of 2.4% and 2.2%,
respectively. Private-sector expenditure on prescribed drugs is forecast to have reached
$14.2 billion in 2010 and $15.1 billion in 2011, with corresponding annual growth rates of
6.6% and 6.8%.
i.
ii.
Drug expenditure data in this report is obtained from the National Health Expenditure Database (NHEX) and is composed of
estimates that represent the final costs to Canadian consumers, including dispensing fees, markups and appropriate taxes.
Total drug expenditure, in this report, includes expenditure on prescribed drugs and non-prescribed drugs (over-the-counter
drugs and personal health supplies). For more information on over-the-counter drugs and personal health supplies, see the
General Methods section of the Methodological Notes.
All figures are in current dollars (unadjusted for inflation) unless otherwise stated.
v
Drug Expenditure in Canada, 1985 to 2011
At the provincial level, 2011 forecast data indicates that
• Total drug expenditure per capita is forecast to have ranged from $702 in British Columbia
and $849 in Manitoba to $1,116 in New Brunswick and $1,139 in Nova Scotia.
• The share of prescribed drug spending in total drug expenditure is forecast to have ranged
from 82.0% in British Columbia and 83.0% in Alberta to 88.2% in Quebec and 89.1% in
Newfoundland and Labrador.
• The proportion of prescribed drugs financed by the public sector in 2011 varied across
the provinces and is forecast to have ranged from 29.7% in New Brunswick and 34.2%
in Prince Edward Island to 48.3% in Alberta and 49.0% in Saskatchewan.
At the international level in 2009, the most recent year for which data was available, among
eight Organisation for Economic Co-operation and Development (OECD) comparator countriesiii
• Canada had the second-highest level of total drug expenditure per capita, after
the United States.
• The public sector funded 38.8% of total drug expenditure in Canada. This was
the second-lowest share, ahead of the United States (31.1%). The share of public drug
expenditure in total drug expenditure was highest in the United Kingdom, at 84.7%.iv
• Public drug expenditure accounted for 9.4% of public-sector health expenditure in Canada.
This proportion places Canada ahead of the United States (7.8%) and New Zealand (7.5 %).
The share of public drug expenditure in public-sector health expenditure was highest in
Japan, at 17.3%.
Factors affecting drug expenditure:
• Numerous factors, many of which are interrelated, may influence drug expenditure. Since
drug prices, as measured by several price indices, have been relatively stable over the past
10 years, factors affecting increased drug spending in Canada essentially relate to the volume
of drug use and the entry of new drugs (typically introduced to the market at higher prices).
iii. Comparator countries are Australia, Canada, France, Germany, Japan, New Zealand, the United Kingdom and the
United States.
iv. 2008 data has been used for the United Kingdom due to unavailability of current data.
vi
Drug Expenditure in Canada, 1985 to 2011
Introduction
Pharmaceutical drugs play an essential role in modern medicine. Through the treatment of
various diseases, they have become an increasingly significant component of the Canadian
health care system.
Drug expenditure data in this report is primarily obtained from the National Health Expenditure
Database (NHEX) maintained by the Canadian Institute for Health Information (CIHI). This
database contains a historical series of macro-level health expenditure statistics by province
and territory, beginning in 1975. Drug expenditure data in NHEX is macro-level data and does
not allow for decomposition of prescription costs or drug classes.
The Drugs category in NHEX is intended to measure final consumption, outside an institutional
setting, of drugs purchased by consumers or third-party payers on their behalf, generally from
retail outlets. Drug expenditure data in NHEX consists of estimates that represent the final costs
to Canadian consumers, including dispensing fees, markups and appropriate taxes. NHEX data
does not include drug expenditure by non-Canadian residents. This classification system used
in NHEX is consistent with international standards developed by the Organisation for Economic
Co-operation and Development (OECD).
Drug expenditure estimates within NHEX provide insight into total drug expenditurev by public
and private payers and by type of drugs (prescribed and non-prescribed) at the provincial/
territorial and national levels. All drug expenditure estimates stated in this report are in current
dollars (unadjusted for inflation) unless otherwise stated.
Drug Expenditure in Canada, 1985 to 2011 is an annual publication and provides updated
information on drug expenditure trends in Canada. This publication includes
• National drug expenditure;
• Provincial and territorial drug expenditure;
• International comparisons; and
• Factors that may affect drug expenditure.
For more information on drug expenditure and the methods used in the preparation of this
document, contact the Pharmaceuticals department at CIHI by phone at 613-241-7860 or by
email at [email protected]
v.
Total drug expenditure in this report includes expenditure on prescribed drugs and non-prescribed drugs. Non-prescribed drugs
consist of over-the-counter drugs (such as cold remedies, cough remedies and headache remedies) and personal health
supplies (such as antiperspirants, dental floss and disposable diabetic syringes). For more information on over-the-counter
drugs and personal health supplies, see the General Methods section of the Methodological Notes.
1
Drug Expenditure in Canada, 1985 to 2011
National Drug Expenditure Overview
The Share of Drugs in Total Health Expenditure
Outlook—2010 and 2011
The share of drugs in total health expenditure is forecast to be 16.0% in both 2010 and
2011 (Figure 1).
Figure 1: Total Drug Expenditure as a Percentage of Total Health Expenditure,
Canada, 1985 to 2011
Source
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
3
Drug Expenditure in Canada, 1985 to 2011
Highlights—2009
Drugs have been one of the fastest growing components of total health expenditure in Canada.
From 1985 to 2009, total health spending grew at an average annual rate of 6.5%. During this
period, total drug expenditure increased at an average annual rate of 8.9%. In every year prior
to 2005, the annual rate of growth for drugs exceeded the rate for total health expenditure
(Figure 2). Drug spending grew particularly rapidly during the 1990s, when many blockbuster
drug classes were established and/or expanded in terms of use and cost. From 2005 to 2009,
the annual rate of growth for drugs was slightly less than the rate for total health expenditure
every year, with the exception of 2006 and 2009. The growth in drug spending during this time
period slowed to an average rate of 6.3% per year.
Figure 2: Annual Growth Rate for Total Drug Expenditure and Total Health
Expenditure, Canada, 1985 to 2011
Source
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
4
Drug Expenditure in Canada, 1985 to 2011
Figure 3: Total Health Expenditure, by Use of Funds, Canada, 2011f
Notes
f: forecast.
$ billions; percentage share of total health expenditure.
Source
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
NHEX provides an overview of all health spending in Canada by spending category and source
of funding. Total health expenditure comprises nine major spending categories. Since 1997,
among major categories of health expenditure, drugs have accounted for the second-largest
share, after hospitals (Figure 3).
Between 1985 and 2009, total drug expenditure grew at an average annual rate of 8.9%, while
total hospital expenditure and total physician expenditure grew at average annual rates of 5.0%
and 6.1%, respectively.
Total drug expenditure grew faster than total hospital expenditure every year between 1985 and
2006.1 From 2007 until 2009, total hospital expenditure had a higher rate of growth than total
drug expenditure.
Total drug expenditure grew at a higher rate than total physician expenditure every year
between 1985 and 2006, with the exception of 2005.1 From 2007 until 2009, total physician
expenditure had a higher rate of growth than total drug expenditure.
See the data tables in Series A for more data on national drug expenditure from 1985 to 2011.
5
Drug Expenditure in Canada, 1985 to 2011
Total Drug Expenditure
Outlook—2010 and 2011
Total drug expenditure is forecast to have reached $30.8 billionvi in 2010 and
$32.0 billion in 2011, representing annual increases of 4.2% and 4.0%, respectively.
Figure 4: Total Drug Expenditure, Canada, 1985 to 2011
Source
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Highlights—2009
Canada’s total drug expenditure increased steadily from $3.8 billion in 1985 to $29.6 billion in
2009 (Figure 4). The average annual rate of growth during this period was 8.9%.
See the data tables in Series A for more data on national drug expenditure from 1985 to 2011.
vi. All figures are in current dollars (unadjusted for inflation) unless otherwise stated.
6
Drug Expenditure in Canada, 1985 to 2011
Total Drug Expenditure per Capita
Outlook—2010 and 2011
Total drug expenditure per capita in Canada is expected to have reached $903 in 2010 and
$929 in 2011, representing annual rates of increase of 3.0% and 2.8%, respectively.
Figure 5: Total Drug Expenditure per Capita, Current and Constant* Dollars,
Canada, 1985 to 2011
Note
* Figures are deflated using the Consumer Price Index to reflect 1985 dollars.
Sources
National Health Expenditure Database, 2011, Canadian Institute for Health Information; Consumer Price Index, Statistics Canada.
Highlights—2009
Per capita drug expenditure trends are similar to those of total drug spending. Total drug
expenditure increased from $147 per capita in 1985 to $877 in 2009 (Figure 5). The average
annual growth rate during this period was 7.7%.
7
Drug Expenditure in Canada, 1985 to 2011
Typically, expenditure is deflated by a price index to measure change in quantity. There is no
authoritative composite price index for all drugs sold in Canada.vii However, measuring drug
expenditure in constant dollars (adjusted for inflation) using the CPIviii reported by Statistics
Canada gives a sense of change in drug expenditure in the context of economy-wide inflation.
Readers should cautiously interpret inflation-adjusted trends in expenditure, since drug-specific
inflation may differ from that depending upon the broad basket of goods and services purchased
by Canadians.
In terms of constant (1985) dollars, per capita drug expenditure increased from $147 in 1985
to $483 in 2009, reflecting an average annual growth rate of 5.1%. Trends in per capita drug
expenditure measured in constant dollars are similar to those of per capita drug expenditure
measured in current dollars, though growth between 1985 and 2009 is less pronounced when
it is considered relative to economy-wide inflation (Figure 5).
See the data tables in Series A for more data on national drug expenditure from 1985 to 2011.
Drug Expenditure: Prescribed and Non-Prescribed Drugs
Outlook—2010 and 2011
Expenditure on prescribed drugsix is expected to have reached $26.0 billion in 2010 and $27.2
billion in 2011, representing growth rates of 4.7% in both years. Expenditure on non-prescribed
drugs is forecast to have reached $4.8 billion in 2010 and $4.9 billion in 2011, representing
increases of 1.7% and 0.5%, respectively.
Non-prescribed drugs, which are typically financed by consumers (households), include over-thecounter drugs (such as cold remedies, cough remedies and headache remedies) and personal
health supplies (such as antiperspirants, dental floss and disposable diabetic syringes).x Since
NHEX consists of macro-level health expenditure data, some over-the-counter drugs and
personal health supplies that are covered under some drug benefit plans may be counted as
prescribed drug expenditures.xi
Prescribed drugs are expected to have accounted for 84.3% of total drug expenditure in
Canada in 2010 and 84.8% in 2011. Conversely, the share of non-prescribed drugs in total
drug expenditure is expected to have accounted for 15.7% in 2010 and 15.2% in 2011.
vii. For more information on drug prices, see the Data Limitations section of the Methodological Notes.
viii. A measure of the average percentage change over time in the cost of a fixed basket of goods and services purchased by
Canadian consumers.
ix. A prescribed drug is a substance considered to be a drug under the Food and Drugs Act, which is sold for human use as the
result of a prescription from a health professional.
x. For more information on over-the-counter drugs and personal health supplies, see the General Methods section of the
Methodological Notes.
xi. For example, diabetic test strips, where covered under drug benefit plans, may be included in prescribed drug expenditure,
subject to source of data.
8
Drug Expenditure in Canada, 1985 to 2011
Figure 6: Total Drug Expenditure, by Type (Prescribed and Non-Prescribed),
Canada, 1985 to 2011
Notes
f: forecast.
Prescribed drug expenditure is based on drugs sold as the result of a prescription from a health professional.
This expenditure can be financed by either the public or the private sector.
Non-prescribed drug expenditure includes spending on over-the-counter drugs and personal health supplies.
This expenditure is financed by the private sector, typically out-of-pocket by consumers (households).
For detailed definitions, please refer to the Methodological Notes.
Source
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Highlights—2009
From 1985 to 2009, expenditure on prescribed drugs grew from $2.6 billion to $24.8 billion, at
an average annual rate of 9.9%. Spending on non-prescribed drugs increased from $1.2 billion
to $4.8 billion, at an average of 5.8% per year (Figure 6). During this period, with the exception
of 1987 and 1994, annual growth in drug spending was higher in prescribed drugs than in
non-prescribed drugs. As a result, prescribed drugs captured a larger share of total drug
spending, rising from 67.5% in 1985 to 83.9% in 2009.
Non-prescribed drug expenditure represented 16.1% of total drug expenditure in 2009.
Over-the-counter drugs accounted for $2.7 billion, or 9.1% of total drug expenditure,
and personal health supplies accounted for $2.1 billion, or 6.9%.
See the data tables in Series A for more data on national drug expenditure from 1985 to 2011.
9
Drug Expenditure in Canada, 1985 to 2011
Prescribed Drug Expenditure by Source of Finance
While non-prescribed drugs are typically financed out-of-pocket by consumers (households),
multiple payers are involved in the financing of prescribed drugs. In the public sector, these payers
include provincial/territorial and federal drug subsidy programs and social security funds (such
as workers’ compensation boards, or WCBs). In the private sector, they include private insurers
and households.
In 2011, $12.1 billion in prescribed drugs are expected to have been financed by the public
sector, while expenditure by the private sector is for both prescribed drugs ($15.1 billion) and
non-prescribed drugs ($4.9 billion). In the private sector, prescribed drugs financed by private
insurers are expected to have been $10.2 billion, with the remainder financed by Canadian
households ($4.9 billion). Non-prescribed drugs are composed of over-the-counter drugs
($2.7 billion) and personal health supplies ($2.1 billion) (Figure 7).
Figure 7: Total Drug Expenditure, by Source of Finance and Type of Expenditure,
Canada, 2011f
Notes
f: forecast.
$ billions; percentage share of total drug expenditure.
Prescribed drug expenditure is based on drugs sold as the result of a prescription from a health professional.
Non-prescribed drugs include over-the-counter drugs and personal health supplies.
For detailed definitions, please refer to the Methodological Notes.
Source
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
10
Drug Expenditure in Canada, 1985 to 2011
Outlook—2010 and 2011
Public-sector expenditure on prescribed drugs is forecast to have reached $11.8 billion in
2010 and $12.1 billion in 2011 (Figure 8), representing annual growth rates of 2.4% and 2.2%,
respectively. Private-sector expenditure on prescribed drugs is forecast to have reached $14.2
billion in 2010 and $15.1 billion in 2011, with corresponding annual growth rates of 6.6% and 6.8%.
The share of prescribed drug expenditure financed by the public sector is forecast to be 45.5%
in 2010 and 44.4% in 2011.
Figure 8: Prescribed Drug Expenditure, by Source of Finance, Canada,
1985 to 2011
Notes
Prescribed drug expenditure is based on drugs sold as the result of a prescription from a health professional.
This expenditure can be financed by either the public or the private sector.
For detailed definitions, please refer to the Methodological Notes.
Source
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
11
Drug Expenditure in Canada, 1985 to 2011
Highlights—2009
The intersections of the two series depicted in Figure 9 (excluding forecasts for 2010 and 2011)
identify four distinct periods of growth in publicly and privately financed prescribed drug expenditure.
Figure 9: Annual Growth Rate for Prescribed Drug Expenditure, by Source of
Finance, Canada, 1985 to 2011
Notes
Prescribed drug expenditure is based on drugs sold as the result of a prescription from a health professional.
This expenditure can be financed by either the public or the private sector.
For detailed definitions, please refer to the Methodological Notes.
Source
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Between 1985 and 1992, expenditure on prescribed drugs in the public sector grew by an average
annual rate of 14.6%, while this rate was 12.0% for prescribed drug expenditure financed by the
private sector. Consequently, the share of prescribed drugs financed from public sources increased
from 43.6% in 1985 to 47.7% in 1992.
From 1992 to 1997, spending on prescribed drugs by the private sector grew at an average
annual rate of 9.1%, more than twice the 4.3% average annual rate of growth in publicly
financed prescribed drug expenditure. Fiscal restraint introduced in several provinces led
to negative growth in publicly financed prescribed drug expenditure in 1996. By 1997, the share
of prescribed drugs financed from public sources had declined to 42.2%, below its share in
1985 (43.6%).
Between 1997 and 2005, expenditure on prescribed drugs by the public sector grew at an average
annual rate of 12.0%, compared with 9.5% in the private sector. The share of prescribed drug
expenditure financed by the public sector reached 46.6% in 2005.
12
Drug Expenditure in Canada, 1985 to 2011
From 2006 to 2009, the public and private sectors changed places each year in terms of leading
the annual growth rate for prescribed drug expenditure. The annual growth rate was higher in the
private sector in 2006 and 2008, while it was higher in the public sector in 2007 and 2009. As a
result, the share of prescribed drug expenditure financed by the public sector remained relatively
stable, at 46.5%, in 2009 compared with its share in 2005 (46.6%).
See the data tables in Series A for more data on national drug expenditure from 1985 to 2011.
Two levels of government—provincial/territorial and federal—as well as social security funds,
such as workers’ compensation boards (WCBs) and the premium component of the Fonds de
l’assurance médicaments (Drug Insurance Fund) in Quebec,xii finance spending on prescribed
drugs by the public sector. Private-sector expenditure on prescribed drugs is financed by two
sources: private insurers and households (out-of-pocket). Table 1 shows the distribution of
prescribed drug expenditure by these sources of finance.
Expenditure by private insurers and out-of-pocket spending by households were available
separately for the first time in 1988.
Table 1: Distribution of Prescribed Drug Expenditure, by Source of Finance, Canada,
1988 and 2011f
2011f
1988
Provincial/Territorial Governments
Federal Direct
Social Security Funds:
Workers’ Compensation Boards
Quebec Drug Insurance Fund*
(Premium Component)
Subtotal Public Sources
Private Insurers
Households (Out-of-Pocket)
Subtotal Private Sources
Total All Sources
$ Millions
1,592.7
89.3
Percentage
42.6
2.4
$ Millions
10,391.5
664.6
Percentage
38.2
2.5
20.8
N/A
0.6
N/A
212.9
793.5
0.8
2.9
1,702.8
1,130.3
903.7
2,034.0
3,736.8
45.6
30.2
24.2
54.4
100.0
12,062.5
10,244.9
4,874.2
15,119.1
27,181.6
44.4
37.7
17.9
55.6
100.0
Notes
* Data not available prior to January 1, 1997, when the program was first introduced in Quebec.
f: forecast.
Source
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
xii.
Since July 1, 2002, the public plan has been financed both by the expenditure allocated to this program by the Quebec
government (provincial government sector) and by the amounts collected by the Drug Insurance Fund as premiums and
proceeds (social security funds sector). The premium component of the Quebec Drug Insurance Fund is considered to be
a social security scheme, while the remaining portion of the program that is paid through the ministère de la Santé et des
Services sociaux is included as a provincial government expenditure. For more information, see the General Methods section
of the Methodological Notes.
13
Drug Expenditure in Canada, 1985 to 2011
Provincial/territorial government expenditure on prescribed drugs was almost $1.6 billion in
1988, accounting for 42.6% of total expenditure on prescribed drugs. By 2011, provincial/
territorial government expenditure is forecast to have grown to $10.4 billion, while its share of
total expenditure on prescribed drugs is expected to have diminished to 38.2%. All provinces/
territories provide some form of prescribed drug coverage to seniors and social assistance
recipients (see Appendix A for an overview of provincial and territorial drug subsidy programs).
Federal direct expenditure was $89.3 million in 1988, equivalent to 2.4% of total expenditure on
prescribed drugs. Federal direct expenditure is forecast to have increased to $664.6 million in
2011, representing 2.5% of total expenditure on prescribed drugs. The federal government
provides drug benefits to Aboriginal Canadians, veterans, members of the military and the
RCMP, prisoners in federal correctional facilities and refugees.
Figure 10: Prescribed Drug Expenditure, by Private-Sector Source of Finance,
Canada, 1988* to 2011
Note
* Expenditure by private insurers and out-of-pocket spending by households were available separately for the first time in 1988.
Source
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
14
Drug Expenditure in Canada, 1985 to 2011
Expenditure by social security funds was $20.8 million in 1988, equivalent to 0.6% of total
prescribed drug expenditure. In 2011, expenditure by social security funds is forecast to have
reached $1.0 billion and to have accounted for 3.7% of total expenditure on prescribed drugs.
Social security funds’ figures have largely represented spending by the premium component of
the Quebec Drug Insurance Fund since its institution in 1997. Seniors (65 and older) and other
residents (those who do not receive social assistance benefits and are not covered by private
group insurance) are required to pay a premium. The amount of the premium varies according
to net family income.
Expenditure on prescribed drugs by private insurers amounted to more than $1.1 billion in 1988,
or 30.2% of prescribed drug expenditure. Private insurers’ spending increased to $10.2 billion
in 2011, and their share of prescribed drug expenditure increased to 37.7%. Private insurers
include group and individual insurance. Many employers offer group benefit plans covering
prescribed drugs for employees and their families. In some cases, individuals will continue
to be covered by a group plan even after they retire.
Out-of-pocket spending by households was an estimated $0.9 billion in 1988, representing
24.2% of total expenditure on prescribed drugs. By 2011, out-of-pocket prescribed drug
expenditure is estimated to have risen to $4.9 billion, while its share of prescribed drug
expenditure will have decreased to 17.9% (Figure 10).
See the data tables in Series A for more data on national drug expenditure from 1985 to 2011.
15
Drug Expenditure in Canada, 1985 to 2011
Drug Expenditure in the Provinces
and Territories
There is considerable variation in the level and growth of drug expenditure across the provinces
and territories. These variations are influenced by several factors, including differences in
provincial/territorial drug subsidy programs (see Appendix A for an overview of provincial and
territorial drug subsidy programs), the extent of private insurance coverage, age and sex distribution
of provincial/territorial populations, the health needs of targeted populations and the manner in
which health care is delivered (including the balance between institutional and ambulatory care).2
Other possible sources of variation in drug expenditure are described in the section Factors
Affecting Drug Expenditure in Canada.
Table 2 provides an overview of provincial/territorial drug expenditure forecast for 2011.
Table 2: Drug Expenditure Summary, by Province/Territory and Canada, 2011f
Total Drug Expenditure
per Capita
Prescribed Drug Expenditure
per Capita
Public Prescribed Drug
Expenditure per Capita
Percentage
Percentage
Percentage of
Percentage
of Total
Percentage of Total Drug
Percentage Prescribed
Amount
Change
Health Exp. Amount
Change
Exp. per
Amount
Change
Drug Exp.
(Dollars) Over 2010 per Capita (Dollars) Over 2010
Capita
(Dollars) Over 2010
per Capita
N.L.
1,032.66
8.2
15.0
920.35
9.4
89.1
319.74
9.0
34.7
950.11
3.1
15.5
790.73
4.5
83.2
270.14
0.2
34.2
N.S.
1,138.91
5.6
18.1
984.67
6.4
86.5
372.86
1.6
37.9
N.B.
1,116.34
4.7
17.6
936.92
5.1
83.9
278.70
-2.7
29.7
Que.
1,034.04
3.7
19.7
912.46
4.6
88.2
414.18
-2.1
45.4
Ont.
939.46
1.5
16.2
785.00
2.0
83.6
353.37
1.7
45.0
Man.
849.46
2.8
13.1
710.37
3.4
83.6
319.17
1.9
44.9
Sask.
929.60
6.3
14.5
799.35
7.4
86.0
391.37
1.2
49.0
Alta.
873.00
4.6
13.3
724.86
5.9
83.0
350.42
5.8
48.3
B.C.
701.83
1.4
12.9
575.49
1.4
82.0
236.89
2.2
41.2
Y.T.
809.34
2.8
9.0
677.45
4.7
83.7
417.66
2.3
61.7
N.W.T.
702.58
0.9
6.9
587.12
1.0
83.6
376.72
0.1
64.2
Nun.
672.19
2.8
5.6
572.50
5.8
85.2
335.48
0.2
58.6
Canada
928.75
2.8
16.0
787.82
3.5
84.8
349.62
1.0
44.4
P.E.I.
Notes
f: forecast.
Total drug expenditure consists of prescribed drugs and non-prescribed products purchased outside an institutional setting.
Prescribed drug expenditure is based on drugs sold as the result of a prescription from a health professional. This expenditure can
be financed by either the public or the private sector.
Public prescribed drug expenditure is the amount of prescribed drug expenditure financed by provincial, territorial and federal
governments, as well as spending from social security funds.
For detailed definitions please refer to the Methodological Notes.
Sources
National Health Expenditure Database, 2011, Canadian Institute for Health Information; Population, Statistics Canada.
17
Drug Expenditure in Canada, 1985 to 2011
In 2011, per capita expenditure on drugs is forecast to have accounted for 16.0% of total per
capita health expenditure in Canada. Among the provinces, the share of drugs in total health
expenditure per capita is expected to have ranged from 12.9% in British Columbia and 13.1%
in Manitoba to 18.1% in Nova Scotia and 19.7% in Quebec. The three territories were expected
to have lower shares than all the provinces, ranging from 5.6% in Nunavut to 9.0% in Yukon.
Total drug expenditure per capita in Canada is expected to have been $929 in 2011. Per
capita spending on drugs in the provinces is forecast to have ranged from $702 and $849 in
British Columbia and Manitoba, respectively, to $1,116 and $1,139 in New Brunswick and
Nova Scotia, respectively. Per capita spending on drugs in the territories is forecast to have
ranged from $672 in Nunavut to $809 in Yukon.
Prescribed drug expenditure per capita is forecast to have accounted for 84.8% of total per
capita expenditure on drugs in Canada in 2011. Among the provinces and territories, the share
of prescribed drugs in total drug expenditure is forecast to have ranged from 82.0% in British
Columbia and 83.0% in Alberta to 88.2% in Quebec and 89.1% in Newfoundland and Labrador.
In 2011, the proportion of prescribed drugs in Canada financed by the public sector is expected
to have been 44.4%. Among the provinces, it is forecast that the proportion will have been
highest in Saskatchewan and Alberta, at 49.0% and 48.3%, respectively, and the lowest in
Prince Edward Island and New Brunswick, at 34.2% and 29.7%, respectively. The proportion is
forecast to have been higher in the territories than in the provinces, ranging from 64.2% in the
Northwest Territories to 58.6% in Nunavut.
The Share of Drugs in Total Health Expenditure
The share of drugs in total health expenditure is forecast to have been higher in 2011 than in
1985 in all provinces and territories except Prince Edward Island, Newfoundland and Labrador
and the Northwest Territories and Nunavut (Figure 11). It should be noted that in Newfoundland
and Labrador between 1986 and 2011, the share of drug expenditure in total health expenditure
is expected to have grown.
In 1985, expenditure on drugs accounted for 9.5% of total health expenditure in Canada.
Newfoundland and Labrador, Prince Edward Island, Nova Scotia, New Brunswick and Ontario
exceeded the national average. Prince Edward Island had the highest share, at 18.0%, followed
by Newfoundland and Labrador, at 16.3%, while among the provinces with a lower share than
the national average, shares ranged from 8.0% in Alberta to 9.3% in Manitoba. The territories
also had a lower share than the national average (8.0% in Yukon and 7.1% in the Northwest
Territories and Nunavut).
18
Drug Expenditure in Canada, 1985 to 2011
Figure 11: Drug Expenditure as a Percentage of Total Health Expenditure,
by Province/Territory and Canada, 1985 and 2011f
Notes
* On April 1, 1999, Nunavut was formed from the eastern part of the Northwest Territories.
f: forecast.
Source
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
In 2011, Nova Scotia, New Brunswick, Quebec and Ontario are forecast to have had
drug expenditure as a percentage of total health expenditure above the Canadian average
(16.0%), with Quebec (19.7%) and Nova Scotia (18.1%) having the highest shares.
Newfoundland and Labrador, Prince Edward Island, Manitoba, Saskatchewan, Alberta and
British Columbia are expected to have been below the Canadian average, with British Columbia
(12.9%) and Manitoba (13.1%) having the lowest shares among the provinces. Yukon and the
combined territories of the Northwest Territories and Nunavut are forecast to have had lower
shares than the provinces, at 9.0% and 6.3%, respectively.
See the data tables in Series B for more data on drug expenditure by province/territory from
1985 to 2011.
19
Drug Expenditure in Canada, 1985 to 2011
Total Drug Expenditure by Source of Finance
In 2011, among the provinces, Quebec (40.1%), Saskatchewan (42.1%) and Alberta (40.1%) are
forecast to have had public shares of total drug expenditure that exceeded the national average
(37.6%). The three territories also are forecast to have had public shares of total drug expenditure
that exceeded the national average, ranging from 53.6% in the Northwest Territories to 49.9% in
Nunavut. Among the provinces with shares below the national average, the share of total drug
expenditure funded by the public sector is expected to have ranged from 37.6% in Ontario to
25.0% in New Brunswick (Figure 12).
Figure 12: Percentage of Total Drug Expenditure by Source of Finance,
by Province/Territory and Canada, 2011f
Note
f: forecast.
Source
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
20
Drug Expenditure in Canada, 1985 to 2011
Total Drug Expenditure per Capita by Source of Finance
In 2011, total drug expenditure per capita in Canada is forecast to have been $929. Per capita
prescribed drug spending financed by the public and private sectors is forecast to have
amounted to $350 and $438, respectively (Figure 13).
Figure 13: Total Drug Expenditure per Capita, by Type and by Source of Finance,
by Province/Territory and Canada, 2011f
Canada
$418
$260
$132
$377
$210
$115
Y.T.
$335
$237
$100
N.W.T.
N.L.
$320
$601
$112
Nun.
$237
$339
$126
B.C.
$350
$374
$148
$391
$408
$130
Alta.
Sask.
Public Rx
Private Rx
Private Non-Rx
$319
$391
$139
Man.
$350
$438
$141
Ont.
$353
$432
$154
$414
$498
$122
P.E.I.
$270
$521
$159
Que.
N.S.
N.B.
$279
$658
$179
$373
$612
$154
Notes
f: forecast.
Prescribed drug expenditure (Rx) is based on drugs sold as the result of a prescription from a health professional.
This expenditure can be financed by either the public or the private sector.
Non-prescribed drug expenditure (Non-Rx) includes spending on over-the-counter drugs and personal health supplies.
This expenditure is financed by the private sector, typically out-of-pocket by consumers (households).
For detailed definitions, please refer to the Methodological Notes.
Sources
National Health Expenditure Database, 2011, Canadian Institute for Health Information; Population, Statistics Canada.
21
Drug Expenditure in Canada, 1985 to 2011
In 2011, among the provinces, per capita spending on drugs by the public sector is forecast
to have ranged from $237 in British Columbia and $270 in Prince Edward Island to $391 in
Saskatchewan and $414 in Quebec. In the territories, per capita spending on drugs by the public
sector is forecast to have ranged from $335 in Nunavut to $418 in Yukon. Along with Quebec,
Saskatchewan and Yukon, it is expected that Nova Scotia ($373), Ontario ($353), Alberta ($350)
and the Northwest Territories ($377) will also have had publicly financed drug expenditure per
capita above the Canadian average ($350).
Among the provinces, prescribed drug expenditure per capita financed by the private sector
is expected to have ranged from $339 in British Columbia and $374 in Alberta to $612 in
Nova Scotia and $658 in New Brunswick. In addition to New Brunswick and Nova Scotia,
Newfoundland and Labrador ($601), Prince Edward Island ($521) and Quebec ($498) are
also forecast to have had privately financed prescribed drug expenditure per capita higher than
the Canadian average ($438). In the three territories, prescribed drug expenditure per capita
financed by the private sector is forecast to have been below the average of all the provinces,
ranging from $210 in the Northwest Territories to $260 in Yukon.
It should be noted that public spending per capita may or may not accurately reflect the amount
spent per person eligible for coverage because the proportion of the population eligible for
coverage by the public sector varies significantly across provinces and territories.
See the data tables in Series B for more data on drug expenditure by province/territory from
1985 to 2011.
Drug Expenditure by Type of Drug and by Source of Finance
Public- and Private-Sector Prescribed and Non-Prescribed
Drugxiii Expenditure
In 2011, in all provinces and territories except British Columbia, the annual growth rate for
prescribed drug spending per capita is forecast to have been higher in the private sector than
in the public sector (Figure 14).
Among the provinces, the annual growth rate for prescribed drug spending per capita in the
private sector ranged from 0.9% in British Columbia and 2.2% in Ontario to 10.9% in Quebec
and 14.1% in Saskatchewan. Among the territories, this same rate ranged from 2.8% in the
Northwest Territories to 14.9% in Nunavut. The annual growth rate for prescribed drug spending
per capita in the public sector ranged from -2.7% in New Brunswick and -2.1% in Quebec to
5.8% in Alberta and 9.0% in Newfoundland and Labrador.
xiii. Non-prescribed drugs consist of over-the-counter drugs (such as cold remedies, cough remedies and headache remedies) and
personal health supplies (such as antiperspirants, dental floss and disposable diabetic syringes). For more information
on over-the-counter drugs and personal health supplies, see the General Methods section of the Methodological Notes.
22
Drug Expenditure in Canada, 1985 to 2011
In 2011, three provinces (Prince Edward Island, New Brunswick and Quebec) and two territories
(the Northwest Territories and Nunavut) are expected to have had annual growth of publicly
financed prescribed drug expenditure per person below the Canadian average (1.0%).
Figure 14: Annual Growth Rate for Public- and Private-Sector Prescribed and
Non-Prescribed Drug Expenditure per Capita, by Province/Territory
and Canada, 2011f
Notes
f: forecast.
Prescribed drug expenditure (Rx) is based on drugs sold as the result of a prescription from a health professional.
This expenditure can be financed by either the public or the private sector.
Non-prescribed drug expenditure (Non-Rx) includes spending on over-the-counter drugs and personal health supplies.
This expenditure is financed by the private sector, typically out-of-pocket by consumers (households).
For detailed definitions, please refer to the Methodological Notes.
Sources
National Health Expenditure Database, 2011, Canadian Institute for Health Information; Population, Statistics Canada.
The analysis of annual growth rates should be interpreted cautiously. The actual change in drug
spending associated with a given growth rate varies based on the initial level of expenditure. For
example, a 10% growth rate for a higher initial level of expenditure would translate into a larger
growth in dollar amounts than for a lower initial level of expenditure.
23
Drug Expenditure in Canada, 1985 to 2011
Public- and Private-Sector Prescribed Drug Expenditure
Between 1985 and 2011, publicly financed prescribed drug expenditure per capita grew at a lower
average annual rate than privately financed prescribed drug expenditure per capita in Nova Scotia,
New Brunswick, Saskatchewan and British Columbia (Figure 15). During this period, among the
provinces, average annual growth in public-sector prescribed drug spending per capita ranged
from 6.5% in British Columbia and 6.7% in Saskatchewan to 9.7% in Alberta and 10.7% in
Prince Edward Island. Prescribed drug expenditure per capita financed by the public sector
grew at a faster rate in Yukon (12.1%) than in all the provinces.
Per capita prescribed drug expenditure financed by the private sector grew at average annual
rates ranging from 4.8% in Prince Edward Island and 5.7% in Newfoundland and Labrador to
10.7% in Nova Scotia and 11.1% in Saskatchewan.
Figure 15: Average Annual Growth Rate for Prescribed Drug Expenditure per
Capita, by Source of Finance, by Province/Territory and Canada,
Between 1985 and 2011f
Notes
* On April 1, 1999, Nunavut was formed from the eastern part of the Northwest Territories.
f: forecast.
Prescribed drug expenditure (Rx) is based on drugs sold as the result of a prescription from a health professional.
This expenditure can be financed by either the public or the private sector.
For detailed definitions, please refer to the Methodological Notes.
Sources
National Health Expenditure Database, 2011, Canadian Institute for Health Information; Population, Statistics Canada.
Figure 16 illustrates provincial/territorial trends in the share of publicly financed prescribed drug
expenditure as a percentage of prescribed drug expenditure, from 1985 to 2009, with forecasts
to 2011.
24
Drug Expenditure in Canada, 1985 to 2011
Figure 16: Public-Sector Prescribed Drug Expenditure as a Percentage of Total Prescribed Drug
Expenditure, by Province/Territory, 1985 to 2011
25
Drug Expenditure in Canada, 1985 to 2011
Figure 16: Public-Sector Prescribed Drug Expenditure as a Percentage of Total Prescribed Drug
Expenditure, by Province/Territory, 1985 to 2011 (cont’d)
Note
* On April 1, 1999, Nunavut was formed from the eastern part of the Northwest Territories.
Source
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
26
Drug Expenditure in Canada, 1985 to 2011
Between 1985 and 2009, the share of prescribed drug expenditure financed by the public sector
increased in Newfoundland and Labrador, Prince Edward Island, Quebec, Ontario, Manitoba,
Alberta, Yukon and the Northwest Territories. Increases in the provinces ranged from 3.8 and
7.0 percentage points in Ontario and Manitoba, respectively, to 16.4 and 24.9 percentage
points in Newfoundland and Labrador and Prince Edward Island, respectively. The Northwest
Territories had a lower increase than the provinces, at 3.6 percentage points, while Yukon
had a higher increase than the provinces, at 35.3 percentage points. Decreases in the share
of prescribed drug expenditure financed by the public sector occurred in Nova Scotia,
New Brunswick, Saskatchewan and British Columbia. Decreases ranged from 12.2 percentage
points in British Columbia to 19.8 percentage points in Saskatchewan.
In 2011, the share of prescribed drug expenditure financed by the public sector in Canada is
expected to have been 44.4%. This is forecast to have been exceeded by Quebec (45.4%),
Ontario (45.0%), Manitoba (44.9%), Saskatchewan (49.0%), Alberta (48.3%), Yukon (61.7%),
the Northwest Territories (64.2%) and Nunavut (58.6%).
27
Drug Expenditure in Canada, 1985 to 2011
International Comparisons
Comparability of Health Expenditure Across Countries
There are 29 countries with health expenditure information that most closely follows the health
care boundary proposed in the Organisation for Economic Co-operation and Development
(OECD) manual A System of Health Accounts (SHA). The OECD states that the data for those
countries is believed to be fairly comparable, although some deviations from SHA definitions
may still exist among the sub-aggregate variables of total health expenditure.
In general, international comparisons should be interpreted with caution, as variation exists
between countries with regard to reporting, inclusion and classification of health expenditure.
Level of income, institutional characteristics and service delivery across countries also cause
differences in the share of drugs in total health expenditure.
Drug expenditure data from 8 of the 29 OECD comparator countries is covered in this section:
Canada, Australia, France, Germany, Japan, New Zealand, the United Kingdom and the
United States.
Share of Drugs in Total Health Expenditure
The OECD maintains a comparative database on health-related statistics, including health
expenditure. This database captures information on expenditure for pharmaceuticals and other
medical non-durables outside an institutional setting (equivalent to drugs purchased in retail
establishments in Canada). Pharmaceutical and other medical non-durables comprise
prescribed drugs, over-the-counter drugs and a wide range of medical non-durables such
as bandages, elastic stockings, incontinence articles, condoms and other mechanical
contraceptive devices.
In 1985, drug expenditure in Canada represented 9.6%xiv of total health expenditure. Japan
had the largest share of drug expenditure in total health expenditure, at 18.0%, and the United
States had the lowest, at 8.7%. By 2009, the most recent year for which data was available,
drug expenditure in Canada had increased its share in total health expenditure by just more
than seven percentage points, to 17.0%. Japan had the highest share of drug expenditure in
total health expenditure, at 19.4%, and New Zealand had the lowest, at 9.3% (Table 3).
xiv. OECD data is standardized for international comparability; consequently, figures calculated from this data may differ from those
calculated from the national health accounts of member countries. Specific to Canada, expenditure on health research and the
training of health care workers with concomitant care of patients is included in the national health accounts but excluded from
OECD health expenditure data.
29
Drug Expenditure in Canada, 1985 to 2011
Table 3: Total Expenditure on Pharmaceutical Goods per Capita and as a Percentage of Total
Health Expenditure, Selected OECD Comparator Countries, 2009
GDP per Capita
(CA$,
PPP)*
Country
†
Rank
Total Drug
Expenditure
per Capita
(CA$,
PPP)*
Total Drug
Expenditure as
a Percentage of
Total Health
Expenditure
Total Health
Expenditure
per Capita
Rank
(CA$,
PPP)*
Rank
Percentage
Rank
Australia
47,798
2
602
6
4,125
6
14.6
Canada‡
45,771
3
890
2
5,223
2
17.0
2
France
40,423
6
767
3
4,763
4
16.1
3
Germany
43,493
4
752
4
5,050
3
14.9
4
Japan†
38,828
7
668
5
3,445
8
19.4
1
New Zealand
5
34,703
8
330
8
3,571
7
9.3
8
United Kingdom
42,689
5
457
7
4,175
5
11.6
7
United States
54,830
1
1,145
1
9,530
1
12.0
6
§
Notes
* Converted to Canadian dollars using purchasing power parities (PPPs) for gross domestic product (GDP).
† 2008 data used for Total Drug Expenditure per Capita, Total Health Expenditure per Capita and Total Drug Expenditure as a
Percentage of Total Health Expenditure.
‡ Canadian data reported by the OECD is as of November 2010. In November 2011, updated and revised Canadian data was
released in Canada. This updated information will not be incorporated into the OECD database until the summer of 2012.
§ 2008 data used for Total Drug Expenditure per Capita and Total Drug Expenditure as a Percentage of Total Health Expenditure.
Source
Organisation for Economic Co-operation and Development, OECD Health Data 2011 (Paris, France: OECD, June 2011).
30
Drug Expenditure in Canada, 1985 to 2011
Figure 17 illustrates the trends of drug expenditure per capita (constant 2000 CA$, PPP)xv in the
eight selected OECD comparator countries.
Figure 17: Drug Expenditure per Capita,* Selected OECD Comparator Countries,
1985 to 2009†, ‡
Notes
* Converted to constant 2000 Canadian dollars using purchasing power parity (PPP) for gross domestic product (GDP).
† 2009 data not available for Australia, Japan and the United Kingdom.
‡ Derived values have been used where data was not available for some countries in certain years: (Germany: 1991; France:
1986–1989; New Zealand: 1998–2003; United Kingdom: 1998–1999).
Source
Organisation for Economic Co-operation and Development, OECD Health Data 2011 (Paris, France: OECD, June 2011).
Between 1985 and 2009, among comparator countries, Australia, Canada and the United States had
the highest average annual rate of growth in per capita drug expenditure, with rates of 5.5%, 5.3%
and 5.2%, respectively. The remaining five countries experienced a lower average annual rate of
growth in per capita drug expenditure, ranging from 2.4% in Germany to 3.3% in the United Kingdom.
To eliminate the differences in price levels between countries, purchasing power parities (PPPs)
are used. To make useful comparisons of trends in drug expenditure per capita over time, it is
necessary to deflate nominal drug expenditure through the use of a suitable price index to
derive real spending per capita. Due to the unavailability of a specific pharmaceutical price
index, the gross domestic product (GDP) is used by the OECD. It should be kept in mind that
prices of patented medicines in Canada usually experience lower inflation than the economy
as a whole, due to the regulation of patented drug prices in Canada.
xv. For purpose of this comparison, the constant 2000 CA$ PPP has been used. The figures are calculated from US$ at a 2000
GDP price level that have been adjusted to CA$ at 2000 PPP rates.
31
Drug Expenditure in Canada, 1985 to 2011
Share of Public Expenditure in Total Expenditure on Drugs
The OECD database on health contains statistics on total expenditure on pharmaceutical goods
and public expenditure on pharmaceutical goods. In Canada, drug expenditure by the public
sector rose from 29.4% of total expenditure on pharmaceutical goods in 1985 to 38.8% in 2009.
In OECD countries, with the exception of those in North America, the entire population usually
has coverage for prescribed drugs through public insurance. Most countries have formularies
restricting the number of drugs covered under public insurance and impose cost-sharing
(deductibles, co-insurance or copayments) with waivers for certain groups of beneficiaries.
Table 4 shows that, among the eight selected OECD comparator countries in 2009, Germany
had the highest level of public drug spending per capita ($583), the United States had the
highest level of total drug expenditure per capita ($1,145) and the United Kingdom had the
highest public share of total drug spending (84.7%).
The high share of total drug expenditure financed by the public sector in some European countries
(for example, Germany) reflects the inclusion of drug benefits provided through employmentrelated social security funds in publicly financed drug expenditure (see Series C for more data
on international comparisons). These funds are social insurance programs covering the entire
community or large sections of the community, and are imposed or controlled by a government
authority. They generally involve compulsory contributions by employees, employers or both,
and the government authority determines the terms upon which benefits are paid to recipients.
In some European countries, expenditure by social security funds represents the major share of
public expenditure on drugs (for example, 94.7% in Germany and 98.2% in France in 2009).3
By contrast, in Canada, until 1996, drug benefits under social security funds included only
spending by WCBs and they represented less than 2% of public expenditure on drugs in retail
establishments. Starting in 1997, they also included expenditure by the premium component of the
Quebec Drug Insurance Fund.xvi The share of social security funds in public expenditure on drugs
in Canada increased from 5.9% in 1997 to 8.0% in 2009. The premium component of the Quebec
Drug Insurance Fund is financed by the mandatory payment of premiums by seniors (65 and older)
and other residents not covered by private group insurance. Social assistance recipients are not
required to pay a premium.
Group insurance plans offered by employers, unions and professional associations that resemble the
European model do exist in Canada; however, since a government authority does not impose group
health insurance in Canada, and policy-holders may voluntarily opt out (except in Quebec), they are
considered privately financed. Private health insurance, composed mainly of group insurance,
accounted for 30.4% of total drug expenditure in retail establishments in Canada in 2009.
xvi. Since July 1, 2002, the public plan has been financed both by the expenditure allocated to this program by the Quebec
government (provincial government sector) and by the amounts collected by the Drug Insurance Fund as premiums and proceeds
(social security funds sector). The premium component of the Quebec Drug Insurance Fund is considered to be a social security
scheme, while the remaining portion of the program that is paid through the ministère de la Santé et des Services sociaux
is included as a provincial government expenditure. For more information, see the General Methods section of the
Methodological Notes.
32
Drug Expenditure in Canada, 1985 to 2011
Table 4: Public Expenditure on Pharmaceutical Goods per Capita and as a Percentage of Total
Expenditure on Pharmaceutical Goods, Selected OECD Comparator Countries, 2009
Public Drug
Expenditure
per Capita
Country
Australia†
Canada‡
France
Germany
Japan†
New Zealand
United Kingdom†
United States
(CA$, PPP)*
324
346
511
583
482
217
387
356
Total Drug Expenditure
per Capita
Rank
7
6
2
1
3
8
4
5
(CA$, PPP)*
602
890
767
752
668
330
457
1,145
Rank
6
2
3
4
5
8
7
1
Public Drug Expenditure
as a Percentage of Total
Drug Expenditure
Percentage
53.8
38.8
66.7
77.6
72.1
65.6
84.7
31.1
Rank
6
7
4
2
3
5
1
8
Notes
* Converted to Canadian dollars using purchasing power parities (PPPs) for gross domestic product (GDP).
† 2008 data.
‡ Canadian data reported by the OECD is as of November 2010. In November 2011, updated and revised Canadian data was
released in Canada. This updated information will not be incorporated into the OECD database until the summer of 2012.
Source
Organisation for Economic Co-operation and Development, OECD Health Data 2011 (Paris, France: OECD, June 2011).
Share of Drugs in Public Expenditure on Health
In Canada, drugs accounted for only 3.8% of health expenditure by the public sector in 1985.
This proportion increased to 9.4% in 2009, reflecting substantially higher growth in drug
expenditure than in other types of public-sector health expenditure between 1985 and 2009.
In 1985, among the comparator countries, the share of drugs in public-sector health expenditure
ranged from 1.8% in the United States to 15.4% in Japan. In 2009, the share of drugs in publicsector health expenditure ranged from 7.5% in New Zealand to 17.3% in Japan (Table 5).
In 2009, the share of drug spending in public-sector health expenditure was lower than
the share of drug spending in total health expenditure in most of the selected countries (the
exceptions were Germany and the United Kingdom), reflecting generally higher cost-sharing
for drugs than for other health expenditure. In the case of Canada, the low share of drugs in
total public expenditure on health (9.4% in 2009), compared with the share of drugs in total
health expenditure (17.0% in 2009), also reflects the absence of universal coverage of
prescribed drugs by public insurance, while there exists universal and full coverage of
medically necessary hospital and physician services.
33
Drug Expenditure in Canada, 1985 to 2011
Table 5: Public Expenditure on Pharmaceutical Goods per Capita and as a Percentage of
Public-Sector Health Expenditure, Selected OECD Comparator Countries, 2009
Public Drug Expenditure
per Capita
Country
Australia†
Canada‡
France
Germany
Japan†
New Zealand
United Kingdom§
United States
(CA$, PPP)*
324
346
511
583
482
217
387
356
Rank
7
6
2
1
3
8
4
5
Public-Sector Health
Expenditure per Capita
(CA$, PPP)*
2,805
3,689
3,712
3,882
2,783
2,873
3,513
4,543
Rank
7
4
3
2
8
6
5
1
Public Drug Expenditure
as a Percentage of PublicSector Health Expenditure
Percentage
11.6
9.4
13.8
15.0
17.3
7.5
12.0
7.8
Rank
5
6
3
2
1
8
4
7
Notes
* Converted to Canadian dollars using purchasing power parities (PPPs) for gross domestic product (GDP).
† 2008 data.
‡ Canadian data reported by the OECD is as of November 2010. In November 2011, updated and revised Canadian data was
released in Canada. This updated information will not be incorporated into the OECD database until the summer of 2012.
§ 2008 data used for Public Drug Expenditure per Capita and Public Drug Expenditure as a Percentage of Public Sector
Health Expenditure.
Source
Organisation for Economic Co-operation and Development, OECD Health Data 2011 (Paris, France: OECD, June 2011).
34
Drug Expenditure in Canada, 1985 to 2011
Factors Affecting Drug Expenditure
in Canada
Numerous factors, many of which are interrelated, may influence drug expenditure. Since drug
prices, as measured by several price indices,xvii have been relatively stable over the past 10 years,
factors affecting increased drug spending in Canada essentially relate to the volume of drug use
and the entry of new drugs (typically introduced to the market at higher prices).
The following review of some of the factors affecting drug expenditure is intended to facilitate
discussion and is not meant to be a systemic review of all relevant literature.
Price-Related Factors
Although the ingredient prices of drugs, once on the market, are relatively stable, the introductory
price and overall cost of drugs may be influenced by several factors. These factors include
international pricing, inflation, changes in retail or wholesale markups and other market forces.
Market forces can be competitive forces (for example, the introduction of new products can
increase drug expenditures while generics can decrease drug expenditure by offering a lowerpriced alternative) or regulatory forces (for example, changes in price controls or extending
patent legislation that prevents a less expensive alternative from coming to the market).
Quantity-Related Factors
There are many factors that can affect the quantity of drugs dispensed. A change in quantity can
be the result of a change in the number of users or in the volume of drugs used (for example, an
increase or decrease in dosage prescribed or length of treatment).
Population-Related Factors
Population size affects the number of potential users in an area (for example, Prince Edward
Island versus Ontario). Demographics such as age, gender and ethnic distribution also influence
drug utilization. For example, the number of drugs people take, and in turn drug spending,
increases with age.4 Drug use can also be influenced by changes in the health status of the
population, which can be the result of the emergence of new diseases, epidemics and changes
in the prevalence or severity of existing disease. Healthier populations may use fewer drugs.
xvii.
For more information on price indices, see the Data Limitations section of the Methodological Notes.
35
Drug Expenditure in Canada, 1985 to 2011
Health System–Related Factors
The health system also plays a role in drug expenditure. Changes in policies and programs,
including regulations around drug plan eligibility and co-insurance, the extent of formulary
listings and the availability of and access to third-party insurance coverage can all affect drug
spending.5 In general, the more accessible and more generous insurance coverage is, the less
costly drugs are to the end consumer and the more likely people are to consume drugs.
New Drugs
New drugs introduced to the market may influence drug expenditure. New drugs can also result in
switching between classes of drugs used to treat similar conditions or switching between drugs
within a class. Provided there is a difference in price, any switching will affect drug expenditure.
New drugs may be safer or have fewer potential side effects than existing drugs. As well, they
may offer an alternative to, or even a replacement for, existing non-drug therapies (for example,
surgery). In addition, new drugs may be used to treat or slow the progression of diseases or
symptoms of diseases that were previously undertreated or untreatable.
Generic Drugs
Generic drugs are usually introduced to the market following the expiration of patents for brand
name drugs. They provide a lower-priced alternative, which often results in switching from the
brand name to the generic product.
Other Factors
Changes in clinical practice guidelines can influence the types of drugs being used by
recommending drugs as first- or second-line therapies. They may also influence the volume
of use by recommending that more or fewer people be treated with certain drugs.
New indications for marketed drugs may influence drug expenditure. New indications can also result in
switching between classes of drugs used to treat similar conditions or switching between drugs within
a class. Provided there is a difference in price, any switching will affect drug expenditure.
Pharmaceutical companies promote their products to prescribers (for example, physicians, dentists
and nurse practitioners) and pharmacists through a practice known as detailing, as well as by
advertising to the general public, known as direct-to-consumer advertising (DTCA). Although DTCA
is regulated in Canada, Canadians are exposed to it through international media. These practices
can influence prescribing practices and consumer preferences, which can in turn influence drug
utilization and spending.
Other factors include changes in pharmaceutical care practices, which can improve patients’
compliance with treatment regimens, or the adoption of primary prevention strategies, such as
improved diet, exercise or other forms of healthy living, which can improve the health status of
the population.
36
Drug Expenditure in Canada, 1985 to 2011
What We Know
• Drug expenditure rose every year between 1985 and 2011, with an average annual growth
rate of 8.5%.
• Since 2005, drug spending has grown more slowly than hospital spending, physician
spending and total health care spending.
• Slowed growth has been due, at least in part, to recent patent expiries of some
high-use drugs.6
• The generic share of the Canadian prescription drug market is expected to increase in the
coming years, as drugs with patents that expired or will expire between 2010 and 2014
accounted for more than one-third (38.2%) of all wholesale spending on prescription drugs in
Canada in 2009.6
• Some public drug programs have recently implemented changes to generic pricing policies.7, 8
• Increased volume of use (related to increases in either the proportion of the population taking
prescription drugs or the amount of drugs people are taking) and changes in the mix of
treatments being used (related to patients switching to more expensive drugs) were the
primary drivers of drug spending growth over the past decade. Population growth and aging
also contributed to increased drug spending during the decade, though to a lesser degree.6
• The prices of patented drugs, which made up two-thirds of retail spending, are regulated in
Canada and cannot grow in excess of the consumer price index (CPI) for extended periods.
• New drugs are often introduced at much higher prices than those of existing therapies.9
However, some new drugs have reduced overall medical expenditures.10, 11
• The number of new chemicals marketed in Canada has declined in the past decade
compared with the 1990s.6
• Cancer drugs and immunosuppressants have been the fastest growing drug classes in the
past five years. Trends in drug development suggest that these classes may continue to drive
drug spending in the years to come.6
• An increasing number of drug therapies are being administered outside of the hospital setting,
thereby shifting costs from hospitalsxviii to the community (for example, in-home cancer treatments).12
What We Don’t Know
• Whether increases in total drug expenditure negatively or positively affect overall
health outcomes.
• How drug use impacts spending in other sectors of health care (for example,
decreased hospitalization).
• How DTCA affects the marketplace, prescribing practices, physician–patient communication
and the public’s understanding of drug therapy in Canada.13
• The impact generic pricing policy changes will have on drug spending.
xviii. Drugs paid through hospital budgets are not identified separately in the NHEX database but are classified as
hospital expenditure.
37
Drug Expenditure in Canada, 1985 to 2011
Methodological Notes
Background
Drug expenditure data in this report is obtained from the National Health Expenditure Database
(NHEX), which is maintained by the Canadian Institute for Health Information (CIHI). This database
contains a historical series of macro-level health expenditure statistics by province and territory,
beginning in 1975. Drug expenditure data in NHEX is macro-level data and does not allow for
decomposition of prescription costs or drug classes.
The Drugs category in NHEX is intended to measure final consumption, outside an institutional
setting, of drugs purchased by consumers or third-party payers on their behalf, generally from
community pharmacies. Drug expenditure data in NHEX consists of estimates that represent the
final costs to Canadian consumers, which include dispensing fees, markups and appropriate taxes.
NHEX data does not account for drug expenditure by non-Canadians (for example, Americans’
purchases from Canadian pharmacies). The classification system employed is consistent with
international standards developed by the Organisation for Economic Co-operation and
Development (OECD).
National Health Expenditure Database
The mandate of the NHEX database is twofold:
1. To support the development and evaluation of health programs in Canada by all levels of
government and within the private sector.
2. To compile information on health expenditure that will accurately portray the importance of
health care as a component of national expenditure.
Health Expenditure—Includes any type of expenditure for which the primary objective is to
improve or prevent the deterioration of health status.
This definition allows economic activities to be measured according to primary purpose and secondary
effects. Activities that are undertaken with the direct purpose of improving or maintaining health are
included. Other activities are not included, even though they may impact health. For example, housing
and income support policies have social welfare goals as their primary purpose and are not considered
to be health expenditure, yet they are recognized as powerful factors in determining population health.
Source of Finance
National health expenditures are reported based on the principle of responsibility for payment rather
than on the source of the funds. It is for this reason, for example, that federal health transfers to
the provinces/territories are included in the provincial/territorial government sector, since it is the
responsibility of provincial/territorial governments to expend federal transfers on health services.
The exception to this principle is that provincial/territorial government health transfers to municipal
governments are included in the provincial/territorial government sector. The following figure depicts
the composition of total health expenditure by source of finance.
39
Drug Expenditure in Canada, 1985 to 2011
Figure 18: Composition of Total Health Expenditure, by Source of Finance*
Note
* The remaining funds in the Quebec Drug Insurance Fund are financed through the Consolidated Revenue Fund;
these expenditures are captured under the provincial government sector.
Public Sector—Includes health care spending by governments and government agencies.xix
It is subdivided into provincial government sector and other public sector, as described below:
1. The provincial government sector includes health spending from provincial/territorial government
funds, federal health transfers to the provinces/territories and provincial/territorial government
health transfers to municipal governments.
2. The federal direct sector refers to direct health care spending by the federal government in
relation to health care services for special groups, such as Aboriginal People, the Canadian
Forces and veterans, as well as expenditures for health research, health promotion and health
protection. Federal direct health expenditure does not include federal health transfers to
the provinces.
3. The municipal government sector expenditure includes health care spending by municipal
governments for institutional services, public health, capital construction and equipment, and
dental services provided by municipalities in the provinces of Nova Scotia, Manitoba and
British Columbia. Designated funds transferred by provincial governments for health purposes
are not included in the municipal sector but are included with provincial government
expenditure. Currently, no estimates of drug spending are included in this sector.
xix. Statistics Canada (Public Sector Statistics Division) publishes estimates of government health expenditure as part of its comprehensive
reporting system of all government expenditure, the Financial Management System (FMS). The FMS public-sector health spending
estimates are lower than those reported by CIHI because different classification methods are applied and a narrower definition of health
expenditure is used in the FMS.
40
Drug Expenditure in Canada, 1985 to 2011
4. Social security funds are social insurance programs that are imposed and controlled by
a government authority. They generally involve compulsory contributions by employees,
employers or both, and the government authority determines the terms upon which benefits
are paid to recipients. Social security funds are distinguished from other social insurance
programs, the terms of which are determined by mutual agreement between individual
employers and their employees. In Canada, social security funds include the health care
spending by workers’ compensation boards (WCBs) and the premium component of the
Quebec Drug Insurance Fund.
• Health spending by WCBs includes what the provincial boards commonly refer to as
medical aid. Non–health related items often reported by the WCBs as medical aid
expenditure—such as funeral expenses, travel and clothing—are removed.
• On January 1, 1997, the government of Quebec created a basic drug insurance plan with
the objective of ensuring the population of Quebec has access to drugs as required by
health status. All residents of Quebec must be covered by drug insurance, whether by
private group insurance or by the public plan administered by the Régie de l’assurance
maladie du Québec (RAMQ). At the beginning of the plan, the Drug Insurance Fund was
the chosen mechanism to pay all drug and pharmaceutical service costs provided to
subscribersxx insured by the RAMQ, as well as their children. Since July 1, 2002, the Drug
Insurance Fund has also covered persons age 65 or older and social assistance recipients
insured by the RAMQ. Accordingly, the public plan has been financed since then both
by the expenditure allocated to this program by the Quebec government (provincial
government sector) and by the amounts collected by the Drug Insurance Fund as
premiums and proceeds (social security funds sector). The premiums are paid by the
subscribers of the Quebec Drug Insurance Fund and by persons age 65 or older insured
by this plan.
Private Sector—Includes health care spending by individuals and private sources as
described below:
1. Non-consumption includes non-patient revenues received by health care institutions, such as
donations and investment income, private spending on health-related capital construction and
equipment, as well as health research funded by private sources. Currently, no estimates of
drug spending are included in this portion of the private sector.
2. Out-of-pocket includes health expenditures made by individuals for health care goods
and services.
3. Private health insurance includes health expenditure paid by commercial and not-for-profit
insurance firms, as well as the cost of administering those claims.
xx. Subscribers are defined as Quebec residents younger than age 65 who do not receive social assistance benefits and who do
not have access to private group insurance.
41
Drug Expenditure in Canada, 1985 to 2011
Hierarchy of Classification
National health expenditure in Canada is based on a system of classification that is consistent
with international standards developed by the OECD for reporting health expenditure.
National health expenditure is grouped within the broad categories of personal health care or
other health expenses:
• Personal health care consists of expenditure for health goods and services used
by individuals.
• Other health expenses consist of expenditure on behalf of society, such as public health;
expenditure made as investments for purposes of future consumption, such as capital
expenditure; the administrative expenses of planning and managing the health care system;
and research.
Personal health expenditure is classified within categories that describe the type of health
care used. Certain categories overlap. The hierarchy of classification that is used to allocate
overlapping categories of expenditure is as follows:
• Institutional setting—Health care services consumed in hospitals or other institutions are
allocated to the institutional category if the institution purchases the services on behalf of
its patients. For example, drugs paid through hospital budgets are classified as hospital
expenditure. This allocates expenditure to the supplier actually paid by patients or
their agents in the form of government or insurance companies. It also reflects
data availability.
• Self-employed provider of service—For example, all expenses of physicians’ practices are
considered to be expenditure for physician services, even though some of these expenses
would be for employment of other health professionals, drugs or personal health supplies.
• Type of good or service—Drugs and personal health supplies are examples.
One of the categories of health expenditure within NHEX is Drugs. Other categories include
Hospitals, Other Institutions, Physicians, Other Professionals, Capital, Public Health and
Administration, and Other Health Spending. In NHEX, these categories are also named Use
of Funds.
Below is a description of the Drugs category within NHEX; it is not a definition supplied by
the OECD.
• Drugs—At the aggregate level, include expenditure on prescribed drugs and non-prescribed
products purchased in retail stores. Estimates represent the final costs to consumers,
including dispensing fees, markups and appropriate taxes. The breakdown of prescribed
drugs, over-the-counter drugs and personal health supplies in NHEX is parallel with the
breakdown in the OECD. This category has been disaggregated at the Canada level in the
data tables to provide information on the following sub-categories:
– Prescribed drugs—substances considered as drugs under the Food and Drugs Act and
sold for human use as the result of a prescription from a health professional.
42
Drug Expenditure in Canada, 1985 to 2011
– Non-prescribed drugsxxi—include two sub-components: over-the-counter drugs and
personal health supplies.
– Over-the-counter drugs—therapeutic drug products not requiring a prescription and
purchased as such.
– Personal health supplies—include items used primarily to promote or maintain health; for
example, oral hygiene products, diagnostic items such as diabetic test strips and medical
items such as incontinence products.
The Drugs category in NHEX does not include drugs dispensed in hospitals and generally
in other institutions. These are included in health expenditure figures for Hospitals or
Other Institutions.
Other Terms
Gross domestic product (GDP)14—GDP implicit price index (in 1997 dollars) is used to compare
annual percentage change of drug expenditure with inflation in the Canadian economy. GDP is the
unduplicated value of production originating within the boundaries of Canada, regardless of the
ownership of the factors of production.
Purchasing power parity (PPP)15—PPPs are the rates of currency conversion that equalize
the purchasing power of different currencies. This means that a given sum of money, when
converted into different currencies at the PPP rates, will buy the same basket of goods and
services in all countries. Thus PPPs are the rates of currency conversion, which eliminate
differences in price levels between countries.
Data Limitations
Data contained in NHEX is estimated. The data is collected from diverse sources and includes
varying classes of financial information. The data is collected and classified according to
methods established by a review committee. CIHI analysts and external experts continue to
improve the comprehensiveness, accuracy and currency of the data in order to provide the
most complete and objective estimates possible. Notwithstanding these improvements,
national health expenditure data consists of estimates and should be used accordingly.
Most private-sector expenditure is estimated from survey data. Prior to 1996, the Family
Expenditure Survey by Statistics Canada,16 an important source of private-sector data, was
not carried out annually; therefore, trend data was imputed for years between surveys.
Private-sector data was revised following a methodology review in the early 1990s. The revised
private-sector data incorporated information estimated directly from new sources for 1988 and
subsequent years. Prior years were estimated using trend data. As a result, readers should use
caution when using the private-sector expenditure data for small provinces and for years prior
to 1988.
xxi. For more information on over-the-counter drugs and personal health supplies, see the General Methods section of the
Methodological Notes.
43
Drug Expenditure in Canada, 1985 to 2011
Drugs in Hospitals
The NHEX database at CIHI uses a classification system that is consistent with international
standards developed by the OECD for the reporting of health expenditure. Similar to the
functional category Pharmaceutical and Other Medical Non-Durables in the OECD System
of Health Accounts, the Drugs category in NHEX is intended to measure final consumption,
outside an institutional setting, of drugs purchased by consumers or third-party payers
on their behalf, generally from retail outlets. Drugs in hospitals are considered as inputs
(intermediate consumption) to the production of health care in hospitals. Consequently, drugs
paid through hospital budgets are not identified separately in NHEX but are classified as
hospital expenditure. Similarly, drugs purchased by residential care facilities for their residents
are classified as institutional expenditure. All expenses of physicians’ and dentists’ practices,
including drugs, are considered to be expenditure for physicians’ and dentists’ services.
Some drug expenditure is also included in the NHEX category of public health (for example,
vaccines). While the above hierarchy of classification is essential in allocating overlapping
categories of expenditure, it also reflects data availability. For example, data on expenditure by
provincial/territorial governments is usually extracted from provincial/territorial government
public accounts. In the accounts, it is generally not possible to isolate drug spending from
other categories of expenditure within program areas (for example, hospitals or public health).
Although other possible data sources exist, the use of a single data source for the different
categories of provincial government health expenditure—such as the provincial/territorial public
accounts—has the major advantage of minimizing the risk of double counting.
Measuring Drug Prices
There is no authoritative composite price index for all drugs sold in Canada. The difficulty lies
in the fact that traditional statistical measurement considers the price of tablets or capsules
rather than measuring the nature of the product itself (that is, its therapeutic properties). In pure
economic terms, the price of a drug is the price per unit of health gain attained. From a practical
perspective, however, people buy tablets, capsules or other forms of medication, some of which
may contain multiple active ingredients.
44
Drug Expenditure in Canada, 1985 to 2011
Figure 19: Patented Medicine Price Index (PMPI), Consumer Price Index (CPI) and
Industrial Product Price Index (IPPI), 1985 to 2011 (1987 = 100),‡,§
Sources
Consumer Price Index and Industrial Product Price Index, Statistics Canada; Patented Medicine Price Index, Patented Medicine
Prices Review Board.
There are several commonly accepted price indices that can potentially be used to measure
shifts in drug prices at the retail level. These include the Consumer Price Index (CPI), the
pharmaceutical component of the Industrial Product Price Index (IPPI [pharma]) and the
Patented Medicine Price Index (PMPI). Each index is built upon a unique set of assumptions
pertaining to inclusion criteria, definitions, updating and weighting methodologies. As a result,
these indices produce differing results (Figure 19).
It is important to determine whether two different products with similar therapeutic elements
used to treat similar health conditions are essentially different. Several price indices assume
they are different products. The consequence is that when new products enter the market, price
indices do not compare their prices to existing products; they are simply added to the basket
of goods.
Collection and Non-Response
The definitions and methods used in the preparation of this document are for the most part
based on those adopted in 1994 by the National Health Expenditure Methodology Review
Committee. This committee included representation from Health Canada, Statistics Canada,
the Quebec ministère de la Santé et des Services sociaux, the Canadian Medical Association
and the Canadian Healthcare Association. Some of the recommendations for change made
during that process are still under development.
45
Drug Expenditure in Canada, 1985 to 2011
General Methods
The following is intended as a general overview of the methods applied to calculate estimates
of drug expenditure in Canada. More detailed information can be obtained by contacting the
National Health Expenditures program area by phone at 613-241-7860, by fax at 613-241-8120
or by email at [email protected]
Provincial/Territorial Government
Provincial/territorial government expenditure principally includes drugs that are dispensed through
provincial/territorial drug subsidy programs (see Appendix A). This drug expenditure data is
extracted predominantly from audited and consolidated provincial/territorial documents detailing
provincial government expenditure (Table 6).
Provincial/territorial government drug spending figures include spending by the provincial/
territorial ministry responsible for health, as well as by other departments that may provide
drug coverage. CIHI’s estimates of provincial and territorial government drug expenditure
were submitted to provincial and territorial departments of health for review and validation.
Provincial/territorial government figures identified as forecasts are based on the growth rates of
major programs reported in provincial and territorial government main estimates and budgets.
Table 6: Provincial/Territorial Government Drug Expenditure Data
Province/Territory
Description
Newfoundland and Drug Expenditure Drug expenditure data is collected from the Provincial Public Accounts
Labrador
Data Source
Volume III, Consolidated Revenue Fund Supplementary Statements and
Schedules for three drug programs: indigents, seniors and the special
drug programs.
46
Prince Edward
Island
Drug Expenditure The Drug Cost Assistance Program is reported under the Provincial
Data Source
Pharmacy program in the Queens Region Health and Community Services
operating statement, which is reported in the P.E.I. Provincial Public
Accounts Volume II.
Nova Scotia
Drug Expenditure Drugs data is extracted from three sources: the Nova Scotia Estimates
Data Source
Supplementary Detail, special tabulations from the N.S. Seniors’
Pharmacare Program and the N.S. Department of Community Services,
Income Assistance and Employment Support Services.
New Brunswick
Drug Expenditure Drugs data is provided through special reports from the Department of
Data Source
Health and the Department of Social Development. A small component of
drug expenditure by the provincial government is from the N.B. Public
Accounts Volume 2, under Payments to Vendors and Grants and
Contribution Payments.
Quebec
Drug Expenditure Provincial government expenditure is extracted from Volume 2 of the
Data Source
Quebec provincial public accounts. Spending on drugs by the provincial
government is represented by total transfers of Program 5, Régie de
l’assurance maladie du Québec, for “médicaments et services
pharmaceutiques.” See also the section below on social security
funds and the Quebec Drug Insurance Fund.
Drug Expenditure in Canada, 1985 to 2011
Table 6: Provincial/Territorial Government Drug Expenditure Data (cont’d)
Province/Territory
Description
Ontario
Drug Expenditure Data is collected from Volume 1 of the Ontario Provincial Public Accounts.
Data Source
Information is collected for the drug programs provided by the Ministry of
Health and Long-Term Care (Ontario Drug Benefit Program, Trillium Drug
Program, Special Drug Program) and by the Ministry of Community and
Social Services, under Social Assistance and Employment under the Adult
and Children’s Service Program.
Manitoba
Drug Expenditure Data is from Manitoba Health’s Pharmacare Program under the Health
Data Source
Services Insurance Fund. Data is also collected from the annual report of
the Manitoba Department of Family Services under Income Assistance of
the Employment and Income Assistance Program.
Saskatchewan
Drug Expenditure Data sources include the Saskatchewan Public Accounts Volume 2 and
Data Source
the Saskatchewan Health Annual Statistical Report for the Drug Plan
and Extended Benefits Branch. Data is collected for the Saskatchewan
Prescription Drug Plan from the annual report. A total for the Supplementary
Health Program (SHP) is also extracted from the annual report. The
distribution of detailed expenditure of the SHP provided in the Statistical
Report for the Drug Plan and Extended Benefits Branch is applied to the
total for the SHP extracted from the public accounts. One of the components
of the SHP that is also collected is “non-formulary drugs.” Drug expenditure
amounts are collected under the Ministry of Social Services in the Supplier
Payments section of the public accounts.
Alberta
Drug Expenditure Drug expenditure data from Alberta Health and Wellness is extracted from
Data Source
its annual report. Detailed claims summary data is provided by Alberta Blue
Cross Non-Group Benefits. The largest single expenditure component of
Alberta Blue Cross Non-Group Benefits is drug benefits. The detailed
claims distribution is applied to the total for Blue Cross Non-Group Benefits
under Practitioner Services, extracted from the annual report of the Ministry
of Health and Wellness.
Drug expenditure information is also collected from Children’s Services,
the Department of Community Development and the Department of Human
Resources and Employment. Drug expenditure amounts are compiled
from various income assistance programs, including Income Support
to Individuals and Families, Social Support to Individuals and Families
and Services to Persons With Disabilities.
British Columbia
Drug Expenditure Data is received in the Financial Management Reports (FMRs) from the
Data Source
Ministry of Health Services. Control totals for major programs are from the
public accounts. With few exceptions, expenditure items from the FMRs
sum to the control totals. The Ministry of Health Services administers drug
subsidization for all targeted groups (seniors, income assistance recipients
and families) under the Medical Services Program.
Yukon
Drug Expenditure Control totals on major programs are extracted from Yukon’s public
Data Source
accounts. Additional details are in a special tabulation provided by
the territorial Ministry of Health and Social Services on spending for
pharmacare, prescription drugs, under the Chronic Disease Program
and Extended Health Benefits for Seniors.
Northwest
Territories
Drug Expenditure Drug expenditure data is provided by the Finance Division of the Department
Data Source
of Health and Social Services under the Extended Health Benefits of the
Supplementary Health Programs.
Nunavut
Drug Expenditure The government of Nunavut is unable to provide drug expenditure amounts
Data Source
to CIHI. The method used to estimate expenditure in Nunavut was to
allocate the same proportion that drugs were in the Northwest Territories
of the aggregate of individual programs in the Northwest Territories that
make up the Supplementary Health Benefits Program in Nunavut.
47
Drug Expenditure in Canada, 1985 to 2011
Federal Direct
Prescribed drug data is derived from information provided by federal government organizations
supplemented with information from the national public accounts. Federal government health
care spending is generally provided according to the province in which the expenditure was
made. Some data, however, is provided only at the national level; in these cases, it is distributed
by the appropriate provincial or territorial population.
Social Security Funds
Social security funds are financially autonomous social insurance schemes that are imposed
and controlled by a government authority. They generally involve compulsory contributions by
employees, employers or both, and the government authority determines the terms by which
benefits are paid to recipients. Social security funds are distinguished from other social
insurance programs, the terms of which are determined by mutual agreement between
individual employers and their employees. In Canada, social security funds include the health
care spending by WCBs and the premium component of the Quebec Drug Insurance Fund.
Workers’ compensation boards—Prescribed drug expenditure for the WCBs and the
Commission de la santé et de la sécurité du travail du Québec is collected through special
tabulations from contacts in each provincial or territorial WCB.
Quebec Drug Insurance Fund—On January 1, 1997, the government of Quebec created
a basic drug insurance plan with the objective of ensuring the population of Quebec has
access to drugs as required by health status. All residents of Quebec must be covered by drug
insurance, whether by private group insurance or by the public plan administered by the Régie
de l’assurance maladie du Québec (RAMQ). At the beginning of the plan, the Drug Insurance
Fund was the chosen mechanism to pay all drug and pharmaceutical service costs provided to
subscribersxxii insured by the RAMQ, as well as their children. Since July 1, 2002, the Drug
Insurance Fund has also covered persons age 65 or older and social assistance recipients
insured by the RAMQ. Accordingly, the public plan has been financed since then, both by the
expenditure allocated to this program by the Quebec government (provincial government sector)
and by the amounts collected by the Drug Insurance Fund as premiums and proceeds (social
security funds sector). The premiums are paid by the subscribers of the Quebec Drug Insurance
Fund and by persons age 65 or older insured by this plan.
The premium component of the Quebec drug program is considered to be a social security
scheme, while the remaining portion of the program that is paid through the ministère de la
Santé et des Services sociaux (MSSS) is included as a provincial government expenditure.
xxii. Subscribers are defined as Quebec residents younger than age 65 who do not receive social assistance benefits and who do
not have access to private group insurance.
48
Drug Expenditure in Canada, 1985 to 2011
Private Sector
Private-sector drug data was revised in 1995 following a methodology review that began in
the early 1990s. Private-sector data under the revised methodology incorporated information
estimated directly from new sources for 1988 and subsequent years. Expenditure amounts
prior to 1988 were estimated using trend data. Therefore, readers should exercise caution
when using the private-sector expenditure data for small provinces and for years prior to 1988.
The recommendations pertaining to prescribed and non-prescribed drugs that were ultimately
implemented included the following:
• Data on drug benefits paid by private insurers was to be estimated based on information
provided by the Canadian Life and Health Insurance Association (CLHIA) and from surveys of
non-profit insurers.
• Out-of-pocket expenditure on prescribed drugs was to be estimated from Statistics Canada’s
Family Expenditure in Canada survey (FAMEX), renamed in 1997 to the Survey of Household
Spending (SHS).
• Non-prescribed drug estimates would include two components: over-the-counter drugs and
personal health supplies. Estimates would be based on information from the market research
firm The Nielsen Company.
As part of the original agreement with the not-for-profit insurance firms that provide data to
NHEX, the administrators of NHEX agreed not to report the components of the private sector—
insurance and out-of-pocket expenditure—at the provincial/territorial level. The purpose
was to protect the proprietary nature of the information of the not-for-profit insurance firms.
Consequently, CIHI only reports the private-sector sum of components by province and the
out-of-pocket and insurance components of the private sector at the national level.
The data sources and methodologies related to these recommendations are described below.
Health insurance drug claims paid are collected from nine not-for-profit insurance companies
and the CLHIA. The CLHIA data is based on its survey of member companies. Currently, drug
spending that may occur by insurance companies providing casualty insurance is not included
in the estimates.
Out-of-pocket prescribed drug expenditure is based on purchased data from the SHS fielded by
Statistics Canada. Specifically, average household costs associated with question 220, in Section
PH of the SHS 2008 Questionnaire, relating to medicines, drugs and pharmaceutical products
prescribed by a doctor are the basis of the estimates. The average household expenditure of
prescribed drugs is multiplied by the number of estimated households reported in the survey.
The SHS is an annual survey that began in 1996. Prior to 1996, full surveys that included both
urban and rural areas were carried out in 1986 and 1992. In 1990, a survey was conducted that
included only metropolitan areas. For the years in which complete surveys were carried out,
data is available for the 10 provinces and for 17 urban centres. Two of the urban centres,
Yellowknife and Whitehorse, were used to derive estimates of expenditure in the territories.
Metropolitan expenditure per household tends to be somewhat higher than provincial estimates.
49
Drug Expenditure in Canada, 1985 to 2011
All relevant categories were updated in complete survey years. For the years in which only
urban surveys were carried out, the percentage changes in urban expenditure within each
province or territory were used to update category estimates from complete survey years.
Between 1992 and 1996, when no surveys were conducted, historical provincial growth
rates of the SHS variables of drug and drug sundries were used to impute missing years.
The non-prescribed drug estimate is based on data from the market research firm The Nielsen
Company, which tracks consumer sales of non-prescribed drugs sold in Canada at retail.
Each year, The Nielsen Company reports retail sales data for two consistent years for more
than 48 non-prescribed drug categories. Data is reported by sales channel,xxiii total dollar
sales volume and regional sales distribution for five regions that include nine provinces.
Newfoundland and Labrador and the territories are not included. The data is processed by
classifying the non-prescribed drug categories as either over-the-counter drugs or personal
health supplies. Regional sales amounts are separated into nine provinces, and estimates for
Newfoundland and Labrador and the territories are calculated using provincial distributions of
“direct costs for health care” from the SHS. Appropriate provincial and federal sales taxes are
incorporated into the estimates.
The following list provides the various drug classes that are supplied to CIHI by The Nielsen
Company. The choice of classes to be included in the non-prescribed drug expenditure estimate
and the classification according to which drugs are included as over-the-counter or personal
health supplies was made by the NHEX Drug Expenditure Review Committee during the NHEX
methodology review and adopted in 1995.
Over-the-Counter Drugs
Personal Health Supplies
Analgesic rubs
Adhesive bandages and dressing strips
Anti-fungals (external)
Antiperspirants
Athletes’ foot products (included in
anti-fungals in later years)
Artificial sweeteners
Cold remedies
Condoms
Athletic supports/braces
Cough remedies
Contact lens preparations
Diarrhea remedies
Cotton swabs
Dietary aids
Cover and tape products
Headache remedies
Dental floss
Headache remedies—child’s acetaminophen
Dentifrice
Hemorrhoidal remedies
Denture adhesives
Infant feeding products
Denture cleansers
Laxatives
Diabetic test strips
Medical nutritional supplements
Disposable diabetic syringes
Milk-intolerant products
Elastic bandages
Nasal preparations
Eye drops and lotions
Oral backache remedies
Feminine hygiene products
Pediculicides
Fever thermometers
xxiii. As a general rule, Statistics Canada definitions govern the classification of stores by class of trade. Sales channels include
drug stores; food stores with pharmacies; grocery banners; and mass merchandiser and warehouse clubs, which are
estimated from The Nielsen Company’s household panel data.
50
Drug Expenditure in Canada, 1985 to 2011
Over-the-Counter Drugs
Personal Health Supplies
Personal lubricants
Incontinence products
Premenstrual products
Medical supports/braces
Sleeping aids
Oral antiseptics
Throat remedies
Pregnancy test kits
Topical wound care
Sanitary pads
Upset stomach remedies
Selected hot/cold compresses
Vitamins—children’s
Selected insoles
Vitamins—adults’
Tampons
Wart removers
Toothbrushes (includes denture brushes)
Calculation Methods
Calculation of Average Annual Rate of Growth
The average annual rate of growth is the constant annual rate necessary for a value at the
beginning of a period to grow to a value at the end of a period over the number of compounding
years in the period. The formula used to calculate the average annual rate of growth is
=e
ln( value at end of period ) − In(value at beginning of period )
T
−1
Where the constant e equals 2.718, which is the base of the natural logarithm, and T equals the
number of years in the period (that is, year at end of period – year at beginning of period).
Calculation of Calendar Year
Some information sources provide data in fiscal years. Calendar-year data was derived by
adding three-quarters of one fiscal year to one-quarter of the previous fiscal year.
Calculation of per Capita Dollars
Per capita expenditure was calculated using the most recent revised population estimates and
forecasts from the Demography Division of Statistics Canada. These take into account the
results of the census adjustment for net census under-count, non-permanent residents and
returning Canadians.
Calculation of Total Health Expenditure
“Total health expenditure” refers to the sum of the public and private sectors. “Canada” refers to
the sum of the 10 provinces and three territories. “Canada average” is the sum of provincial and
territorial expenditure divided by the sum of provincial and territorial data of another variable,
such as population.
51
Drug Expenditure in Canada, 1985 to 2011
Calculation of Deflated Drug Expenditure per Capita Using CPI
Where drug expenditure per capita is presented in constant 1985 dollars, constant dollar drug
expenditure per capita was calculated using the CPI, provided by Statistics Canada. A more
complete explanation of the methodology for calculating the CPI is available from Statistics Canada.17
Forecasting Methods
Provincial government–sector drug spending forecasts are based on the growth rates of drug
subsidy programs of provincial health departments reported in provincial main estimates and
budgets. In the case of territorial government forecasts of the Northwest Territories and Nunavut,
estimates were based on amounts reported in their main estimates. In other sectors, the figures
for these two territories were calculated by developing a forecast for the Northwest Territories,
including Nunavut. The share of Nunavut spending in the last year of actual data of the combined
total of the Northwest Territories and Nunavut was used as a proxy to break out the forecasts for
the Northwest Territories and Nunavut.
Forecasts for federal direct, WCBs and private sector were entirely based on econometric
analysis of time series trends. For each series, up to 40 different univariate forecasting
specifications were evaluated, and the best one (based on the root mean square error of
prediction) was selected. The functional forms studied included the exponential smoothing
family (simple, double, Holt, Brown, Winters, damped trend, etc.); time trends; and ARIMA
specifications. Logarithmic transformations were used when the data warranted their use.
Forecasts of health expenditure are identified in the figures by special symbols and in the data
tables by the letter f.
Sources of Data
Drug expenditure estimates from NHEX are compiled based on information from the
following sources.
Provincial Government Sector
• Provincial public accounts and main estimates
• Provincial departments of health annual reports and statistical supplements, where available
• Annual reports of various foundations, agencies and commissions
• Special tabulations and specific information from various provincial departments reporting
health expenditure
Federal Direct Sector
• Public Accounts of Canada
• Special tabulations and information from
– Health Canada
– Veterans Affairs Canada
52
Drug Expenditure in Canada, 1985 to 2011
– Department of National Defence
– Solicitor General of Canada
– Statistics Canada
– Citizenship and Immigration Canada
Social Security Funds Sector
• Special tabulations on medical aid spending provided by the provincial and territorial WCBs
• Annual reports of provincial and territorial WCBs
• Annual report of the RAMQ
Private Sector
• Private insurance component:
– The not-for-profit portion is captured from special tabulations provided by the not-for-profit
insurance companies.
– The commercial portion is captured by a special tabulation provided by the CLHIA.
• Out-of-pocket component:
– SHS, Statistics Canada (formerly the FAMEX)
– Over-the-Counter Drugs and Personal Health Supplies—Market Review of Selected Drug
Categories at Retail, a special tabulation purchased from The Nielsen Company Canada
Economic and Demographic Data
• Gross domestic product:
– Purchased from National Accounts and Environment Division, Statistics Canada, for all
years except the latest
– Purchased from The Conference Board of Canada (GDP growth rates) for the latest year
• Population—purchased from Demography Division, Statistics Canada
• Provincial government expenditure—special tabulation purchased from Public Institutions
Division, Statistics Canada
• Price indices:
– PMPI: from Patented Medicine Prices Review Board
– CPI and Industrial IPPI: purchased from the Prices Division, Statistics Canada
53
Series A—Expenditure on Drugs by Type,
by Source of Finance and as a Share of Public,
Private and Total Health Expenditure, Canada,
1985 to 2011
Drug Expenditure in Canada, 1985 to 2011
Table A Canada—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Canada, 1985 to 2011
Provincial/
Territorial
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers
Out of
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Federal
Year
CA
Subtotal
Private
Total
Prescribed
Drugs
OvertheCounter
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
Personal
Total
Health
Non-Presc.
Supplies
Drugs
1985
1986
1987
1988
1989
1,048.1
1,240.6
1,406.7
1,592.7
1,838.0
58.0
63.3
68.2
89.3
110.0
12.6
15.2
17.8
20.8
22.9
-----------
1,118.7
1,319.2
1,492.7
1,702.8
1,970.9
------1,130.3
1,260.6
------903.7
1,031.4
1,447.7
1,698.8
1,800.4
2,034.0
2,292.0
2,566.5
3,018.0
3,293.1
3,736.8
4,262.9
-----------
-----------
1,235.9
1,399.0
1,621.7
1,784.9
1,975.6
1990
1991
1992
1993
1994
2,120.2
2,428.0
2,710.7
2,817.0
2,845.0
130.3
145.6
159.7
187.6
207.1
27.5
33.2
38.1
40.2
35.5
-----------
2,278.0
2,606.7
2,908.5
3,044.9
3,087.6
1,466.8
1,671.5
1,947.3
2,089.3
2,105.2
1,127.0
1,190.4
1,244.9
1,469.4
1,568.2
2,593.9
2,861.9
3,192.3
3,558.7
3,673.3
4,871.8
5,468.7
6,100.7
6,603.5
6,760.9
----1,290.0
1,373.0
1,475.1
----1,128.1
1,203.1
1,288.9
2,058.7
2,236.6
2,418.1
2,576.0
2,764.0
1995
1996
1997
1998
1999
3,099.7
3,052.3
3,133.4
3,462.5
3,914.2
227.8
234.0
252.5
283.7
321.0
37.8
41.4
42.7
47.9
53.7
----169.1
213.4
262.4
3,365.3
3,327.7
3,597.7
4,007.5
4,551.3
2,350.1
2,476.6
2,785.2
3,220.5
3,387.0
1,683.6
1,796.7
2,148.0
2,223.0
2,302.0
4,033.8
4,273.3
4,933.2
5,443.5
5,689.0
7,399.0
7,601.0
8,530.9
9,451.1
10,240.3
1,474.2
1,508.0
1,569.2
1,661.7
1,782.1
1,314.2
1,338.8
1,407.6
1,509.7
1,576.7
2,788.4
2,846.7
2,976.8
3,171.3
3,358.8
2000
2001
2002
2003
2004
4,559.3
5,228.8
5,839.0
6,376.6
6,996.6
343.3
392.0
448.2
508.2
528.6
64.8
75.8
86.5
102.6
121.1
327.8
367.4
433.2
577.8
615.5
5,295.2
6,064.1
6,807.0
7,565.2
8,261.8
3,866.8
4,489.0
5,009.4
5,692.6
6,229.2
2,562.5
2,613.5
2,934.4
3,155.9
3,364.8
6,429.3
7,102.5
7,943.9
8,848.5
9,594.0
11,724.6
13,166.6
14,750.9
16,413.7
17,855.8
1,815.3
1,882.4
1,972.2
2,047.6
2,159.3
1,605.0
1,654.0
1,712.5
1,714.6
1,770.9
3,420.3
3,536.4
3,684.7
3,762.2
3,930.2
2005
2006
2007
2008
2009
7,594.9
8,188.6
8,672.0
9,188.4
9,954.3
564.4
609.9
626.7
639.8
650.7
133.4
148.5
157.3
168.9
179.2
618.7
669.0
712.1
774.7
744.0
8,911.5
9,616.0
10,168.0
10,771.8
11,528.2
6,714.3
7,269.4
7,896.8
8,467.2
8,976.9
3,484.1
3,945.5
3,934.9
4,167.8
4,302.1
10,198.4
11,214.9
11,831.7
12,634.9
13,279.0
19,109.9
20,830.9
21,999.6
23,406.8
24,807.3
2,245.5
2,348.8
2,478.3
2,531.9
2,704.0
1,838.5
1,914.4
1,961.7
1,983.8
2,052.4
4,084.0
4,263.2
4,439.9
4,515.7
4,756.5
2010f
f
2011
10,176.7
10,391.5
652.3
664.6
195.1
212.9
779.0
793.5
11,803.1
12,062.5
9,555.6
10,244.9
4,603.0
4,874.2
14,158.6
15,119.1
25,961.7
27,181.6
2,748.0
2,733.0
2,091.1
2,129.3
4,839.1
4,862.4
1985
1986
1987
1988
1989
--18.4
13.4
13.2
15.4
--9.2
7.7
30.9
23.2
--20.9
16.9
16.6
10.0
-----------
--17.9
13.2
14.1
15.7
--------11.5
--------14.1
--17.3
6.0
13.0
12.7
--17.6
9.1
13.5
14.1
-----------
-----------
1990
1991
1992
1993
1994
15.4
14.5
11.6
3.9
1.0
18.4
11.7
9.7
17.5
10.4
20.0
20.8
14.8
5.7
-11.9
-----------
15.6
14.4
11.6
4.7
1.4
16.4
14.0
16.5
7.3
0.8
9.3
5.6
4.6
18.0
6.7
13.2
10.3
11.5
11.5
3.2
14.3
12.3
11.6
8.2
2.4
------6.4
7.4
------6.6
7.1
4.2
8.6
8.1
6.5
7.3
1995
1996
1997
1998
1999
9.0
-1.5
2.7
10.5
13.0
10.0
2.7
7.9
12.4
13.1
6.5
9.6
3.2
12.0
12.1
------26.2
23.0
9.0
-1.1
8.1
11.4
13.6
11.6
5.4
12.5
15.6
5.2
7.4
6.7
19.6
3.5
3.6
9.8
5.9
15.4
10.3
4.5
9.4
2.7
12.2
10.8
8.4
-0.1
2.3
4.1
5.9
7.2
2.0
1.9
5.1
7.3
4.4
0.9
2.1
4.6
6.5
5.9
2000
2001
2002
2003
2004
16.5
14.7
11.7
9.2
9.7
7.0
14.2
14.3
13.4
4.0
20.7
17.0
14.1
18.7
18.0
24.9
12.1
17.9
33.4
6.5
16.3
14.5
12.3
11.1
9.2
14.2
16.1
11.6
13.6
9.4
11.3
2.0
12.3
7.5
6.6
13.0
10.5
11.8
11.4
8.4
14.5
12.3
12.0
11.3
8.8
1.9
3.7
4.8
3.8
5.5
1.8
3.1
3.5
0.1
3.3
1.8
3.4
4.2
2.1
4.5
2005
2006
2007
2008
2009
8.6
7.8
5.9
6.0
8.3
6.8
8.1
2.7
2.1
1.7
10.2
11.3
5.9
7.4
6.1
0.5
8.1
6.4
8.8
-4.0
7.9
7.9
5.7
5.9
7.0
7.8
8.3
8.6
7.2
6.0
3.5
13.2
-0.3
5.9
3.2
6.3
10.0
5.5
6.8
5.1
7.0
9.0
5.6
6.4
6.0
4.0
4.6
5.5
2.2
6.8
3.8
4.1
2.5
1.1
3.5
3.9
4.4
4.1
1.7
5.3
2010f
f
2011
2.2
2.1
0.2
1.9
8.9
9.1
4.7
1.9
2.4
2.2
6.4
7.2
7.0
5.9
6.6
6.8
4.7
4.7
1.6
-0.5
1.9
1.8
1.7
0.5
1985
1986
1987
1988
1989
27.6
28.1
28.6
28.8
29.5
1.5
1.4
1.4
1.6
1.8
0.3
0.3
0.4
0.4
0.4
-----------
29.4
29.9
30.4
30.8
31.6
------20.5
20.2
------16.4
16.5
38.1
38.5
36.6
36.8
36.7
67.5
68.3
67.0
67.7
68.3
-----------
-----------
32.5
31.7
33.0
32.3
31.7
1990
1991
1992
1993
1994
30.6
31.5
31.8
30.7
29.9
1.9
1.9
1.9
2.0
2.2
0.4
0.4
0.4
0.4
0.4
-----------
32.9
33.8
34.1
33.2
32.4
21.2
21.7
22.9
22.8
22.1
16.3
15.4
14.6
16.0
16.5
37.4
37.1
37.5
38.8
38.6
70.3
71.0
71.6
71.9
71.0
----15.1
15.0
15.5
----13.2
13.1
13.5
29.7
29.0
28.4
28.1
29.0
1995
1996
1997
1998
1999
30.4
29.2
27.2
27.4
28.8
2.2
2.2
2.2
2.2
2.4
0.4
0.4
0.4
0.4
0.4
----1.5
1.7
1.9
33.0
31.9
31.3
31.7
33.5
23.1
23.7
24.2
25.5
24.9
16.5
17.2
18.7
17.6
16.9
39.6
40.9
42.9
43.1
41.8
72.6
72.8
74.1
74.9
75.3
14.5
14.4
13.6
13.2
13.1
12.9
12.8
12.2
12.0
11.6
27.4
27.2
25.9
25.1
24.7
(Annual Percentage Change)
--13.2
15.9
10.1
10.7
(Percentage Share of Total Drug Expenditure)
2000
30.1
2.3
0.4
2.2
35.0
25.5
16.9
42.5
77.4
12.0
10.6
22.6
2001
2002
2003
2004
31.3
31.7
31.6
32.1
2.3
2.4
2.5
2.4
0.5
0.5
0.5
0.6
2.2
2.4
2.9
2.8
36.3
36.9
37.5
37.9
26.9
27.2
28.2
28.6
15.6
15.9
15.6
15.4
42.5
43.1
43.9
44.0
78.8
80.0
81.4
82.0
11.3
10.7
10.1
9.9
9.9
9.3
8.5
8.1
21.2
20.0
18.6
18.0
2005
2006
2007
2008
2009
32.7
32.6
32.8
32.9
33.7
2.4
2.4
2.4
2.3
2.2
0.6
0.6
0.6
0.6
0.6
2.7
2.7
2.7
2.8
2.5
38.4
38.3
38.5
38.6
39.0
28.9
29.0
29.9
30.3
30.4
15.0
15.7
14.9
14.9
14.6
44.0
44.7
44.7
45.3
44.9
82.4
83.0
83.2
83.8
83.9
9.7
9.4
9.4
9.1
9.1
7.9
7.6
7.4
7.1
6.9
17.6
17.0
16.8
16.2
16.1
2010f
f
2011
33.0
32.4
2.1
2.1
0.6
0.7
2.5
2.5
38.3
37.6
31.0
32.0
14.9
15.2
f: forecast.
56
46.0
84.3
8.9
6.8
15.7
47.2
84.8
8.5
6.6
15.2
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table A Canada—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Canada, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Private
Total
Total
Public
($ Millions)
Year
(Percentage Share)
1985
1986
1987
1988
1989
1,118.7
1,319.2
1,492.7
1,702.8
1,970.9
2,683.6
3,097.9
3,422.2
3,818.9
4,267.7
3,802.3
4,417.1
4,914.9
5,521.7
6,238.5
30,095.5
32,529.4
35,055.7
38,163.7
41,911.9
9,746.9
10,808.7
11,733.5
12,796.4
14,184.3
39,842.4
43,338.1
46,789.2
50,960.1
56,096.2
3.7
4.1
4.3
4.5
4.7
27.5
28.7
29.2
29.8
30.1
9.5
10.2
10.5
10.8
11.1
1990
1991
1992
1993
1994
2,278.0
2,606.7
2,908.5
3,044.9
3,087.6
4,652.5
5,098.5
5,610.4
6,134.7
6,437.4
6,930.5
7,705.3
8,518.8
9,179.6
9,524.9
45,449.2
49,382.9
51,637.9
51,922.0
52,537.2
15,577.1
16,906.9
18,112.0
19,578.1
20,574.2
61,026.3
66,289.8
69,749.9
71,500.0
73,111.4
5.0
5.3
5.6
5.9
5.9
29.9
30.2
31.0
31.3
31.3
11.4
11.6
12.2
12.8
13.0
1995
1996
1997
1998
1999
3,365.3
3,327.7
3,597.7
4,007.5
4,551.3
6,822.2
7,120.0
7,910.0
8,614.9
9,047.9
10,187.4
10,447.8
11,507.7
12,622.4
13,599.2
52,716.3
52,803.4
55,201.3
59,186.0
63,182.8
21,370.1
21,910.5
23,533.1
24,897.9
27,180.7
74,086.4
74,713.9
78,734.4
84,083.9
90,363.4
6.4
6.3
6.5
6.8
7.2
31.9
32.5
33.6
34.6
33.3
13.8
14.0
14.6
15.0
15.0
2000
2001
2002
2003
2004
5,295.2
6,064.1
6,807.0
7,565.2
8,261.8
9,849.6
10,638.9
11,628.6
12,610.7
13,524.2
15,144.8
16,703.0
18,435.6
20,176.0
21,786.0
69,253.9
74,991.5
79,945.7
86,653.0
92,271.2
29,335.2
32,216.8
35,147.5
37,025.4
39,515.9
98,589.1
107,208.3
115,093.2
123,678.4
131,787.1
7.6
8.1
8.5
8.7
9.0
33.6
33.0
33.1
34.1
34.2
15.4
15.6
16.0
16.3
16.5
2005
2006
2007
2008
2009
8,911.5
9,616.0
10,168.0
10,771.8
11,528.2
14,282.4
15,478.1
16,271.6
17,150.6
18,035.5
23,193.8
25,094.1
26,439.6
27,922.4
29,563.7
98,603.9
105,121.3
112,531.0
121,451.3
129,089.4
42,049.5
45,802.3
47,916.3
50,772.2
53,023.3
140,653.4
150,923.6
160,447.3
172,223.5
182,112.7
9.0
9.1
9.0
8.9
8.9
34.0
33.8
34.0
33.8
34.0
16.5
16.6
16.5
16.2
16.2
2010f
f
2011
11,803.1
12,062.5
18,997.7
19,981.5
30,800.8
32,043.9
136,857.2
140,968.4
55,996.7
59,530.7
192,853.9
200,499.1
8.6
8.6
33.9
33.6
16.0
16.0
1985
1986
1987
1988
1989
--17.9
13.2
14.1
15.7
--15.4
10.5
11.6
11.8
--16.2
11.3
12.3
13.0
--8.1
7.8
8.9
9.8
--10.9
8.6
9.1
10.8
--8.8
8.0
8.9
10.1
1990
1991
1992
1993
1994
15.6
14.4
11.6
4.7
1.4
9.0
9.6
10.0
9.3
4.9
11.1
11.2
10.6
7.8
3.8
8.4
8.7
4.6
0.6
1.2
9.8
8.5
7.1
8.1
5.1
8.8
8.6
5.2
2.5
2.3
1995
1996
1997
1998
1999
9.0
-1.1
8.1
11.4
13.6
6.0
4.4
11.1
8.9
5.0
7.0
2.6
10.1
9.7
7.7
0.3
0.2
4.5
7.2
6.8
3.9
2.5
7.4
5.8
9.2
1.3
0.8
5.4
6.8
7.5
2000
2001
2002
2003
2004
16.3
14.5
12.3
11.1
9.2
8.9
8.0
9.3
8.4
7.2
11.4
10.3
10.4
9.4
8.0
9.6
8.3
6.6
8.4
6.5
7.9
9.8
9.1
5.3
6.7
9.1
8.7
7.4
7.5
6.6
2005
2006
2007
2008
2009
7.9
7.9
5.7
5.9
7.0
5.6
8.4
5.1
5.4
5.2
6.5
8.2
5.4
5.6
5.9
6.9
6.6
7.0
7.9
6.3
6.4
8.9
4.6
6.0
4.4
6.7
7.3
6.3
7.3
5.7
2010 f
f
2011
2.4
2.2
5.3
5.2
4.2
4.0
6.0
3.0
5.6
6.3
5.9
4.0
CA
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
29.4
29.9
30.4
30.8
31.6
70.6
70.1
69.6
69.2
68.4
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
32.9
33.8
34.1
33.2
32.4
67.1
66.2
65.9
66.8
67.6
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
33.0
31.9
31.3
31.7
33.5
67.0
68.1
68.7
68.3
66.5
100.0
100.0
100.0
100.0
100.0
2000
35.0
65.0
100.0
2001
2002
2003
2004
36.3
36.9
37.5
37.9
63.7
63.1
62.5
62.1
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009
38.4
38.3
38.5
38.6
39.0
61.6
61.7
61.5
61.4
61.0
100.0
100.0
100.0
100.0
100.0
2010f
f
2011
38.3
37.6
61.7
62.4
100.0
100.0
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
57
Drug Expenditure in Canada, 1985 to 2011
Table A Canada—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Canada, 1985 to 2011
Provincial/
Territorial
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers
Out of
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Federal
Year
CA
Subtotal
Private
Total
Prescribed
Drugs
OvertheCounter
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
Personal
Total
Health
Non-Presc.
Supplies
Drugs
1985
1986
1987
1988
1989
40.56
47.53
53.18
59.44
67.37
2.24
2.43
2.58
3.33
4.03
0.49
0.58
0.67
0.78
0.84
-----------
43.29
50.54
56.44
63.55
72.24
------42.18
46.21
------33.72
37.81
56.02
65.09
68.07
75.91
84.01
99.31
115.63
124.51
139.46
156.25
-----------
-----------
47.82
53.60
61.32
66.61
72.42
1990
1991
1992
1993
1994
76.55
86.62
95.56
98.22
98.11
4.70
5.19
5.63
6.54
7.14
0.99
1.18
1.34
1.40
1.22
-----------
82.24
92.99
102.53
106.16
106.47
52.96
59.63
68.65
72.84
72.59
40.69
42.47
43.89
51.23
54.08
93.65
102.10
112.53
124.07
126.67
175.89
195.09
215.07
230.23
233.14
----45.48
47.87
50.87
----39.77
41.95
44.45
74.33
79.79
85.24
89.81
95.31
1995
1996
1997
1998
1999
105.78
103.08
104.77
114.81
128.74
7.78
7.90
8.44
9.41
10.56
1.29
1.40
1.43
1.59
1.77
----5.65
7.08
8.63
114.85
112.38
120.30
132.89
149.70
80.20
83.64
93.13
106.79
111.40
57.46
60.68
71.82
73.71
75.71
137.66
144.32
164.95
180.51
187.12
252.51
256.70
285.24
313.39
336.81
50.31
50.93
52.47
55.10
58.61
44.85
45.21
47.07
50.06
51.86
95.16
96.14
99.53
105.16
110.47
2000
2001
2002
2003
2004
148.57
168.56
186.12
201.31
218.68
11.19
12.64
14.29
16.04
16.52
2.11
2.44
2.76
3.24
3.79
10.68
11.84
13.81
18.24
19.24
172.55
195.48
216.97
238.83
258.22
126.00
144.71
159.68
179.71
194.69
83.50
84.25
93.53
99.63
105.17
209.50
228.96
253.21
279.34
299.86
382.04
424.44
470.18
518.17
558.08
59.15
60.68
62.86
64.64
67.49
52.30
53.32
54.59
54.13
55.35
111.45
114.00
117.45
118.77
122.84
2005
2006
2007
2008
2009
235.05
251.37
263.35
275.80
295.20
17.47
18.72
19.03
19.20
19.30
4.13
4.56
4.78
5.07
5.31
19.15
20.54
21.62
23.25
22.06
275.79
295.19
308.78
323.32
341.88
207.80
223.15
239.81
254.15
266.22
107.83
121.11
119.49
125.10
127.58
315.62
344.27
359.30
379.25
393.80
591.42
639.45
668.08
702.57
735.68
69.49
72.10
75.26
76.00
80.19
56.90
58.77
59.57
59.54
60.87
126.39
130.87
134.83
135.54
141.06
2010f
f
2011
298.36
301.18
19.12
19.26
5.72
6.17
22.84
23.00
346.04
349.62
280.15
296.94
134.95
141.27
415.10
438.21
761.14
787.82
80.57
79.21
61.31
61.72
141.87
140.93
1985
1986
1987
1988
1989
--17.2
11.9
11.8
13.3
--8.1
6.3
29.2
21.0
--19.7
15.4
15.1
8.1
-----------
--16.8
11.7
12.6
13.7
--------9.5
--------12.1
--16.2
4.6
11.5
10.7
--16.4
7.7
12.0
12.0
-----------
-----------
1990
1991
1992
1993
1994
13.6
13.2
10.3
2.8
-0.1
16.7
10.4
8.4
16.2
9.2
18.2
19.4
13.4
4.5
-12.8
-----------
13.8
13.1
10.3
3.5
0.3
14.6
12.6
15.1
6.1
-0.3
7.6
4.4
3.3
16.7
5.6
11.5
9.0
10.2
10.3
2.1
12.6
10.9
10.2
7.1
1.3
------5.3
6.3
------5.5
6.0
2.6
7.3
6.8
5.4
6.1
1995
1996
1997
1998
1999
7.8
-2.6
1.6
9.6
12.1
8.9
1.6
6.8
11.4
12.2
5.4
8.5
2.2
11.1
11.2
------25.2
22.0
7.9
-2.1
7.0
10.5
12.6
10.5
4.3
11.3
14.7
4.3
6.3
5.6
18.4
2.6
2.7
8.7
4.8
14.3
9.4
3.7
8.3
1.7
11.1
9.9
7.5
-1.1
1.2
3.0
5.0
6.4
0.9
0.8
4.1
6.4
3.6
-0.2
1.0
3.5
5.7
5.1
(Annual Percentage Change)
2000
15.4
6.0
19.6
23.7
15.3
13.1
10.3
12.0
13.4
0.9
0.9
--12.1
14.4
8.6
8.7
0.9
2001
13.5
13.0
15.7
10.9
13.3
14.8
0.9
9.3
11.1
2.6
1.9
2.3
2002
10.4
13.1
12.8
16.6
11.0
10.3
11.0
10.6
10.8
3.6
2.4
3.0
2003
8.2
12.3
17.5
32.1
10.1
12.5
6.5
10.3
10.2
2.8
-0.8
1.1
2004
8.6
3.0
16.9
5.5
8.1
8.3
5.6
7.3
7.7
4.4
2.3
3.4
2005
2006
2007
2008
2009
7.5
6.9
4.8
4.7
7.0
5.7
7.2
1.6
0.9
0.5
9.1
10.4
4.8
6.1
4.8
-0.5
7.2
5.3
7.5
-5.1
6.8
7.0
4.6
4.7
5.7
6.7
7.4
7.5
6.0
4.7
2.5
12.3
-1.3
4.7
2.0
5.3
9.1
4.4
5.6
3.8
6.0
8.1
4.5
5.2
4.7
3.0
3.8
4.4
1.0
5.5
2.8
3.3
1.4
0.0
2.2
2.9
3.5
3.0
0.5
4.1
2010f
f
2011
1.1
0.9
-0.9
0.7
7.7
7.9
3.5
0.7
1.2
1.0
5.2
6.0
5.8
4.7
5.4
5.6
3.5
3.5
0.5
-1.7
0.7
0.7
0.6
-0.7
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--14.4
7.1
7.2
8.8
--5.3
1.6
24.7
16.4
--16.9
10.6
10.6
3.5
-----------
--14.0
6.9
8.1
9.1
-----------
-----------
--13.4
-0.2
7.0
6.1
--13.6
2.9
7.5
7.5
1990
1991
1992
1993
1994
10.6
10.4
9.1
1.3
-1.2
13.6
7.6
7.1
14.7
8.1
15.2
16.6
12.2
3.1
-13.9
-----------
10.8
10.3
9.0
2.1
-0.8
-----------
-----------
8.4
6.3
9.0
8.8
1.0
1995
1996
1997
1998
1999
5.5
-4.2
0.6
10.0
10.3
6.5
0.0
5.8
11.9
10.4
3.0
6.8
1.2
11.6
9.4
------25.6
20.2
5.5
-3.8
6.1
10.9
10.8
-----------
-----------
6.3
3.2
13.3
9.9
1.9
-----------
--9.3
9.7
4.1
4.1
9.5
8.2
9.0
5.6
0.2
------3.8
5.2
------4.0
4.9
-0.4
4.6
5.6
3.9
5.0
6.0
0.0
10.1
10.3
5.7
-3.4
-0.4
2.0
5.5
4.6
-1.4
-0.9
3.1
6.8
1.8
-2.5
-0.6
2.5
6.1
3.2
2000
11.3
1.9
15.5
19.6
11.2
---
---
7.9
9.3
-3.2
-3.3
-3.2
2001
2002
2003
2004
12.1
9.4
5.3
6.0
11.6
12.0
9.4
0.4
14.4
11.7
14.6
14.3
9.5
15.6
29.2
2.9
11.9
9.9
7.2
5.5
---------
---------
7.9
9.5
7.4
4.8
9.7
9.7
7.3
5.1
1.2
2.6
-0.1
1.8
0.6
1.3
-3.7
-0.3
0.9
2.0
-1.8
0.8
2005
2006
2007
2008
4.5
4.1
1.1
-0.1
2.7
4.4
-2.0
-4.0
6.1
7.6
1.1
1.3
-3.5
4.4
1.6
2.7
3.8
4.2
0.9
-0.2
---------
---------
2.2
6.3
0.7
0.7
3.0
5.3
0.8
0.3
0.0
1.0
0.7
-3.9
-0.2
0.5
-2.3
-4.9
-0.1
0.7
-0.7
-4.3
2009
9.7
3.2
7.5
-2.4
8.4
---
---
6.5
7.4
8.2
4.9
6.8
2010f
-1.9
-3.9
4.7
0.6
-1.7
---
---
2.5
0.5
-2.5
-2.2
-2.4
f
-3.0
-3.3
3.9
-3.3
-3.0
---
---
2011
f: forecast.
58
-----------
1.6
-0.5
-5.7
-3.3
-4.7
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table A Canada—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Canada, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Year
Health Expenditure
Private
Public
GDP Implicit
Price Index—Canada
Total
(1997 = 100)
($ per Capita)
1985
1986
1987
1988
1989
43.29
50.54
56.44
63.55
72.24
103.84
118.69
129.39
142.52
156.43
147.13
169.23
185.82
206.07
228.67
1,164.56
1,246.28
1,325.41
1,424.26
1,536.26
377.16
414.11
443.63
477.56
519.92
1,541.72
1,660.39
1,769.04
1,901.82
2,056.18
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
82.24
92.99
102.53
106.16
106.47
167.98
181.89
197.78
213.89
221.98
250.22
274.88
300.31
320.05
328.46
1,640.91
1,761.70
1,820.36
1,810.27
1,811.68
562.40
603.14
638.49
682.59
709.48
2,203.31
2,364.84
2,458.85
2,492.87
2,521.16
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
114.85
112.38
120.30
132.89
149.70
232.82
240.45
264.48
285.67
297.59
347.67
352.84
384.78
418.56
447.28
1,799.05
1,783.24
1,845.74
1,962.59
2,078.12
729.30
739.95
786.87
825.61
893.99
2,528.35
2,523.19
2,632.61
2,788.20
2,972.10
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
172.55
195.48
216.97
238.83
258.22
320.95
342.96
370.66
398.12
422.69
493.49
538.44
587.63
636.95
680.92
2,256.63
2,417.42
2,548.27
2,735.60
2,883.91
955.88
1,038.54
1,120.32
1,168.88
1,235.06
3,212.52
3,455.96
3,668.59
3,904.47
4,118.96
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009
275.79
295.19
308.78
323.32
341.88
442.01
475.14
494.13
514.79
534.86
717.81
770.32
802.91
838.11
876.74
3,051.61
3,226.95
3,417.31
3,645.44
3,828.25
1,301.36
1,406.01
1,455.11
1,523.96
1,572.45
4,352.97
4,632.96
4,872.41
5,169.40
5,400.70
117.5
120.8
125.2
131.3
127.8
2010f
f
2011
346.04
349.62
556.97
579.14
903.02
928.75
4,012.38
4,085.79
1,641.71
1,725.42
5,654.09
5,811.22
131.5
136.8
1985
1986
1987
1988
1989
--16.8
11.7
12.6
13.7
--14.3
9.0
10.2
9.8
--15.0
9.8
10.9
11.0
--7.0
6.3
7.5
7.9
--9.8
7.1
7.6
8.9
--7.7
6.5
7.5
8.1
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
13.8
13.1
10.3
3.5
0.3
7.4
8.3
8.7
8.1
3.8
9.4
9.9
9.3
6.6
2.6
6.8
7.4
3.3
-0.6
0.1
8.2
7.2
5.9
6.9
3.9
7.2
7.3
4.0
1.4
1.1
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
7.9
-2.1
7.0
10.5
12.6
4.9
3.3
10.0
8.0
4.2
5.8
1.5
9.1
8.8
6.9
-0.7
-0.9
3.5
6.3
5.9
2.8
1.5
6.3
4.9
8.3
0.3
-0.2
4.3
5.9
6.6
2.3
1.7
1.0
-0.4
1.8
7.8
10.3
CA
(Annual Percentage Change)
2000
15.3
8.6
6.9
8.1
4.1
2001
13.3
6.9
9.1
7.1
8.6
7.6
1.4
2002
11.0
8.1
9.1
5.4
7.9
6.2
1.0
2003
10.1
7.4
8.4
7.4
4.3
6.4
2.9
2004
8.1
6.2
6.9
5.4
5.7
5.5
2.6
2005
2006
2007
2008
2009
6.8
7.0
4.6
4.7
5.7
4.6
7.5
4.0
4.2
3.9
5.4
7.3
4.2
4.4
4.6
5.8
5.7
5.9
6.7
5.0
5.4
8.0
3.5
4.7
3.2
5.7
6.4
5.2
6.1
4.5
3.0
2.8
3.7
4.9
-2.7
2010 f
f
2011
1.2
1.0
4.1
4.0
3.0
2.8
4.8
1.8
4.4
5.1
4.7
2.8
2.9
4.0
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--14.0
6.9
8.1
9.1
--11.5
4.3
5.6
5.2
--12.2
5.1
6.4
6.4
--4.2
1.6
2.9
3.3
--7.0
2.4
3.1
4.3
--4.9
1.8
3.0
3.6
1990
1991
1992
1993
1994
10.8
10.3
9.0
2.1
-0.8
4.4
5.5
7.5
6.7
2.7
6.4
7.1
8.0
5.1
1.5
3.8
4.6
2.1
-2.0
-1.0
5.1
4.5
4.6
5.5
2.8
4.1
4.6
2.7
-0.1
0.0
1995
1996
1997
1998
1999
5.5
-3.8
6.1
10.9
10.8
2.5
1.6
9.0
8.4
2.4
3.5
-0.2
8.1
9.2
5.1
-3.0
-2.6
2.5
6.8
4.1
0.5
-0.2
5.3
5.4
6.5
-2.1
-1.9
3.3
6.3
4.8
2000
11.2
3.7
6.2
4.5
2.8
4.0
2001
2002
2003
2004
11.9
9.9
7.2
5.5
5.5
7.0
4.5
3.6
7.8
8.1
5.5
4.3
5.8
4.4
4.5
2.8
7.3
6.8
1.4
3.1
6.2
5.1
3.5
2.9
2005
2006
2007
2008
3.8
4.2
0.9
-0.2
1.6
4.7
0.3
-0.7
2.4
4.5
0.5
-0.5
2.8
2.9
2.2
1.8
2.4
5.2
-0.2
-0.1
2.7
3.6
1.5
1.2
7.2
8.4
6.6
7.3
7.7
5.9
2010 f
2009
-1.7
1.2
0.1
1.9
1.5
f
-3.0
0.0
-1.1
-2.2
1.1
2011
f: forecast.
1.7
-1.2
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
59
Series B—Expenditure on Drugs by Type, by
Source of Finance and as a Share of Public,
Private and Total Health Expenditure,
by Province/Territory, 1985 to 2011
Drug Expenditure in Canada, 1985 to 2011
Table B N.L.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Newfoundland and Labrador, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out of
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Federal
Year
N.L.
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter
Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
18.0
21.4
24.7
28.2
31.2
2.3
2.7
3.1
1.6
1.3
0.1
0.2
0.3
0.4
0.4
-----------
20.4
24.4
28.1
30.2
32.9
-----------
-----------
82.8
51.6
55.1
58.7
62.5
103.2
76.0
83.2
88.9
95.4
-----------
-----------
24.9
28.2
32.7
32.3
32.0
1990
1991
1992
1993
1994
35.3
40.3
43.9
47.8
52.1
1.6
1.7
1.7
2.2
2.5
0.6
0.8
1.1
1.2
1.2
-----------
37.5
42.8
46.6
51.1
55.8
-----------
-----------
64.7
65.8
72.9
76.1
77.9
102.2
108.5
119.5
127.2
133.7
----20.6
21.7
22.9
----17.9
18.2
18.3
34.3
37.8
38.6
39.9
41.2
1995
1996
1997
1998
1999
54.5
54.5
53.6
56.1
60.0
2.8
2.7
3.3
3.7
4.1
1.5
1.8
1.9
2.4
2.8
-----------
58.8
59.0
58.8
62.1
66.9
-----------
-----------
85.6
90.0
87.9
93.7
103.3
144.4
149.0
146.7
155.8
170.2
22.5
24.7
21.4
23.3
25.6
19.9
21.9
18.9
21.0
22.5
42.3
46.7
40.3
44.3
48.1
2000
2001
2002
2003
2004
68.0
77.9
86.9
96.0
101.7
5.8
6.6
7.4
8.1
7.8
3.8
4.2
5.0
4.7
4.8
-----------
77.6
88.7
99.3
108.9
114.4
-----------
-----------
119.9
129.2
150.2
169.0
178.4
197.5
217.9
249.5
277.8
292.7
26.1
25.8
26.6
27.0
27.8
22.2
22.6
23.0
22.5
23.1
48.3
48.3
49.7
49.5
50.9
2005
2006
2007
2008
2009
106.0
108.1
116.9
122.3
128.7
8.0
7.7
7.3
7.1
7.5
5.1
5.1
5.1
5.2
6.2
-----------
119.0
121.0
129.4
134.5
142.4
-----------
-----------
196.7
208.4
241.2
229.2
250.9
315.8
329.4
370.6
363.7
393.3
27.4
28.3
29.6
29.6
32.4
22.3
23.0
23.3
23.1
24.5
49.7
51.3
52.8
52.7
57.0
2010f
135.8
7.6
6.2
---
149.6
---
---
279.4
429.0
32.6
24.8
57.5
2011f
148.0
7.8
6.8
---
162.6
---
---
305.4
467.9
32.0
25.1
57.1
-----------
-----------
--13.2
16.0
-1.0
-1.0
(Annual Percentage Change)
1985
1986
1987
1988
1989
--19.2
15.4
13.9
10.6
--20.4
13.5
-48.0
-20.2
--35.5
34.3
50.0
14.5
-----------
--19.4
15.3
7.4
9.0
-----------
-----------
---37.6
6.7
6.6
6.6
---26.3
9.4
6.8
7.4
1990
1991
1992
1993
1994
13.4
14.1
8.8
8.9
9.1
21.5
9.6
-3.5
31.4
12.4
38.7
25.5
40.5
9.2
7.4
-----------
14.0
14.1
8.9
9.7
9.2
-----------
-----------
3.4
1.7
10.8
4.5
2.3
7.1
6.2
10.1
6.5
5.1
------5.4
5.3
------1.1
0.8
7.1
10.3
2.0
3.4
3.3
1995
1996
1997
1998
1999
4.6
0.0
-1.6
4.6
7.0
12.3
-2.7
23.0
10.5
12.0
22.5
18.8
3.4
28.6
16.0
-----------
5.4
0.4
-0.4
5.6
7.7
-----------
-----------
9.9
5.1
-2.3
6.5
10.3
8.0
3.2
-1.5
6.2
9.3
-1.8
10.1
-13.4
8.8
9.9
8.6
10.3
-14.0
11.5
7.0
2.8
10.2
-13.7
10.0
8.5
2000
2001
2002
2003
2004
13.4
14.5
11.5
10.6
5.9
40.7
15.5
11.9
8.3
-3.0
37.7
8.8
19.9
-4.9
2.2
-----------
16.1
14.3
12.0
9.6
5.1
-----------
-----------
16.0
7.8
16.2
12.5
5.5
16.0
10.3
14.5
11.4
5.4
2.2
-1.4
3.3
1.2
3.2
-1.4
1.7
2.1
-2.3
2.5
0.5
0.1
2.8
-0.4
2.8
2005
2006
2007
2008
2009
4.2
2.0
8.1
4.6
5.2
1.8
-3.1
-5.0
-3.5
5.6
4.5
1.5
-0.7
1.0
20.7
-----------
4.1
1.7
6.9
4.0
5.8
-----------
-----------
10.3
5.9
15.7
-5.0
9.5
7.9
4.3
12.5
-1.9
8.1
-1.6
3.4
4.4
0.2
9.5
-3.2
2.9
1.3
-0.6
6.1
-2.3
3.2
3.0
-0.2
8.0
2010f
f
2011
5.5
9.0
1.9
1.9
-1.0
10.6
-----
5.0
8.7
-----
-----
11.4
9.3
9.1
9.1
0.6
-2.0
1.3
1.1
0.9
-0.6
1985
1986
1987
1988
1989
14.0
20.6
21.3
23.2
24.4
1.8
2.6
2.7
1.3
1.0
0.1
0.2
0.2
0.3
0.3
-----------
15.9
23.4
24.3
24.9
25.8
-----------
-----------
64.6
49.6
47.5
48.4
49.1
80.6
73.0
71.8
73.3
74.9
-----------
-----------
19.4
27.0
28.2
26.7
25.1
1990
1991
1992
1993
1994
25.9
27.5
27.8
28.6
29.8
1.2
1.2
1.1
1.3
1.4
0.4
0.5
0.7
0.7
0.7
-----------
27.5
29.2
29.5
30.6
31.9
-----------
-----------
47.4
44.9
46.1
45.6
44.6
74.9
74.2
75.6
76.1
76.5
----13.0
13.0
13.1
----11.4
10.9
10.5
25.1
25.8
24.4
23.9
23.5
1995
1996
1997
1998
1999
29.2
27.9
28.7
28.0
27.5
1.5
1.4
1.8
1.8
1.9
0.8
0.9
1.0
1.2
1.3
-----------
31.5
30.2
31.4
31.0
30.6
-----------
-----------
45.9
46.0
47.0
46.8
47.3
77.3
76.2
78.5
77.9
78.0
12.0
12.6
11.4
11.6
11.7
10.6
11.2
10.1
10.5
10.3
22.7
23.8
21.5
22.1
22.0
(Percentage Share of Total Drug Expenditure)
2000
27.7
2.3
1.6
---
31.6
---
---
48.8
80.3
10.6
9.0
19.7
2001
2002
2003
2004
29.3
29.0
29.3
29.6
2.5
2.5
2.5
2.3
1.6
1.7
1.4
1.4
---------
33.3
33.2
33.3
33.3
---------
---------
48.5
50.2
51.6
51.9
81.8
83.4
84.9
85.2
9.7
8.9
8.2
8.1
8.5
7.7
6.9
6.7
18.2
16.6
15.1
14.8
2005
2006
2007
2008
2009
29.0
28.4
27.6
29.4
28.6
2.2
2.0
1.7
1.7
1.7
1.4
1.4
1.2
1.2
1.4
-----------
32.6
31.8
30.6
32.3
31.6
-----------
-----------
53.8
54.7
57.0
55.0
55.7
86.4
86.5
87.5
87.3
87.3
7.5
7.4
7.0
7.1
7.2
6.1
6.0
5.5
5.6
5.4
13.6
13.5
12.5
12.7
12.7
27.9
1.6
1.3
28.2
1.5
1.3
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
-----
30.7
31.0
-----
-----
57.4
58.2
88.2
89.1
6.7
6.1
5.1
4.8
11.8
10.9
2010f
f
2011
62
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B N.L.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Newfoundland and Labrador, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Private
Total
Public
($ Millions)
Year
Total
(Percentage Share)
1985
1986
1987
1988
1989
20.4
24.4
28.1
30.2
32.9
107.7
79.8
87.8
91.0
94.6
128.1
104.2
115.9
121.2
127.4
588.8
642.9
693.6
733.8
787.7
197.1
169.6
188.0
197.1
203.9
785.8
812.5
881.6
930.9
991.6
3.5
3.8
4.1
4.1
4.2
54.6
47.1
46.7
46.2
46.4
16.3
12.8
13.1
13.0
12.9
1990
1991
1992
1993
1994
37.5
42.8
46.6
51.1
55.8
99.0
103.6
111.4
116.0
119.1
136.5
146.4
158.0
167.1
174.9
875.9
905.7
928.3
924.9
948.1
220.6
247.5
269.1
284.2
301.1
1,096.4
1,153.2
1,197.4
1,209.1
1,249.3
4.3
4.7
5.0
5.5
5.9
44.9
41.8
41.4
40.8
39.6
12.4
12.7
13.2
13.8
14.0
1995
1996
1997
1998
1999
58.8
59.0
58.8
62.1
66.9
128.0
136.7
128.2
138.0
151.4
186.7
195.6
187.0
200.1
218.3
973.1
974.4
1,020.8
1,107.8
1,250.8
296.4
279.0
284.5
325.6
332.5
1,269.4
1,253.4
1,305.4
1,433.4
1,583.3
6.0
6.1
5.8
5.6
5.3
43.2
49.0
45.1
42.4
45.5
14.7
15.6
14.3
14.0
13.8
2000
2001
2002
2003
2004
77.6
88.7
99.3
108.9
114.4
168.2
177.5
199.8
218.5
229.2
245.8
266.2
299.1
327.3
343.6
1,318.7
1,415.5
1,510.0
1,591.3
1,628.9
368.6
387.4
416.0
470.5
509.2
1,687.2
1,802.9
1,926.1
2,061.8
2,138.1
5.9
6.3
6.6
6.8
7.0
45.6
45.8
48.0
46.4
45.0
14.6
14.8
15.5
15.9
16.1
2005
2006
2007
2008
2009
119.0
121.0
129.4
134.5
142.4
246.4
259.7
294.0
281.9
307.9
365.5
380.7
423.4
416.4
450.3
1,684.8
1,783.2
1,926.8
2,096.8
2,313.8
550.4
561.5
632.3
638.2
686.6
2,235.2
2,344.7
2,559.2
2,735.0
3,000.4
7.1
6.8
6.7
6.4
6.2
44.8
46.3
46.5
44.2
44.8
16.4
16.2
16.5
15.2
15.0
2010f
149.6
336.9
486.5
2,540.0
757.6
3,297.5
5.9
44.5
14.8
2011f
162.6
362.5
525.0
2,694.7
805.3
3,500.0
6.0
45.0
15.0
N.L.
(Annual Percentage Change)
1985
1986
1987
1988
1989
--19.4
15.3
7.4
9.0
---25.9
9.9
3.7
3.9
---18.6
11.2
4.6
5.1
--9.2
7.9
5.8
7.4
---13.9
10.9
4.8
3.4
--3.4
8.5
5.6
6.5
1990
1991
1992
1993
1994
14.0
14.1
8.9
9.7
9.2
4.7
4.7
7.6
4.1
2.7
7.1
7.3
8.0
5.8
4.7
11.2
3.4
2.5
-0.4
2.5
8.2
12.2
8.7
5.6
6.0
10.6
5.2
3.8
1.0
3.3
1995
1996
1997
1998
1999
5.4
0.4
-0.4
5.6
7.7
7.4
6.8
-6.2
7.6
9.7
6.8
4.8
-4.4
7.0
9.1
2.6
0.1
4.8
8.5
12.9
-1.6
-5.9
2.0
14.4
2.1
1.6
-1.3
4.1
9.8
10.5
2000
2001
2002
2003
2004
16.1
14.3
12.0
9.6
5.1
11.1
5.6
12.6
9.3
4.9
12.6
8.3
12.4
9.4
5.0
5.4
7.3
6.7
5.4
2.4
10.8
5.1
7.4
13.1
8.2
6.6
6.9
6.8
7.0
3.7
2005
2006
2007
2008
2009
4.1
1.7
6.9
4.0
5.8
7.5
5.4
13.2
-4.1
9.2
6.4
4.2
11.2
-1.6
8.1
3.4
5.8
8.1
8.8
10.3
8.1
2.0
12.6
0.9
7.6
4.5
4.9
9.1
6.9
9.7
2010f
f
2011
5.0
8.7
9.4
7.6
8.0
7.9
9.8
6.1
10.3
6.3
9.9
6.1
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
15.9
23.4
24.3
24.9
25.8
84.1
76.6
75.7
75.1
74.2
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
27.5
29.2
29.5
30.6
31.9
72.5
70.8
70.5
69.4
68.1
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
31.5
30.2
31.4
31.0
30.6
68.5
69.8
68.6
69.0
69.4
100.0
100.0
100.0
100.0
100.0
2000
31.6
68.4
100.0
2001
2002
2003
2004
33.3
33.2
33.3
33.3
66.7
66.8
66.7
66.7
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009
32.6
31.8
30.6
32.3
31.6
67.4
68.2
69.4
67.7
68.4
100.0
100.0
100.0
100.0
100.0
2010f
f
2011
30.7
31.0
69.3
69.0
100.0
100.0
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
63
Drug Expenditure in Canada, 1985 to 2011
Table B N.L.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Newfoundland and Labrador, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Subtotal
Insurers*
Out of
Social Security Funds
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Federal
Year
N.L.
Subtotal
Private
Total
Prescribed
Drugs
OvertheCounter
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
Personal
Total
Health
Non-Presc.
Supplies
Drugs
1985
1986
1987
1988
1989
31.05
37.19
43.00
49.00
54.05
3.94
4.77
5.42
2.82
2.25
0.24
0.32
0.44
0.66
0.75
-----------
35.23
42.28
48.86
52.48
57.04
-----------
-----------
142.89
89.58
95.77
102.08
108.52
178.12
131.86
144.63
154.56
165.56
-----------
-----------
42.96
48.89
56.82
56.25
55.53
1990
1991
1992
1993
1994
61.11
69.56
75.61
82.36
90.69
2.72
2.97
2.87
3.77
4.28
1.03
1.30
1.82
1.99
2.15
-----------
64.87
73.83
80.30
88.12
97.12
-----------
-----------
111.92
113.48
125.66
131.28
135.64
176.79
187.30
205.95
219.40
232.75
----35.54
37.46
39.83
----30.94
31.30
31.86
59.30
65.26
66.48
68.77
71.69
1995
1996
1997
1998
1999
96.05
97.36
97.30
103.81
112.49
4.86
4.80
6.00
6.76
7.67
2.67
3.22
3.38
4.43
5.20
-----------
103.58
105.37
106.67
115.01
125.36
-----------
-----------
150.89
160.78
159.58
173.46
193.70
254.47
266.15
266.25
288.47
319.07
39.59
44.17
38.85
43.13
47.96
35.02
39.17
34.22
38.93
42.18
74.61
83.34
73.08
82.06
90.14
2000
2001
2002
2003
2004
128.84
149.21
167.25
185.27
196.64
10.90
12.73
14.32
15.54
15.11
7.24
7.97
9.60
9.15
9.37
-----------
146.98
169.91
191.17
209.96
221.13
-----------
-----------
226.98
247.46
289.07
325.97
344.79
373.96
417.37
480.24
535.94
565.91
49.52
49.41
51.30
52.01
53.78
42.00
43.21
44.35
43.41
44.57
91.52
92.63
95.65
95.42
98.35
2005
2006
2007
2008
2009
206.17
211.91
230.95
241.59
253.26
15.48
15.11
14.47
13.97
14.70
9.86
10.08
10.09
10.19
12.25
-----------
231.51
237.10
255.51
265.75
280.21
-----------
-----------
382.64
408.42
476.27
452.73
493.82
614.15
645.53
731.78
718.49
774.03
53.25
55.48
58.39
58.53
63.84
43.42
45.00
45.95
45.67
48.27
96.67
100.48
104.34
104.20
112.12
2010f
f
2011
266.37
291.08
14.93
15.26
12.09
13.40
-----
293.39
319.74
-----
-----
548.21
600.61
841.60
920.35
64.00
62.89
48.75
49.42
112.75
112.31
1985
1986
1987
1988
1989
--19.8
15.6
14.0
10.3
--21.0
13.7
-48.0
-20.4
--36.2
34.7
50.0
14.2
-----------
--20.0
15.6
7.4
8.7
-----------
-----------
---37.3
6.9
6.6
6.3
---26.0
9.7
6.9
7.1
-----------
-----------
--13.8
16.2
-1.0
-1.3
1990
1991
1992
1993
1994
13.1
13.8
8.7
8.9
10.1
21.2
9.3
-3.5
31.4
13.4
38.3
25.2
40.4
9.3
8.4
-----------
13.7
13.8
8.8
9.7
10.2
-----------
-----------
3.1
1.4
10.7
4.5
3.3
6.8
5.9
10.0
6.5
6.1
------5.4
6.3
------1.2
1.8
6.8
10.0
1.9
3.4
4.3
1995
1996
1997
1998
1999
5.9
1.4
-0.1
6.7
8.4
13.7
-1.3
25.0
12.8
13.4
24.1
20.4
5.1
31.2
17.4
-----------
6.7
1.7
1.2
7.8
9.0
-----------
-----------
11.2
6.6
-0.7
8.7
11.7
9.3
4.6
0.0
8.3
10.6
-0.6
11.6
-12.0
11.0
11.2
9.9
11.8
-12.6
13.8
8.3
4.1
11.7
-12.3
12.3
9.8
2000
14.5
42.2
39.1
---
17.2
---
---
17.2
17.2
3.2
-0.4
2001
15.8
16.8
10.1
---
15.6
---
---
9.0
11.6
-0.2
2.9
1.2
2002
12.1
12.5
20.4
---
12.5
---
---
16.8
15.1
3.8
2.6
3.3
-0.2
(Annual Percentage Change)
1.5
2003
10.8
8.5
-4.7
---
9.8
---
---
12.8
11.6
1.4
-2.1
2004
6.1
-2.8
2.5
---
5.3
---
---
5.8
5.6
3.4
2.7
3.1
2005
2006
2007
2008
2009
4.8
2.8
9.0
4.6
4.8
2.5
-2.4
-4.2
-3.5
5.2
5.1
2.3
0.0
1.0
20.2
-----------
4.7
2.4
7.8
4.0
5.4
-----------
-----------
11.0
6.7
16.6
-4.9
9.1
8.5
5.1
13.4
-1.8
7.7
-1.0
4.2
5.2
0.3
9.1
-2.6
3.6
2.1
-0.6
5.7
-1.7
3.9
3.8
-0.1
7.6
2010f
f
2011
5.2
9.3
1.6
2.2
-1.3
10.9
-----
4.7
9.0
-----
-----
11.0
9.6
8.7
9.4
0.2
-1.7
1.0
1.4
0.6
-0.4
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
64
1985
1986
1987
1988
1989
--17.0
10.9
9.4
5.7
--18.2
9.0
-52.5
-25.0
--33.4
29.9
45.5
9.6
-----------
--17.2
10.8
2.9
4.1
-----------
-----------
---40.1
2.2
2.1
1.7
---28.8
4.9
2.3
2.6
-----------
-----------
1990
1991
1992
1993
1994
10.0
11.1
7.4
7.5
9.0
18.2
6.6
-4.8
29.9
12.3
35.3
22.4
39.1
7.8
7.3
-----------
10.7
11.1
7.5
8.3
9.1
-----------
-----------
0.1
-1.4
9.5
3.0
2.2
1995
1996
1997
1998
1999
3.6
-0.3
-1.1
7.1
6.6
11.4
-3.0
24.0
13.2
11.6
21.7
18.7
4.1
31.7
15.6
-----------
4.3
0.1
0.2
8.3
7.2
-----------
-----------
8.9
4.9
-1.7
9.1
9.9
--11.0
11.5
-5.5
-5.8
3.8
3.2
8.7
5.1
5.0
------4.0
5.2
-------0.3
0.7
3.8
7.3
0.6
2.0
3.2
7.0
2.9
-1.0
8.8
8.8
-2.9
9.9
-13.0
11.4
9.4
7.6
10.2
-13.6
14.2
6.5
1.7
10.0
-13.3
12.7
8.0
2000
10.4
38.1
35.0
---
13.1
---
---
13.1
13.1
-0.9
-4.5
-2.6
2001
2002
2003
2004
14.5
11.0
7.9
3.5
15.4
11.4
5.6
-5.4
8.8
19.4
-7.6
-0.1
---------
14.2
11.5
6.9
2.7
---------
---------
7.7
15.8
9.9
3.2
10.3
14.0
8.7
3.0
-1.6
2.8
-1.5
0.8
1.5
1.6
-5.0
0.1
-0.1
2.2
-3.1
0.5
2005
2006
2007
2008
2009
1.8
0.0
5.3
-0.3
7.5
-0.5
-5.2
-7.9
-8.3
7.9
2.1
-0.5
-3.7
-3.8
22.9
-----------
1.7
-0.4
4.1
-0.9
8.1
-----------
-----------
8.0
3.9
12.9
-9.8
11.8
5.5
2.3
9.7
-6.7
10.4
-4.0
1.4
1.6
-4.6
11.8
-5.6
0.8
-1.6
-5.5
8.4
-4.7
1.1
0.2
-5.0
10.3
2010f
2.2
-1.4
-4.3
f
2011
5.3
-1.8
6.9
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
-----
1.8
5.0
-----
-----
8.1
5.6
5.8
5.4
-2.7
-5.7
-2.0
-2.6
-2.4
-4.4
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B N.L.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Newfoundland and Labrador, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Year
Health Expenditure
Private
Public
GDP Implicit
Price Index—Canada
Total
(1997 = 100)
($ per Capita)
1985
1986
1987
1988
1989
35.23
42.28
48.86
52.48
57.04
185.85
138.46
152.59
158.33
164.05
221.08
180.75
201.45
210.81
221.09
1,016.34
1,115.18
1,205.91
1,276.14
1,366.63
340.16
294.15
326.89
342.81
353.75
1,356.50
1,409.34
1,532.79
1,618.95
1,720.39
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
64.87
73.83
80.30
88.12
97.12
171.22
178.73
192.14
200.04
207.33
236.09
252.56
272.44
288.16
304.44
1,515.29
1,562.86
1,600.38
1,594.84
1,650.45
381.55
427.13
463.99
489.99
524.20
1,896.84
1,989.99
2,064.37
2,084.83
2,174.65
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
103.58
105.37
106.67
115.01
125.36
225.50
244.12
232.65
255.52
283.85
329.08
349.49
339.33
370.54
409.21
1,714.87
1,740.60
1,852.68
2,051.73
2,344.87
522.27
498.31
516.33
603.02
623.44
2,237.14
2,238.91
2,369.01
2,654.75
2,968.31
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
146.98
169.91
191.17
209.96
221.13
318.50
340.09
384.72
421.39
443.14
465.48
510.00
575.89
631.36
664.27
2,497.29
2,711.82
2,907.00
3,069.40
3,148.88
698.00
742.15
800.89
907.53
984.26
3,195.28
3,453.96
3,707.89
3,976.93
4,133.15
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009
231.51
237.10
255.51
265.75
280.21
479.31
508.91
580.61
556.94
605.93
710.82
746.01
836.12
822.69
886.14
3,276.97
3,494.28
3,805.10
4,142.32
4,553.46
1,070.49
1,100.28
1,248.76
1,260.69
1,351.20
4,347.46
4,594.56
5,053.85
5,403.02
5,904.66
117.5
120.8
125.2
131.3
127.8
2010f
f
2011
293.39
319.74
660.96
712.92
954.35
1,032.66
4,982.90
5,300.01
1,486.15
1,583.83
6,469.05
6,883.84
131.5
136.8
1985
1986
1987
1988
1989
--20.0
15.6
7.4
8.7
---25.5
10.2
3.8
3.6
---18.2
11.5
4.6
4.9
--9.7
8.1
5.8
7.1
---13.5
11.1
4.9
3.2
--3.9
8.8
5.6
6.3
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
13.7
13.8
8.8
9.7
10.2
4.4
4.4
7.5
4.1
3.6
6.8
7.0
7.9
5.8
5.6
10.9
3.1
2.4
-0.3
3.5
7.9
11.9
8.6
5.6
7.0
10.3
4.9
3.7
1.0
4.3
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
6.7
1.7
1.2
7.8
9.0
8.8
8.3
-4.7
9.8
11.1
8.1
6.2
-2.9
9.2
10.4
3.9
1.5
6.4
10.7
14.3
-0.4
-4.6
3.6
16.8
3.4
2.9
0.1
5.8
12.1
11.8
2.3
1.7
1.0
-0.4
1.8
6.5
12.0
N.L.
(Annual Percentage Change)
2000
17.2
12.2
13.7
7.6
4.1
2001
15.6
6.8
9.6
8.6
6.3
8.1
1.4
2002
12.5
13.1
12.9
7.2
7.9
7.4
1.0
2003
9.8
9.5
9.6
5.6
13.3
7.3
2.9
2004
5.3
5.2
5.2
2.6
8.5
3.9
2.6
2005
2006
2007
2008
2009
4.7
2.4
7.8
4.0
5.4
8.2
6.2
14.1
-4.1
8.8
7.0
4.9
12.1
-1.6
7.7
4.1
6.6
8.9
8.9
9.9
8.8
2.8
13.5
1.0
7.2
5.2
5.7
10.0
6.9
9.3
3.0
2.8
3.7
4.9
-2.7
2010f
f
2011
4.7
9.0
9.1
7.9
7.7
8.2
9.4
6.4
10.0
6.6
9.6
6.4
2.9
4.0
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--17.2
10.8
2.9
4.1
---28.3
5.5
-0.8
-1.0
---21.0
6.7
0.1
0.3
--6.9
3.4
1.3
2.5
---16.3
6.4
0.4
-1.4
--1.1
4.0
1.1
1.7
1990
1991
1992
1993
1994
10.7
11.1
7.5
8.3
9.1
1.3
1.6
6.2
2.7
2.5
3.8
4.2
6.6
4.3
4.6
7.9
0.4
1.1
-1.8
2.4
4.8
9.2
7.4
4.2
5.9
7.2
2.2
2.5
-0.4
3.2
1995
1996
1997
1998
1999
4.3
0.1
0.2
8.3
7.2
6.4
6.6
-5.7
10.3
9.3
5.8
4.5
-3.9
9.6
8.6
1.6
-0.2
5.4
11.2
12.5
-2.7
-6.3
2.6
17.2
1.6
0.5
-1.6
4.8
12.5
10.0
2000
13.1
8.1
9.6
2.4
7.9
3.5
2001
2002
2003
2004
14.2
11.5
6.9
2.7
5.4
12.1
6.6
2.6
8.2
11.9
6.7
2.6
7.2
6.2
2.7
0.0
5.0
6.9
10.4
5.9
6.7
6.3
4.4
1.3
2005
2006
2007
2008
2009
1.7
-0.4
4.1
-0.9
8.1
5.2
3.4
10.4
-8.9
11.5
4.0
2.2
8.4
-6.5
10.4
1.1
3.8
5.2
4.0
12.6
5.8
0.0
9.8
-3.9
9.9
2.2
2.9
6.3
2.0
12.0
2010 f
f
2011
1.8
5.0
6.1
3.9
4.8
4.2
6.5
2.4
7.0
2.6
6.6
2.4
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
65
Drug Expenditure in Canada, 1985 to 2011
Table B P.E.I.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Prince Edward Island, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out of
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Federal
Year
P.E.I.
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter
Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
1.7
2.1
3.5
4.6
5.5
0.8
0.9
1.0
0.6
0.5
0.0
0.1
0.1
0.1
0.1
-----------
2.5
3.1
4.6
5.3
6.0
-----------
-----------
19.5
12.9
10.2
12.4
15.0
22.0
16.0
14.7
17.7
21.0
-----------
-----------
10.7
12.1
14.0
11.8
9.9
1990
1991
1992
1993
1994
6.5
7.4
7.6
7.5
7.7
0.6
0.7
0.7
0.8
0.9
0.1
0.1
0.4
0.3
0.3
-----------
7.3
8.2
8.6
8.6
8.9
-----------
-----------
18.0
17.1
18.8
21.8
23.8
25.3
25.3
27.5
30.5
32.8
----8.6
9.0
9.2
----7.8
8.4
8.7
10.6
13.5
16.4
17.4
17.9
1995
1996
1997
1998
1999
8.5
8.5
9.1
10.4
12.0
1.0
1.0
1.0
1.2
1.4
0.4
0.4
0.4
0.5
0.6
-----------
9.8
9.8
10.6
12.2
13.9
-----------
-----------
28.4
29.7
28.8
33.0
33.6
38.3
39.5
39.4
45.1
47.6
8.5
6.8
7.1
8.6
9.1
8.3
6.3
6.9
8.5
8.5
16.8
13.1
14.0
17.1
17.6
2000
2001
2002
2003
2004
14.0
15.7
16.9
18.4
19.9
2.3
2.7
2.7
2.9
2.9
0.7
0.8
0.7
0.7
0.7
-----------
17.0
19.1
20.3
22.0
23.4
-----------
-----------
36.0
43.0
38.1
43.7
47.8
53.0
62.2
58.4
65.7
71.2
8.8
9.7
10.4
10.7
10.7
8.0
8.4
9.0
9.0
8.9
16.8
18.1
19.4
19.7
19.6
2005
2006
2007
2008
2009
22.3
24.2
25.8
28.7
32.4
2.9
2.8
2.8
2.8
2.8
0.7
0.8
0.9
0.9
0.9
-----------
25.9
27.8
29.4
32.4
36.0
-----------
-----------
52.2
56.8
56.9
56.7
63.7
78.1
84.6
86.3
89.1
99.7
10.2
10.6
11.3
12.2
12.5
8.3
8.7
9.0
9.6
9.5
18.5
19.3
20.4
21.8
22.0
2010f
f
2011
34.7
34.8
2.8
2.8
0.9
0.9
-----
38.3
38.6
-----
-----
69.3
74.3
107.7
112.9
13.2
12.8
10.2
10.0
23.4
22.8
1985
1986
1987
1988
1989
--27.8
63.7
32.4
17.9
--16.1
12.6
-40.9
-17.4
--44.0
39.7
20.2
0.9
-----------
--24.4
48.5
16.1
13.7
-----------
-----------
---34.1
-21.0
21.5
21.5
---27.5
-7.6
19.8
19.1
-----------
-----------
1990
1991
1992
1993
1994
19.8
13.5
2.5
-1.7
2.8
30.7
7.0
-4.5
24.8
12.0
20.5
-0.4
218.0
-13.7
-1.5
-----------
20.7
12.7
5.2
-0.3
3.5
-----------
-----------
19.8
-4.7
10.0
15.9
9.2
20.1
0.3
8.5
10.8
7.6
------4.9
1.7
------7.8
3.7
7.5
27.3
21.5
6.3
2.7
1995
1996
1997
1998
1999
10.2
0.0
7.4
14.6
14.7
8.6
-3.8
8.3
16.2
14.0
9.8
4.4
14.7
21.0
11.9
-----------
10.0
-0.2
7.8
15.1
14.5
-----------
-----------
19.2
4.3
-3.0
14.5
2.0
16.7
3.2
-0.3
14.6
5.4
-7.1
-20.6
5.4
21.2
5.7
-5.1
-24.1
9.2
23.2
0.1
-6.1
-22.3
7.2
22.2
3.0
2000
2001
2002
2003
2004
16.8
12.4
7.7
9.2
7.7
66.4
16.8
0.7
6.4
0.4
26.3
4.4
-9.4
-1.6
-2.8
-----------
22.1
12.6
6.0
8.4
6.5
-----------
-----------
7.2
19.4
-11.5
14.8
9.3
11.6
17.2
-6.1
12.6
8.3
-3.7
10.0
7.4
2.5
0.6
-6.0
5.3
7.2
0.2
-0.9
-4.8
7.7
7.3
1.4
-0.1
2005
2006
2007
2008
2009
12.4
8.2
6.6
11.3
12.8
-0.1
-1.4
-1.0
-1.5
0.6
7.6
9.7
7.0
10.8
-7.9
-----------
10.7
7.1
5.9
10.1
11.2
-----------
-----------
9.3
8.8
0.3
-0.4
12.4
9.8
8.2
2.1
3.2
11.9
-5.2
4.3
7.0
7.4
2.8
-6.5
4.7
3.4
6.5
-1.4
-5.8
4.5
5.4
7.0
0.9
2010f
f
2011
7.2
0.3
0.2
1.9
-1.8
8.2
-----
6.5
0.6
-----
-----
8.9
7.2
8.0
4.8
5.7
-3.6
7.2
-1.6
6.3
-2.8
1985
1986
1987
1988
1989
5.1
7.6
12.1
15.7
17.6
2.3
3.2
3.5
2.0
1.6
0.1
0.2
0.3
0.3
0.3
-----------
7.6
11.0
15.9
18.1
19.6
-----------
-----------
59.7
45.9
35.3
42.0
48.5
67.3
56.9
51.3
60.0
68.1
-----------
-----------
32.7
43.1
48.7
40.0
31.9
1990
1991
1992
1993
1994
18.2
19.1
17.3
15.6
15.2
1.8
1.8
1.5
1.7
1.8
0.3
0.3
0.9
0.7
0.7
-----------
20.3
21.2
19.7
18.0
17.6
-----------
-----------
50.1
44.1
42.9
45.6
47.1
70.4
65.2
62.6
63.6
64.7
----19.6
18.8
18.1
----17.8
17.6
17.2
29.6
34.8
37.4
36.4
35.3
1995
1996
1997
1998
1999
15.4
16.1
17.0
16.8
18.4
1.8
1.8
1.9
1.9
2.1
0.7
0.7
0.8
0.9
0.9
-----------
17.8
18.7
19.8
19.5
21.4
-----------
-----------
51.6
56.5
54.0
53.0
51.6
69.5
75.1
73.8
72.5
73.0
15.5
12.9
13.4
13.9
14.0
15.1
12.0
12.9
13.6
13.0
30.5
24.9
26.2
27.5
27.0
2000
20.0
3.3
1.1
---
24.4
---
---
51.6
76.0
12.6
11.4
24.0
2001
2002
2003
2004
19.6
21.7
21.6
21.9
3.3
3.5
3.3
3.2
1.0
0.9
0.8
0.7
---------
23.9
26.1
25.8
25.8
---------
---------
53.6
49.0
51.2
52.6
77.5
75.1
77.0
78.4
12.1
13.4
12.5
11.8
10.5
11.6
10.6
9.8
22.5
24.9
23.0
21.6
2005
2006
2007
2008
2009
23.1
23.3
24.1
25.9
26.6
3.0
2.7
2.6
2.5
2.3
0.8
0.8
0.8
0.9
0.7
-----------
26.8
26.7
27.6
29.2
29.6
-----------
-----------
54.0
54.6
53.3
51.1
52.3
80.9
81.4
80.9
80.3
81.9
10.5
10.2
10.6
11.0
10.3
8.6
8.4
8.5
8.7
7.8
19.1
18.6
19.1
19.7
18.1
26.5
2.1
0.7
25.7
2.1
0.7
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
-----
29.2
28.4
-----
-----
52.9
54.8
82.1
83.2
10.1
9.4
7.8
7.4
17.9
16.8
(Annual Percentage Change)
--13.2
16.0
-16.1
-16.1
(Percentage Share of Total Drug Expenditure)
2010f
f
2011
66
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B P.E.I.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Prince Edward Island, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Private
Total
Public
($ Millions)
Year
Total
(Percentage Share)
1985
1986
1987
1988
1989
2.5
3.1
4.6
5.3
6.0
30.2
25.0
24.2
24.1
24.9
32.7
28.0
28.8
29.4
30.9
128.3
138.0
149.7
163.0
174.4
52.9
49.6
53.3
56.5
64.9
181.2
187.6
202.9
219.5
239.3
1.9
2.2
3.1
3.3
3.5
57.1
50.3
45.4
42.6
38.3
18.0
15.0
14.2
13.4
12.9
1990
1991
1992
1993
1994
7.3
8.2
8.6
8.6
8.9
28.6
30.6
35.2
39.3
41.8
35.9
38.8
43.9
47.9
50.7
186.3
203.8
209.2
218.2
217.0
70.0
76.8
85.8
93.5
96.7
256.2
280.6
295.0
311.7
313.7
3.9
4.0
4.1
4.0
4.1
40.9
39.9
41.1
42.0
43.2
14.0
13.8
14.9
15.4
16.2
1995
1996
1997
1998
1999
9.8
9.8
10.6
12.2
13.9
45.2
42.7
42.8
50.1
51.2
55.1
52.5
53.4
62.2
65.2
222.8
233.0
229.9
245.5
259.0
104.6
106.1
110.4
115.9
119.7
327.4
339.1
340.3
361.4
378.7
4.4
4.2
4.6
5.0
5.4
43.2
40.3
38.8
43.2
42.8
16.8
15.5
15.7
17.2
17.2
2000
2001
2002
2003
2004
17.0
19.1
20.3
22.0
23.4
52.8
61.1
57.5
63.4
67.4
69.8
80.2
77.7
85.4
90.8
277.7
328.5
365.6
379.7
375.9
123.7
147.5
139.8
161.3
162.3
401.4
475.9
505.4
541.0
538.2
6.1
5.8
5.6
5.8
6.2
42.7
41.4
41.1
39.3
41.5
17.4
16.9
15.4
15.8
16.9
2005
2006
2007
2008
2009
25.9
27.8
29.4
32.4
36.0
70.7
76.1
77.3
78.5
85.7
96.6
103.9
106.7
110.9
121.7
412.8
434.0
465.9
510.4
572.3
163.2
187.7
188.4
185.2
206.9
576.0
621.7
654.3
695.6
779.2
6.3
6.4
6.3
6.3
6.3
43.3
40.5
41.0
42.4
41.4
16.8
16.7
16.3
15.9
15.6
2010f
f
2011
38.3
38.6
92.8
97.1
131.1
135.6
624.5
640.7
218.0
232.3
842.5
873.1
6.1
6.0
42.5
41.8
15.6
15.5
1985
1986
1987
1988
1989
--24.4
48.5
16.1
13.7
---17.3
-3.1
-0.3
3.1
---14.2
2.6
2.3
5.0
--7.6
8.5
8.9
7.0
---6.3
7.4
6.2
14.8
--3.5
8.2
8.2
9.0
1990
1991
1992
1993
1994
20.7
12.7
5.2
-0.3
3.5
14.9
7.2
15.1
11.4
6.3
16.0
8.3
13.0
9.1
5.8
6.8
9.4
2.7
4.3
-0.6
7.7
9.8
11.6
9.0
3.4
7.0
9.5
5.1
5.7
0.6
1995
1996
1997
1998
1999
10.0
-0.2
7.8
15.1
14.5
8.4
-5.6
0.2
17.0
2.3
8.7
-4.6
1.6
16.6
4.7
2.7
4.6
-1.3
6.8
5.5
8.2
1.4
4.1
5.0
3.3
4.4
3.5
0.4
6.2
4.8
2000
2001
2002
2003
2004
22.1
12.6
6.0
8.4
6.5
3.1
15.7
-6.0
10.3
6.4
7.1
14.9
-3.1
9.8
6.4
7.2
18.3
11.3
3.8
-1.0
3.3
19.3
-5.2
15.4
0.6
6.0
18.6
6.2
7.0
-0.5
2005
2006
2007
2008
2009
10.7
7.1
5.9
10.1
11.2
4.9
7.6
1.6
1.5
9.2
6.4
7.5
2.7
3.9
9.8
9.8
5.1
7.4
9.6
12.1
0.6
15.0
0.3
-1.7
11.7
7.0
7.9
5.2
6.3
12.0
2010 f
f
2011
6.5
0.6
8.2
4.7
7.7
3.5
9.1
2.6
5.4
6.6
8.1
3.6
P.E.I.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
7.6
11.0
15.9
18.1
19.6
92.4
89.0
84.1
81.9
80.4
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
20.3
21.2
19.7
18.0
17.6
79.7
78.8
80.3
82.0
82.4
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
17.8
18.7
19.8
19.5
21.4
82.2
81.3
80.2
80.5
78.6
100.0
100.0
100.0
100.0
100.0
2000
24.4
75.6
100.0
2001
2002
2003
2004
23.9
26.1
25.8
25.8
76.1
73.9
74.2
74.2
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009
26.8
26.7
27.6
29.2
29.6
73.2
73.3
72.4
70.8
70.4
100.0
100.0
100.0
100.0
100.0
2010f
f
2011
29.2
28.4
70.8
71.6
100.0
100.0
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
67
Drug Expenditure in Canada, 1985 to 2011
Table B P.E.I.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Prince Edward Island, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Subtotal
Insurers*
Out of
Social Security Funds
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Federal
Year
P.E.I.
Subtotal
Private
Total
Prescribed
Drugs
OvertheCounter
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
Personal
Total
Health
Non-Presc.
Supplies
Drugs
1985
1986
1987
1988
1989
13.08
16.61
27.17
35.77
41.92
6.01
6.94
7.80
4.59
3.77
0.33
0.47
0.66
0.79
0.79
-----------
19.42
24.02
35.62
41.15
46.48
-----------
-----------
152.95
100.25
79.09
95.54
115.34
172.37
124.27
114.72
136.69
161.82
-----------
-----------
83.63
94.14
109.04
90.98
75.86
1990
1991
1992
1993
1994
50.03
56.89
58.12
56.53
57.56
4.91
5.26
5.01
6.18
6.86
0.95
0.94
2.99
2.56
2.49
-----------
55.88
63.09
66.12
65.27
66.91
-----------
-----------
137.70
131.41
144.08
165.28
178.75
193.59
194.50
210.20
230.55
245.65
----65.73
68.24
68.75
----59.68
63.70
65.44
81.26
103.63
125.41
131.94
134.19
1995
1996
1997
1998
1999
62.95
62.35
66.82
76.76
87.75
7.39
7.04
7.61
8.86
10.07
2.72
2.81
3.21
3.90
4.35
-----------
73.06
72.20
77.64
89.52
102.17
-----------
-----------
211.56
218.51
211.50
242.67
246.71
284.62
290.71
289.13
332.19
348.88
63.37
49.84
52.38
63.65
67.05
61.67
46.35
50.46
62.32
62.19
125.04
96.19
102.85
125.97
129.24
2000
2001
2002
2003
2004
102.36
114.85
123.41
134.35
144.18
16.74
19.53
19.63
20.82
20.83
5.48
5.72
5.17
5.08
4.91
-----------
124.58
140.10
148.21
160.24
169.92
-----------
-----------
264.09
314.79
278.01
318.33
346.45
388.67
454.89
426.22
478.57
516.37
64.46
70.80
75.90
77.57
77.74
58.37
61.36
65.64
65.60
64.73
122.84
132.16
141.54
143.17
142.46
2005
2006
2007
2008
2009
161.68
175.23
186.53
205.58
229.39
20.75
20.49
20.26
19.76
19.67
5.28
5.80
6.20
6.80
6.19
-----------
187.71
201.52
212.98
232.14
255.24
-----------
-----------
377.81
411.68
412.01
406.27
451.46
565.52
613.20
624.99
638.41
706.71
73.51
76.85
82.11
87.34
88.77
60.35
63.33
65.36
68.90
67.21
133.86
140.18
147.47
156.24
155.98
2010f
f
2011
243.90
243.79
19.55
19.85
6.03
6.50
-----
269.48
270.14
-----
-----
487.45
520.59
756.93
790.73
93.04
89.34
71.46
70.05
164.50
159.38
1985
1986
1987
1988
1989
--27.0
63.5
31.7
17.2
--15.4
12.4
-41.2
-17.9
--43.2
39.5
19.5
0.3
-----------
--23.7
48.3
15.5
13.0
-----------
-----------
---34.5
-21.1
20.8
20.7
---27.9
-7.7
19.2
18.4
-----------
-----------
1990
1991
1992
1993
1994
19.3
13.7
2.2
-2.7
1.8
30.2
7.2
-4.8
23.5
10.9
20.1
-0.2
216.8
-14.6
-2.4
-----------
20.2
12.9
4.8
-1.3
2.5
-----------
-----------
19.4
-4.6
9.6
14.7
8.1
19.6
0.5
8.1
9.7
6.6
------3.8
0.8
------6.7
2.7
7.1
27.5
21.0
5.2
1.7
1995
1996
1997
1998
1999
9.4
-0.9
7.2
14.9
14.3
7.8
-4.7
8.0
16.5
13.6
9.0
3.4
14.4
21.3
11.5
-----------
9.2
-1.2
7.5
15.3
14.1
-----------
-----------
18.4
3.3
-3.2
14.7
1.7
15.9
2.1
-0.5
14.9
5.0
-7.8
-21.4
5.1
21.5
5.3
-5.8
-24.8
8.9
23.5
-0.2
-6.8
-23.1
6.9
22.5
2.6
-3.9
-6.1
-5.0
(Annual Percentage Change)
---
---
--12.6
15.8
-16.6
-16.6
2000
16.7
66.2
26.2
---
21.9
7.0
11.4
2001
12.2
16.7
4.3
---
12.5
---
---
19.2
17.0
9.8
5.1
7.6
2002
7.5
0.5
-9.6
---
5.8
---
---
-11.7
-6.3
7.2
7.0
7.1
2003
8.9
6.1
-1.8
---
8.1
---
---
14.5
12.3
2.2
-0.1
1.2
2004
7.3
0.0
-3.2
---
6.0
---
---
8.8
7.9
0.2
-1.3
-0.5
2005
2006
2007
2008
2009
12.1
8.4
6.4
10.2
11.6
-0.3
-1.3
-1.2
-2.4
-0.5
7.4
9.9
6.9
9.7
-8.9
-----------
10.5
7.4
5.7
9.0
10.0
-----------
-----------
9.1
9.0
0.1
-1.4
11.1
9.5
8.4
1.9
2.1
10.7
-5.4
4.5
6.8
6.4
1.6
-6.8
4.9
3.2
5.4
-2.5
-6.0
4.7
5.2
6.0
-0.2
2010f
f
2011
6.3
0.0
-0.6
1.5
-2.6
7.8
-----
5.6
0.2
-----
-----
8.0
6.8
7.1
4.5
4.8
-4.0
6.3
-2.0
5.5
-3.1
-----------
-----------
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
68
1985
1986
1987
1988
1989
--24.2
58.8
27.2
12.6
--12.6
7.7
-45.7
-22.4
--40.4
34.8
15.0
-4.3
-----------
--20.9
43.6
11.0
8.4
-----------
-----------
---37.3
-25.8
16.3
16.2
---30.7
-12.4
14.6
13.8
--9.8
11.1
-21.1
-21.2
1990
1991
1992
1993
1994
16.3
10.9
0.9
-4.2
0.7
27.2
4.4
-6.1
22.1
9.8
17.1
-3.0
215.6
-16.1
-3.5
-----------
17.2
10.1
3.5
-2.7
1.4
-----------
-----------
16.4
-7.3
8.4
13.3
7.0
16.6
-2.3
6.8
8.2
5.5
------2.4
-0.3
------5.3
1.6
4.1
24.8
19.8
3.8
0.6
1995
1996
1997
1998
1999
7.0
-2.6
6.2
15.3
12.5
5.5
-6.4
7.1
16.9
11.8
6.7
1.7
13.4
21.7
9.7
-----------
6.9
-2.8
6.5
15.7
12.3
-----------
-----------
16.0
1.6
-4.2
15.2
-0.1
13.5
0.5
-1.5
15.3
3.2
-10.2
-23.0
4.1
21.9
3.5
-8.1
-26.5
7.9
23.9
-2.0
-9.2
-24.7
5.9
22.9
0.8
2000
12.5
62.1
22.1
---
17.8
---
---
2.9
7.3
-8.0
-10.2
-9.1
2001
2002
2003
2004
10.8
6.4
6.0
4.7
15.3
-0.6
3.2
-2.6
3.0
-10.6
-4.7
-5.8
---------
11.1
4.7
5.2
3.5
---------
---------
17.8
-12.7
11.6
6.2
15.7
-7.3
9.4
5.3
8.5
6.1
-0.7
-2.4
3.8
5.9
-3.0
-3.9
6.2
6.1
-1.7
-3.1
2005
2006
2007
2008
2009
9.1
5.6
2.8
5.3
14.3
-3.4
-4.1
-4.8
-7.3
2.2
4.4
7.1
3.2
4.8
-6.2
-----------
7.5
4.6
2.0
4.1
12.7
-----------
-----------
6.0
6.2
-3.6
-6.3
13.8
6.5
5.6
-1.8
-2.7
13.4
-8.4
1.7
3.2
1.5
4.3
-9.8
2.1
-0.5
0.6
0.3
-9.0
1.9
1.5
1.1
2.5
2010f
3.4
-3.5
-5.6
f
2011
-4.0
-2.5
3.8
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
-----
2.6
-3.7
-----
-----
5.0
2.8
4.2
0.5
1.9
-8.0
3.4
-6.0
2.5
-7.1
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B P.E.I.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Prince Edward Island, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Year
Health Expenditure
Private
Public
GDP Implicit
Price Index—Canada
Total
(1997 = 100)
($ per Capita)
1985
1986
1987
1988
1989
19.42
24.02
35.62
41.15
46.48
236.58
194.39
188.13
186.53
191.20
256.00
218.41
223.76
227.67
237.68
1,004.74
1,074.57
1,164.10
1,260.71
1,340.84
414.66
386.13
414.24
437.42
499.18
1,419.40
1,460.70
1,578.34
1,698.12
1,840.01
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
55.88
63.09
66.12
65.27
66.91
218.96
235.04
269.50
297.22
312.94
274.84
298.14
335.62
362.49
379.85
1,426.83
1,563.81
1,599.57
1,651.43
1,626.43
535.91
589.69
655.88
707.51
724.66
1,962.74
2,153.50
2,255.45
2,358.94
2,351.09
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
73.06
72.20
77.64
89.52
102.17
336.60
314.70
314.34
368.63
375.95
409.66
386.90
391.98
458.15
478.12
1,657.77
1,716.36
1,689.18
1,807.78
1,900.33
778.40
781.25
811.16
853.14
878.29
2,436.16
2,497.61
2,500.34
2,660.92
2,778.63
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
124.58
140.10
148.21
160.24
169.92
386.93
446.95
419.55
461.50
488.91
511.51
587.05
567.76
621.74
658.83
2,034.62
2,403.43
2,669.89
2,764.67
2,726.81
905.97
1,078.93
1,020.75
1,174.86
1,176.96
2,940.60
3,482.35
3,690.64
3,939.54
3,903.77
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009
187.71
201.52
212.98
232.14
255.24
511.68
551.86
559.48
562.51
607.44
699.38
753.38
772.46
794.65
862.69
2,987.19
3,146.58
3,372.06
3,657.60
4,056.11
1,180.97
1,361.24
1,363.48
1,327.39
1,466.43
4,168.16
4,507.83
4,735.54
4,984.99
5,522.54
117.5
120.8
125.2
131.3
127.8
2010f
f
2011
269.48
270.14
651.95
679.97
921.43
950.11
4,389.61
4,487.90
1,532.25
1,627.41
5,921.87
6,115.31
131.5
136.8
1985
1986
1987
1988
1989
--23.7
48.3
15.5
13.0
---17.8
-3.2
-0.9
2.5
---14.7
2.4
1.7
4.4
--7.0
8.3
8.3
6.4
---6.9
7.3
5.6
14.1
--2.9
8.1
7.6
8.4
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
20.2
12.9
4.8
-1.3
2.5
14.5
7.3
14.7
10.3
5.3
15.6
8.5
12.6
8.0
4.8
6.4
9.6
2.3
3.2
-1.5
7.4
10.0
11.2
7.9
2.4
6.7
9.7
4.7
4.6
-0.3
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
9.2
-1.2
7.5
15.3
14.1
7.6
-6.5
-0.1
17.3
2.0
7.8
-5.6
1.3
16.9
4.4
1.9
3.5
-1.6
7.0
5.1
7.4
0.4
3.8
5.2
2.9
3.6
2.5
0.1
6.4
4.4
2.3
1.7
1.0
-0.4
1.8
P.E.I.
(Annual Percentage Change)
2000
21.9
2.9
7.0
7.1
3.2
5.8
4.1
2001
12.5
15.5
14.8
18.1
19.1
18.4
1.4
2002
5.8
-6.1
-3.3
11.1
-5.4
6.0
1.0
2003
8.1
10.0
9.5
3.6
15.1
6.7
2.9
2004
6.0
5.9
6.0
-1.4
0.2
-0.9
2.6
2005
2006
2007
2008
2009
10.5
7.4
5.7
9.0
10.0
4.7
7.9
1.4
0.5
8.0
6.2
7.7
2.5
2.9
8.6
9.5
5.3
7.2
8.5
10.9
0.3
15.3
0.2
-2.6
10.5
6.8
8.1
5.1
5.3
10.8
3.0
2.8
3.7
4.9
-2.7
2010f
f
2011
5.6
0.2
7.3
4.3
6.8
3.1
8.2
2.2
4.5
6.2
7.2
3.3
2.9
4.0
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--20.9
43.6
11.0
8.4
---20.6
-8.0
-5.4
-2.1
---17.5
-2.3
-2.8
-0.2
--4.1
3.6
3.8
1.8
---9.7
2.5
1.1
9.6
--0.1
3.3
3.1
3.8
1990
1991
1992
1993
1994
17.2
10.1
3.5
-2.7
1.4
11.5
4.6
13.4
8.8
4.2
12.6
5.7
11.3
6.6
3.7
3.4
6.8
1.0
1.8
-2.6
4.3
7.3
10.0
6.4
1.3
3.6
7.0
3.5
3.1
-1.4
1995
1996
1997
1998
1999
6.9
-2.8
6.5
15.7
12.3
5.2
-8.2
-1.1
17.7
0.2
5.5
-7.2
0.3
17.3
2.5
-0.4
1.9
-2.6
7.5
3.3
5.1
-1.3
2.8
5.6
1.1
1.3
0.9
-0.9
6.9
2.6
2000
17.8
-1.2
2.9
3.0
-1.0
1.7
2001
2002
2003
2004
11.1
4.7
5.2
3.5
14.2
-7.2
7.1
3.3
13.4
-4.3
6.6
3.4
16.8
10.0
0.7
-4.0
17.7
-6.4
12.2
-2.4
17.1
4.9
3.8
-3.5
2005
2006
2007
2008
2009
7.5
4.6
2.0
4.1
12.7
1.6
5.1
-2.3
-4.3
10.7
3.1
4.9
-1.1
-2.0
11.3
6.5
2.5
3.5
3.6
13.6
-2.7
12.5
-3.5
-7.5
13.2
3.8
5.4
1.4
0.4
13.5
2010f
f
2011
2.6
-3.7
4.4
0.3
3.9
-0.9
5.3
-1.8
1.5
2.2
4.3
-0.7
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
69
Drug Expenditure in Canada, 1985 to 2011
Table B N.S.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Nova Scotia, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out of
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Federal
Year
N.S.
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter
Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
45.5
53.1
62.3
72.2
82.1
2.3
2.4
2.6
3.4
4.2
0.2
0.2
0.2
0.3
0.3
-----------
48.0
55.7
65.1
76.0
86.6
-----------
-----------
38.7
59.6
67.7
74.8
82.5
86.7
115.3
132.8
150.8
169.1
-----------
-----------
61.1
69.2
80.2
78.9
77.7
1990
1991
1992
1993
1994
83.0
83.0
89.0
88.5
83.2
5.0
5.6
5.9
6.8
7.3
0.3
0.5
0.5
0.6
0.6
-----------
88.3
89.1
95.4
95.9
91.1
-----------
-----------
96.0
106.2
118.4
132.7
137.8
184.2
195.3
213.8
228.6
228.9
----48.7
51.3
51.8
----44.3
47.9
49.3
79.3
80.6
93.0
99.1
101.1
1995
1996
1997
1998
1999
83.9
83.3
86.8
99.5
110.7
8.9
8.4
9.8
14.4
14.8
0.7
0.7
0.7
0.8
1.1
-----------
93.5
92.5
97.3
114.7
126.5
-----------
-----------
148.7
159.4
170.5
198.7
201.5
242.2
251.8
267.9
313.4
328.0
47.8
53.8
49.6
54.8
55.5
46.5
50.0
47.4
53.7
51.5
94.2
103.8
96.9
108.5
107.0
2000
2001
2002
2003
2004
117.3
128.7
140.8
156.2
170.0
18.8
22.3
24.2
25.9
26.4
1.4
1.9
2.2
2.5
3.0
-----------
137.4
152.9
167.2
184.6
199.4
-----------
-----------
227.3
247.5
282.2
299.5
324.5
364.7
400.4
449.5
484.1
523.9
55.3
60.5
64.6
68.7
72.1
50.1
52.4
55.9
58.1
60.0
105.4
112.9
120.5
126.9
132.1
2005
2006
2007
2008
2009
186.1
231.8
252.3
269.0
293.0
27.4
34.7
30.4
28.2
28.9
3.4
4.8
5.6
6.8
6.9
-----------
216.8
271.3
288.3
304.1
328.9
-----------
-----------
359.9
396.8
423.5
423.0
459.5
576.7
668.1
711.8
727.0
788.5
71.6
73.7
80.1
80.4
76.8
58.8
60.8
63.7
63.4
58.1
130.4
134.5
143.8
143.9
134.9
2010f
f
2011
307.2
311.3
29.1
29.7
9.7
10.6
-----
346.0
351.6
-----
-----
526.3
576.9
872.3
928.6
81.6
81.7
62.7
63.8
144.3
145.4
1985
1986
1987
1988
1989
--16.7
17.2
16.0
13.7
--3.8
8.3
32.7
21.9
--16.4
4.2
48.7
-7.8
-----------
--16.1
16.8
16.8
14.0
-----------
-----------
--54.0
13.6
10.4
10.4
--33.0
15.1
13.5
12.2
-----------
-----------
--13.2
16.0
-1.6
-1.6
1990
1991
1992
1993
1994
1.0
0.1
7.2
-0.5
-6.0
20.1
12.4
5.3
15.4
6.6
6.4
41.5
2.6
20.2
6.1
-----------
1.9
0.9
7.1
0.6
-5.0
-----------
-----------
16.3
10.6
11.5
12.1
3.9
8.9
6.0
9.5
6.9
0.1
------5.2
1.0
------8.1
3.0
2.1
1.7
15.4
6.6
1.9
1995
1996
1997
1998
1999
0.8
-0.7
4.2
14.5
11.3
21.6
-5.0
16.2
47.4
2.5
15.7
5.2
-1.0
16.2
27.0
-----------
2.6
-1.1
5.3
17.9
10.3
-----------
-----------
7.9
7.2
7.0
16.5
1.4
5.8
4.0
6.4
17.0
4.7
-7.8
12.7
-7.9
10.7
1.2
-5.7
7.7
-5.4
13.4
-4.1
-6.8
10.2
-6.7
12.0
-1.5
2000
2001
2002
2003
2004
5.9
9.8
9.4
10.9
8.8
27.1
18.6
8.6
7.0
2.0
28.6
39.0
18.0
12.3
19.2
-----------
8.6
11.3
9.4
10.4
8.0
-----------
-----------
12.8
8.9
14.0
6.1
8.4
11.2
9.8
12.2
7.7
8.2
-0.3
9.3
6.8
6.4
4.9
-2.7
4.6
6.6
4.0
3.3
-1.5
7.1
6.7
5.3
4.2
2005
2006
2007
2008
2009
9.5
24.6
8.9
6.6
8.9
3.7
26.9
-12.5
-7.1
2.5
12.0
41.6
17.6
21.3
2.0
-----------
8.7
25.1
6.3
5.4
8.2
-----------
-----------
10.9
10.2
6.7
-0.1
8.6
10.1
15.8
6.5
2.1
8.5
-0.7
3.0
8.6
0.4
-4.5
-2.1
3.4
4.9
-0.5
-8.3
-1.3
3.2
6.9
0.0
-6.2
2010f
f
2011
4.8
1.3
0.6
1.9
39.8
9.7
-----
5.2
1.6
-----
-----
14.5
9.6
10.6
6.5
6.3
0.1
7.8
1.7
6.9
0.8
1985
1986
1987
1988
1989
30.8
28.8
29.2
31.5
33.3
1.5
1.3
1.2
1.5
1.7
0.1
0.1
0.1
0.1
0.1
-----------
32.5
30.2
30.5
33.1
35.1
-----------
-----------
26.2
32.3
31.8
32.5
33.4
58.7
62.5
62.3
65.6
68.5
-----------
-----------
41.3
37.5
37.7
34.4
31.5
1990
1991
1992
1993
1994
31.5
30.1
29.0
27.0
25.2
1.9
2.0
1.9
2.1
2.2
0.1
0.2
0.2
0.2
0.2
-----------
33.5
32.3
31.1
29.3
27.6
-----------
-----------
36.4
38.5
38.6
40.5
41.8
69.9
70.8
69.7
69.8
69.4
----15.9
15.6
15.7
----14.4
14.6
14.9
30.1
29.2
30.3
30.2
30.6
1995
1996
1997
1998
1999
24.9
23.4
23.8
23.6
25.4
2.6
2.4
2.7
3.4
3.4
0.2
0.2
0.2
0.2
0.2
-----------
27.8
26.0
26.7
27.2
29.1
-----------
-----------
44.2
44.8
46.7
47.1
46.3
72.0
70.8
73.4
74.3
75.4
14.2
15.1
13.6
13.0
12.8
13.8
14.1
13.0
12.7
11.8
28.0
29.2
26.6
25.7
24.6
2000
24.9
4.0
0.3
---
29.2
---
---
48.4
77.6
11.8
10.7
22.4
2001
2002
2003
2004
25.1
24.7
25.6
25.9
4.3
4.2
4.2
4.0
0.4
0.4
0.4
0.5
---------
29.8
29.3
30.2
30.4
---------
---------
48.2
49.5
49.0
49.5
78.0
78.9
79.2
79.9
11.8
11.3
11.2
11.0
10.2
9.8
9.5
9.2
22.0
21.1
20.8
20.1
2005
2006
2007
2008
2009
26.3
28.9
29.5
30.9
31.7
3.9
4.3
3.6
3.2
3.1
0.5
0.6
0.7
0.8
0.8
-----------
30.7
33.8
33.7
34.9
35.6
-----------
-----------
50.9
49.4
49.5
48.6
49.8
81.6
83.2
83.2
83.5
85.4
10.1
9.2
9.4
9.2
8.3
8.3
7.6
7.4
7.3
6.3
18.4
16.8
16.8
16.5
14.6
30.2
2.9
1.0
29.0
2.8
1.0
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
-----
34.0
32.7
-----
-----
51.8
53.7
85.8
86.5
8.0
7.6
6.2
5.9
14.2
13.5
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
2010f
f
2011
70
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B N.S.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Nova Scotia, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Private
Total
Public
($ Millions)
Year
Total
(Percentage Share)
1985
1986
1987
1988
1989
48.0
55.7
65.1
76.0
86.6
99.8
128.8
147.9
153.7
160.2
147.8
184.5
213.0
229.7
246.8
947.2
1,023.2
1,165.5
1,165.0
1,281.5
285.3
353.7
395.0
420.3
470.3
1,232.5
1,376.9
1,560.6
1,585.2
1,751.8
5.1
5.4
5.6
6.5
6.8
35.0
36.4
37.4
36.6
34.1
12.0
13.4
13.6
14.5
14.1
1990
1991
1992
1993
1994
88.3
89.1
95.4
95.9
91.1
175.3
186.8
211.4
231.8
238.9
263.5
275.9
306.8
327.7
330.0
1,376.6
1,451.2
1,477.0
1,445.5
1,413.1
490.4
518.8
554.5
579.5
610.2
1,866.9
1,970.0
2,031.6
2,025.0
2,023.4
6.4
6.1
6.5
6.6
6.4
35.7
36.0
38.1
40.0
39.1
14.1
14.0
15.1
16.2
16.3
1995
1996
1997
1998
1999
93.5
92.5
97.3
114.7
126.5
242.9
263.2
267.5
307.2
308.5
336.4
355.7
364.8
421.9
435.0
1,440.0
1,438.2
1,669.3
1,786.8
1,899.7
621.3
650.8
694.9
766.1
778.2
2,061.3
2,089.0
2,364.2
2,552.9
2,677.9
6.5
6.4
5.8
6.4
6.7
39.1
40.4
38.5
40.1
39.6
16.3
17.0
15.4
16.5
16.2
2000
2001
2002
2003
2004
137.4
152.9
167.2
184.6
199.4
332.7
360.4
402.7
426.4
456.7
470.1
513.3
569.9
611.0
656.1
1,968.4
2,082.7
2,264.3
2,483.8
2,588.0
868.2
930.6
1,042.5
1,111.7
1,137.0
2,836.6
3,013.3
3,306.8
3,595.5
3,725.0
7.0
7.3
7.4
7.4
7.7
38.3
38.7
38.6
38.4
40.2
16.6
17.0
17.2
17.0
17.6
2005
2006
2007
2008
2009
216.8
271.3
288.3
304.1
328.9
490.3
531.3
567.3
566.8
594.5
707.1
802.6
855.6
870.9
923.4
2,822.7
3,178.6
3,407.1
3,586.4
3,680.3
1,207.8
1,333.1
1,413.2
1,484.5
1,652.0
4,030.5
4,511.7
4,820.3
5,071.0
5,332.3
7.7
8.5
8.5
8.5
8.9
40.6
39.9
40.1
38.2
36.0
17.5
17.8
17.8
17.2
17.3
2010f
f
2011
346.0
351.6
670.6
722.4
1,016.5
1,074.0
3,951.8
4,069.6
1,738.9
1,860.5
5,690.7
5,930.1
8.8
8.6
38.6
38.8
17.9
18.1
1985
1986
1987
1988
1989
--16.1
16.8
16.8
14.0
--29.1
14.9
3.9
4.2
--24.9
15.4
7.8
7.5
--8.0
13.9
-0.1
10.0
--24.0
11.7
6.4
11.9
--11.7
13.3
1.6
10.5
1990
1991
1992
1993
1994
1.9
0.9
7.1
0.6
-5.0
9.4
6.6
13.2
9.6
3.1
6.8
4.7
11.2
6.8
0.7
7.4
5.4
1.8
-2.1
-2.2
4.3
5.8
6.9
4.5
5.3
6.6
5.5
3.1
-0.3
-0.1
1995
1996
1997
1998
1999
2.6
-1.1
5.3
17.9
10.3
1.7
8.3
1.6
14.9
0.4
2.0
5.7
2.6
15.7
3.1
1.9
-0.1
16.1
7.0
6.3
1.8
4.7
6.8
10.2
1.6
1.9
1.3
13.2
8.0
4.9
2000
2001
2002
2003
2004
8.6
11.3
9.4
10.4
8.0
7.9
8.3
11.7
5.9
7.1
8.1
9.2
11.0
7.2
7.4
3.6
5.8
8.7
9.7
4.2
11.6
7.2
12.0
6.6
2.3
5.9
6.2
9.7
8.7
3.6
2005
2006
2007
2008
2009
8.7
25.1
6.3
5.4
8.2
7.4
8.4
6.8
-0.1
4.9
7.8
13.5
6.6
1.8
6.0
9.1
12.6
7.2
5.3
2.6
6.2
10.4
6.0
5.0
11.3
8.2
11.9
6.8
5.2
5.2
2010 f
f
2011
5.2
1.6
12.8
7.7
10.1
5.7
7.4
3.0
5.3
7.0
6.7
4.2
N.S.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
32.5
30.2
30.5
33.1
35.1
67.5
69.8
69.5
66.9
64.9
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
33.5
32.3
31.1
29.3
27.6
66.5
67.7
68.9
70.7
72.4
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
27.8
26.0
26.7
27.2
29.1
72.2
74.0
73.3
72.8
70.9
100.0
100.0
100.0
100.0
100.0
2000
29.2
70.8
100.0
2001
2002
2003
2004
29.8
29.3
30.2
30.4
70.2
70.7
69.8
69.6
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009
30.7
33.8
33.7
34.9
35.6
69.3
66.2
66.3
65.1
64.4
100.0
100.0
100.0
100.0
100.0
2010f
f
2011
34.0
32.7
66.0
67.3
100.0
100.0
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
71
Drug Expenditure in Canada, 1985 to 2011
Table B N.S.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Nova Scotia, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Subtotal
Insurers*
Out of
Social Security Funds
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Federal
Year
N.S.
Subtotal
Private
Total
Prescribed
Drugs
OvertheCounter
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
Personal
Total
Health
Non-Presc.
Supplies
Drugs
1985
1986
1987
1988
1989
51.41
59.72
69.69
80.51
90.89
2.59
2.67
2.88
3.81
4.61
0.21
0.24
0.25
0.37
0.34
-----------
54.21
62.63
72.82
84.68
95.83
-----------
-----------
43.74
67.05
75.80
83.31
91.30
97.94
129.68
148.61
167.99
187.13
-----------
-----------
69.01
77.77
89.77
87.95
85.92
1990
1991
1992
1993
1994
91.20
90.73
96.80
95.81
89.76
5.50
6.14
6.44
7.39
7.86
0.36
0.50
0.51
0.61
0.65
-----------
97.05
97.37
103.75
103.82
98.27
-----------
-----------
105.50
116.04
128.74
143.56
148.69
202.55
213.41
232.49
247.38
246.96
----53.01
55.48
55.85
----48.13
51.79
53.16
87.16
88.07
101.14
107.28
109.01
1995
1996
1997
1998
1999
90.40
89.46
93.13
106.74
118.53
9.54
9.03
10.48
15.46
15.82
0.75
0.78
0.78
0.90
1.14
-----------
100.69
99.28
104.39
123.11
135.49
-----------
-----------
160.23
171.12
182.88
213.19
215.75
260.92
270.39
287.28
336.30
351.24
51.45
57.77
53.15
58.85
59.42
50.07
53.72
50.79
57.63
55.12
101.52
111.49
103.94
116.48
114.55
2000
2001
2002
2003
2004
125.55
138.03
150.66
166.78
181.22
20.11
23.89
25.89
27.63
28.16
1.47
2.05
2.41
2.70
3.21
-----------
147.13
163.96
178.95
197.11
212.59
-----------
-----------
243.42
265.49
302.01
319.83
346.01
390.56
429.45
480.96
516.95
558.60
59.24
64.85
69.13
73.39
76.87
53.64
56.20
59.79
62.06
64.01
112.88
121.05
128.92
135.45
140.88
2005
2006
2007
2008
2009
198.78
247.14
269.66
287.19
312.04
29.26
37.04
32.47
30.14
30.80
3.60
5.09
6.00
7.27
7.39
-----------
231.64
289.27
308.13
324.59
350.23
-----------
-----------
384.51
422.99
452.51
451.53
489.34
616.15
712.26
760.64
776.12
839.57
76.49
78.60
85.57
85.84
81.77
62.80
64.77
68.11
67.72
61.91
139.29
143.38
153.69
153.57
143.68
2010f
f
2011
325.92
330.12
30.88
31.45
10.30
11.29
-----
367.10
372.86
-----
-----
558.37
611.81
925.47
984.67
86.59
86.61
66.50
67.62
153.09
154.24
1985
1986
1987
1988
1989
--16.2
16.7
15.5
12.9
--3.3
7.8
32.1
21.0
--15.8
3.7
48.1
-8.5
-----------
--15.5
16.3
16.3
13.2
-----------
-----------
--53.3
13.0
9.9
9.6
--32.4
14.6
13.0
11.4
-----------
-----------
--12.7
15.4
-2.0
-2.3
1990
1991
1992
1993
1994
0.3
-0.5
6.7
-1.0
-6.3
19.3
11.7
4.8
14.8
6.3
5.8
40.7
2.1
19.7
5.7
-----------
1.3
0.3
6.5
0.1
-5.3
-----------
-----------
15.6
10.0
10.9
11.5
3.6
8.2
5.4
8.9
6.4
-0.2
------4.7
0.7
------7.6
2.6
1.4
1.0
14.8
6.1
1.6
1995
1996
1997
1998
1999
0.7
-1.0
4.1
14.6
11.0
21.4
-5.3
16.0
47.5
2.3
15.6
4.8
-1.1
16.3
26.7
-----------
2.5
-1.4
5.2
17.9
10.1
-----------
-----------
7.8
6.8
6.9
16.6
1.2
5.7
3.6
6.2
17.1
4.4
-7.9
12.3
-8.0
10.7
1.0
-5.8
7.3
-5.5
13.5
-4.3
-6.9
9.8
-6.8
12.1
-1.7
11.2
-0.3
-2.7
-1.5
(Annual Percentage Change)
2000
5.9
27.1
28.5
---
8.6
2001
9.9
18.8
39.3
---
11.4
---
---
9.1
10.0
9.5
4.8
7.2
2002
9.1
8.4
17.7
---
9.1
---
---
---
---
13.8
12.8
12.0
6.6
6.4
6.5
2003
10.7
6.8
12.0
---
10.2
---
---
5.9
7.5
6.2
3.8
5.1
2004
8.7
1.9
19.0
---
7.9
---
---
8.2
8.1
4.8
3.1
4.0
2005
2006
2007
2008
2009
9.7
24.3
9.1
6.5
8.7
3.9
26.6
-12.3
-7.2
2.2
12.2
41.2
17.8
21.2
1.7
-----------
9.0
24.9
6.5
5.3
7.9
-----------
-----------
11.1
10.0
7.0
-0.2
8.4
10.3
15.6
6.8
2.0
8.2
-0.5
2.8
8.9
0.3
-4.7
-1.9
3.1
5.2
-0.6
-8.6
-1.1
2.9
7.2
-0.1
-6.4
2010f
f
2011
4.4
1.3
0.3
1.8
39.3
9.7
-----
4.8
1.6
-----
-----
14.1
9.6
10.2
6.4
5.9
0.0
7.4
1.7
6.5
0.7
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
72
1985
1986
1987
1988
1989
--13.4
11.9
11.0
8.3
--0.5
3.1
27.6
16.4
--13.0
-1.0
43.6
-13.1
-----------
--12.7
11.5
11.8
8.6
-----------
-----------
--50.5
8.3
5.4
5.0
--29.6
9.9
8.5
6.8
-----------
-----------
--9.9
10.7
-6.5
-6.9
1990
1991
1992
1993
1994
-2.7
-3.3
5.4
-2.5
-7.4
16.3
9.0
3.6
13.4
5.2
2.7
37.9
0.9
18.2
4.6
-----------
-1.8
-2.4
5.3
-1.4
-6.4
-----------
-----------
12.5
7.2
9.7
10.1
2.5
5.2
2.6
7.7
5.0
-1.3
------3.2
-0.4
------6.2
1.5
-1.6
-1.7
13.6
4.6
0.5
1995
1996
1997
1998
1999
-1.6
-2.7
3.1
15.0
9.2
19.1
-7.0
15.1
48.0
0.5
13.3
3.1
-2.1
16.7
24.9
-----------
0.1
-3.1
4.2
18.4
8.2
-----------
-----------
5.4
5.1
5.9
17.0
-0.6
3.3
2.0
5.3
17.5
2.6
-10.2
10.6
-9.0
11.2
-0.8
-8.2
5.6
-6.5
13.9
-6.2
-9.2
8.2
-7.8
12.5
-3.5
2000
1.8
23.0
24.4
---
4.5
---
---
8.7
7.1
-4.4
-6.8
-5.6
2001
2002
2003
2004
8.6
8.1
7.8
6.1
17.4
7.3
3.9
-0.7
37.9
16.7
9.1
16.4
---------
10.1
8.1
7.3
5.3
---------
---------
7.7
12.7
3.0
5.6
8.6
11.0
4.6
5.5
8.1
5.6
3.3
2.2
3.4
5.3
0.9
0.5
5.9
5.5
2.2
1.4
2005
2006
2007
2008
2009
6.7
21.5
5.4
1.6
11.4
0.9
23.8
-16.0
-12.1
4.9
9.2
38.4
14.2
16.3
4.4
-----------
6.0
22.1
2.8
0.5
10.6
-----------
-----------
8.1
7.2
3.3
-5.1
11.1
7.3
12.8
3.1
-2.8
10.9
-3.5
0.0
5.2
-4.6
-2.0
-4.9
0.3
1.5
-5.4
-5.9
-4.1
0.1
3.5
-4.9
-3.7
2010f
1.5
-2.7
36.3
f
2011
-2.7
-2.2
5.7
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
-----
1.9
-2.4
-----
-----
11.2
5.6
7.3
2.4
3.0
-4.0
4.5
-2.3
3.6
-3.2
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B N.S.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Nova Scotia, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Year
Health Expenditure
Private
Public
GDP Implicit
Price Index—Canada
Total
(1997 = 100)
($ per Capita)
1985
1986
1987
1988
1989
54.21
62.63
72.82
84.68
95.83
112.74
144.82
165.57
171.26
177.23
166.95
207.46
238.39
255.94
273.06
1,070.18
1,150.53
1,304.53
1,298.16
1,417.87
322.36
397.71
442.14
468.32
520.32
1,392.54
1,548.24
1,746.68
1,766.48
1,938.19
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
97.05
97.37
103.75
103.82
98.27
192.66
204.11
229.88
250.84
257.70
289.71
301.48
333.62
354.66
355.97
1,513.31
1,585.86
1,606.22
1,564.33
1,524.47
539.08
566.94
603.05
627.19
658.31
2,052.39
2,152.81
2,209.26
2,191.52
2,182.78
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
100.69
99.28
104.39
123.11
135.49
261.74
282.61
286.83
329.67
330.30
362.43
381.89
391.22
452.78
465.79
1,551.41
1,544.13
1,790.15
1,917.40
2,034.29
669.35
698.71
745.24
822.05
833.35
2,220.76
2,242.84
2,535.39
2,739.45
2,867.64
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
147.13
163.96
178.95
197.11
212.59
356.30
386.53
430.93
455.28
486.90
503.43
550.50
609.88
652.40
699.49
2,107.72
2,233.74
2,422.95
2,652.19
2,759.19
929.70
998.07
1,115.60
1,187.04
1,212.20
3,037.42
3,231.81
3,538.56
3,839.23
3,971.38
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009
231.64
289.27
308.13
324.59
350.23
523.80
566.37
606.20
605.10
633.02
755.44
855.64
914.33
929.69
983.25
3,015.69
3,388.67
3,640.86
3,828.63
3,918.88
1,290.40
1,421.18
1,510.17
1,584.80
1,759.07
4,306.09
4,809.85
5,151.03
5,413.43
5,677.95
117.5
120.8
125.2
131.3
127.8
2010f
f
2011
367.10
372.86
711.46
766.05
1,078.56
1,138.91
4,192.86
4,315.55
1,844.97
1,972.94
6,037.83
6,288.49
131.5
136.8
1985
1986
1987
1988
1989
--15.5
16.3
16.3
13.2
--28.5
14.3
3.4
3.5
--24.3
14.9
7.4
6.7
--7.5
13.4
-0.5
9.2
--23.4
11.2
5.9
11.1
--11.2
12.8
1.1
9.7
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
1.3
0.3
6.5
0.1
-5.3
8.7
5.9
12.6
9.1
2.7
6.1
4.1
10.7
6.3
0.4
6.7
4.8
1.3
-2.6
-2.5
3.6
5.2
6.4
4.0
5.0
5.9
4.9
2.6
-0.8
-0.4
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
2.5
-1.4
5.2
17.9
10.1
1.6
8.0
1.5
14.9
0.2
1.8
5.4
2.4
15.7
2.9
1.8
-0.5
15.9
7.1
6.1
1.7
4.4
6.7
10.3
1.4
1.7
1.0
13.0
8.0
4.7
2.3
1.7
1.0
-0.4
1.8
N.S.
(Annual Percentage Change)
2000
8.6
11.6
5.9
4.1
2001
11.4
8.5
9.3
6.0
7.4
6.4
1.4
2002
9.1
11.5
7.9
10.8
8.1
8.5
3.6
11.8
9.5
1.0
2003
10.2
5.7
7.0
9.5
6.4
8.5
2.9
2004
7.9
6.9
7.2
4.0
2.1
3.4
2.6
2005
2006
2007
2008
2009
9.0
24.9
6.5
5.3
7.9
7.6
8.1
7.0
-0.2
4.6
8.0
13.3
6.9
1.7
5.8
9.3
12.4
7.4
5.2
2.4
6.5
10.1
6.3
4.9
11.0
8.4
11.7
7.1
5.1
4.9
3.0
2.8
3.7
4.9
-2.7
2010f
f
2011
4.8
1.6
12.4
7.7
9.7
5.6
7.0
2.9
4.9
6.9
6.3
4.2
2.9
4.0
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--12.7
11.5
11.8
8.6
--25.7
9.6
-1.1
-1.1
--21.5
10.2
2.8
2.1
--4.7
8.6
-5.0
4.7
--20.6
6.4
1.4
6.5
--8.4
8.1
-3.4
5.2
1990
1991
1992
1993
1994
-1.8
-2.4
5.3
-1.4
-6.4
5.7
3.2
11.4
7.7
1.6
3.1
1.3
9.4
4.9
-0.7
3.7
2.0
0.0
-4.0
-3.6
0.6
2.4
5.1
2.6
3.9
2.9
2.1
1.4
-2.2
-1.5
1995
1996
1997
1998
1999
0.1
-3.1
4.2
18.4
8.2
-0.8
6.3
0.5
15.4
-1.6
-0.5
3.7
1.5
16.2
1.1
-0.6
-2.1
14.9
7.5
4.3
-0.7
2.7
5.7
10.7
-0.4
-0.6
-0.7
12.1
8.5
2.9
2000
4.5
3.8
4.0
-0.5
7.5
1.8
2001
2002
2003
2004
10.1
8.1
7.3
5.3
7.1
10.4
2.8
4.4
8.0
9.7
4.1
4.6
4.6
7.4
6.6
1.4
6.0
10.7
3.5
-0.5
5.0
8.4
5.6
0.9
2005
2006
2007
2008
2009
6.0
22.1
2.8
0.5
10.6
4.6
5.3
3.4
-5.0
7.3
5.0
10.5
3.2
-3.2
8.5
6.3
9.6
3.8
0.3
5.1
3.4
7.3
2.6
0.1
13.7
5.4
8.9
3.4
0.2
7.6
2010f
f
2011
1.9
-2.4
9.4
3.7
6.7
1.6
4.0
-1.1
1.9
2.9
3.4
0.2
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
73
Drug Expenditure in Canada, 1985 to 2011
Table B N.B.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, New Brunswick, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out of
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Federal
Year
N.B.
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter
Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
33.9
39.6
46.2
48.5
52.7
1.7
1.8
1.9
2.7
3.1
0.1
0.2
0.2
0.2
0.3
-----------
35.7
41.5
48.4
51.4
56.0
-----------
-----------
38.8
45.6
56.1
61.4
67.1
74.4
87.1
104.5
112.7
123.1
-----------
-----------
48.4
54.8
63.6
61.6
59.6
1990
1991
1992
1993
1994
58.3
62.4
60.0
56.8
56.0
3.7
4.1
4.2
5.2
5.7
0.4
0.4
0.5
0.6
0.6
-----------
62.4
67.0
64.8
62.5
62.3
-----------
-----------
80.3
88.8
102.2
111.3
118.4
142.7
155.8
167.0
173.8
180.7
----35.6
37.0
37.3
----32.3
34.5
35.5
61.0
66.1
67.9
71.5
72.8
1995
1996
1997
1998
1999
58.3
54.8
56.1
62.1
69.0
6.4
6.4
7.1
8.6
10.8
0.6
0.7
0.7
0.9
1.1
-----------
65.4
61.9
64.0
71.6
80.8
-----------
-----------
127.8
126.7
143.9
149.7
167.0
193.1
188.6
207.9
221.3
247.8
34.4
32.9
44.5
42.5
47.6
33.5
30.6
42.6
41.6
44.1
67.9
63.6
87.1
84.2
91.7
2000
2001
2002
2003
2004
78.4
90.1
101.3
112.3
124.4
14.2
17.2
18.8
21.0
21.6
1.4
1.7
2.1
2.6
3.3
-----------
94.0
109.0
122.2
135.9
149.3
-----------
-----------
187.7
218.9
241.9
271.4
276.1
281.6
327.9
364.1
407.2
425.4
47.6
46.5
49.7
50.6
52.2
43.1
40.3
43.0
42.8
43.5
90.7
86.9
92.6
93.4
95.7
2005
2006
2007
2008
2009
135.8
146.4
152.7
160.9
175.2
22.3
22.7
23.3
24.3
23.8
3.7
4.0
4.0
4.2
4.4
-----------
161.9
173.0
180.0
189.4
203.3
-----------
-----------
327.0
343.7
349.6
378.3
407.0
488.9
516.7
529.6
567.8
610.3
50.1
52.7
56.8
57.8
70.3
41.1
43.4
45.2
45.6
53.2
91.2
96.0
102.1
103.4
123.4
2010f
f
2011
187.5
180.9
23.5
24.0
4.4
4.8
-----
215.4
209.7
-----
-----
455.0
495.3
670.4
705.0
74.1
76.9
56.9
58.1
130.9
135.0
1985
1986
1987
1988
1989
--16.9
16.8
5.0
8.6
--7.6
9.3
36.1
17.3
--14.5
15.9
18.5
15.6
-----------
--16.4
16.4
6.3
9.1
-----------
-----------
--17.6
23.0
9.3
9.3
--17.1
19.9
7.9
9.2
-----------
-----------
1990
1991
1992
1993
1994
10.7
7.0
-3.9
-5.4
-1.4
18.6
12.5
2.0
22.5
10.6
56.5
11.2
24.7
3.7
5.4
-----------
11.4
7.4
-3.4
-3.5
-0.4
-----------
-----------
19.7
10.6
15.1
8.9
6.4
15.9
9.2
7.1
4.1
4.0
------3.9
0.9
------6.8
2.9
2.2
8.3
2.8
5.3
1.8
1995
1996
1997
1998
1999
4.2
-6.0
2.5
10.7
11.0
11.6
0.1
11.0
21.1
25.2
8.4
13.1
0.1
19.3
23.4
-----------
4.9
-5.2
3.3
12.0
12.9
-----------
-----------
7.9
-0.8
13.6
4.0
11.6
6.9
-2.3
10.2
6.4
12.0
-7.8
-4.2
35.2
-4.5
11.8
-5.7
-8.5
38.9
-2.1
6.0
-6.8
-6.3
37.0
-3.4
8.9
2000
2001
2002
2003
2004
13.6
14.9
12.5
10.8
10.8
31.9
20.8
9.3
11.7
3.1
28.3
25.8
19.0
25.8
25.2
-----------
16.2
16.0
12.1
11.2
9.9
-----------
-----------
12.4
16.6
10.5
12.2
1.8
13.6
16.4
11.0
11.8
4.5
0.1
-2.3
6.7
1.9
3.2
-2.3
-6.5
6.5
-0.3
1.6
-1.0
-4.2
6.6
0.9
2.4
2005
2006
2007
2008
2009
9.2
7.8
4.3
5.4
8.8
3.3
1.7
2.4
4.3
-1.9
13.9
6.6
1.5
5.7
2.7
-----------
8.4
6.9
4.0
5.3
7.3
-----------
-----------
18.4
5.1
1.7
8.2
7.6
14.9
5.7
2.5
7.2
7.5
-4.1
5.1
8.0
1.7
21.6
-5.4
5.5
4.3
0.8
16.7
-4.7
5.3
6.3
1.3
19.4
2010f
f
2011
7.0
-3.5
-1.1
1.9
0.9
9.0
-----
5.9
-2.6
-----
-----
11.8
8.9
9.8
5.2
5.4
3.9
6.9
2.1
6.1
3.1
1985
1986
1987
1988
1989
27.6
27.9
27.5
27.8
28.8
1.3
1.3
1.2
1.5
1.7
0.1
0.1
0.1
0.1
0.1
-----------
29.0
29.2
28.8
29.5
30.7
-----------
-----------
31.6
32.1
33.4
35.2
36.7
60.6
61.4
62.2
64.7
67.4
-----------
-----------
39.4
38.6
37.8
35.3
32.6
1990
1991
1992
1993
1994
28.6
28.1
25.5
23.1
22.1
1.8
1.9
1.8
2.1
2.3
0.2
0.2
0.2
0.2
0.2
-----------
30.6
30.2
27.6
25.5
24.6
-----------
-----------
39.4
40.0
43.5
45.4
46.7
70.1
70.2
71.1
70.9
71.3
----15.2
15.1
14.7
----13.8
14.1
14.0
29.9
29.8
28.9
29.1
28.7
1995
1996
1997
1998
1999
22.3
21.7
19.0
20.3
20.3
2.5
2.5
2.4
2.8
3.2
0.2
0.3
0.2
0.3
0.3
-----------
25.0
24.6
21.7
23.4
23.8
-----------
-----------
49.0
50.2
48.8
49.0
49.2
74.0
74.8
70.5
72.4
73.0
13.2
13.1
15.1
13.9
14.0
12.8
12.1
14.4
13.6
13.0
26.0
25.2
29.5
27.6
27.0
2000
21.0
3.8
0.4
---
25.2
---
---
50.4
75.6
12.8
11.6
24.4
2001
2002
2003
2004
21.7
22.2
22.4
23.9
4.1
4.1
4.2
4.1
0.4
0.5
0.5
0.6
---------
26.3
26.7
27.1
28.6
---------
---------
52.8
53.0
54.2
53.0
79.1
79.7
81.3
81.6
11.2
10.9
10.1
10.0
9.7
9.4
8.6
8.3
20.9
20.3
18.7
18.4
2005
2006
2007
2008
2009
23.4
23.9
24.2
24.0
23.9
3.9
3.7
3.7
3.6
3.2
0.6
0.6
0.6
0.6
0.6
-----------
27.9
28.2
28.5
28.2
27.7
-----------
-----------
56.4
56.1
55.3
56.4
55.5
84.3
84.3
83.8
84.6
83.2
8.6
8.6
9.0
8.6
9.6
7.1
7.1
7.2
6.8
7.2
15.7
15.7
16.2
15.4
16.8
23.4
2.9
0.5
21.5
2.9
0.6
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
-----
26.9
25.0
-----
-----
56.8
59.0
83.7
83.9
9.2
9.2
7.1
6.9
16.3
16.1
(Annual Percentage Change)
--13.2
16.0
-3.1
-3.1
(Percentage Share of Total Drug Expenditure)
2010f
f
2011
74
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B N.B.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, New Brunswick, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Private
Total
Public
($ Millions)
Year
Total
(Percentage Share)
1985
1986
1987
1988
1989
35.7
41.5
48.4
51.4
56.0
87.2
100.4
119.7
122.9
126.7
122.9
142.0
168.1
174.3
182.8
752.2
805.3
888.9
961.0
1,047.7
274.1
285.9
305.1
330.5
352.4
1,026.2
1,091.1
1,194.0
1,291.5
1,400.1
4.7
5.2
5.4
5.3
5.3
31.8
35.1
39.2
37.2
36.0
12.0
13.0
14.1
13.5
13.1
1990
1991
1992
1993
1994
62.4
67.0
64.8
62.5
62.3
141.2
154.9
170.1
182.8
191.2
203.7
221.9
234.9
245.3
253.5
1,136.1
1,186.9
1,233.1
1,236.1
1,272.2
397.4
442.4
466.7
503.0
520.8
1,533.5
1,629.3
1,699.8
1,739.1
1,793.0
5.5
5.6
5.3
5.1
4.9
35.5
35.0
36.4
36.3
36.7
13.3
13.6
13.8
14.1
14.1
1995
1996
1997
1998
1999
65.4
61.9
64.0
71.6
80.8
195.6
190.3
231.0
233.8
258.7
261.0
252.2
295.0
305.5
339.5
1,323.0
1,325.3
1,305.7
1,370.6
1,469.5
496.4
488.4
551.4
553.6
607.0
1,819.3
1,813.7
1,857.2
1,924.2
2,076.5
4.9
4.7
4.9
5.2
5.5
39.4
39.0
41.9
42.2
42.6
14.3
13.9
15.9
15.9
16.4
2000
2001
2002
2003
2004
94.0
109.0
122.2
135.9
149.3
278.4
305.8
334.6
364.8
371.8
372.3
414.7
456.7
500.7
521.1
1,580.0
1,740.0
1,829.1
1,947.6
2,115.3
638.6
727.8
786.5
840.9
864.5
2,218.6
2,467.8
2,615.6
2,788.5
2,979.8
5.9
6.3
6.7
7.0
7.1
43.6
42.0
42.5
43.4
43.0
16.8
16.8
17.5
18.0
17.5
2005
2006
2007
2008
2009
161.9
173.0
180.0
189.4
203.3
418.2
439.7
451.7
481.7
530.4
580.0
612.7
631.6
671.1
733.7
2,309.8
2,526.9
2,647.5
2,841.7
3,005.4
984.2
1,054.7
1,075.5
1,141.6
1,296.9
3,294.0
3,581.6
3,723.0
3,983.2
4,302.3
7.0
6.8
6.8
6.7
6.8
42.5
41.7
42.0
42.2
40.9
17.6
17.1
17.0
16.8
17.1
2010f
f
2011
215.4
209.7
585.9
630.3
801.3
840.0
3,165.3
3,266.2
1,384.9
1,518.0
4,550.2
4,784.2
6.8
6.4
42.3
41.5
17.6
17.6
1985
1986
1987
1988
1989
--16.4
16.4
6.3
9.1
--15.2
19.2
2.7
3.1
--15.6
18.4
3.7
4.8
--7.1
10.4
8.1
9.0
--4.3
6.7
8.3
6.6
--6.3
9.4
8.2
8.4
1990
1991
1992
1993
1994
11.4
7.4
-3.4
-3.5
-0.4
11.5
9.6
9.8
7.4
4.6
11.4
9.0
5.8
4.4
3.3
8.4
4.5
3.9
0.2
2.9
12.8
11.3
5.5
7.8
3.5
9.5
6.2
4.3
2.3
3.1
1995
1996
1997
1998
1999
4.9
-5.2
3.3
12.0
12.9
2.3
-2.7
21.4
1.2
10.6
3.0
-3.3
17.0
3.5
11.1
4.0
0.2
-1.5
5.0
7.2
-4.7
-1.6
12.9
0.4
9.6
1.5
-0.3
2.4
3.6
7.9
2000
2001
2002
2003
2004
16.2
16.0
12.1
11.2
9.9
7.6
9.8
9.4
9.0
1.9
9.7
11.4
10.1
9.6
4.1
7.5
10.1
5.1
6.5
8.6
5.2
14.0
8.1
6.9
2.8
6.8
11.2
6.0
6.6
6.9
2005
2006
2007
2008
2009
8.4
6.9
4.0
5.3
7.3
12.5
5.1
2.7
6.6
10.1
11.3
5.6
3.1
6.3
9.3
9.2
9.4
4.8
7.3
5.8
13.8
7.2
2.0
6.1
13.6
10.5
8.7
3.9
7.0
8.0
2010 f
f
2011
5.9
-2.6
10.5
7.6
9.2
4.8
5.3
3.2
6.8
9.6
5.8
5.1
N.B.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
29.0
29.2
28.8
29.5
30.7
71.0
70.8
71.2
70.5
69.3
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
30.6
30.2
27.6
25.5
24.6
69.4
69.8
72.4
74.5
75.4
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
25.0
24.6
21.7
23.4
23.8
75.0
75.4
78.3
76.6
76.2
100.0
100.0
100.0
100.0
100.0
2000
25.2
74.8
100.0
2001
2002
2003
2004
26.3
26.7
27.1
28.6
73.7
73.3
72.9
71.4
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009
27.9
28.2
28.5
28.2
27.7
72.1
71.8
71.5
71.8
72.3
100.0
100.0
100.0
100.0
100.0
2010f
f
2011
26.9
25.0
73.1
75.0
100.0
100.0
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
75
Drug Expenditure in Canada, 1985 to 2011
Table B N.B.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, New Brunswick, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Subtotal
Insurers*
Out of
Social Security Funds
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Federal
Year
N.B.
Subtotal
Private
Total
Prescribed
Drugs
OvertheCounter
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
Personal
Total
Health
Non-Presc.
Supplies
Drugs
1985
1986
1987
1988
1989
46.80
54.59
63.50
66.43
71.66
2.29
2.46
2.68
3.63
4.23
0.19
0.22
0.25
0.30
0.34
-----------
49.28
57.26
66.43
70.36
76.23
-----------
-----------
53.60
62.92
77.12
84.01
91.22
102.88
120.18
143.55
154.37
167.45
-----------
-----------
66.89
75.59
87.33
84.30
81.12
1990
1991
1992
1993
1994
78.82
83.75
80.19
75.83
74.59
4.99
5.57
5.66
6.92
7.64
0.53
0.59
0.73
0.75
0.79
-----------
84.34
89.90
86.57
83.50
83.03
-----------
-----------
108.44
119.11
136.60
148.60
157.80
192.78
209.01
223.17
232.11
240.84
----47.57
49.37
49.72
----43.20
46.09
47.33
82.40
88.62
90.77
95.47
97.05
1995
1996
1997
1998
1999
77.65
72.83
74.59
82.80
91.89
8.52
8.51
9.45
11.47
14.36
0.86
0.97
0.97
1.16
1.43
-----------
87.02
82.31
85.01
95.43
107.68
-----------
-----------
170.11
168.45
191.27
199.42
222.50
257.14
250.76
276.28
294.85
330.18
45.80
43.79
59.18
56.66
63.36
44.57
40.72
56.54
55.47
58.77
90.37
84.51
115.72
112.13
122.13
2000
2001
2002
2003
2004
104.41
120.09
135.05
149.49
165.45
18.94
22.90
25.01
27.91
28.74
1.84
2.31
2.75
3.46
4.33
-----------
125.19
145.31
162.81
180.86
198.52
-----------
-----------
250.06
291.92
322.44
361.25
367.17
375.25
437.23
485.25
542.11
565.69
63.43
62.06
66.19
67.38
69.43
57.44
53.78
57.25
56.99
57.81
120.87
115.84
123.44
124.37
127.25
2005
2006
2007
2008
2009
180.77
196.29
204.81
215.47
233.78
29.73
30.47
31.21
32.47
31.76
4.93
5.30
5.38
5.68
5.81
-----------
215.43
232.05
241.39
253.62
271.35
-----------
-----------
435.23
460.87
468.93
506.53
543.11
650.66
692.93
710.33
760.15
814.46
66.65
70.61
76.24
77.37
93.75
54.72
58.18
60.69
61.04
70.99
121.37
128.79
136.93
138.42
164.74
2010f
f
2011
249.38
240.48
31.30
31.86
5.84
6.37
-----
286.52
278.70
-----
-----
605.22
658.22
891.74
936.92
98.51
102.23
75.66
77.18
174.16
179.42
1985
1986
1987
1988
1989
--16.6
16.3
4.6
7.9
--7.4
8.9
35.6
16.6
--14.3
15.5
18.1
14.8
-----------
--16.2
16.0
5.9
8.3
-----------
-----------
--17.4
22.6
8.9
8.6
--16.8
19.4
7.5
8.5
-----------
-----------
1990
1991
1992
1993
1994
10.0
6.3
-4.3
-5.4
-1.6
17.8
11.6
1.6
22.4
10.4
55.5
10.4
24.3
3.6
5.2
-----------
10.6
6.6
-3.7
-3.5
-0.6
-----------
-----------
18.9
9.8
14.7
8.8
6.2
15.1
8.4
6.8
4.0
3.8
------3.8
0.7
------6.7
2.7
1.6
7.6
2.4
5.2
1.7
1995
1996
1997
1998
1999
4.1
-6.2
2.4
11.0
11.0
11.5
-0.1
11.0
21.4
25.2
8.3
12.9
0.1
19.6
23.4
-----------
4.8
-5.4
3.3
12.3
12.8
-----------
-----------
7.8
-1.0
13.5
4.3
11.6
6.8
-2.5
10.2
6.7
12.0
-7.9
-4.4
35.1
-4.3
11.8
-5.8
-8.6
38.8
-1.9
5.9
-6.9
-6.5
36.9
-3.1
8.9
(Annual Percentage Change)
2000
--13.0
15.5
-3.5
-3.8
13.6
31.9
28.3
---
16.3
---
---
12.4
13.6
0.1
-2.3
-1.0
2001
15.0
20.9
25.9
---
16.1
---
---
16.7
16.5
-2.2
-6.4
-4.2
2002
12.5
9.2
18.9
---
12.0
---
---
10.5
11.0
6.7
6.5
2003
10.7
11.6
25.7
---
11.1
---
---
12.0
11.7
1.8
-0.5
0.8
2004
10.7
3.0
25.0
---
9.8
---
---
1.6
4.4
3.0
1.5
2.3
2005
2006
2007
2008
2009
9.3
8.6
4.3
5.2
8.5
3.4
2.5
2.4
4.1
-2.2
14.0
7.4
1.5
5.5
2.3
-----------
8.5
7.7
4.0
5.1
7.0
-----------
-----------
18.5
5.9
1.7
8.0
7.2
15.0
6.5
2.5
7.0
7.1
-4.0
5.9
8.0
1.5
21.2
-5.4
6.3
4.3
0.6
16.3
-4.6
6.1
6.3
1.1
19.0
2010f
f
2011
6.7
-3.6
-1.5
1.8
0.6
8.9
-----
5.6
-2.7
-----
-----
11.4
8.8
9.5
5.1
5.1
3.8
6.6
2.0
5.7
3.0
6.6
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
76
1985
1986
1987
1988
1989
--13.8
11.6
0.1
3.3
--4.6
4.2
31.1
12.0
--11.5
10.7
13.6
10.3
-----------
--13.4
11.3
1.4
3.8
-----------
-----------
--14.6
17.8
4.4
4.0
--14.0
14.7
3.0
3.9
-----------
-----------
--10.2
10.8
-8.0
-8.3
1990
1991
1992
1993
1994
7.0
3.5
-5.5
-6.9
-2.7
14.8
8.9
0.3
21.0
9.3
52.5
7.6
23.0
2.2
4.1
-----------
7.6
3.8
-5.0
-5.0
-1.7
-----------
-----------
15.8
7.1
13.4
7.3
5.1
12.1
5.7
5.5
2.6
2.7
------2.3
-0.4
------5.3
1.6
-1.5
4.8
1.2
3.7
0.6
1995
1996
1997
1998
1999
1.8
-7.9
1.4
11.4
9.2
9.1
-1.8
10.0
21.8
23.4
6.0
11.2
-0.9
20.1
21.5
-----------
2.5
-7.1
2.3
12.7
11.0
-----------
-----------
5.5
-2.7
12.6
4.7
9.8
4.4
-4.2
9.2
7.2
10.2
-10.2
-6.1
34.2
-3.8
10.0
-8.2
-10.3
37.9
-1.5
4.1
-9.2
-8.2
35.9
-2.7
7.1
2000
9.5
27.8
24.2
---
12.2
---
---
8.3
9.5
-4.0
-6.4
-5.1
2001
2002
2003
2004
13.7
11.4
7.8
8.1
19.6
8.2
8.7
0.4
24.6
17.9
22.8
22.4
---------
14.7
11.0
8.2
7.2
---------
---------
15.4
9.4
9.1
-0.9
15.2
9.9
8.8
1.8
-3.5
5.6
-1.1
0.5
-7.7
5.4
-3.4
-1.1
-5.5
5.5
-2.1
-0.3
2005
2006
2007
2008
2009
6.2
5.8
0.7
0.3
11.2
0.4
-0.3
-1.3
-0.8
0.5
11.0
4.6
-2.1
0.6
5.0
-----------
5.5
4.9
0.3
0.2
9.7
-----------
-----------
15.5
3.1
-1.9
3.2
9.9
12.0
3.7
-1.2
2.1
9.9
-7.0
3.1
4.3
-3.4
23.9
-8.4
3.5
0.6
-4.3
19.0
-7.6
3.3
2.6
-3.8
21.7
2010f
3.7
-4.4
-2.3
f
2011
-7.6
-2.2
4.9
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
-----
2.6
-6.7
-----
-----
8.5
4.8
6.5
1.1
2.1
-0.2
3.6
-2.0
2.8
-1.0
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B N.B.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, New Brunswick, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Year
Health Expenditure
Private
Public
GDP Implicit
Price Index—Canada
Total
(1997 = 100)
($ per Capita)
1985
1986
1987
1988
1989
49.28
57.26
66.43
70.36
76.23
120.48
138.51
164.45
168.31
172.34
169.76
195.77
230.88
238.67
248.57
1,039.37
1,110.46
1,221.26
1,315.80
1,425.04
378.68
394.24
419.14
452.46
479.28
1,418.05
1,504.71
1,640.40
1,768.26
1,904.32
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
84.34
89.90
86.57
83.50
83.03
190.84
207.73
227.37
244.07
254.85
275.18
297.63
313.94
327.57
337.88
1,535.00
1,592.01
1,648.30
1,650.79
1,695.79
536.96
593.38
623.91
671.67
694.18
2,071.96
2,185.39
2,272.21
2,322.46
2,389.97
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
87.02
82.31
85.01
95.43
107.68
260.48
252.96
306.99
311.55
344.63
347.50
335.27
392.00
406.98
452.31
1,761.67
1,761.66
1,735.08
1,826.14
1,957.71
660.95
649.20
732.76
737.64
808.66
2,422.62
2,410.86
2,467.84
2,563.77
2,766.37
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
125.19
145.31
162.81
180.86
198.52
370.93
407.76
445.88
485.62
494.42
496.12
553.07
608.69
666.48
692.94
2,105.17
2,320.35
2,437.73
2,592.58
2,812.70
850.90
970.56
1,048.19
1,119.37
1,149.59
2,956.07
3,290.91
3,485.93
3,711.94
3,962.29
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009
215.43
232.05
241.39
253.62
271.35
556.60
589.67
605.86
644.95
707.85
772.03
821.72
847.26
898.57
979.20
3,074.33
3,388.73
3,551.24
3,804.63
4,010.78
1,309.94
1,414.38
1,442.58
1,528.39
1,730.77
4,384.27
4,803.11
4,993.82
5,333.01
5,741.55
117.5
120.8
125.2
131.3
127.8
2010f
f
2011
286.52
278.70
779.38
837.64
1,065.90
1,116.34
4,210.50
4,340.71
1,842.26
2,017.37
6,052.75
6,358.08
131.5
136.8
1985
1986
1987
1988
1989
--16.2
16.0
5.9
8.3
--15.0
18.7
2.4
2.4
--15.3
17.9
3.4
4.1
--6.8
10.0
7.7
8.3
--4.1
6.3
7.9
5.9
--6.1
9.0
7.8
7.7
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
10.6
6.6
-3.7
-3.5
-0.6
10.7
8.9
9.5
7.3
4.4
10.7
8.2
5.5
4.3
3.1
7.7
3.7
3.5
0.2
2.7
12.0
10.5
5.1
7.7
3.4
8.8
5.5
4.0
2.2
2.9
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
4.8
-5.4
3.3
12.3
12.8
2.2
-2.9
21.4
1.5
10.6
2.8
-3.5
16.9
3.8
11.1
3.9
0.0
-1.5
5.2
7.2
-4.8
-1.8
12.9
0.7
9.6
1.4
-0.5
2.4
3.9
7.9
2.3
1.7
1.0
-0.4
1.8
N.B.
(Annual Percentage Change)
9.7
7.5
5.2
6.9
4.1
2001
16.1
9.9
11.5
10.2
14.1
11.3
1.4
2002
2000
12.0
16.3
9.3
7.6
10.1
5.1
8.0
5.9
1.0
2003
11.1
8.9
9.5
6.4
6.8
6.5
2.9
2004
9.8
1.8
4.0
8.5
2.7
6.7
2.6
2005
2006
2007
2008
2009
8.5
7.7
4.0
5.1
7.0
12.6
5.9
2.7
6.5
9.8
11.4
6.4
3.1
6.1
9.0
9.3
10.2
4.8
7.1
5.4
13.9
8.0
2.0
5.9
13.2
10.6
9.6
4.0
6.8
7.7
3.0
2.8
3.7
4.9
-2.7
2010 f
f
2011
5.6
-2.7
10.1
7.5
8.9
4.7
5.0
3.1
6.4
9.5
5.4
5.0
2.9
4.0
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--13.4
11.3
1.4
3.8
--12.2
14.0
-2.2
-2.2
--12.5
13.2
-1.1
-0.4
--4.0
5.2
3.2
3.7
--1.3
1.6
3.4
1.4
--3.3
4.3
3.3
3.1
1990
1991
1992
1993
1994
7.6
3.8
-5.0
-5.0
-1.7
7.7
6.1
8.2
5.9
3.3
7.7
5.4
4.2
2.9
2.0
4.7
1.0
2.3
-1.3
1.6
9.0
7.7
3.9
6.2
2.3
5.8
2.7
2.7
0.8
1.8
1995
1996
1997
1998
1999
2.5
-7.1
2.3
12.7
11.0
-0.1
-4.6
20.4
1.9
8.8
0.5
-5.2
15.9
4.3
9.3
1.5
-1.7
-2.5
5.7
5.4
-7.1
-3.4
11.9
1.1
7.8
-1.0
-2.2
1.4
4.3
6.1
2000
12.2
3.5
5.6
3.4
1.1
2.8
2001
2002
2003
2004
14.7
11.0
8.2
7.2
8.6
8.3
6.0
-0.8
10.1
9.0
6.6
1.4
8.9
4.0
3.5
5.9
12.7
7.0
3.9
0.1
10.0
4.9
3.6
4.2
2005
2006
2007
2008
2009
5.5
4.9
0.3
0.2
9.7
9.6
3.1
-0.9
1.6
12.5
8.4
3.6
-0.6
1.2
11.7
6.3
7.4
1.1
2.3
8.1
10.9
5.2
-1.7
1.1
15.9
7.6
6.8
0.3
1.9
10.4
2010 f
f
2011
2.6
-6.7
7.2
3.5
5.9
0.7
2.0
-0.9
3.5
5.5
2.5
1.1
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
77
Drug Expenditure in Canada, 1985 to 2011
Table B Que.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Quebec, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out of
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Federal
Year
Que.
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter
Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
250.4
291.2
333.8
384.1
437.1
7.4
8.1
8.8
10.7
12.8
2.1
2.7
3.2
3.2
3.5
-----------
260.0
301.9
345.8
398.0
453.4
-----------
-----------
342.6
463.0
466.6
523.3
582.4
602.6
764.9
812.4
921.4
1,035.8
-----------
-----------
230.5
261.0
302.7
366.9
444.8
1990
1991
1992
1993
1994
502.9
604.0
650.5
686.1
742.1
15.3
16.7
18.1
21.1
23.0
4.2
4.9
5.1
5.0
5.6
-----------
522.4
625.6
673.7
712.3
770.7
-----------
-----------
638.9
709.4
770.9
882.3
898.5
1,161.2
1,335.0
1,444.6
1,594.6
1,669.2
----306.5
312.4
326.8
----264.2
280.8
306.6
468.3
534.5
570.7
593.1
633.4
1995
1996
1997
1998
1999
807.0
733.4
700.3
779.8
918.6
24.1
24.0
26.0
29.5
34.4
6.3
6.9
7.4
8.1
9.3
----169.1
213.4
262.4
837.4
764.3
902.7
1,030.8
1,224.7
-----------
-----------
1,005.9
1,079.9
1,227.2
1,228.4
1,433.5
1,843.3
1,844.1
2,129.9
2,259.2
2,658.2
334.4
322.1
293.5
312.2
334.1
314.5
314.6
294.6
316.7
332.4
649.0
636.7
588.1
628.9
666.6
2000
2001
2002
2003
2004
1,118.4
1,309.4
1,439.5
1,538.9
1,678.1
35.0
38.4
44.7
50.7
53.5
11.1
13.5
15.4
18.0
21.1
327.8
367.4
433.2
577.8
615.5
1,492.4
1,728.6
1,932.8
2,185.4
2,368.2
-----------
-----------
1,612.8
1,752.2
1,968.7
2,130.9
2,357.0
3,105.2
3,480.8
3,901.6
4,316.3
4,725.2
321.2
337.0
347.1
350.7
371.7
324.3
331.7
340.6
340.4
352.4
645.4
668.7
687.6
691.0
724.1
2005
2006
2007
2008
2009
1,798.7
1,955.6
2,164.9
2,297.2
2,443.5
57.3
62.2
66.2
71.1
69.5
23.0
26.4
29.6
32.8
36.1
618.7
669.0
712.1
774.7
744.0
2,497.8
2,713.1
2,972.7
3,175.8
3,293.0
-----------
-----------
2,492.4
2,706.9
2,894.0
3,017.1
3,195.2
4,990.2
5,420.1
5,866.6
6,192.9
6,488.2
426.3
439.4
464.2
491.7
538.5
385.1
399.1
402.4
421.8
440.9
811.4
838.5
866.6
913.5
979.4
2010f
f
2011
2,460.6
2,395.5
68.4
69.7
38.7
42.0
779.0
793.5
3,346.7
3,300.7
-----
-----
3,553.4
3,970.9
6,900.1
7,271.7
537.4
525.8
444.4
443.1
981.8
968.9
1985
1986
1987
1988
1989
--16.3
14.6
15.1
13.8
--8.4
9.1
21.6
20.0
--27.3
19.2
1.0
7.2
-----------
--16.1
14.5
15.1
13.9
-----------
-----------
--35.1
0.8
12.2
11.3
--26.9
6.2
13.4
12.4
-----------
-----------
--13.2
16.0
21.2
21.2
1990
1991
1992
1993
1994
15.0
20.1
7.7
5.5
8.2
19.2
9.4
8.2
16.7
8.7
20.8
16.6
3.3
-0.1
11.7
-----------
15.2
19.8
7.7
5.7
8.2
-----------
-----------
9.7
11.0
8.7
14.4
1.8
12.1
15.0
8.2
10.4
4.7
------1.9
4.6
------6.3
9.2
5.3
14.1
6.8
3.9
6.8
1995
1996
1997
1998
1999
8.7
-9.1
-4.5
11.4
17.8
5.0
-0.7
8.5
13.4
16.6
12.1
9.7
6.2
10.0
15.1
------26.2
23.0
8.7
-8.7
18.1
14.2
18.8
-----------
-----------
11.9
7.4
13.6
0.1
16.7
10.4
0.0
15.5
6.1
17.7
2.3
-3.7
-8.9
6.4
7.0
2.6
0.0
-6.4
7.5
5.0
2.5
-1.9
-7.6
6.9
6.0
(Annual Percentage Change)
2000
2001
21.8
17.1
1.9
9.6
19.7
20.8
24.9
12.1
21.9
15.8
-----
-----
12.5
8.6
16.8
12.1
-3.9
4.9
-2.5
2.3
-3.2
3.6
2002
9.9
16.6
14.3
17.9
11.8
---
---
12.4
12.1
3.0
2.7
2.8
2003
2004
6.9
9.0
13.4
5.5
17.1
17.3
33.4
6.5
13.1
8.4
-----
-----
8.2
10.6
10.6
9.5
1.0
6.0
-0.1
3.5
0.5
4.8
2005
2006
2007
2008
2009
7.2
8.7
10.7
6.1
6.4
7.0
8.6
6.4
7.5
-2.3
9.0
14.7
11.9
10.8
10.1
0.5
8.1
6.4
8.8
-4.0
5.5
8.6
9.6
6.8
3.7
-----------
-----------
5.7
8.6
6.9
4.3
5.9
5.6
8.6
8.2
5.6
4.8
14.7
3.1
5.6
5.9
9.5
9.3
3.6
0.8
4.8
4.5
12.1
3.3
3.3
5.4
7.2
2010f
f
2011
0.7
-2.6
-1.6
1.9
7.4
8.6
4.7
1.9
1.6
-1.4
-----
-----
11.2
11.7
6.3
5.4
-0.2
-2.2
0.8
-0.3
0.2
-1.3
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
30.1
28.4
29.9
29.8
29.5
0.9
0.8
0.8
0.8
0.9
0.3
0.3
0.3
0.3
0.2
-----------
31.2
29.4
31.0
30.9
30.6
-----------
-----------
41.1
45.1
41.8
40.6
39.3
72.3
74.6
72.9
71.5
70.0
-----------
-----------
27.7
25.4
27.1
28.5
30.0
1990
1991
1992
1993
1994
30.9
32.3
32.3
31.4
32.2
0.9
0.9
0.9
1.0
1.0
0.3
0.3
0.3
0.2
0.2
-----------
32.1
33.5
33.4
32.6
33.5
-----------
-----------
39.2
37.9
38.3
40.3
39.0
71.3
71.4
71.7
72.9
72.5
----15.2
14.3
14.2
----13.1
12.8
13.3
28.7
28.6
28.3
27.1
27.5
1995
1996
1997
1998
1999
32.4
29.6
25.8
27.0
27.6
1.0
1.0
1.0
1.0
1.0
0.3
0.3
0.3
0.3
0.3
----6.2
7.4
7.9
33.6
30.8
33.2
35.7
36.8
-----------
-----------
40.4
43.5
45.2
42.5
43.1
74.0
74.3
78.4
78.2
80.0
13.4
13.0
10.8
10.8
10.0
12.6
12.7
10.8
11.0
10.0
26.0
25.7
21.6
21.8
20.0
2000
29.8
0.9
0.3
8.7
39.8
---
---
43.0
82.8
8.6
8.6
17.2
2001
2002
2003
2004
31.6
31.4
30.7
30.8
0.9
1.0
1.0
1.0
0.3
0.3
0.4
0.4
8.9
9.4
11.5
11.3
41.7
42.1
43.6
43.5
---------
---------
42.2
42.9
42.6
43.3
83.9
85.0
86.2
86.7
8.1
7.6
7.0
6.8
8.0
7.4
6.8
6.5
16.1
15.0
13.8
13.3
2005
2006
2007
2008
2009
31.0
31.2
32.2
32.3
32.7
1.0
1.0
1.0
1.0
0.9
0.4
0.4
0.4
0.5
0.5
10.7
10.7
10.6
10.9
10.0
43.1
43.4
44.1
44.7
44.1
-----------
-----------
43.0
43.3
43.0
42.5
42.8
86.0
86.6
87.1
87.1
86.9
7.3
7.0
6.9
6.9
7.2
6.6
6.4
6.0
5.9
5.9
14.0
13.4
12.9
12.9
13.1
31.2
0.9
0.5
29.1
0.8
0.5
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
9.9
9.6
42.5
40.1
-----
-----
45.1
48.2
87.5
88.2
6.8
6.4
5.6
5.4
12.5
11.8
2010f
f
2011
78
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B Que.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Quebec, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Private
Total
Public
($ Millions)
Year
Total
(Percentage Share)
1985
1986
1987
1988
1989
260.0
301.9
345.8
398.0
453.4
573.1
724.0
769.3
890.3
1,027.2
833.0
1,025.9
1,115.1
1,288.3
1,480.7
7,927.6
8,051.3
8,636.4
9,428.4
10,108.6
2,104.4
2,486.1
2,632.2
2,850.8
3,181.7
10,031.9
10,537.4
11,268.6
12,279.2
13,290.3
3.3
3.7
4.0
4.2
4.5
27.2
29.1
29.2
31.2
32.3
8.3
9.7
9.9
10.5
11.1
1990
1991
1992
1993
1994
522.4
625.6
673.7
712.3
770.7
1,107.1
1,243.8
1,341.6
1,475.4
1,532.0
1,629.5
1,869.5
2,015.3
2,187.7
2,302.6
10,814.1
11,815.3
12,234.5
12,459.6
12,674.4
3,497.4
3,819.3
4,141.5
4,444.6
4,653.5
14,311.5
15,634.6
16,376.1
16,904.2
17,327.9
4.8
5.3
5.5
5.7
6.1
31.7
32.6
32.4
33.2
32.9
11.4
12.0
12.3
12.9
13.3
1995
1996
1997
1998
1999
837.4
764.3
902.7
1,030.8
1,224.7
1,654.9
1,716.6
1,815.2
1,857.3
2,100.1
2,492.3
2,480.9
2,717.9
2,888.0
3,324.8
12,704.3
12,248.5
13,033.2
14,123.0
14,456.5
4,663.6
4,727.9
4,976.0
5,050.8
5,616.8
17,367.9
16,976.4
18,009.2
19,173.7
20,073.3
6.6
6.2
6.9
7.3
8.5
35.5
36.3
36.5
36.8
37.4
14.4
14.6
15.1
15.1
16.6
2000
2001
2002
2003
2004
1,492.4
1,728.6
1,932.8
2,185.4
2,368.2
2,258.3
2,420.9
2,656.4
2,822.0
3,081.0
3,750.6
4,149.5
4,589.2
5,007.4
5,449.3
15,699.7
16,986.3
17,862.7
18,908.0
20,122.9
5,967.7
6,621.8
7,141.6
7,671.7
7,888.3
21,667.5
23,608.1
25,004.4
26,579.6
28,011.2
9.5
10.2
10.8
11.6
11.8
37.8
36.6
37.2
36.8
39.1
17.3
17.6
18.4
18.8
19.5
2005
2006
2007
2008
2009
2,497.8
2,713.1
2,972.7
3,175.8
3,293.0
3,303.8
3,545.4
3,760.6
3,930.6
4,174.6
5,801.6
6,258.6
6,733.2
7,106.4
7,467.6
21,217.7
22,527.1
23,909.9
25,601.8
27,440.3
8,567.8
9,109.1
9,561.5
10,259.4
10,750.4
29,785.5
31,636.2
33,471.4
35,861.2
38,190.6
11.8
12.0
12.4
12.4
12.0
38.6
38.9
39.3
38.3
38.8
19.5
19.8
20.1
19.8
19.6
2010f
f
2011
3,346.7
3,300.7
4,535.2
4,939.8
7,881.9
8,240.6
28,492.7
29,554.6
11,517.4
12,371.6
40,010.2
41,926.2
11.7
11.2
39.4
39.9
19.7
19.7
1985
1986
1987
1988
1989
--16.1
14.5
15.1
13.9
--26.3
6.3
15.7
15.4
--23.2
8.7
15.5
14.9
--1.6
7.3
9.2
7.2
--18.1
5.9
8.3
11.6
--5.0
6.9
9.0
8.2
1990
1991
1992
1993
1994
15.2
19.8
7.7
5.7
8.2
7.8
12.3
7.9
10.0
3.8
10.0
14.7
7.8
8.6
5.3
7.0
9.3
3.5
1.8
1.7
9.9
9.2
8.4
7.3
4.7
7.7
9.2
4.7
3.2
2.5
1995
1996
1997
1998
1999
8.7
-8.7
18.1
14.2
18.8
8.0
3.7
5.7
2.3
13.1
8.2
-0.5
9.6
6.3
15.1
0.2
-3.6
6.4
8.4
2.4
0.2
1.4
5.2
1.5
11.2
0.2
-2.3
6.1
6.5
4.7
2000
2001
21.9
15.8
7.5
7.2
12.8
10.6
8.6
8.2
6.2
11.0
7.9
9.0
2002
11.8
9.7
10.6
5.2
7.9
5.9
2003
2004
13.1
8.4
6.2
9.2
9.1
8.8
5.9
6.4
7.4
2.8
6.3
5.4
2005
2006
2007
2008
2009
5.5
8.6
9.6
6.8
3.7
7.2
7.3
6.1
4.5
6.2
6.5
7.9
7.6
5.5
5.1
5.4
6.2
6.1
7.1
7.2
8.6
6.3
5.0
7.3
4.8
6.3
6.2
5.8
7.1
6.5
1.6
-1.4
8.6
8.9
5.5
4.5
3.8
3.7
7.1
7.4
4.8
4.8
Que.
(Annual Percentage Change)
2010 f
f
2011
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
31.2
29.4
31.0
30.9
30.6
68.8
70.6
69.0
69.1
69.4
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
32.1
33.5
33.4
32.6
33.5
67.9
66.5
66.6
67.4
66.5
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
33.6
30.8
33.2
35.7
36.8
66.4
69.2
66.8
64.3
63.2
100.0
100.0
100.0
100.0
100.0
2000
39.8
60.2
100.0
2001
2002
2003
2004
41.7
42.1
43.6
43.5
58.3
57.9
56.4
56.5
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009
43.1
43.4
44.1
44.7
44.1
56.9
56.6
55.9
55.3
55.9
100.0
100.0
100.0
100.0
100.0
2010f
f
2011
42.5
40.1
57.5
59.9
100.0
100.0
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
79
Drug Expenditure in Canada, 1985 to 2011
Table B Que.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Quebec, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Subtotal
Insurers*
Out of
Social Security Funds
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Federal
Year
Que.
Subtotal
Private
Total
Prescribed
Drugs
OvertheCounter
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
Personal
Total
Health
Non-Presc.
Supplies
Drugs
1985
1986
1987
1988
1989
37.57
43.40
49.21
56.16
63.09
1.12
1.20
1.30
1.56
1.85
0.32
0.40
0.47
0.47
0.50
-----------
39.00
45.00
50.98
58.20
65.44
-----------
-----------
51.40
69.01
68.80
76.52
84.06
90.40
114.02
119.78
134.72
149.50
-----------
-----------
34.58
38.91
44.62
53.65
64.20
1990
1991
1992
1993
1994
71.80
85.50
91.52
95.89
103.18
2.18
2.37
2.55
2.95
3.20
0.60
0.69
0.71
0.71
0.78
-----------
74.58
88.56
94.78
99.55
107.16
-----------
-----------
91.21
100.41
108.46
123.31
124.94
165.80
188.97
203.23
222.86
232.10
----43.12
43.65
45.44
----37.17
39.24
42.63
66.86
75.65
80.29
82.89
88.07
1995
1996
1997
1998
1999
111.78
101.20
96.26
106.88
125.43
3.34
3.31
3.57
4.04
4.69
0.88
0.96
1.01
1.11
1.27
----23.25
29.25
35.84
116.00
105.46
124.09
141.28
167.23
-----------
-----------
139.34
149.01
168.69
168.37
195.75
255.33
254.47
292.78
309.65
362.98
46.32
44.45
40.34
42.79
45.62
43.57
43.42
40.50
43.40
45.40
89.89
87.86
80.84
86.19
91.02
2000
2001
2002
2003
2004
152.02
177.02
193.33
205.33
222.29
4.76
5.19
6.01
6.77
7.09
1.51
1.82
2.07
2.40
2.80
44.56
49.67
58.19
77.10
81.53
202.85
233.69
259.59
291.60
313.71
-----------
-----------
219.22
236.88
264.41
284.32
312.23
422.07
470.57
524.00
575.92
625.94
43.66
45.56
46.61
46.79
49.24
44.07
44.84
45.74
45.41
46.68
87.73
90.40
92.35
92.20
95.91
2005
2006
2007
2008
2009
236.74
256.25
281.61
296.37
312.13
7.54
8.15
8.61
9.18
8.88
3.03
3.46
3.84
4.23
4.61
81.43
87.66
92.63
99.95
95.04
328.74
355.52
386.69
409.72
420.65
-----------
-----------
328.03
354.70
376.45
389.23
408.16
656.77
710.22
763.15
798.95
828.81
56.11
57.58
60.39
63.43
68.79
50.68
52.30
52.34
54.42
56.32
106.79
109.87
112.73
117.85
125.10
2010f
f
2011
311.17
300.59
8.65
8.75
4.90
5.28
98.52
99.57
423.24
414.18
-----
-----
449.38
498.28
872.62
912.46
67.96
65.98
56.20
55.60
124.16
121.58
1985
1986
1987
1988
1989
--15.5
13.4
14.1
12.3
--7.7
7.9
20.6
18.4
--26.4
17.9
0.1
5.8
-----------
--15.4
13.3
14.1
12.4
-----------
-----------
--34.3
-0.3
11.2
9.8
--26.1
5.1
12.5
11.0
-----------
-----------
--12.5
14.7
20.2
19.7
1990
1991
1992
1993
1994
13.8
19.1
7.0
4.8
7.6
17.9
8.4
7.6
15.9
8.2
19.5
15.6
2.6
-0.8
11.2
-----------
14.0
18.7
7.0
5.0
7.6
-----------
-----------
8.5
10.1
8.0
13.7
1.3
10.9
14.0
7.5
9.7
4.1
------1.2
4.1
------5.6
8.6
4.1
13.2
6.1
3.2
6.2
1995
1996
1997
1998
1999
8.3
-9.5
-4.9
11.0
17.4
4.6
-1.1
8.0
13.1
16.2
11.7
9.2
5.8
9.7
14.6
------25.8
22.5
8.2
-9.1
17.7
13.9
18.4
-----------
-----------
11.5
6.9
13.2
-0.2
16.3
10.0
-0.3
15.1
5.8
17.2
1.9
-4.1
-9.2
6.1
6.6
2.2
-0.3
-6.7
7.2
4.6
2.1
-2.3
-8.0
6.6
5.6
2000
21.2
16.3
-4.3
-2.9
-3.6
2001
16.4
9.0
20.1
11.5
15.2
---
---
8.1
11.5
4.4
1.7
3.0
2002
9.2
15.8
13.5
17.1
11.1
---
---
11.6
11.4
2.3
2.0
2.2
-0.2
(Annual Percentage Change)
1.4
19.1
24.3
21.3
---
---
12.0
2003
6.2
12.7
16.4
32.5
12.3
---
---
7.5
9.9
0.4
-0.7
2004
8.3
4.7
16.4
5.8
7.6
---
---
9.8
8.7
5.2
2.8
4.0
2005
2006
2007
2008
2009
6.5
8.2
9.9
5.2
5.3
6.3
8.1
5.6
6.7
-3.3
8.3
14.2
11.0
9.9
9.0
-0.1
7.6
5.7
7.9
-4.9
4.8
8.1
8.8
6.0
2.7
-----------
-----------
5.1
8.1
6.1
3.4
4.9
4.9
8.1
7.5
4.7
3.7
14.0
2.6
4.9
5.0
8.4
8.6
3.2
0.1
4.0
3.5
11.3
2.9
2.6
4.5
6.2
2010f
f
2011
-0.3
-3.4
-2.6
1.1
6.3
7.8
3.7
1.1
0.6
-2.1
-----
-----
10.1
10.9
5.3
4.6
-1.2
-2.9
-0.2
-1.1
-0.8
-2.1
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
80
1985
1986
1987
1988
1989
--12.7
8.7
9.6
7.8
--4.9
3.2
16.0
13.9
--23.6
13.1
-4.4
1.2
-----------
--12.6
8.5
9.6
7.9
-----------
-----------
--31.5
-5.1
6.7
5.3
--23.3
0.3
8.0
6.4
-----------
-----------
--9.7
10.0
15.7
15.1
1990
1991
1992
1993
1994
10.8
16.3
5.8
3.3
6.5
14.9
5.7
6.3
14.5
7.1
16.4
12.9
1.4
-2.2
10.1
-----------
10.9
16.0
5.8
3.6
6.5
-----------
-----------
5.5
7.3
6.8
12.3
0.2
7.9
11.2
6.3
8.2
3.0
-------0.2
3.0
------4.1
7.5
1.1
10.4
4.9
1.8
5.2
1995
1996
1997
1998
1999
6.0
-11.1
-5.9
11.5
15.6
2.2
-2.7
7.0
13.5
14.4
9.3
7.6
4.8
10.1
12.8
------26.3
20.7
5.9
-10.8
16.7
14.3
16.6
-----------
-----------
9.2
5.3
12.2
0.2
14.5
7.7
-2.0
14.1
6.2
15.4
-0.4
-5.7
-10.2
6.5
4.8
-0.1
-2.0
-7.7
7.6
2.8
-0.3
-3.9
-9.0
7.1
3.8
2000
17.1
-2.7
15.0
20.2
17.2
---
---
7.9
12.2
-8.4
-7.0
-7.7
2001
2002
2003
2004
15.1
8.2
3.3
5.7
7.6
14.8
9.8
2.1
18.8
12.5
13.5
13.8
10.1
16.1
29.6
3.2
13.9
10.0
9.4
5.0
---------
---------
6.7
10.6
4.6
7.2
10.1
10.3
7.0
6.1
3.0
1.3
-2.5
2.6
0.4
1.0
-3.6
0.2
1.7
1.1
-3.1
1.4
2005
2006
2007
2008
2009
3.5
5.4
6.2
0.4
8.0
3.3
5.3
1.9
1.8
-0.6
5.3
11.4
7.4
5.0
11.7
-3.1
4.8
2.0
3.0
-2.2
1.8
5.3
5.1
1.1
5.4
-----------
-----------
2.1
5.3
2.5
-1.5
7.6
1.9
5.3
3.8
-0.2
6.4
11.0
-0.2
1.2
0.2
11.2
5.6
0.4
-3.6
-0.9
6.2
8.3
0.1
-1.1
-0.3
8.9
2010f
-3.3
-5.5
3.3
f
2011
-7.4
-2.9
3.8
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
0.7
-2.9
-2.3
-6.1
-----
-----
7.2
6.9
2.3
0.6
-4.1
-6.9
-3.2
-5.1
-3.7
-6.1
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B Que.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Quebec, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Year
Health Expenditure
Private
Public
GDP Implicit
Price Index—Canada
Total
(1997 = 100)
($ per Capita)
1985
1986
1987
1988
1989
39.00
45.00
50.98
58.20
65.44
85.97
107.92
113.42
130.18
148.26
124.97
152.93
164.40
188.37
213.70
1,189.31
1,200.16
1,273.33
1,378.61
1,458.95
315.70
370.59
388.08
416.85
459.21
1,505.01
1,570.76
1,661.41
1,795.46
1,918.16
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
74.58
88.56
94.78
99.55
107.16
158.07
176.07
188.75
206.20
213.01
232.66
264.62
283.53
305.75
320.17
1,544.02
1,672.46
1,721.23
1,741.32
1,762.32
499.35
540.63
582.66
621.16
647.05
2,043.36
2,213.09
2,303.89
2,362.48
2,409.37
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
116.00
105.46
124.09
141.28
167.23
229.23
236.87
249.53
254.56
286.77
345.22
342.33
373.62
395.84
454.00
1,759.73
1,690.17
1,791.60
1,935.72
1,974.04
645.98
652.41
684.03
692.27
766.97
2,405.71
2,342.58
2,475.62
2,627.99
2,741.01
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
202.85
233.69
259.59
291.60
313.71
306.95
327.28
356.76
376.53
408.14
509.80
560.97
616.35
668.13
721.85
2,133.98
2,296.37
2,399.05
2,522.85
2,665.65
811.16
895.20
959.16
1,023.61
1,044.95
2,945.14
3,191.58
3,358.21
3,546.46
3,710.60
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009
328.74
355.52
386.69
409.72
420.65
434.82
464.57
489.18
507.08
533.26
763.56
820.09
875.88
916.80
953.92
2,792.53
2,951.83
3,110.26
3,302.90
3,505.24
1,127.63
1,193.61
1,243.78
1,323.57
1,373.26
3,920.16
4,145.45
4,354.05
4,626.46
4,878.50
117.5
120.8
125.2
131.3
127.8
2010f
f
2011
423.24
414.18
573.54
619.86
996.78
1,034.04
3,603.31
3,708.56
1,456.54
1,552.41
5,059.85
5,260.97
131.5
136.8
1985
1986
1987
1988
1989
--15.4
13.3
14.1
12.4
--25.5
5.1
14.8
13.9
--22.4
7.5
14.6
13.4
--0.9
6.1
8.3
5.8
--17.4
4.7
7.4
10.2
--4.4
5.8
8.1
6.8
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
14.0
18.7
7.0
5.0
7.6
6.6
11.4
7.2
9.2
3.3
8.9
13.7
7.1
7.8
4.7
5.8
8.3
2.9
1.2
1.2
8.7
8.3
7.8
6.6
4.2
6.5
8.3
4.1
2.5
2.0
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
8.2
-9.1
17.7
13.9
18.4
7.6
3.3
5.3
2.0
12.7
7.8
-0.8
9.1
5.9
14.7
-0.1
-4.0
6.0
8.0
2.0
-0.2
1.0
4.8
1.2
10.8
-0.2
-2.6
5.7
6.2
4.3
2.3
1.7
1.0
-0.4
1.8
Que.
(Annual Percentage Change)
2000
21.3
7.0
12.3
8.1
5.8
2001
15.2
6.6
10.0
7.6
10.4
8.4
1.4
2002
11.1
9.0
9.9
4.5
7.1
5.2
7.4
1.0
4.1
2003
12.3
5.5
8.4
5.2
6.7
5.6
2.9
2004
7.6
8.4
8.0
5.7
2.1
4.6
2.6
2005
2006
2007
2008
2009
4.8
8.1
8.8
6.0
2.7
6.5
6.8
5.3
3.7
5.2
5.8
7.4
6.8
4.7
4.0
4.8
5.7
5.4
6.2
6.1
7.9
5.9
4.2
6.4
3.8
5.6
5.7
5.0
6.3
5.4
3.0
2.8
3.7
4.9
-2.7
2010 f
f
2011
0.6
-2.1
7.6
8.1
4.5
3.7
2.8
2.9
6.1
6.6
3.7
4.0
2.9
4.0
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--12.6
8.5
9.6
7.9
--22.7
0.4
10.3
9.3
--19.6
2.8
10.1
8.9
---1.9
1.4
3.7
1.3
--14.6
0.0
2.9
5.6
--1.6
1.0
3.5
2.3
1990
1991
1992
1993
1994
10.9
16.0
5.8
3.6
6.5
3.6
8.6
5.9
7.8
2.2
5.8
11.0
5.9
6.4
3.6
2.8
5.6
1.7
-0.3
0.1
5.7
5.5
6.5
5.2
3.1
3.5
5.5
2.8
1.1
0.9
1995
1996
1997
1998
1999
5.9
-10.8
16.7
14.3
16.6
5.3
1.7
4.4
2.5
10.8
5.5
-2.5
8.1
6.4
12.9
-2.5
-5.6
5.0
8.5
0.2
-2.5
-0.7
3.9
1.6
9.0
-2.5
-4.3
4.7
6.6
2.5
2000
17.2
2.9
8.2
4.0
1.7
3.3
2001
2002
2003
2004
13.9
10.0
9.4
5.0
5.3
8.0
2.6
5.8
8.7
8.8
5.5
5.5
6.3
3.4
2.3
3.1
9.0
6.1
3.8
-0.5
7.0
4.2
2.7
2.0
2005
2006
2007
2008
2009
1.8
5.3
5.1
1.1
5.4
3.5
4.0
1.6
-1.2
7.9
2.8
4.6
3.1
-0.2
6.8
1.8
2.9
1.7
1.3
8.8
4.9
3.1
0.5
1.5
6.5
2.6
3.0
1.4
1.4
8.2
2010 f
f
2011
-2.3
-6.1
4.6
4.1
1.5
-0.3
-0.1
-1.1
3.1
2.6
0.8
0.0
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
81
Drug Expenditure in Canada, 1985 to 2011
Table B Ont.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Ontario, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out of
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Federal
Year
Ont.
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter
Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
399.4
481.2
574.4
663.8
749.5
13.8
14.5
15.4
24.5
30.7
7.2
8.8
10.1
12.0
13.5
-----------
420.5
504.5
599.9
700.4
793.8
-----------
-----------
579.4
706.8
748.2
845.3
951.9
999.9
1,211.2
1,348.1
1,545.6
1,745.7
-----------
-----------
487.9
552.4
640.6
711.0
789.2
1990
1991
1992
1993
1994
881.2
1,012.7
1,183.6
1,248.0
1,235.8
36.2
37.9
41.0
46.7
50.7
16.2
20.2
23.3
24.2
18.5
-----------
933.6
1,070.8
1,247.8
1,318.9
1,305.1
-----------
-----------
1,089.7
1,201.1
1,376.9
1,482.1
1,508.7
2,023.3
2,271.9
2,624.8
2,801.0
2,813.7
----521.5
558.9
616.3
----455.3
478.5
516.1
816.5
883.5
976.7
1,037.5
1,132.4
1995
1996
1997
1998
1999
1,379.6
1,362.7
1,407.6
1,550.0
1,700.0
52.9
53.9
57.6
65.9
73.7
19.5
21.6
22.3
23.9
25.4
-----------
1,452.0
1,438.2
1,487.5
1,639.8
1,799.2
-----------
-----------
1,660.0
1,735.3
2,103.4
2,466.3
2,387.7
3,112.0
3,173.5
3,590.9
4,106.1
4,186.9
615.7
641.2
710.3
750.6
799.7
528.8
540.5
603.4
646.0
679.7
1,144.5
1,181.7
1,313.7
1,396.6
1,479.4
2000
2001
2002
2003
2004
1,943.4
2,212.6
2,536.2
2,829.4
3,141.0
72.6
83.0
94.5
106.6
108.8
31.1
35.4
41.4
51.9
63.3
-----------
2,047.0
2,330.9
2,672.1
2,987.8
3,313.0
-----------
-----------
2,719.9
3,016.0
3,344.4
3,766.1
4,034.1
4,767.0
5,346.9
6,016.5
6,753.9
7,347.1
824.7
840.5
887.8
910.1
954.0
699.8
719.6
740.5
728.3
750.1
1,524.6
1,560.1
1,628.3
1,638.4
1,704.1
2005
2006
2007
2008
2009
3,439.1
3,693.4
3,813.7
4,063.1
4,405.8
121.4
131.2
135.1
135.8
134.3
71.7
79.4
83.5
88.8
95.3
-----------
3,632.1
3,904.0
4,032.3
4,287.6
4,635.4
-----------
-----------
4,290.8
4,637.8
4,905.2
5,353.2
5,471.8
7,922.9
8,541.8
8,937.5
9,640.9
10,107.2
978.4
1,017.9
1,104.2
1,101.9
1,165.9
770.5
800.6
852.7
842.6
869.1
1,748.9
1,818.4
1,956.9
1,944.5
2,035.0
2010f
f
2011
4,354.7
4,475.2
133.7
136.2
102.3
112.8
-----
4,590.7
4,724.2
-----
-----
5,581.3
5,770.4
10,172.0
10,494.6
1,169.2
1,167.8
887.3
897.1
2,056.5
2,064.9
1985
1986
1987
1988
1989
--20.5
19.4
15.6
12.9
--4.8
5.9
59.4
25.3
--20.8
15.2
19.2
12.6
-----------
--20.0
18.9
16.7
13.3
-----------
-----------
--22.0
5.9
13.0
12.6
--21.1
11.3
14.6
12.9
-----------
-----------
--13.2
16.0
11.0
11.0
1990
1991
1992
1993
1994
17.6
14.9
16.9
5.4
-1.0
18.0
4.8
8.0
13.9
8.7
19.8
24.4
15.4
3.9
-23.3
-----------
17.6
14.7
16.5
5.7
-1.0
-----------
-----------
14.5
10.2
14.6
7.6
1.8
15.9
12.3
15.5
6.7
0.5
------7.2
10.3
------5.1
7.8
3.5
8.2
10.6
6.2
9.1
1995
1996
1997
1998
1999
11.6
-1.2
3.3
10.1
9.7
4.3
1.8
7.0
14.4
11.9
5.1
10.9
2.9
7.4
6.3
-----------
11.3
-1.0
3.4
10.2
9.7
-----------
-----------
10.0
4.5
21.2
17.3
-3.2
10.6
2.0
13.2
14.3
2.0
-0.1
4.1
10.8
5.7
6.5
2.5
2.2
11.6
7.1
5.2
1.1
3.3
11.2
6.3
5.9
2000
2001
2002
2003
2004
14.3
13.9
14.6
11.6
11.0
-1.6
14.3
13.9
12.8
2.0
22.3
13.8
17.0
25.2
22.0
-----------
13.8
13.9
14.6
11.8
10.9
-----------
-----------
13.9
10.9
10.9
12.6
7.1
13.9
12.2
12.5
12.3
8.8
3.1
1.9
5.6
2.5
4.8
3.0
2.8
2.9
-1.6
3.0
3.1
2.3
4.4
0.6
4.0
2005
2006
2007
2008
2009
9.5
7.4
3.3
6.5
8.4
11.6
8.1
3.0
0.5
-1.1
13.3
10.7
5.2
6.3
7.4
-----------
9.6
7.5
3.3
6.3
8.1
-----------
-----------
6.4
8.1
5.8
9.1
2.2
7.8
7.8
4.6
7.9
4.8
2.6
4.0
8.5
-0.2
5.8
2.7
3.9
6.5
-1.2
3.1
2.6
4.0
7.6
-0.6
4.7
2010f
f
2011
-1.2
2.8
-0.5
1.9
7.4
10.3
-----
-1.0
2.9
-----
-----
2.0
3.4
0.6
3.2
0.3
-0.1
2.1
1.1
1.1
0.4
1985
1986
1987
1988
1989
26.8
27.3
28.9
29.4
29.6
0.9
0.8
0.8
1.1
1.2
0.5
0.5
0.5
0.5
0.5
-----------
28.3
28.6
30.2
31.0
31.3
-----------
-----------
38.9
40.1
37.6
37.5
37.6
67.2
68.7
67.8
68.5
68.9
-----------
-----------
32.8
31.3
32.2
31.5
31.1
1990
1991
1992
1993
1994
31.0
32.1
32.9
32.5
31.3
1.3
1.2
1.1
1.2
1.3
0.6
0.6
0.6
0.6
0.5
-----------
32.9
33.9
34.6
34.4
33.1
-----------
-----------
38.4
38.1
38.2
38.6
38.2
71.2
72.0
72.9
73.0
71.3
----14.5
14.6
15.6
----12.6
12.5
13.1
28.8
28.0
27.1
27.0
28.7
1995
1996
1997
1998
1999
32.4
31.3
28.7
28.2
30.0
1.2
1.2
1.2
1.2
1.3
0.5
0.5
0.5
0.4
0.4
-----------
34.1
33.0
30.3
29.8
31.8
-----------
-----------
39.0
39.8
42.9
44.8
42.1
73.1
72.9
73.2
74.6
73.9
14.5
14.7
14.5
13.6
14.1
12.4
12.4
12.3
11.7
12.0
26.9
27.1
26.8
25.4
26.1
2000
30.9
1.2
0.5
---
32.5
---
---
43.2
75.8
13.1
11.1
24.2
2001
2002
2003
2004
32.0
33.2
33.7
34.7
1.2
1.2
1.3
1.2
0.5
0.5
0.6
0.7
---------
33.7
35.0
35.6
36.6
---------
---------
43.7
43.7
44.9
44.6
77.4
78.7
80.5
81.2
12.2
11.6
10.8
10.5
10.4
9.7
8.7
8.3
22.6
21.3
19.5
18.8
2005
2006
2007
2008
2009
35.6
35.6
35.0
35.1
36.3
1.3
1.3
1.2
1.2
1.1
0.7
0.8
0.8
0.8
0.8
-----------
37.6
37.7
37.0
37.0
38.2
-----------
-----------
44.4
44.8
45.0
46.2
45.1
81.9
82.4
82.0
83.2
83.2
10.1
9.8
10.1
9.5
9.6
8.0
7.7
7.8
7.3
7.2
18.1
17.6
18.0
16.8
16.8
35.6
1.1
0.8
35.6
1.1
0.9
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
-----
37.5
37.6
-----
-----
45.6
45.9
83.2
83.6
9.6
9.3
7.3
7.1
16.8
16.4
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
2010f
f
2011
82
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B Ont.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Ontario, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Private
Total
Public
($ Millions)
Year
Total
(Percentage Share)
1985
1986
1987
1988
1989
420.5
504.5
599.9
700.4
793.8
1,067.2
1,259.2
1,388.9
1,556.3
1,741.1
1,487.7
1,763.7
1,988.8
2,256.7
2,534.9
10,443.3
11,730.2
13,011.9
14,497.9
16,093.9
3,999.5
4,367.1
4,854.5
5,321.9
5,876.9
14,442.8
16,097.2
17,866.4
19,819.8
21,970.8
4.0
4.3
4.6
4.8
4.9
26.7
28.8
28.6
29.2
29.6
10.3
11.0
11.1
11.4
11.5
1990
1991
1992
1993
1994
933.6
1,070.8
1,247.8
1,318.9
1,305.1
1,906.2
2,084.6
2,353.7
2,519.6
2,641.0
2,839.8
3,155.4
3,601.5
3,838.5
3,946.1
17,332.8
19,156.1
20,001.5
19,821.7
20,008.4
6,466.2
7,038.2
7,573.7
8,253.2
8,740.7
23,799.1
26,194.3
27,575.2
28,074.9
28,749.1
5.4
5.6
6.2
6.7
6.5
29.5
29.6
31.1
30.5
30.2
11.9
12.0
13.1
13.7
13.7
1995
1996
1997
1998
1999
1,452.0
1,438.2
1,487.5
1,639.8
1,799.2
2,804.5
2,917.0
3,417.2
3,862.9
3,867.1
4,256.5
4,355.2
4,904.7
5,502.8
5,666.3
19,875.0
20,038.3
20,481.1
22,030.1
23,344.6
9,411.7
9,655.3
10,314.0
11,095.5
12,094.6
29,286.7
29,693.7
30,795.1
33,125.6
35,439.2
7.3
7.2
7.3
7.4
7.7
29.8
30.2
33.1
34.8
32.0
14.5
14.7
15.9
16.6
16.0
2000
2001
2002
2003
2004
2,047.0
2,330.9
2,672.1
2,987.8
3,313.0
4,244.5
4,576.2
4,972.6
5,404.4
5,738.2
6,291.5
6,907.1
7,644.8
8,392.3
9,051.2
25,957.7
27,606.2
29,563.0
33,136.8
35,588.2
13,082.2
14,186.0
15,841.5
16,447.8
17,727.8
39,040.0
41,792.2
45,404.6
49,584.6
53,316.0
7.9
8.4
9.0
9.0
9.3
32.4
32.3
31.4
32.9
32.4
16.1
16.5
16.8
16.9
17.0
2005
2006
2007
2008
2009
3,632.1
3,904.0
4,032.3
4,287.6
4,635.4
6,039.7
6,456.3
6,862.1
7,297.7
7,506.8
9,671.8
10,360.3
10,894.4
11,585.4
12,142.2
37,852.7
40,162.8
43,068.3
46,168.1
49,202.9
18,760.6
19,991.2
21,052.9
21,821.9
22,607.8
56,613.3
60,154.0
64,121.2
67,990.0
71,810.7
9.6
9.7
9.4
9.3
9.4
32.2
32.3
32.6
33.4
33.2
17.1
17.2
17.0
17.0
16.9
2010f
f
2011
4,590.7
4,724.2
7,637.8
7,835.3
12,228.5
12,559.5
51,676.7
52,308.3
23,792.3
25,129.3
75,468.9
77,437.6
8.9
9.0
32.1
31.2
16.2
16.2
1985
1986
1987
1988
1989
--20.0
18.9
16.7
13.3
--18.0
10.3
12.1
11.9
--18.6
12.8
13.5
12.3
--12.3
10.9
11.4
11.0
--9.2
11.2
9.6
10.4
--11.5
11.0
10.9
10.9
1990
1991
1992
1993
1994
17.6
14.7
16.5
5.7
-1.0
9.5
9.4
12.9
7.0
4.8
12.0
11.1
14.1
6.6
2.8
7.7
10.5
4.4
-0.9
0.9
10.0
8.8
7.6
9.0
5.9
8.3
10.1
5.3
1.8
2.4
1995
1996
1997
1998
1999
11.3
-1.0
3.4
10.2
9.7
6.2
4.0
17.1
13.0
0.1
7.9
2.3
12.6
12.2
3.0
-0.7
0.8
2.2
7.6
6.0
7.7
2.6
6.8
7.6
9.0
1.9
1.4
3.7
7.6
7.0
2000
2001
2002
2003
2004
13.8
13.9
14.6
11.8
10.9
9.8
7.8
8.7
8.7
6.2
11.0
9.8
10.7
9.8
7.9
11.2
6.4
7.1
12.1
7.4
8.2
8.4
11.7
3.8
7.8
10.2
7.0
8.6
9.2
7.5
2005
2006
2007
2008
2009
9.6
7.5
3.3
6.3
8.1
5.3
6.9
6.3
6.3
2.9
6.9
7.1
5.2
6.3
4.8
6.4
6.1
7.2
7.2
6.6
5.8
6.6
5.3
3.7
3.6
6.2
6.3
6.6
6.0
5.6
2010 f
f
2011
-1.0
2.9
1.7
2.6
0.7
2.7
5.0
1.2
5.2
5.6
5.1
2.6
Ont.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
28.3
28.6
30.2
31.0
31.3
71.7
71.4
69.8
69.0
68.7
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
32.9
33.9
34.6
34.4
33.1
67.1
66.1
65.4
65.6
66.9
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
34.1
33.0
30.3
29.8
31.8
65.9
67.0
69.7
70.2
68.2
100.0
100.0
100.0
100.0
100.0
2000
32.5
67.5
100.0
2001
2002
2003
2004
33.7
35.0
35.6
36.6
66.3
65.0
64.4
63.4
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009
37.6
37.7
37.0
37.0
38.2
62.4
62.3
63.0
63.0
61.8
100.0
100.0
100.0
100.0
100.0
2010f
f
2011
37.5
37.6
62.5
62.4
100.0
100.0
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
83
Drug Expenditure in Canada, 1985 to 2011
Table B Ont.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Ontario, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Subtotal
Insurers*
Out of
Social Security Funds
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Federal
Year
Ont.
Subtotal
Private
Total
Prescribed
Drugs
OvertheCounter
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
Personal
Total
Health
Non-Presc.
Supplies
Drugs
1985
1986
1987
1988
1989
42.96
50.99
59.56
67.45
74.16
1.49
1.54
1.59
2.49
3.04
0.78
0.93
1.05
1.22
1.34
-----------
45.23
53.45
62.20
71.16
78.53
-----------
-----------
62.31
74.88
77.58
85.88
94.18
107.54
128.33
139.78
157.04
172.71
-----------
-----------
52.47
58.53
66.43
72.24
78.08
1990
1991
1992
1993
1994
85.57
97.11
111.98
116.76
114.23
3.52
3.64
3.88
4.37
4.69
1.58
1.93
2.20
2.26
1.71
-----------
90.66
102.68
118.06
123.39
120.64
-----------
-----------
105.82
115.18
130.27
138.67
139.46
196.48
217.86
248.33
262.06
260.09
----49.33
52.29
56.97
----43.07
44.77
47.71
79.29
84.72
92.41
97.06
104.67
1995
1996
1997
1998
1999
125.99
122.95
125.36
136.36
147.75
4.83
4.86
5.13
5.80
6.41
1.78
1.95
1.98
2.10
2.21
-----------
132.60
129.76
132.48
144.26
156.37
-----------
-----------
151.60
156.57
187.33
216.97
207.51
284.20
286.34
319.81
361.23
363.88
56.23
57.86
63.26
66.04
69.50
48.29
48.77
53.74
56.83
59.07
104.52
106.63
117.00
122.87
128.57
2000
2001
2002
2003
2004
166.31
185.97
209.57
230.73
252.89
6.21
6.97
7.81
8.69
8.76
2.66
2.97
3.42
4.23
5.09
-----------
175.18
195.91
220.80
243.65
266.74
-----------
-----------
232.76
253.50
276.35
307.12
324.80
407.94
449.41
497.15
550.77
591.54
70.58
70.64
73.36
74.22
76.81
59.89
60.49
61.19
59.39
60.39
130.47
131.13
134.54
133.61
137.20
2005
2006
2007
2008
2009
273.69
291.62
298.11
314.18
337.22
9.66
10.36
10.56
10.50
10.28
5.71
6.27
6.53
6.86
7.29
-----------
289.06
308.24
315.20
331.54
354.80
-----------
-----------
341.47
366.18
383.43
413.94
418.82
630.53
674.42
698.63
745.49
773.62
77.86
80.37
86.31
85.21
89.24
61.32
63.21
66.65
65.15
66.52
139.18
143.58
152.97
150.36
155.76
2010f
f
2011
329.64
334.75
10.12
10.19
7.74
8.44
-----
347.50
353.37
-----
-----
422.48
431.63
769.98
785.00
88.50
87.35
67.17
67.11
155.67
154.46
1985
1986
1987
1988
1989
--18.7
16.8
13.2
9.9
--3.3
3.6
56.2
22.0
--19.0
12.8
16.8
9.6
-----------
--18.2
16.4
14.4
10.4
-----------
-----------
--20.2
3.6
10.7
9.7
--19.3
8.9
12.3
10.0
-----------
-----------
1990
1991
1992
1993
1994
15.4
13.5
15.3
4.3
-2.2
15.8
3.5
6.5
12.6
7.4
17.6
22.8
13.8
2.7
-24.2
-----------
15.4
13.3
15.0
4.5
-2.2
-----------
-----------
12.4
8.8
13.1
6.4
0.6
13.8
10.9
14.0
5.5
-0.8
------6.0
8.9
------3.9
6.6
1.5
6.9
9.1
5.0
7.8
1995
1996
1997
1998
1999
10.3
-2.4
2.0
8.8
8.4
3.1
0.6
5.6
13.0
10.5
3.9
9.6
1.6
6.1
5.0
-----------
9.9
-2.1
2.1
8.9
8.4
-----------
-----------
8.7
3.3
19.6
15.8
-4.4
9.3
0.8
11.7
13.0
0.7
-1.3
2.9
9.3
4.4
5.2
1.2
1.0
10.2
5.7
3.9
-0.1
2.0
9.7
5.0
4.6
---
12.2
(Annual Percentage Change)
2000
12.6
-3.1
20.4
---
12.0
---
12.1
1.5
1.4
--11.6
13.5
8.8
8.1
1.5
2001
11.8
12.3
11.8
---
11.8
---
---
8.9
10.2
0.1
1.0
0.5
2002
12.7
12.0
15.1
---
12.7
---
---
9.0
10.6
3.8
1.2
2.6
-0.7
2003
10.1
11.3
23.6
---
10.4
---
---
11.1
10.8
1.2
-2.9
2004
9.6
0.7
20.5
---
9.5
---
---
5.8
7.4
3.5
1.7
2.7
2005
2006
2007
2008
2009
8.2
6.5
2.2
5.4
7.3
10.3
7.3
1.9
-0.6
-2.1
12.0
9.8
4.2
5.1
6.3
-----------
8.4
6.6
2.3
5.2
7.0
-----------
-----------
5.1
7.2
4.7
8.0
1.2
6.6
7.0
3.6
6.7
3.8
1.4
3.2
7.4
-1.3
4.7
1.5
3.1
5.4
-2.2
2.1
1.4
3.2
6.5
-1.7
3.6
2010f
f
2011
-2.3
1.6
-1.6
0.7
6.2
9.0
-----
-2.1
1.7
-----
-----
0.9
2.2
-0.5
2.0
-0.8
-1.3
1.0
-0.1
-0.1
-0.8
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
84
1985
1986
1987
1988
1989
--15.9
12.1
8.7
5.4
--0.5
-1.1
51.6
17.4
--16.2
8.0
12.3
5.0
-----------
--15.4
11.6
9.9
5.8
-----------
-----------
--17.4
-1.1
6.2
5.1
--16.5
4.2
7.8
5.4
-----------
-----------
--8.8
8.7
4.2
3.5
1990
1991
1992
1993
1994
12.4
10.7
14.1
2.8
-3.3
12.8
0.7
5.3
11.2
6.3
14.6
20.0
12.6
1.3
-25.3
-----------
12.4
10.5
13.7
3.1
-3.3
-----------
-----------
9.3
6.1
11.8
5.0
-0.5
10.7
8.1
12.7
4.1
-1.8
------4.6
7.8
------2.5
5.5
-1.5
4.1
7.8
3.6
6.7
1995
1996
1997
1998
1999
8.0
-4.1
1.0
9.2
6.5
0.7
-1.1
4.6
13.4
8.7
1.5
7.9
0.6
6.6
3.2
-----------
7.6
-3.8
1.1
9.3
6.6
-----------
-----------
6.4
1.6
18.7
16.3
-6.2
6.9
-0.9
10.7
13.4
-1.1
-3.6
1.2
8.3
4.8
3.4
-1.1
-0.7
9.2
6.2
2.1
-2.5
0.3
8.7
5.5
2.8
2000
8.5
-7.2
16.3
---
7.9
---
---
8.1
8.0
-2.6
-2.7
-2.6
2001
2002
2003
2004
10.5
11.6
7.2
7.0
10.9
10.9
8.4
-1.9
10.4
14.0
20.7
17.9
---------
10.5
11.7
7.5
6.9
---------
---------
7.6
8.0
8.2
3.2
8.8
9.6
7.9
4.8
-1.3
2.8
-1.7
0.9
-0.4
0.1
-5.8
-0.9
-0.8
1.6
-3.6
0.1
2005
2006
2007
2008
2009
5.2
3.8
-1.5
0.5
10.0
7.3
4.5
-1.7
-5.5
0.6
9.0
7.0
0.5
0.3
9.0
-----------
5.4
3.8
-1.4
0.3
9.7
-----------
-----------
2.1
4.4
1.0
3.1
3.9
3.6
4.2
-0.1
1.8
6.5
-1.6
0.4
3.7
-6.2
7.4
-1.5
0.3
1.8
-7.1
4.8
-1.6
0.4
2.9
-6.6
6.3
2010 f
-5.2
-4.5
3.2
f
2011
-2.4
-3.3
5.0
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
-----
-5.0
-2.3
-----
-----
-2.1
-1.8
-3.4
-2.0
-3.8
-5.3
-2.0
-4.1
-3.0
-4.8
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B Ont.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Ontario, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Year
Health Expenditure
Private
Public
GDP Implicit
Price Index—Canada
Total
(1997 = 100)
($ per Capita)
1985
1986
1987
1988
1989
45.23
53.45
62.20
71.16
78.53
114.79
133.42
144.01
158.13
172.26
160.01
186.87
206.21
229.28
250.79
1,123.23
1,242.85
1,349.18
1,473.03
1,592.27
430.17
462.71
503.36
540.72
581.43
1,553.40
1,705.55
1,852.54
2,013.75
2,173.70
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
90.66
102.68
118.06
123.39
120.64
185.11
199.90
222.68
235.73
244.13
275.77
302.58
340.74
359.12
364.76
1,683.15
1,836.97
1,892.32
1,854.51
1,849.50
627.92
674.92
716.54
772.16
807.95
2,311.07
2,511.89
2,608.87
2,626.67
2,657.46
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
132.60
129.76
132.48
144.26
156.37
256.12
263.20
304.34
339.84
336.08
388.72
392.96
436.81
484.10
492.45
1,815.07
1,808.02
1,824.07
1,938.07
2,028.84
859.52
871.18
918.57
976.12
1,051.12
2,674.59
2,679.20
2,742.64
2,914.19
3,079.97
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
175.18
195.91
220.80
243.65
266.74
363.23
384.63
410.89
440.73
462.00
538.41
580.54
631.69
684.38
728.74
2,221.39
2,320.31
2,442.81
2,702.27
2,865.32
1,119.54
1,192.33
1,309.00
1,341.31
1,427.33
3,340.92
3,512.64
3,751.81
4,043.58
4,292.65
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009
289.06
308.24
315.20
331.54
354.80
480.66
509.76
536.39
564.30
574.58
769.71
818.00
851.59
895.85
929.38
3,012.44
3,171.08
3,366.57
3,569.99
3,766.03
1,493.03
1,578.42
1,645.67
1,687.39
1,730.42
4,505.47
4,749.50
5,012.24
5,257.38
5,496.46
117.5
120.8
125.2
131.3
127.8
2010f
f
2011
347.50
353.37
578.16
586.08
925.65
939.46
3,911.74
3,912.71
1,800.99
1,879.69
5,712.73
5,792.40
131.5
136.8
1985
1986
1987
1988
1989
--18.2
16.4
14.4
10.4
--16.2
7.9
9.8
8.9
--16.8
10.4
11.2
9.4
--10.6
8.6
9.2
8.1
--7.6
8.8
7.4
7.5
--9.8
8.6
8.7
7.9
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
15.4
13.3
15.0
4.5
-2.2
7.5
8.0
11.4
5.9
3.6
10.0
9.7
12.6
5.4
1.6
5.7
9.1
3.0
-2.0
-0.3
8.0
7.5
6.2
7.8
4.6
6.3
8.7
3.9
0.7
1.2
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
9.9
-2.1
2.1
8.9
8.4
4.9
2.8
15.6
11.7
-1.1
6.6
1.1
11.2
10.8
1.7
-1.9
-0.4
0.9
6.3
4.7
6.4
1.4
5.4
6.3
7.7
0.6
0.2
2.4
6.3
5.7
2.3
1.7
1.0
-0.4
1.8
Ont.
(Annual Percentage Change)
2000
12.0
8.1
9.3
9.5
6.5
8.5
4.1
2001
11.8
5.9
7.8
4.5
6.5
5.1
1.4
2002
12.7
6.8
8.8
5.3
9.8
6.8
1.0
2003
10.4
7.3
8.3
10.6
2.5
7.8
2.9
2004
9.5
4.8
6.5
6.0
6.4
6.2
2.6
2005
2006
2007
2008
2009
8.4
6.6
2.3
5.2
7.0
4.0
6.1
5.2
5.2
1.8
5.6
6.3
4.1
5.2
3.7
5.1
5.3
6.2
6.0
5.5
4.6
5.7
4.3
2.5
2.6
5.0
5.4
5.5
4.9
4.5
3.0
2.8
3.7
4.9
-2.7
2010 f
f
2011
-2.1
1.7
0.6
1.4
-0.4
1.5
3.9
0.0
4.1
4.4
3.9
1.4
2.9
4.0
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--15.4
11.6
9.9
5.8
--13.4
3.2
5.3
4.4
--14.0
5.6
6.7
4.8
--7.8
3.8
4.7
3.5
--4.8
4.0
2.9
3.0
--7.0
3.9
4.2
3.4
1990
1991
1992
1993
1994
12.4
10.5
13.7
3.1
-3.3
4.4
5.2
10.1
4.4
2.5
6.9
7.0
11.3
4.0
0.5
2.7
6.4
1.8
-3.4
-1.4
5.0
4.7
4.9
6.3
3.5
3.3
5.9
2.6
-0.8
0.1
1995
1996
1997
1998
1999
7.6
-3.8
1.1
9.3
6.6
2.6
1.1
14.6
12.1
-2.9
4.2
-0.6
10.2
11.3
-0.1
-4.2
-2.1
-0.1
6.7
2.9
4.0
-0.3
4.4
6.7
5.9
-1.7
-1.5
1.4
6.7
3.9
2000
7.9
4.0
5.2
5.4
2.4
4.4
2001
2002
2003
2004
10.5
11.7
7.5
6.9
4.5
5.8
4.4
2.2
6.5
7.8
5.4
3.9
3.1
4.2
7.7
3.4
5.1
8.7
-0.4
3.8
3.8
5.8
4.9
3.6
2005
2006
2007
2008
2009
5.4
3.8
-1.4
0.3
9.7
1.0
3.3
1.5
0.3
4.5
2.6
3.5
0.4
0.3
6.5
2.1
2.5
2.5
1.2
8.2
1.6
2.9
0.6
-2.3
5.3
1.9
2.6
1.9
0.0
7.3
2010 f
f
2011
-5.0
-2.3
-2.3
-2.6
-3.3
-2.5
0.9
-4.0
1.1
0.4
1.0
-2.6
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
85
Drug Expenditure in Canada, 1985 to 2011
Table B Man.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Manitoba, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out of
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Federal
Year
Man.
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter
Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
32.5
34.6
42.3
47.5
45.5
6.5
7.2
7.7
9.3
11.5
0.3
0.4
0.4
0.5
0.6
-----------
39.2
42.2
50.4
57.3
57.6
-----------
-----------
60.0
68.2
61.9
68.1
74.9
99.2
110.4
112.3
125.4
132.5
-----------
-----------
61.0
69.1
80.1
75.4
70.9
1990
1991
1992
1993
1994
48.5
55.4
68.1
68.1
61.1
13.8
16.2
18.6
21.9
24.6
0.7
0.7
0.8
0.7
0.8
-----------
62.9
72.4
87.5
90.7
86.5
-----------
-----------
86.2
95.8
101.6
118.5
129.1
149.1
168.2
189.1
209.2
215.6
----51.5
50.4
52.3
----41.6
41.9
42.5
75.3
81.5
93.2
92.2
94.8
1995
1996
1997
1998
1999
79.6
73.8
73.7
85.9
105.6
27.8
28.6
31.3
33.7
36.9
0.8
0.9
1.0
1.0
1.1
-----------
108.3
103.2
106.0
120.5
143.6
-----------
-----------
148.0
163.4
186.7
189.0
180.5
256.3
266.7
292.7
309.5
324.2
50.8
54.2
48.1
55.3
58.4
41.7
47.3
43.7
50.9
50.8
92.5
101.5
91.8
106.3
109.3
2000
2001
2002
2003
2004
130.9
160.8
189.6
217.7
234.6
38.4
44.5
52.0
60.7
65.3
1.3
1.6
1.7
2.1
2.3
-----------
170.7
207.0
243.3
280.4
302.2
-----------
-----------
205.3
212.3
239.4
266.7
277.2
376.0
419.3
482.7
547.1
579.4
60.8
64.0
65.6
68.3
71.9
52.6
53.6
54.8
56.3
58.0
113.3
117.6
120.4
124.6
129.9
2005
2006
2007
2008
2009
249.5
260.2
271.6
279.6
287.2
70.9
79.4
83.8
85.9
89.4
2.4
2.6
2.7
3.2
3.3
-----------
322.7
342.3
358.2
368.6
379.9
-----------
-----------
293.3
344.8
362.5
375.1
436.9
616.1
687.0
720.6
743.7
816.7
74.2
78.5
82.0
87.6
96.8
60.3
63.2
62.8
66.0
70.9
134.4
141.7
144.8
153.6
167.7
2010f
f
2011
293.1
302.3
90.3
92.0
3.6
3.7
-----
386.9
398.0
-----
-----
461.5
487.8
848.5
885.9
100.0
99.5
72.4
74.0
172.4
173.5
1985
1986
1987
1988
1989
--6.6
22.2
12.4
-4.1
--11.1
7.4
19.8
24.1
--23.4
10.2
25.2
8.5
-----------
--7.4
19.6
13.6
0.5
-----------
-----------
--13.7
-9.3
10.1
10.1
--11.3
1.7
11.7
5.7
-----------
-----------
--13.2
16.0
-5.9
-5.9
1990
1991
1992
1993
1994
6.5
14.3
22.9
-0.1
-10.2
19.7
17.8
14.4
17.9
12.1
16.1
7.1
17.9
-10.4
5.3
-----------
9.3
15.0
20.9
3.6
-4.7
-----------
-----------
15.0
11.2
6.1
16.6
8.9
12.5
12.8
12.5
10.6
3.0
-------2.3
3.8
------0.6
1.6
6.2
8.2
14.4
-1.0
2.8
1995
1996
1997
1998
1999
30.2
-7.3
-0.1
16.5
22.9
13.3
2.8
9.6
7.4
9.7
9.2
4.7
7.9
2.5
13.8
-----------
25.2
-4.6
2.7
13.7
19.2
-----------
-----------
14.6
10.4
14.2
1.2
-4.5
18.9
4.1
9.7
5.7
4.7
-2.9
6.7
-11.2
15.0
5.6
-1.9
13.3
-7.6
16.6
-0.2
-2.4
9.7
-9.5
15.8
2.8
2000
2001
2002
2003
2004
24.0
22.8
17.9
14.8
7.7
4.0
16.0
16.7
16.7
7.7
20.6
18.0
7.9
19.9
13.0
-----------
18.8
21.3
17.6
15.3
7.8
-----------
-----------
13.7
3.4
12.8
11.4
4.0
16.0
11.5
15.1
13.3
5.9
4.1
5.3
2.4
4.1
5.3
3.4
2.0
2.2
2.8
3.0
3.7
3.8
2.3
3.5
4.3
2005
2006
2007
2008
2009
6.4
4.3
4.4
2.9
2.7
8.5
12.1
5.5
2.6
4.1
1.4
10.9
5.2
15.0
3.7
-----------
6.8
6.0
4.6
2.9
3.0
-----------
-----------
5.8
17.5
5.1
3.5
16.5
6.3
11.5
4.9
3.2
9.8
3.2
5.9
4.4
6.8
10.5
3.8
4.8
-0.6
5.1
7.5
3.5
5.4
2.2
6.1
9.2
2010f
f
2011
2.1
3.1
1.0
1.9
8.9
4.5
-----
1.9
2.9
-----
-----
5.7
5.7
3.9
4.4
3.4
-0.6
2.1
2.2
2.8
0.6
1985
1986
1987
1988
1989
20.3
19.3
22.0
23.7
22.4
4.1
4.0
4.0
4.6
5.7
0.2
0.2
0.2
0.3
0.3
-----------
24.5
23.5
26.2
28.5
28.3
-----------
-----------
37.4
38.0
32.2
33.9
36.8
61.9
61.5
58.4
62.5
65.1
-----------
-----------
38.1
38.5
41.6
37.5
34.9
1990
1991
1992
1993
1994
21.6
22.2
24.1
22.6
19.7
6.1
6.5
6.6
7.3
7.9
0.3
0.3
0.3
0.2
0.2
-----------
28.0
29.0
31.0
30.1
27.9
-----------
-----------
38.4
38.4
36.0
39.3
41.6
66.4
67.4
67.0
69.4
69.5
----18.3
16.7
16.8
----14.7
13.9
13.7
33.6
32.6
33.0
30.6
30.5
1995
1996
1997
1998
1999
22.8
20.0
19.2
20.7
24.4
8.0
7.8
8.2
8.1
8.5
0.2
0.2
0.2
0.2
0.3
-----------
31.0
28.0
27.6
29.0
33.1
-----------
-----------
42.4
44.4
48.6
45.4
41.7
73.5
72.4
76.1
74.4
74.8
14.6
14.7
12.5
13.3
13.5
12.0
12.8
11.4
12.2
11.7
26.5
27.6
23.9
25.6
25.2
2000
26.8
7.8
0.3
---
34.9
---
---
42.0
76.8
12.4
10.7
23.2
2001
2002
2003
2004
30.0
31.4
32.4
33.1
8.3
8.6
9.0
9.2
0.3
0.3
0.3
0.3
---------
38.5
40.3
41.7
42.6
---------
---------
39.5
39.7
39.7
39.1
78.1
80.0
81.4
81.7
11.9
10.9
10.2
10.1
10.0
9.1
8.4
8.2
21.9
20.0
18.6
18.3
2005
2006
2007
2008
2009
33.2
31.4
31.4
31.2
29.2
9.4
9.6
9.7
9.6
9.1
0.3
0.3
0.3
0.4
0.3
-----------
43.0
41.3
41.4
41.1
38.6
-----------
-----------
39.1
41.6
41.9
41.8
44.4
82.1
82.9
83.3
82.9
83.0
9.9
9.5
9.5
9.8
9.8
8.0
7.6
7.3
7.4
7.2
17.9
17.1
16.7
17.1
17.0
28.7
8.8
0.3
28.5
8.7
0.4
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
-----
37.9
37.6
-----
-----
45.2
46.1
83.1
83.6
9.8
9.4
7.1
7.0
16.9
16.4
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
2010f
f
2011
86
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B Man.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Manitoba, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Private
Total
Public
($ Millions)
Year
Total
(Percentage Share)
1985
1986
1987
1988
1989
39.2
42.2
50.4
57.3
57.6
121.0
137.3
141.9
143.4
145.8
160.2
179.4
192.4
200.7
203.4
1,310.9
1,425.8
1,530.2
1,634.3
1,773.2
415.6
463.9
449.9
435.4
484.2
1,726.5
1,889.7
1,980.2
2,069.6
2,257.4
3.0
3.0
3.3
3.5
3.2
29.1
29.6
31.5
32.9
30.1
9.3
9.5
9.7
9.7
9.0
1990
1991
1992
1993
1994
62.9
72.4
87.5
90.7
86.5
161.5
177.3
194.8
210.8
223.9
224.4
249.6
282.3
301.5
310.4
1,951.1
2,006.0
2,099.3
2,088.9
2,115.7
533.2
570.0
602.6
660.2
689.2
2,484.3
2,576.0
2,701.9
2,749.1
2,804.9
3.2
3.6
4.2
4.3
4.1
30.3
31.1
32.3
31.9
32.5
9.0
9.7
10.4
11.0
11.1
1995
1996
1997
1998
1999
108.3
103.2
106.0
120.5
143.6
240.5
264.9
278.5
295.2
289.8
348.8
368.2
384.5
415.8
433.4
2,179.4
2,185.3
2,251.9
2,388.6
2,714.9
736.1
786.8
848.6
897.7
985.9
2,915.5
2,972.0
3,100.5
3,286.3
3,700.8
5.0
4.7
4.7
5.0
5.3
32.7
33.7
32.8
32.9
29.4
12.0
12.4
12.4
12.7
11.7
2000
2001
2002
2003
2004
170.7
207.0
243.3
280.4
302.2
318.6
329.9
359.8
391.3
407.1
489.3
536.9
603.1
671.7
709.4
3,005.3
3,184.5
3,360.1
3,645.0
3,889.4
1,058.2
1,197.1
1,247.1
1,282.1
1,345.3
4,063.6
4,381.6
4,607.2
4,927.1
5,234.7
5.7
6.5
7.2
7.7
7.8
30.1
27.6
28.8
30.5
30.3
12.0
12.3
13.1
13.6
13.6
2005
2006
2007
2008
2009
322.7
342.3
358.2
368.6
379.9
427.8
486.5
507.2
528.7
604.6
750.5
828.7
865.4
897.3
984.4
4,188.8
4,429.3
4,682.5
5,020.9
5,472.5
1,429.5
1,547.1
1,600.0
1,726.8
1,841.5
5,618.3
5,976.4
6,282.5
6,747.7
7,314.0
7.7
7.7
7.6
7.3
6.9
29.9
31.4
31.7
30.6
32.8
13.4
13.9
13.8
13.3
13.5
2010f
f
2011
386.9
398.0
634.0
661.3
1,020.9
1,059.3
5,697.1
6,021.0
1,958.0
2,038.4
7,655.0
8,059.4
6.8
6.6
32.4
32.4
13.3
13.1
1985
1986
1987
1988
1989
--7.4
19.6
13.6
0.5
--13.5
3.4
1.1
1.7
--12.0
7.2
4.4
1.4
--8.8
7.3
6.8
8.5
--11.6
-3.0
-3.2
11.2
--9.5
4.8
4.5
9.1
1990
1991
1992
1993
1994
9.3
15.0
20.9
3.6
-4.7
10.7
9.8
9.9
8.2
6.2
10.3
11.2
13.1
6.8
3.0
10.0
2.8
4.7
-0.5
1.3
10.1
6.9
5.7
9.6
4.4
10.1
3.7
4.9
1.7
2.0
1995
1996
1997
1998
1999
25.2
-4.6
2.7
13.7
19.2
7.4
10.1
5.1
6.0
-1.8
12.4
5.6
4.4
8.1
4.3
3.0
0.3
3.0
6.1
13.7
6.8
6.9
7.9
5.8
9.8
3.9
1.9
4.3
6.0
12.6
2000
2001
2002
2003
2004
18.8
21.3
17.6
15.3
7.8
10.0
3.5
9.0
8.8
4.1
12.9
9.7
12.3
11.4
5.6
10.7
6.0
5.5
8.5
6.7
7.3
13.1
4.2
2.8
4.9
9.8
7.8
5.1
6.9
6.2
2005
2006
2007
2008
2009
6.8
6.0
4.6
2.9
3.0
5.1
13.7
4.3
4.2
14.4
5.8
10.4
4.4
3.7
9.7
7.7
5.7
5.7
7.2
9.0
6.3
8.2
3.4
7.9
6.6
7.3
6.4
5.1
7.4
8.4
2010f
f
2011
1.9
2.9
4.9
4.3
3.7
3.8
4.1
5.7
6.3
4.1
4.7
5.3
Man.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
24.5
23.5
26.2
28.5
28.3
75.5
76.5
73.8
71.5
71.7
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
28.0
29.0
31.0
30.1
27.9
72.0
71.0
69.0
69.9
72.1
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
31.0
28.0
27.6
29.0
33.1
69.0
72.0
72.4
71.0
66.9
100.0
100.0
100.0
100.0
100.0
2000
34.9
65.1
100.0
2001
2002
2003
2004
38.5
40.3
41.7
42.6
61.5
59.7
58.3
57.4
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009
43.0
41.3
41.4
41.1
38.6
57.0
58.7
58.6
58.9
61.4
100.0
100.0
100.0
100.0
100.0
2010f
f
2011
37.9
37.6
62.1
62.4
100.0
100.0
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
87
Drug Expenditure in Canada, 1985 to 2011
Table B Man.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Manitoba, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Subtotal
Insurers*
Out of
Social Security Funds
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Federal
Year
Man.
Subtotal
Private
Total
Prescribed
Drugs
OvertheCounter
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
Personal
Total
Health
Non-Presc.
Supplies
Drugs
1985
1986
1987
1988
1989
29.98
31.68
38.48
43.10
41.26
6.00
6.60
7.05
8.42
10.44
0.28
0.34
0.38
0.47
0.51
-----------
36.26
38.62
45.91
51.99
52.20
-----------
-----------
55.40
62.48
56.33
61.78
67.91
91.67
101.10
102.25
113.77
120.11
-----------
-----------
56.35
63.26
72.94
68.38
64.25
1990
1991
1992
1993
1994
43.87
49.95
61.22
60.90
54.43
12.47
14.63
16.69
19.59
21.86
0.59
0.63
0.74
0.66
0.69
-----------
56.92
65.21
78.65
81.15
76.99
-----------
-----------
77.93
86.34
91.33
106.06
114.94
134.85
151.55
169.98
187.21
191.92
----46.32
45.06
46.55
----37.42
37.46
37.86
68.11
73.41
83.73
82.52
84.41
1995
1996
1997
1998
1999
70.49
65.03
64.88
75.51
92.43
24.65
25.22
27.59
29.60
32.32
0.75
0.78
0.84
0.86
0.98
-----------
95.89
91.03
93.31
105.97
125.72
-----------
-----------
131.08
144.10
164.30
166.11
158.03
226.97
235.13
257.61
272.09
283.75
44.97
47.77
42.34
48.64
51.13
36.96
41.69
38.45
44.77
44.50
81.93
89.46
80.79
93.41
95.63
2000
2001
2002
2003
2004
114.11
139.70
164.09
187.38
200.39
33.47
38.69
45.00
52.22
55.82
1.17
1.38
1.48
1.77
1.98
-----------
148.75
179.77
210.57
241.36
258.19
-----------
-----------
178.93
184.40
207.17
229.51
236.82
327.68
364.17
417.74
470.87
495.01
52.97
55.61
56.75
58.77
61.42
45.82
46.57
47.43
48.48
49.58
98.79
102.18
104.18
107.26
111.00
2005
2006
2007
2008
2009
212.51
219.78
227.59
231.90
235.46
60.36
67.07
70.19
71.27
73.34
2.00
2.20
2.30
2.61
2.68
-----------
274.87
289.06
300.08
305.79
311.48
-----------
-----------
249.84
291.19
303.69
311.15
358.21
524.71
580.25
603.76
616.94
669.69
63.18
66.33
68.69
72.65
79.36
51.32
53.35
52.61
54.74
58.14
114.50
119.68
121.30
127.39
137.50
2010f
f
2011
237.21
242.38
73.12
73.81
2.88
2.98
-----
313.21
319.17
-----
-----
373.60
391.20
686.81
710.37
80.97
79.77
58.60
59.32
139.57
139.09
1985
1986
1987
1988
1989
--5.6
21.5
12.0
-4.3
--10.1
6.8
19.4
23.9
--22.4
9.5
24.8
8.3
-----------
--6.5
18.9
13.2
0.4
-----------
-----------
--12.8
-9.8
9.7
9.9
--10.3
1.1
11.3
5.6
-----------
-----------
--12.3
15.3
-6.3
-6.0
1990
1991
1992
1993
1994
6.3
13.9
22.6
-0.5
-10.6
19.5
17.3
14.1
17.4
11.6
15.9
6.8
17.5
-10.8
4.8
-----------
9.0
14.6
20.6
3.2
-5.1
-----------
-----------
14.8
10.8
5.8
16.1
8.4
12.3
12.4
12.2
10.1
2.5
-------2.7
3.3
------0.1
1.1
6.0
7.8
14.1
-1.4
2.3
1995
1996
1997
1998
1999
29.5
-7.7
-0.2
16.4
22.4
12.7
2.3
9.4
7.3
9.2
8.7
4.2
7.8
2.4
13.3
-----------
24.6
-5.1
2.5
13.6
18.6
-----------
-----------
14.0
9.9
14.0
1.1
-4.9
18.3
3.6
9.6
5.6
4.3
-3.4
6.2
-11.4
14.9
5.1
-2.4
12.8
-7.8
16.4
-0.6
-2.9
9.2
-9.7
15.6
2.4
(Annual Percentage Change)
3.5
20.1
2001
22.4
15.6
17.6
---
20.9
---
---
3.1
11.1
5.0
1.6
3.4
2002
2000
17.5
23.5
16.3
7.5
---
---
17.1
18.3
---
---
---
---
12.3
13.2
14.7
15.5
2.0
3.6
1.8
3.0
2.0
3.3
2003
14.2
16.1
19.2
---
14.6
---
---
10.8
12.7
3.6
2.2
3.0
2004
6.9
6.9
12.1
---
7.0
---
---
3.2
5.1
4.5
2.3
3.5
2005
2006
2007
2008
2009
6.0
3.4
3.6
1.9
1.5
8.1
11.1
4.6
1.5
2.9
1.1
9.9
4.3
13.8
2.5
-----------
6.5
5.2
3.8
1.9
1.9
-----------
-----------
5.5
16.6
4.3
2.5
15.1
6.0
10.6
4.1
2.2
8.6
2.9
5.0
3.6
5.8
9.2
3.5
3.9
-1.4
4.0
6.2
3.2
4.5
1.4
5.0
7.9
2010f
f
2011
0.7
2.2
-0.3
0.9
7.5
3.5
-----
0.6
1.9
-----
-----
4.3
4.7
2.6
3.4
2.0
-1.5
0.8
1.2
1.5
-0.3
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
88
1985
1986
1987
1988
1989
--2.8
16.7
7.5
-8.8
--7.3
2.0
14.9
19.4
--19.6
4.8
20.2
3.8
-----------
--3.7
14.1
8.7
-4.2
-----------
-----------
--10.0
-14.6
5.1
5.3
--7.5
-3.6
6.7
1.0
-----------
-----------
--9.5
10.6
-10.8
-10.6
1990
1991
1992
1993
1994
3.3
11.1
21.3
-2.0
-11.7
16.4
14.6
12.8
16.0
10.5
12.9
4.0
16.3
-12.2
3.7
-----------
6.0
11.8
19.4
1.7
-6.2
-----------
-----------
11.7
8.0
4.5
14.7
7.3
9.3
9.6
10.9
8.7
1.4
-------4.2
2.2
-------1.3
0.0
3.0
5.0
12.8
-2.9
1.2
1995
1996
1997
1998
1999
27.2
-9.4
-1.2
16.8
20.6
10.4
0.6
8.4
7.7
7.4
6.3
2.6
6.8
2.8
11.5
-----------
22.2
-6.7
1.5
14.0
16.8
-----------
-----------
11.7
8.3
13.0
1.5
-6.7
15.9
1.9
8.6
6.1
2.5
-5.7
4.6
-12.4
15.3
3.3
-4.7
11.1
-8.8
16.9
-2.4
-5.3
7.5
-10.7
16.1
0.6
2000
19.4
-0.6
16.0
---
14.2
---
---
9.1
11.4
-0.5
-1.2
-0.8
2001
2002
2003
2004
21.1
16.4
11.3
4.4
14.3
15.2
13.2
4.3
16.2
6.4
16.3
9.6
---------
19.5
16.1
11.7
4.4
---------
---------
1.7
11.3
7.9
0.6
9.8
13.7
9.8
2.5
3.6
1.0
0.7
1.9
0.3
0.8
-0.7
-0.3
2.1
0.9
0.1
0.9
2005
2006
2007
2008
2009
3.0
0.6
-0.1
-3.0
4.2
5.1
8.3
1.0
-3.3
5.6
-1.9
7.2
0.6
9.0
5.3
-----------
3.5
2.4
0.1
-3.0
4.6
-----------
-----------
2.5
13.8
0.6
-2.4
17.8
3.0
7.8
0.4
-2.7
11.3
-0.1
2.2
-0.1
0.9
11.9
0.5
1.2
-5.1
-0.8
8.9
0.1
1.7
-2.3
0.2
10.6
2010f
-2.2
-3.2
4.6
f
2011
-1.8
-3.0
-0.5
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
-----
-2.4
-2.1
-----
-----
1.4
0.7
-0.4
-0.6
-0.9
-5.5
-2.2
-2.8
-1.4
-4.3
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B Man.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Manitoba, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Year
Health Expenditure
Private
Public
GDP Implicit
Price Index—Canada
Total
(1997 = 100)
($ per Capita)
1985
1986
1987
1988
1989
36.26
38.62
45.91
51.99
52.20
111.76
125.74
129.27
130.16
132.15
148.02
164.36
175.18
182.14
184.35
1,211.28
1,306.04
1,393.62
1,482.95
1,606.82
383.98
424.97
409.78
395.06
438.77
1,595.25
1,731.01
1,803.40
1,878.01
2,045.59
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
56.92
65.21
78.65
81.15
76.99
146.04
159.76
175.06
188.58
199.34
202.96
224.97
253.71
269.73
276.33
1,764.67
1,807.82
1,886.70
1,869.05
1,883.55
482.25
513.71
541.56
590.76
613.62
2,246.92
2,321.53
2,428.27
2,459.81
2,497.17
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
95.89
91.03
93.31
105.97
125.72
213.01
233.57
245.09
259.52
253.66
308.90
324.60
338.40
365.50
379.38
1,930.11
1,926.73
1,982.07
2,099.81
2,376.29
651.90
693.69
746.91
789.20
862.92
2,582.01
2,620.42
2,728.98
2,889.01
3,239.21
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
148.75
179.77
210.57
241.36
258.19
277.72
286.58
311.35
336.76
347.82
426.47
466.36
521.92
578.13
606.02
2,619.32
2,766.07
2,907.70
3,137.12
3,322.67
922.32
1,039.77
1,079.23
1,103.43
1,149.28
3,541.64
3,805.84
3,986.93
4,240.55
4,471.95
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009
274.87
289.06
300.08
305.79
311.48
364.34
410.87
424.99
438.54
495.71
639.21
699.92
725.06
744.33
807.19
3,567.54
3,740.87
3,923.16
4,164.91
4,487.29
1,217.48
1,306.65
1,340.54
1,432.45
1,509.93
4,785.02
5,047.52
5,263.70
5,597.37
5,997.22
117.5
120.8
125.2
131.3
127.8
2010f
f
2011
313.21
319.17
513.17
530.30
826.38
849.46
4,611.46
4,828.27
1,584.87
1,634.61
6,196.32
6,462.88
131.5
136.8
1985
1986
1987
1988
1989
--6.5
18.9
13.2
0.4
--12.5
2.8
0.7
1.5
--11.0
6.6
4.0
1.2
--7.8
6.7
6.4
8.4
--10.7
-3.6
-3.6
11.1
--8.5
4.2
4.1
8.9
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
9.0
14.6
20.6
3.2
-5.1
10.5
9.4
9.6
7.7
5.7
10.1
10.8
12.8
6.3
2.4
9.8
2.4
4.4
-0.9
0.8
9.9
6.5
5.4
9.1
3.9
9.8
3.3
4.6
1.3
1.5
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
24.6
-5.1
2.5
13.6
18.6
6.9
9.7
4.9
5.9
-2.3
11.8
5.1
4.3
8.0
3.8
2.5
-0.2
2.9
5.9
13.2
6.2
6.4
7.7
5.7
9.3
3.4
1.5
4.1
5.9
12.1
2.3
1.7
1.0
-0.4
1.8
Man.
(Annual Percentage Change)
12.4
10.2
6.9
2001
20.9
3.2
9.4
5.6
12.7
7.5
1.4
2002
2000
17.1
18.3
8.6
9.5
11.9
5.1
3.8
4.8
9.3
1.0
4.1
2003
14.6
8.2
10.8
7.9
2.2
6.4
2.9
2004
7.0
3.3
4.8
5.9
4.2
5.5
2.6
2005
2006
2007
2008
2009
6.5
5.2
3.8
1.9
1.9
4.7
12.8
3.4
3.2
13.0
5.5
9.5
3.6
2.7
8.4
7.4
4.9
4.9
6.2
7.7
5.9
7.3
2.6
6.9
5.4
7.0
5.5
4.3
6.3
7.1
3.0
2.8
3.7
4.9
-2.7
2010f
f
2011
0.6
1.9
3.5
3.3
2.4
2.8
2.8
4.7
5.0
3.1
3.3
4.3
2.9
4.0
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--3.7
14.1
8.7
-4.2
--9.7
-1.9
-3.8
-3.0
--8.2
1.8
-0.5
-3.4
--5.0
2.0
1.9
3.8
--7.9
-8.3
-8.1
6.5
--5.7
-0.6
-0.4
4.4
1990
1991
1992
1993
1994
6.0
11.8
19.4
1.7
-6.2
7.5
6.6
8.3
6.3
4.6
7.1
8.1
11.5
4.9
1.3
6.8
-0.3
3.1
-2.4
-0.3
6.9
3.8
4.2
7.6
2.8
6.8
0.6
3.3
-0.1
0.4
1995
1996
1997
1998
1999
22.2
-6.7
1.5
14.0
16.8
4.5
8.0
3.9
6.3
-4.1
9.4
3.4
3.3
8.4
2.0
0.1
-1.8
1.9
6.4
11.4
3.9
4.7
6.7
6.1
7.5
1.1
-0.2
3.2
6.3
10.3
2000
14.2
5.4
8.3
6.1
2.8
5.2
2001
2002
2003
2004
19.5
16.1
11.7
4.4
1.8
7.6
5.3
0.7
8.0
10.9
7.9
2.2
4.2
4.1
5.0
3.3
11.4
2.8
-0.7
1.6
6.1
3.7
3.5
2.9
2005
2006
2007
2008
2009
3.5
2.4
0.1
-3.0
4.6
1.7
10.0
-0.2
-1.7
15.7
2.5
6.7
-0.1
-2.2
11.2
4.4
2.1
1.2
1.3
10.4
2.9
4.5
-1.1
2.0
8.1
4.0
2.7
0.6
1.5
9.9
2010 f
f
2011
-2.4
-2.1
0.6
-0.7
-0.6
-1.2
-0.2
0.7
2.0
-0.9
0.4
0.3
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
89
Drug Expenditure in Canada, 1985 to 2011
Table B Sask.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Saskatchewan, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out of
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Federal
Year
Sask.
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter
Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
67.6
81.1
67.8
63.0
74.8
6.3
7.1
7.7
9.7
12.2
0.1
0.1
0.2
0.3
0.2
-----------
74.0
88.3
75.7
73.1
87.2
-----------
-----------
26.8
33.8
42.5
53.5
67.3
100.8
122.1
118.2
126.5
154.5
-----------
-----------
35.3
40.0
46.4
58.3
73.2
1990
1991
1992
1993
1994
88.7
93.5
85.0
57.8
56.2
14.5
16.8
19.0
22.4
25.0
0.3
0.3
0.3
0.4
0.4
-----------
103.5
110.6
104.3
80.6
81.6
-----------
-----------
79.5
89.2
99.5
126.7
141.3
183.0
199.8
203.8
207.3
222.9
----40.6
49.9
51.7
----35.6
44.9
45.5
74.4
73.0
76.2
94.8
97.2
1995
1996
1997
1998
1999
63.8
66.6
69.3
78.9
89.1
28.0
28.8
31.2
33.7
38.8
0.5
0.8
0.8
0.9
1.1
-----------
92.2
96.2
101.3
113.6
129.0
-----------
-----------
146.8
148.1
161.2
167.4
174.0
239.0
244.3
262.5
280.9
303.0
50.1
47.4
48.9
47.6
52.8
44.7
44.8
47.3
46.7
48.7
94.8
92.2
96.2
94.4
101.5
2000
2001
2002
2003
2004
100.2
116.3
133.9
151.4
168.1
42.3
48.1
55.2
62.5
64.9
1.3
1.6
1.9
2.2
2.5
-----------
143.8
165.9
191.0
216.1
235.5
-----------
-----------
185.6
216.1
222.5
252.3
274.1
329.4
382.1
413.6
468.4
509.6
55.9
57.1
58.1
57.4
60.4
51.0
50.5
51.3
50.0
51.8
106.9
107.7
109.4
107.4
112.3
2005
2006
2007
2008
2009
185.4
201.9
241.0
269.0
286.2
68.2
73.1
75.7
78.5
82.9
2.6
2.8
3.0
3.4
3.5
-----------
256.2
277.9
319.7
350.9
372.6
-----------
-----------
286.1
282.5
300.9
289.2
322.3
542.3
560.4
620.7
640.1
694.9
61.7
63.0
65.2
69.0
74.9
53.4
54.0
53.2
54.5
57.5
115.2
117.0
118.4
123.5
132.3
2010f
f
2011
316.4
323.6
84.0
85.5
4.1
4.6
-----
404.5
413.7
-----
-----
373.9
431.3
778.4
845.0
77.5
78.0
58.8
59.7
136.2
137.7
1985
1986
1987
1988
1989
--20.0
-16.4
-7.1
18.7
--13.1
8.9
26.1
25.3
--2.4
42.4
58.9
-28.9
-----------
--19.3
-14.2
-3.5
19.4
-----------
-----------
--25.8
25.8
25.8
25.8
--21.1
-3.2
7.0
22.1
-----------
-----------
--13.2
16.0
25.6
25.6
1990
1991
1992
1993
1994
18.7
5.4
-9.1
-32.0
-2.8
18.6
16.1
12.9
18.1
11.7
9.8
5.4
20.3
32.9
-2.2
-----------
18.6
6.9
-5.7
-22.7
1.3
-----------
-----------
18.2
12.2
11.5
27.3
11.5
18.5
9.2
2.0
1.7
7.5
------22.7
3.6
------26.3
1.3
1.6
-1.9
4.5
24.4
2.5
1995
1996
1997
1998
1999
13.6
4.4
4.0
13.9
12.9
11.7
3.0
8.3
8.1
15.1
16.1
63.1
4.3
9.6
22.0
-----------
13.0
4.3
5.3
12.1
13.6
-----------
-----------
3.9
0.9
8.8
3.9
3.9
7.2
2.2
7.4
7.0
7.8
-3.0
-5.4
3.1
-2.5
10.8
-1.9
0.4
5.5
-1.2
4.1
-2.5
-2.7
4.3
-1.9
7.5
2000
2001
2002
2003
2004
12.4
16.1
15.1
13.1
11.0
9.0
13.8
14.9
13.1
3.8
16.4
18.5
20.9
14.4
17.3
-----------
11.4
15.4
15.1
13.1
9.0
-----------
-----------
6.7
16.4
3.0
13.4
8.6
8.7
16.0
8.2
13.2
8.8
5.8
2.2
1.7
-1.3
5.3
4.9
-1.0
1.5
-2.6
3.7
5.4
0.7
1.6
-1.9
4.5
2005
2006
2007
2008
2009
10.3
8.9
19.4
11.6
6.4
5.1
7.3
3.5
3.7
5.6
2.2
9.3
6.1
13.8
3.2
-----------
8.8
8.5
15.1
9.7
6.2
-----------
-----------
4.4
-1.3
6.5
-3.9
11.4
6.4
3.3
10.8
3.1
8.6
2.2
2.1
3.5
5.9
8.4
3.1
1.1
-1.4
2.4
5.4
2.6
1.6
1.2
4.3
7.1
2010f
f
2011
10.5
2.3
1.3
1.9
16.6
12.5
-----
8.5
2.3
-----
-----
16.0
15.4
12.0
8.6
3.5
0.6
2.2
1.7
3.0
1.1
1985
1986
1987
1988
1989
49.6
50.0
41.2
34.1
32.8
4.6
4.4
4.7
5.3
5.4
0.1
0.1
0.1
0.2
0.1
-----------
54.4
54.5
46.0
39.5
38.3
-----------
-----------
19.7
20.8
25.8
28.9
29.5
74.1
75.3
71.8
68.5
67.9
-----------
-----------
25.9
24.7
28.2
31.5
32.1
1990
1991
1992
1993
1994
34.5
34.3
30.3
19.1
17.5
5.6
6.2
6.8
7.4
7.8
0.1
0.1
0.1
0.1
0.1
-----------
40.2
40.5
37.2
26.7
25.5
-----------
-----------
30.9
32.7
35.5
41.9
44.1
71.1
73.3
72.8
68.6
69.6
----14.5
16.5
16.1
----12.7
14.9
14.2
28.9
26.7
27.2
31.4
30.4
1995
1996
1997
1998
1999
19.1
19.8
19.3
21.0
22.0
8.4
8.6
8.7
9.0
9.6
0.1
0.2
0.2
0.2
0.3
-----------
27.6
28.6
28.2
30.3
31.9
-----------
-----------
44.0
44.0
44.9
44.6
43.0
71.6
72.6
73.2
74.9
74.9
15.0
14.1
13.6
12.7
13.1
13.4
13.3
13.2
12.4
12.0
28.4
27.4
26.8
25.1
25.1
2000
23.0
9.7
0.3
---
32.9
---
---
42.5
75.5
12.8
11.7
24.5
2001
2002
2003
2004
23.7
25.6
26.3
27.0
9.8
10.6
10.9
10.4
0.3
0.4
0.4
0.4
---------
33.9
36.5
37.5
37.9
---------
---------
44.1
42.6
43.8
44.1
78.0
79.1
81.3
81.9
11.7
11.1
10.0
9.7
10.3
9.8
8.7
8.3
22.0
20.9
18.7
18.1
2005
2006
2007
2008
2009
28.2
29.8
32.6
35.2
34.6
10.4
10.8
10.2
10.3
10.0
0.4
0.4
0.4
0.4
0.4
-----------
39.0
41.0
43.3
45.9
45.0
-----------
-----------
43.5
41.7
40.7
37.9
39.0
82.5
82.7
84.0
83.8
84.0
9.4
9.3
8.8
9.0
9.1
8.1
8.0
7.2
7.1
6.9
17.5
17.3
16.0
16.2
16.0
34.6
9.2
0.5
32.9
8.7
0.5
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
-----
44.2
42.1
-----
-----
40.9
43.9
85.1
86.0
8.5
7.9
6.4
6.1
14.9
14.0
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
2010f
f
2011
90
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B Sask.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Saskatchewan, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Private
Total
Public
($ Millions)
Year
Total
(Percentage Share)
1985
1986
1987
1988
1989
74.0
88.3
75.7
73.1
87.2
62.1
73.7
88.9
111.7
140.4
136.1
162.0
164.6
184.8
227.7
1,195.5
1,325.9
1,372.2
1,468.3
1,629.2
333.2
377.7
395.5
369.3
423.7
1,528.8
1,703.6
1,767.8
1,837.6
2,052.9
6.2
6.7
5.5
5.0
5.4
18.6
19.5
22.5
30.2
33.1
8.9
9.5
9.3
10.1
11.1
1990
1991
1992
1993
1994
103.5
110.6
104.3
80.6
81.6
153.9
162.2
175.8
221.5
238.5
257.4
272.8
280.1
302.1
320.1
1,792.1
1,828.9
1,819.5
1,727.8
1,778.8
460.1
490.9
505.8
574.1
606.4
2,252.2
2,319.8
2,325.4
2,301.9
2,385.2
5.8
6.0
5.7
4.7
4.6
33.4
33.0
34.7
38.6
39.3
11.4
11.8
12.0
13.1
13.4
1995
1996
1997
1998
1999
92.2
96.2
101.3
113.6
129.0
241.6
240.4
257.4
261.8
275.4
333.8
336.6
358.6
375.3
404.5
1,820.8
1,862.3
1,976.1
2,103.5
2,250.4
621.5
627.7
680.1
674.7
727.0
2,442.3
2,490.0
2,656.2
2,778.2
2,977.4
5.1
5.2
5.1
5.4
5.7
38.9
38.3
37.8
38.8
37.9
13.7
13.5
13.5
13.5
13.6
2000
2001
2002
2003
2004
143.8
165.9
191.0
216.1
235.5
292.5
323.8
332.0
359.7
386.3
436.3
489.7
523.0
575.8
621.8
2,381.2
2,581.5
2,719.3
2,895.9
3,100.3
778.6
875.5
903.8
975.0
1,025.7
3,159.8
3,457.0
3,623.1
3,870.8
4,126.0
6.0
6.4
7.0
7.5
7.6
37.6
37.0
36.7
36.9
37.7
13.8
14.2
14.4
14.9
15.1
2005
2006
2007
2008
2009
256.2
277.9
319.7
350.9
372.6
401.3
399.5
419.4
412.8
454.6
657.5
677.4
739.1
763.7
827.3
3,365.4
3,600.6
3,876.1
4,213.0
4,471.9
1,054.1
1,164.3
1,217.3
1,223.2
1,346.4
4,419.5
4,764.8
5,093.4
5,436.2
5,818.3
7.6
7.7
8.2
8.3
8.3
38.1
34.3
34.5
33.7
33.8
14.9
14.2
14.5
14.0
14.2
2010f
f
2011
404.5
413.7
510.1
569.0
914.6
982.7
4,812.1
5,143.1
1,497.2
1,645.2
6,309.3
6,788.2
8.4
8.0
34.1
34.6
14.5
14.5
1985
1986
1987
1988
1989
--19.3
-14.2
-3.5
19.4
--18.7
20.5
25.7
25.7
--19.0
1.6
12.3
23.2
--10.9
3.5
7.0
11.0
--13.4
4.7
-6.6
14.7
--11.4
3.8
4.0
11.7
1990
1991
1992
1993
1994
18.6
6.9
-5.7
-22.7
1.3
9.6
5.4
8.4
26.0
7.7
13.0
6.0
2.7
7.9
5.9
10.0
2.1
-0.5
-5.0
3.0
8.6
6.7
3.0
13.5
5.6
9.7
3.0
0.2
-1.0
3.6
1995
1996
1997
1998
1999
13.0
4.3
5.3
12.1
13.6
1.3
-0.5
7.1
1.7
5.2
4.3
0.8
6.6
4.6
7.8
2.4
2.3
6.1
6.4
7.0
2.5
1.0
8.3
-0.8
7.8
2.4
2.0
6.7
4.6
7.2
2000
2001
2002
2003
2004
11.4
15.4
15.1
13.1
9.0
6.2
10.7
2.5
8.3
7.4
7.9
12.2
6.8
10.1
8.0
5.8
8.4
5.3
6.5
7.1
7.1
12.4
3.2
7.9
5.2
6.1
9.4
4.8
6.8
6.6
2005
2006
2007
2008
2009
8.8
8.5
15.1
9.7
6.2
3.9
-0.4
5.0
-1.6
10.1
5.7
3.0
9.1
3.3
8.3
8.5
7.0
7.7
8.7
6.1
2.8
10.5
4.6
0.5
10.1
7.1
7.8
6.9
6.7
7.0
2010 f
f
2011
8.5
2.3
12.2
11.5
10.6
7.4
7.6
6.9
11.2
9.9
8.4
7.6
Sask.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
54.4
54.5
46.0
39.5
38.3
45.6
45.5
54.0
60.5
61.7
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
40.2
40.5
37.2
26.7
25.5
59.8
59.5
62.8
73.3
74.5
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
27.6
28.6
28.2
30.3
31.9
72.4
71.4
71.8
69.7
68.1
100.0
100.0
100.0
100.0
100.0
2000
32.9
67.1
100.0
2001
2002
2003
2004
33.9
36.5
37.5
37.9
66.1
63.5
62.5
62.1
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009
39.0
41.0
43.3
45.9
45.0
61.0
59.0
56.7
54.1
55.0
100.0
100.0
100.0
100.0
100.0
2010f
f
2011
44.2
42.1
55.8
57.9
100.0
100.0
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
91
Drug Expenditure in Canada, 1985 to 2011
Table B Sask.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Saskatchewan, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Subtotal
Insurers*
Out of
Social Security Funds
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Federal
Year
Sask.
Subtotal
Private
Total
Prescribed
Drugs
OvertheCounter
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
Personal
Total
Health
Non-Presc.
Supplies
Drugs
1985
1986
1987
1988
1989
65.90
78.76
65.64
61.28
73.37
6.11
6.89
7.48
9.47
11.97
0.14
0.14
0.20
0.32
0.23
-----------
72.15
85.79
73.32
71.08
85.58
-----------
-----------
26.16
32.80
41.13
52.00
66.00
98.31
118.59
114.45
123.08
151.57
-----------
-----------
34.43
38.85
44.90
56.67
71.80
1990
1991
1992
1993
1994
88.11
93.26
84.66
57.37
55.63
14.37
16.75
18.90
22.26
24.80
0.26
0.27
0.33
0.44
0.43
-----------
102.73
110.29
103.88
80.07
80.85
-----------
-----------
78.97
89.00
99.15
125.84
139.94
181.70
199.30
203.03
205.90
220.79
----40.47
49.53
51.18
----35.45
44.64
45.12
73.85
72.76
75.92
94.17
96.29
1995
1996
1997
1998
1999
62.89
65.33
68.04
77.57
87.81
27.57
28.25
30.62
33.12
38.22
0.49
0.80
0.83
0.91
1.12
-----------
90.94
94.39
99.49
111.61
127.15
-----------
-----------
144.72
145.37
158.31
164.51
171.45
235.66
239.76
257.80
276.11
298.60
49.43
46.51
48.02
46.83
52.05
44.05
44.00
46.46
45.92
47.95
93.48
90.51
94.48
92.75
100.01
2000
2001
2002
2003
2004
99.38
116.26
134.44
152.23
168.98
41.95
48.10
55.48
62.83
65.19
1.31
1.56
1.90
2.18
2.55
-----------
142.64
165.92
191.82
217.24
236.72
-----------
-----------
184.19
216.10
223.47
253.61
275.48
326.83
382.02
415.28
470.85
512.20
55.45
57.12
58.36
57.69
60.72
50.65
50.52
51.52
50.26
52.11
106.09
107.64
109.88
107.95
112.84
2005
2006
2007
2008
2009
187.28
203.49
240.98
265.33
278.14
68.87
73.72
75.67
77.42
80.52
2.62
2.86
3.01
3.38
3.44
-----------
258.76
280.07
319.66
346.13
362.10
-----------
-----------
289.02
284.76
300.87
285.29
313.18
547.79
564.83
620.53
631.42
675.28
62.36
63.51
65.19
68.10
72.75
53.97
54.44
53.23
53.75
55.84
116.33
117.95
118.42
121.86
128.59
2010f
f
2011
302.59
306.07
80.29
80.91
3.94
4.39
-----
386.82
391.37
-----
-----
357.59
407.98
744.40
799.35
74.12
73.75
56.19
56.50
130.30
130.25
1985
1986
1987
1988
1989
--19.5
-16.7
-6.6
19.7
--12.7
8.5
26.6
26.4
--2.1
41.9
59.6
-28.3
-----------
--18.9
-14.5
-3.1
20.4
-----------
-----------
--25.4
25.4
26.4
26.9
--20.6
-3.5
7.5
23.2
-----------
-----------
--12.8
15.6
26.2
26.7
1990
1991
1992
1993
1994
20.1
5.9
-9.2
-32.2
-3.0
20.0
16.6
12.8
17.8
11.4
11.1
5.9
20.1
32.6
-2.4
-----------
20.0
7.4
-5.8
-22.9
1.0
-----------
-----------
19.7
12.7
11.4
26.9
11.2
19.9
9.7
1.9
1.4
7.2
------22.4
3.3
------25.9
1.1
2.8
-1.5
4.3
24.0
2.3
1995
1996
1997
1998
1999
13.1
3.9
4.1
14.0
13.2
11.1
2.5
8.4
8.2
15.4
15.6
62.3
4.4
9.7
22.3
-----------
12.5
3.8
5.4
12.2
13.9
-----------
-----------
3.4
0.5
8.9
3.9
4.2
6.7
1.7
7.5
7.1
8.1
-3.4
-5.9
3.3
-2.5
11.1
-2.4
-0.1
5.6
-1.2
4.4
-2.9
-3.2
4.4
-1.8
7.8
(Annual Percentage Change)
2000
13.2
9.8
17.2
---
12.2
---
---
7.4
9.5
6.5
5.6
2001
17.0
14.6
19.4
---
16.3
---
---
17.3
16.9
3.0
-0.3
1.5
2002
15.6
15.3
21.4
---
15.6
---
---
3.4
8.7
2.2
2.0
2.1
6.1
-1.8
2003
13.2
13.3
14.6
---
13.3
---
---
13.5
13.4
-1.2
-2.4
2004
11.0
3.7
17.2
---
9.0
---
---
8.6
8.8
5.3
3.7
4.5
2005
2006
2007
2008
2009
10.8
8.7
18.4
10.1
4.8
5.6
7.1
2.6
2.3
4.0
2.7
9.1
5.2
12.3
1.7
-----------
9.3
8.2
14.1
8.3
4.6
-----------
-----------
4.9
-1.5
5.7
-5.2
9.8
6.9
3.1
9.9
1.8
6.9
2.7
1.8
2.6
4.5
6.8
3.6
0.9
-2.2
1.0
3.9
3.1
1.4
0.4
2.9
5.5
2010f
f
2011
8.8
1.1
-0.3
0.8
14.7
11.3
-----
6.8
1.2
-----
-----
14.2
14.1
10.2
7.4
1.9
-0.5
0.6
0.6
1.3
0.0
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
92
1985
1986
1987
1988
1989
--16.7
-21.4
-11.2
15.2
--9.9
3.7
22.1
21.9
---0.7
37.2
55.1
-32.9
-----------
--16.1
-19.3
-7.6
15.8
-----------
-----------
--22.6
20.7
21.9
22.4
--17.8
-8.2
3.0
18.6
-----------
-----------
--10.0
10.8
21.7
22.1
1990
1991
1992
1993
1994
17.1
3.1
-10.5
-33.7
-4.1
17.0
13.8
11.5
16.3
10.3
8.1
3.1
18.9
31.1
-3.5
-----------
17.0
4.6
-7.1
-24.4
-0.1
-----------
-----------
16.6
10.0
10.1
25.5
10.1
16.8
6.9
0.6
0.0
6.1
------20.9
2.2
------24.5
0.0
-0.2
-4.2
3.1
22.6
1.2
1995
1996
1997
1998
1999
10.7
2.2
3.2
14.4
11.4
8.8
0.8
7.4
8.6
13.6
13.3
60.6
3.4
10.1
20.5
-----------
10.1
2.1
4.4
12.6
12.1
-----------
-----------
1.1
-1.2
7.9
4.4
2.4
4.4
0.1
6.5
7.5
6.3
-5.7
-7.6
2.3
-2.0
9.3
-4.7
-1.8
4.6
-0.7
2.6
-5.3
-4.8
3.4
-1.4
6.0
2000
9.1
5.7
13.1
---
8.1
---
---
3.3
5.4
2.4
1.5
2.0
2001
2002
2003
2004
15.6
14.6
10.3
8.4
13.3
14.3
10.4
1.2
18.0
20.4
11.7
14.6
---------
15.0
14.6
10.4
6.4
---------
---------
16.0
2.4
10.6
6.0
15.5
7.7
10.5
6.2
1.7
1.1
-4.0
2.7
-1.6
0.9
-5.3
1.1
0.1
1.0
-4.7
1.9
2005
2006
2007
2008
2009
7.8
5.9
14.7
5.2
7.5
2.6
4.3
-1.0
-2.6
6.7
-0.3
6.3
1.6
7.5
4.4
-----------
6.3
5.4
10.5
3.4
7.3
-----------
-----------
1.9
-4.3
2.0
-10.0
12.5
3.9
0.3
6.2
-3.1
9.7
-0.3
-1.0
-1.0
-0.4
9.5
0.6
-1.9
-5.9
-3.9
6.6
0.1
-1.4
-3.3
-2.0
8.2
2010f
5.8
-3.2
11.8
f
2011
-2.8
-3.2
7.3
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
-----
3.9
-2.8
-----
-----
11.2
10.1
7.3
3.4
-1.1
-4.5
-2.3
-3.4
-1.6
-4.0
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B Sask.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Saskatchewan, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Year
Health Expenditure
Private
Public
GDP Implicit
Price Index—Canada
Total
(1997 = 100)
($ per Capita)
1985
1986
1987
1988
1989
72.15
85.79
73.32
71.08
85.58
60.60
71.65
86.03
108.66
137.80
132.75
157.44
159.35
179.74
223.37
1,165.85
1,288.21
1,328.72
1,428.29
1,598.43
324.93
366.97
383.01
359.28
415.71
1,490.78
1,655.19
1,711.73
1,787.57
2,014.15
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
102.73
110.29
103.88
80.07
80.85
152.81
161.76
175.07
220.01
236.23
255.54
272.06
278.95
300.07
317.09
1,779.42
1,824.01
1,812.37
1,716.06
1,762.05
456.84
489.59
503.84
570.20
600.67
2,236.27
2,313.60
2,316.20
2,286.26
2,362.72
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
90.94
94.39
99.49
111.61
127.15
238.20
235.89
252.79
257.26
271.46
329.14
330.27
352.28
368.86
398.61
1,795.42
1,827.39
1,941.00
2,067.32
2,217.76
612.84
615.97
668.05
663.07
716.46
2,408.26
2,443.35
2,609.05
2,730.39
2,934.21
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
142.64
165.92
191.82
217.24
236.72
290.28
323.74
333.35
361.56
388.31
432.93
489.66
525.17
578.80
625.04
2,362.84
2,581.16
2,730.52
2,911.21
3,116.22
772.58
875.38
907.57
980.13
1,030.97
3,135.42
3,456.55
3,638.09
3,891.34
4,147.20
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009
258.76
280.07
319.66
346.13
362.10
405.36
402.71
419.29
407.15
441.77
664.12
682.78
738.95
753.27
803.87
3,399.24
3,629.15
3,875.15
4,155.66
4,345.34
1,064.72
1,173.53
1,216.97
1,206.56
1,308.31
4,463.96
4,802.67
5,092.12
5,362.22
5,653.66
117.5
120.8
125.2
131.3
127.8
2010f
f
2011
386.82
391.37
487.89
538.23
874.71
929.60
4,602.11
4,864.94
1,431.88
1,556.19
6,033.99
6,421.13
131.5
136.8
1985
1986
1987
1988
1989
--18.9
-14.5
-3.1
20.4
--18.2
20.1
26.3
26.8
--18.6
1.2
12.8
24.3
--10.5
3.1
7.5
11.9
--12.9
4.4
-6.2
15.7
--11.0
3.4
4.4
12.7
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
20.0
7.4
-5.8
-22.9
1.0
10.9
5.9
8.2
25.7
7.4
14.4
6.5
2.5
7.6
5.7
11.3
2.5
-0.6
-5.3
2.7
9.9
7.2
2.9
13.2
5.3
11.0
3.5
0.1
-1.3
3.3
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
12.5
3.8
5.4
12.2
13.9
0.8
-1.0
7.2
1.8
5.5
3.8
0.3
6.7
4.7
8.1
1.9
1.8
6.2
6.5
7.3
2.0
0.5
8.5
-0.7
8.1
1.9
1.5
6.8
4.7
7.5
2.3
1.7
1.0
-0.4
1.8
Sask.
(Annual Percentage Change)
12.2
6.9
8.6
6.5
7.8
6.9
2001
16.3
11.5
13.1
9.2
13.3
10.2
1.4
2002
2000
15.6
3.0
7.3
5.8
3.7
5.3
1.0
4.1
2003
13.3
8.5
10.2
6.6
8.0
7.0
2.9
2004
9.0
7.4
8.0
7.0
5.2
6.6
2.6
2005
2006
2007
2008
2009
9.3
8.2
14.1
8.3
4.6
4.4
-0.7
4.1
-2.9
8.5
6.3
2.8
8.2
1.9
6.7
9.1
6.8
6.8
7.2
4.6
3.3
10.2
3.7
-0.9
8.4
7.6
7.6
6.0
5.3
5.4
3.0
2.8
3.7
4.9
-2.7
2010 f
f
2011
6.8
1.2
10.4
10.3
8.8
6.3
5.9
5.7
9.4
8.7
6.7
6.4
2.9
4.0
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--16.1
-19.3
-7.6
15.8
--15.4
15.3
21.8
22.2
--15.8
-3.5
8.3
19.7
--7.7
-1.6
3.0
7.3
--10.1
-0.4
-10.7
11.1
--8.2
-1.3
-0.1
8.1
1990
1991
1992
1993
1994
17.0
4.6
-7.1
-24.4
-0.1
7.9
3.1
7.0
24.2
6.3
11.4
3.7
1.3
6.1
4.6
8.3
-0.3
-1.9
-6.8
1.6
6.9
4.4
1.6
11.7
4.2
8.0
0.7
-1.1
-2.7
2.2
1995
1996
1997
1998
1999
10.1
2.1
4.4
12.6
12.1
-1.5
-2.6
6.2
2.2
3.7
1.5
-1.3
5.7
5.1
6.3
-0.4
0.1
5.2
6.9
5.5
-0.3
-1.2
7.5
-0.3
6.2
-0.4
-0.2
5.8
5.1
5.7
2000
8.1
2.8
4.5
2.4
3.7
2.8
2001
2002
2003
2004
15.0
14.6
10.4
6.4
10.2
1.9
5.6
4.8
11.8
6.2
7.3
5.4
7.9
4.7
3.7
4.5
12.0
2.6
5.1
2.6
8.9
4.2
4.1
4.0
2005
2006
2007
2008
2009
6.3
5.4
10.5
3.4
7.3
1.4
-3.4
0.4
-7.8
11.2
3.2
0.0
4.5
-2.9
9.4
6.1
4.0
3.1
2.4
7.3
0.3
7.4
0.0
-5.7
11.1
4.6
4.8
2.3
0.4
8.1
2010f
f
2011
3.9
-2.8
7.5
6.3
5.9
2.3
3.0
1.7
6.5
4.7
3.8
2.4
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
93
Drug Expenditure in Canada, 1985 to 2011
Table B Alta.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Alberta, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out of
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Federal
Year
Alta.
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter
Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
69.5
83.2
95.7
108.0
159.7
6.4
7.0
7.4
9.1
11.1
0.9
1.2
1.5
1.6
1.8
-----------
76.7
91.4
104.6
118.7
172.7
-----------
-----------
134.5
147.9
153.1
172.6
194.5
211.2
239.3
257.7
291.3
367.2
-----------
-----------
113.1
128.1
148.5
163.3
179.6
1990
1991
1992
1993
1994
179.5
189.2
205.6
205.8
208.1
13.2
15.3
17.1
20.4
22.8
2.2
2.7
3.0
3.7
3.3
-----------
194.9
207.1
225.6
229.9
234.2
-----------
-----------
219.0
241.2
256.8
297.0
309.4
413.9
448.3
482.4
526.9
543.7
----103.3
114.2
119.3
----91.2
98.7
106.1
184.3
192.8
194.4
213.0
225.4
1995
1996
1997
1998
1999
212.5
232.6
254.8
278.1
328.2
26.0
26.3
29.3
32.8
41.2
3.1
3.5
3.5
4.2
5.2
-----------
241.5
262.4
287.6
315.0
374.6
-----------
-----------
323.6
360.2
403.5
430.1
494.4
565.1
622.6
691.1
745.1
869.1
119.8
128.3
144.5
153.1
167.1
108.9
112.5
125.9
135.0
136.7
228.6
240.8
270.4
288.1
303.8
2000
2001
2002
2003
2004
387.1
451.0
515.2
588.2
646.8
45.1
51.4
57.7
64.9
67.8
5.7
7.7
8.7
10.2
10.9
-----------
437.8
510.1
581.7
663.2
725.5
-----------
-----------
556.5
617.5
686.9
754.3
800.9
994.3
1,127.7
1,268.6
1,417.5
1,526.4
173.4
190.6
199.0
220.0
236.8
150.0
160.8
169.6
177.3
187.2
323.4
351.4
368.6
397.3
424.0
2005
2006
2007
2008
2009
709.3
758.9
792.5
827.7
1,003.3
71.6
75.3
76.8
77.0
78.8
10.9
11.6
11.3
11.4
10.9
-----------
791.7
845.8
880.6
916.0
1,093.0
-----------
-----------
848.5
995.1
1,045.1
1,118.0
1,205.5
1,640.2
1,840.9
1,925.7
2,034.0
2,298.5
240.8
270.6
292.0
302.1
320.3
194.9
212.9
222.7
227.6
231.7
435.6
483.6
514.7
529.7
552.1
2010f
f
2011
1,142.4
1,237.9
79.3
80.8
11.2
11.2
-----
1,232.9
1,330.0
-----
-----
1,314.3
1,421.1
2,547.2
2,751.1
327.2
322.0
231.1
240.2
558.3
562.2
1985
1986
1987
1988
1989
--19.8
15.1
12.7
48.0
--9.8
6.1
22.8
22.5
--33.7
23.4
13.0
10.2
-----------
--19.1
14.5
13.5
45.5
-----------
-----------
--10.0
3.5
12.7
12.7
--13.3
7.7
13.0
26.1
-----------
-----------
--13.2
16.0
10.0
10.0
1990
1991
1992
1993
1994
12.4
5.4
8.7
0.1
1.1
18.0
16.1
11.8
19.6
11.9
22.6
19.6
11.9
23.9
-11.4
-----------
12.9
6.3
8.9
1.9
1.9
-----------
-----------
12.6
10.1
6.5
15.7
4.2
12.7
8.3
7.6
9.2
3.2
------10.6
4.5
------8.3
7.4
2.7
4.6
0.8
9.5
5.8
1995
1996
1997
1998
1999
2.1
9.5
9.6
9.1
18.0
13.7
1.3
11.5
11.8
25.8
-5.1
11.9
-0.3
21.3
22.9
-----------
3.1
8.6
9.6
9.5
18.9
-----------
-----------
4.6
11.3
12.0
6.6
15.0
3.9
10.2
11.0
7.8
16.6
0.4
7.1
12.6
6.0
9.2
2.6
3.3
11.9
7.2
1.3
1.4
5.3
12.3
6.5
5.5
2000
2001
2002
2003
2004
17.9
16.5
14.2
14.2
10.0
9.3
14.1
12.2
12.4
4.5
9.8
36.1
13.6
16.2
6.9
-----------
16.9
16.5
14.0
14.0
9.4
-----------
-----------
12.6
11.0
11.2
9.8
6.2
14.4
13.4
12.5
11.7
7.7
3.8
9.9
4.4
10.5
7.6
9.7
7.3
5.4
4.6
5.6
6.4
8.7
4.9
7.8
6.7
2005
2006
2007
2008
2009
9.7
7.0
4.4
4.4
21.2
5.6
5.2
2.0
0.3
2.4
0.1
6.7
-2.6
0.6
-4.2
-----------
9.1
6.8
4.1
4.0
19.3
-----------
-----------
5.9
17.3
5.0
7.0
7.8
7.5
12.2
4.6
5.6
13.0
1.7
12.4
7.9
3.4
6.1
4.1
9.3
4.6
2.2
1.8
2.7
11.0
6.4
2.9
4.2
2010f
f
2011
13.9
8.4
0.6
1.9
2.8
0.3
-----
12.8
7.9
-----
-----
9.0
8.1
10.8
8.0
2.1
-1.6
-0.3
4.0
1.1
0.7
1985
1986
1987
1988
1989
21.4
22.6
23.6
23.7
29.2
2.0
1.9
1.8
2.0
2.0
0.3
0.3
0.4
0.4
0.3
-----------
23.7
24.9
25.8
26.1
31.6
-----------
-----------
41.5
40.3
37.7
38.0
35.6
65.1
65.1
63.4
64.1
67.2
-----------
-----------
34.9
34.9
36.6
35.9
32.8
1990
1991
1992
1993
1994
30.0
29.5
30.4
27.8
27.1
2.2
2.4
2.5
2.8
3.0
0.4
0.4
0.4
0.5
0.4
-----------
32.6
32.3
33.3
31.1
30.5
-----------
-----------
36.6
37.6
37.9
40.1
40.2
69.2
69.9
71.3
71.2
70.7
----15.3
15.4
15.5
----13.5
13.3
13.8
30.8
30.1
28.7
28.8
29.3
1995
1996
1997
1998
1999
26.8
26.9
26.5
26.9
28.0
3.3
3.0
3.1
3.2
3.5
0.4
0.4
0.4
0.4
0.4
-----------
30.4
30.4
29.9
30.5
31.9
-----------
-----------
40.8
41.7
42.0
41.6
42.2
71.2
72.1
71.9
72.1
74.1
15.1
14.9
15.0
14.8
14.2
13.7
13.0
13.1
13.1
11.7
28.8
27.9
28.1
27.9
25.9
2000
29.4
3.4
0.4
---
33.2
---
---
42.2
75.5
13.2
11.4
24.5
2001
2002
2003
2004
30.5
31.5
32.4
33.2
3.5
3.5
3.6
3.5
0.5
0.5
0.6
0.6
---------
34.5
35.5
36.5
37.2
---------
---------
41.7
42.0
41.6
41.1
76.2
77.5
78.1
78.3
12.9
12.2
12.1
12.1
10.9
10.4
9.8
9.6
23.8
22.5
21.9
21.7
2005
2006
2007
2008
2009
34.2
32.6
32.5
32.3
35.2
3.4
3.2
3.1
3.0
2.8
0.5
0.5
0.5
0.4
0.4
-----------
38.1
36.4
36.1
35.7
38.3
-----------
-----------
40.9
42.8
42.8
43.6
42.3
79.0
79.2
78.9
79.3
80.6
11.6
11.6
12.0
11.8
11.2
9.4
9.2
9.1
8.9
8.1
21.0
20.8
21.1
20.7
19.4
36.8
2.6
0.4
37.4
2.4
0.3
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
-----
39.7
40.1
-----
-----
42.3
42.9
82.0
83.0
10.5
9.7
7.4
7.2
18.0
17.0
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
2010f
f
2011
94
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B Alta.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Alberta, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Private
Total
Public
($ Millions)
Year
Total
(Percentage Share)
1985
1986
1987
1988
1989
76.7
91.4
104.6
118.7
172.7
247.6
276.0
301.6
335.9
374.0
324.3
367.4
406.2
454.6
546.7
3,239.1
3,537.9
3,514.4
3,645.6
4,031.0
831.3
910.6
985.5
1,184.9
1,318.8
4,070.4
4,448.5
4,499.9
4,830.6
5,349.8
2.4
2.6
3.0
3.3
4.3
29.8
30.3
30.6
28.3
28.4
8.0
8.3
9.0
9.4
10.2
1990
1991
1992
1993
1994
194.9
207.1
225.6
229.9
234.2
403.4
434.0
451.2
510.0
534.8
598.3
641.1
676.9
739.8
769.1
4,326.9
4,557.5
4,846.4
4,800.5
4,527.8
1,422.5
1,505.1
1,584.2
1,719.9
1,785.7
5,749.4
6,062.5
6,430.7
6,520.4
6,313.4
4.5
4.5
4.7
4.8
5.2
28.4
28.8
28.5
29.7
30.0
10.4
10.6
10.5
11.3
12.2
1995
1996
1997
1998
1999
241.5
262.4
287.6
315.0
374.6
552.2
601.0
673.9
718.1
798.3
793.8
863.4
961.5
1,033.2
1,172.9
4,283.5
4,466.5
4,942.1
5,354.0
6,140.2
1,809.0
1,854.2
2,140.1
2,265.9
2,561.6
6,092.5
6,320.6
7,082.2
7,619.8
8,701.7
5.6
5.9
5.8
5.9
6.1
30.5
32.4
31.5
31.7
31.2
13.0
13.7
13.6
13.6
13.5
2000
2001
2002
2003
2004
437.8
510.1
581.7
663.2
725.5
879.9
968.9
1,055.5
1,151.6
1,224.9
1,317.7
1,479.1
1,637.2
1,814.8
1,950.4
6,792.9
7,744.0
8,456.4
9,105.3
9,950.0
2,808.8
3,218.4
3,337.4
3,522.5
3,882.3
9,601.8
10,962.4
11,793.7
12,627.7
13,832.3
6.4
6.6
6.9
7.3
7.3
31.3
30.1
31.6
32.7
31.6
13.7
13.5
13.9
14.4
14.1
2005
2006
2007
2008
2009
791.7
845.8
880.6
916.0
1,093.0
1,284.1
1,478.7
1,559.8
1,647.7
1,757.5
2,075.9
2,324.5
2,440.4
2,563.7
2,850.5
11,041.0
12,156.3
13,356.4
14,848.4
15,694.7
4,129.9
4,835.8
5,118.2
5,546.5
5,824.1
15,170.8
16,992.1
18,474.6
20,394.9
21,518.8
7.2
7.0
6.6
6.2
7.0
31.1
30.6
30.5
29.7
30.2
13.7
13.7
13.2
12.6
13.2
2010f
f
2011
1,232.9
1,330.0
1,872.6
1,983.3
3,105.5
3,313.3
17,722.5
18,377.5
6,168.5
6,558.2
23,891.0
24,935.7
7.0
7.2
30.4
30.2
13.0
13.3
1985
1986
1987
1988
1989
--19.1
14.5
13.5
45.5
--11.5
9.3
11.3
11.4
--13.3
10.6
11.9
20.3
--9.2
-0.7
3.7
10.6
--9.5
8.2
20.2
11.3
--9.3
1.2
7.3
10.7
1990
1991
1992
1993
1994
12.9
6.3
8.9
1.9
1.9
7.8
7.6
4.0
13.0
4.9
9.4
7.2
5.6
9.3
4.0
7.3
5.3
6.3
-0.9
-5.7
7.9
5.8
5.3
8.6
3.8
7.5
5.4
6.1
1.4
-3.2
1995
1996
1997
1998
1999
3.1
8.6
9.6
9.5
18.9
3.3
8.8
12.1
6.6
11.2
3.2
8.8
11.4
7.5
13.5
-5.4
4.3
10.6
8.3
14.7
1.3
2.5
15.4
5.9
13.1
-3.5
3.7
12.0
7.6
14.2
2000
2001
2002
2003
2004
16.9
16.5
14.0
14.0
9.4
10.2
10.1
8.9
9.1
6.4
12.3
12.2
10.7
10.8
7.5
10.6
14.0
9.2
7.7
9.3
9.7
14.6
3.7
5.5
10.2
10.3
14.2
7.6
7.1
9.5
2005
2006
2007
2008
2009
9.1
6.8
4.1
4.0
19.3
4.8
15.2
5.5
5.6
6.7
6.4
12.0
5.0
5.1
11.2
11.0
10.1
9.9
11.2
5.7
6.4
17.1
5.8
8.4
5.0
9.7
12.0
8.7
10.4
5.5
2010 f
f
2011
12.8
7.9
6.5
5.9
8.9
6.7
12.9
3.7
5.9
6.3
11.0
4.4
Alta.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
23.7
24.9
25.8
26.1
31.6
76.3
75.1
74.2
73.9
68.4
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
32.6
32.3
33.3
31.1
30.5
67.4
67.7
66.7
68.9
69.5
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
30.4
30.4
29.9
30.5
31.9
69.6
69.6
70.1
69.5
68.1
100.0
100.0
100.0
100.0
100.0
2000
33.2
66.8
100.0
2001
2002
2003
2004
34.5
35.5
36.5
37.2
65.5
64.5
63.5
62.8
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009
38.1
36.4
36.1
35.7
38.3
61.9
63.6
63.9
64.3
61.7
100.0
100.0
100.0
100.0
100.0
2010f
f
2011
39.7
40.1
60.3
59.9
100.0
100.0
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
95
Drug Expenditure in Canada, 1985 to 2011
Table B Alta.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Alberta, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Subtotal
Insurers*
Out of
Social Security Funds
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Federal
Year
Alta.
Subtotal
Private
Total
Prescribed
Drugs
OvertheCounter
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
Personal
Total
Health
Non-Presc.
Supplies
Drugs
1985
1986
1987
1988
1989
28.91
34.23
39.32
43.98
64.01
2.65
2.87
3.04
3.71
4.47
0.37
0.48
0.60
0.67
0.73
-----------
31.93
37.59
42.96
48.36
69.20
-----------
-----------
55.96
60.86
62.87
70.31
77.94
87.89
98.44
105.83
118.67
147.14
-----------
-----------
47.07
52.69
60.99
66.53
71.96
1990
1991
1992
1993
1994
70.48
72.98
78.09
77.14
77.07
5.16
5.89
6.48
7.65
8.46
0.87
1.02
1.13
1.38
1.21
-----------
76.52
79.89
85.70
86.18
86.74
-----------
-----------
86.00
93.03
97.53
111.35
114.58
162.51
172.92
183.24
197.53
201.32
----39.22
42.82
44.18
----34.62
37.01
39.28
72.36
74.37
73.84
79.83
83.46
1995
1996
1997
1998
1999
77.70
83.81
90.05
95.90
111.14
9.50
9.49
10.37
11.31
13.97
1.13
1.25
1.22
1.45
1.74
-----------
88.33
94.55
101.64
108.66
126.85
-----------
-----------
118.34
129.79
142.56
148.33
167.42
206.67
224.34
244.20
256.98
294.27
43.80
46.23
51.05
52.80
56.59
39.81
40.53
44.49
46.55
46.29
83.62
86.77
95.55
99.36
102.88
2000
2001
2002
2003
2004
128.81
147.55
165.33
186.05
201.62
15.00
16.82
18.51
20.52
21.13
1.88
2.52
2.81
3.22
3.39
-----------
145.69
166.89
186.65
209.79
226.14
-----------
-----------
185.19
202.01
220.43
238.59
249.65
330.88
368.91
407.08
448.38
475.78
57.71
62.35
63.86
69.59
73.81
49.90
52.62
54.41
56.09
58.34
107.62
114.96
118.28
125.68
132.16
2005
2006
2007
2008
2009
216.20
221.83
225.61
230.46
273.31
21.81
22.00
21.85
21.43
21.47
3.31
3.39
3.22
3.17
2.97
-----------
241.33
247.22
250.68
255.06
297.76
-----------
-----------
258.63
290.87
297.53
311.31
328.40
499.96
538.09
548.22
566.36
626.16
73.38
79.10
83.13
84.11
87.27
59.40
62.24
63.39
63.37
63.13
132.78
141.34
146.52
147.48
150.39
2010f
f
2011
307.01
326.16
21.32
21.30
3.01
2.96
-----
331.34
350.42
-----
-----
353.23
374.44
684.56
724.86
87.94
84.85
62.10
63.29
150.04
148.14
1985
1986
1987
1988
1989
--18.4
14.9
11.9
45.5
--8.6
5.9
21.8
20.5
--32.2
23.2
12.1
8.4
-----------
--17.7
14.3
12.6
43.1
-----------
-----------
--8.7
3.3
11.8
10.9
--12.0
7.5
12.1
24.0
-----------
-----------
--11.9
15.8
9.1
8.2
1990
1991
1992
1993
1994
10.1
3.5
7.0
-1.2
-0.1
15.6
14.0
10.1
18.0
10.5
20.1
17.5
10.2
22.3
-12.5
-----------
10.6
4.4
7.3
0.6
0.6
-----------
-----------
10.3
8.2
4.8
14.2
2.9
10.4
6.4
6.0
7.8
1.9
------9.2
3.2
------6.9
6.1
0.6
2.8
-0.7
8.1
4.5
1995
1996
1997
1998
1999
0.8
7.9
7.4
6.5
15.9
12.3
-0.2
9.3
9.1
23.5
-6.3
10.3
-2.2
18.4
20.6
-----------
1.8
7.0
7.5
6.9
16.7
-----------
-----------
3.3
9.7
9.8
4.0
12.9
2.7
8.6
8.9
5.2
14.5
-0.8
5.5
10.4
3.4
7.2
1.4
1.8
9.8
4.6
-0.6
0.2
3.8
10.1
4.0
3.6
---
10.6
(Annual Percentage Change)
2000
15.9
7.4
7.9
---
14.9
---
12.4
2.0
7.8
4.6
2001
14.6
12.2
33.8
---
14.6
---
---
9.1
11.5
8.0
5.4
6.8
2002
12.0
10.1
11.4
---
11.8
---
---
9.1
10.3
2.4
3.4
2.9
2003
12.5
10.8
14.6
---
12.4
---
---
8.2
10.1
9.0
3.1
6.3
2004
8.4
3.0
5.4
---
7.8
---
---
4.6
6.1
6.1
4.0
5.2
2005
2006
2007
2008
2009
7.2
2.6
1.7
2.1
18.6
3.3
0.8
-0.7
-1.9
0.2
-2.2
2.3
-5.1
-1.6
-6.3
-----------
6.7
2.4
1.4
1.7
16.7
-----------
-----------
3.6
12.5
2.3
4.6
5.5
5.1
7.6
1.9
3.3
10.6
-0.6
7.8
5.1
1.2
3.8
1.8
4.8
1.9
0.0
-0.4
0.5
6.4
3.7
0.7
2.0
2010f
f
2011
12.3
6.2
-0.7
-0.1
1.4
-1.7
-----
11.3
5.8
-----
-----
7.6
6.0
9.3
5.9
0.8
-3.5
-1.6
1.9
-0.2
-1.3
-----------
-----------
--9.1
11.0
4.6
3.6
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
96
1985
1986
1987
1988
1989
--15.6
10.1
7.3
41.0
--5.8
1.1
17.3
15.9
--29.4
18.5
7.6
3.8
-----------
--14.9
9.5
8.1
38.5
-----------
-----------
--5.9
-1.4
7.3
6.3
--9.2
2.8
7.6
19.4
1990
1991
1992
1993
1994
7.1
0.8
5.7
-2.6
-1.2
12.6
11.3
8.8
16.6
9.4
17.1
14.8
8.9
20.8
-13.6
-----------
7.5
1.6
6.0
-0.9
-0.4
-----------
-----------
7.3
5.4
3.6
12.7
1.8
7.4
3.6
4.7
6.4
0.8
------7.7
2.1
------5.5
5.0
-2.5
0.0
-2.0
6.7
3.4
1995
1996
1997
1998
1999
-1.5
6.2
6.5
6.9
14.1
10.0
-1.9
8.3
9.5
21.7
-8.6
8.6
-3.2
18.8
18.8
-----------
-0.5
5.4
6.5
7.3
14.9
-----------
-----------
0.9
8.0
8.8
4.5
11.1
0.3
6.9
7.9
5.7
12.7
-3.2
3.9
9.4
3.9
5.4
-1.0
0.1
8.8
5.1
-2.4
-2.1
2.1
9.1
4.4
1.7
2000
11.8
3.3
3.8
---
10.7
---
---
6.5
8.3
-2.1
3.7
0.5
2001
2002
2003
2004
13.2
11.0
9.6
5.8
10.8
9.0
7.9
0.4
32.4
10.4
11.7
2.8
---------
13.2
10.8
9.5
5.2
---------
---------
7.7
8.1
5.3
2.0
10.1
9.3
7.2
3.5
6.7
1.4
6.1
3.5
4.1
2.4
0.2
1.4
5.5
1.8
3.4
2.6
2005
2006
2007
2008
2009
4.2
-0.2
-2.0
-2.7
21.3
0.3
-1.9
-4.4
-6.8
2.9
-5.2
-0.5
-8.8
-6.5
-3.5
-----------
3.7
-0.4
-2.3
-3.1
19.4
-----------
-----------
0.6
9.7
-1.4
-0.2
8.2
2.1
4.8
-1.8
-1.6
13.3
-3.6
5.0
1.4
-3.7
6.5
-1.2
2.0
-1.8
-4.9
2.3
-2.5
3.6
0.0
-4.2
4.7
2010f
9.4
-3.7
-1.5
f
2011
2.2
-4.1
-5.7
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
-----
8.3
1.8
-----
-----
4.6
2.0
6.4
1.9
-2.2
-7.5
-4.6
-2.1
-3.2
-5.3
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B Alta.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Alberta, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Year
Health Expenditure
Private
Public
GDP Implicit
Price Index—Canada
Total
(1997 = 100)
($ per Capita)
1985
1986
1987
1988
1989
31.93
37.59
42.96
48.36
69.20
103.03
113.54
123.86
136.84
149.90
134.95
151.13
166.81
185.20
219.10
1,347.98
1,455.36
1,443.08
1,485.33
1,615.48
345.94
374.58
404.68
482.78
528.50
1,693.92
1,829.95
1,847.76
1,968.11
2,143.98
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
76.52
79.89
85.70
86.18
86.74
158.36
167.40
171.37
191.18
198.04
234.87
247.29
257.08
277.36
284.78
1,698.71
1,757.86
1,840.71
1,799.67
1,676.53
558.47
580.52
601.71
644.78
661.19
2,257.18
2,338.38
2,442.42
2,444.45
2,337.72
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
88.33
94.55
101.64
108.66
126.85
201.95
216.56
238.11
247.68
270.31
290.28
311.11
339.75
356.34
397.16
1,566.45
1,609.45
1,746.27
1,846.55
2,079.12
661.54
668.13
756.21
781.48
867.37
2,227.99
2,277.57
2,502.48
2,628.02
2,946.49
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
145.69
166.89
186.65
209.79
226.14
292.81
316.98
338.71
364.28
381.80
438.50
483.87
525.36
574.06
607.94
2,260.59
2,533.41
2,713.56
2,880.16
3,101.44
934.74
1,052.90
1,070.93
1,114.22
1,210.13
3,195.32
3,586.31
3,784.49
3,994.38
4,311.57
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009
241.33
247.22
250.68
255.06
297.76
391.41
432.21
444.05
458.78
478.79
632.74
679.43
694.74
713.84
776.55
3,365.41
3,553.18
3,802.32
4,134.44
4,275.63
1,258.82
1,413.46
1,457.07
1,544.40
1,586.63
4,624.23
4,966.64
5,259.40
5,678.84
5,862.25
117.5
120.8
125.2
131.3
127.8
2010f
f
2011
331.34
350.42
503.26
522.58
834.60
873.00
4,762.90
4,842.19
1,657.78
1,727.97
6,420.69
6,570.15
131.5
136.8
1985
1986
1987
1988
1989
--17.7
14.3
12.6
43.1
--10.2
9.1
10.5
9.5
--12.0
10.4
11.0
18.3
--8.0
-0.8
2.9
8.8
--8.3
8.0
19.3
9.5
--8.0
1.0
6.5
8.9
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
10.6
4.4
7.3
0.6
0.6
5.6
5.7
2.4
11.6
3.6
7.2
5.3
4.0
7.9
2.7
5.2
3.5
4.7
-2.2
-6.8
5.7
3.9
3.7
7.2
2.5
5.3
3.6
4.4
0.1
-4.4
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
1.8
7.0
7.5
6.9
16.7
2.0
7.2
10.0
4.0
9.1
1.9
7.2
9.2
4.9
11.5
-6.6
2.7
8.5
5.7
12.6
0.1
1.0
13.2
3.3
11.0
-4.7
2.2
9.9
5.0
12.1
2.3
1.7
1.0
-0.4
1.8
Alta.
(Annual Percentage Change)
8.3
10.4
8.7
7.8
8.4
2001
14.6
8.3
10.3
12.1
12.6
12.2
1.4
2002
2000
11.8
14.9
6.9
8.6
7.1
1.7
5.5
1.0
4.1
2003
12.4
7.5
9.3
6.1
4.0
5.5
2.9
2004
7.8
4.8
5.9
7.7
8.6
7.9
2.6
2005
2006
2007
2008
2009
6.7
2.4
1.4
1.7
16.7
2.5
10.4
2.7
3.3
4.4
4.1
7.4
2.3
2.7
8.8
8.5
5.6
7.0
8.7
3.4
4.0
12.3
3.1
6.0
2.7
7.3
7.4
5.9
8.0
3.2
3.0
2.8
3.7
4.9
-2.7
2010 f
f
2011
11.3
5.8
5.1
3.8
7.5
4.6
11.4
1.7
4.5
4.2
9.5
2.3
2.9
4.0
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--14.9
9.5
8.1
38.5
--7.4
4.3
6.0
5.0
--9.2
5.6
6.5
13.7
--5.2
-5.6
-1.6
4.2
--5.5
3.3
14.8
4.9
--5.2
-3.8
2.0
4.4
1990
1991
1992
1993
1994
7.5
1.6
6.0
-0.9
-0.4
2.6
3.0
1.1
10.1
2.5
4.2
2.5
2.7
6.5
1.6
2.1
0.7
3.5
-3.7
-7.9
2.6
1.2
2.4
5.7
1.4
2.3
0.8
3.2
-1.4
-5.5
1995
1996
1997
1998
1999
-0.5
5.4
6.5
7.3
14.9
-0.4
5.6
9.0
4.5
7.3
-0.4
5.5
8.2
5.3
9.6
-8.9
1.1
7.5
6.2
10.8
-2.3
-0.7
12.2
3.8
9.2
-7.0
0.6
8.9
5.5
10.3
2000
10.7
4.2
6.3
4.6
3.7
4.3
2001
2002
2003
2004
13.2
10.8
9.5
5.2
6.9
5.8
4.7
2.2
9.0
7.5
6.4
3.3
10.7
6.1
3.2
5.1
11.3
0.7
1.1
6.0
10.9
4.5
2.6
5.4
2005
2006
2007
2008
2009
3.7
-0.4
-2.3
-3.1
19.4
-0.5
7.6
-0.9
-1.5
7.1
1.1
4.6
-1.4
-2.1
11.5
5.5
2.8
3.3
3.9
6.1
1.0
9.5
-0.6
1.1
5.4
4.2
4.6
2.2
3.1
5.9
2010 f
f
2011
8.3
1.8
2.2
-0.2
4.5
0.6
8.5
-2.3
1.5
0.2
6.6
-1.7
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
97
Drug Expenditure in Canada, 1985 to 2011
Table B B.C.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, British Columbia, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out of
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Federal
Year
B.C.
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter
Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
128.5
151.4
153.5
169.8
196.5
7.8
8.6
9.2
14.0
18.0
1.4
1.5
1.7
2.0
2.1
-----------
137.7
161.5
164.4
185.7
216.7
-----------
-----------
121.1
105.6
134.9
159.6
188.9
258.8
267.0
299.2
345.3
405.6
-----------
-----------
157.7
178.5
207.0
219.3
232.3
1990
1991
1992
1993
1994
232.6
275.4
311.8
346.0
339.4
21.2
24.4
26.5
32.1
35.8
2.4
2.7
3.1
3.5
4.0
-----------
256.3
302.4
341.5
381.6
379.2
-----------
-----------
216.8
241.1
268.1
303.1
323.2
473.0
543.5
609.5
684.7
702.5
----149.5
164.4
183.5
----134.7
146.0
156.9
248.6
266.2
284.2
310.4
340.4
1995
1996
1997
1998
1999
349.5
379.4
418.7
457.8
515.6
40.5
44.2
45.3
49.5
54.2
4.2
3.9
4.0
5.1
5.9
-----------
394.1
427.5
468.0
512.4
575.7
-----------
-----------
353.5
374.9
412.2
480.0
505.7
747.6
802.4
880.2
992.4
1,081.5
186.0
192.2
196.5
208.5
226.4
163.8
166.3
172.7
185.0
196.7
349.7
358.4
369.2
393.5
423.1
2000
2001
2002
2003
2004
595.4
659.1
670.3
657.7
700.4
58.2
65.6
76.0
88.0
92.6
6.8
7.4
7.2
7.6
9.0
-----------
660.4
732.1
753.4
753.3
801.9
-----------
-----------
570.1
641.0
759.4
881.4
1,009.6
1,230.5
1,373.1
1,512.8
1,634.7
1,811.5
235.6
245.1
257.5
278.3
295.6
199.6
209.6
220.3
225.5
231.6
435.3
454.7
477.8
503.7
527.2
2005
2006
2007
2008
2009
750.0
793.8
825.6
856.0
883.1
96.6
101.4
104.5
107.2
108.7
9.8
10.8
11.3
12.0
11.5
-----------
856.3
906.0
941.4
975.2
1,003.3
-----------
-----------
1,035.5
1,224.0
1,232.4
1,375.4
1,443.7
1,891.8
2,130.0
2,173.8
2,350.6
2,447.0
299.1
308.1
286.1
292.7
308.0
239.4
244.2
221.3
224.2
231.3
538.5
552.3
507.4
516.8
539.3
2010f
f
2011
927.8
964.9
108.9
110.9
13.8
15.0
-----
1,050.5
1,090.9
-----
-----
1,519.9
1,559.3
2,570.4
2,650.2
327.4
329.5
236.7
252.4
564.2
581.8
1985
1986
1987
1988
1989
--17.8
1.4
10.6
15.8
--9.6
7.3
51.5
29.1
--4.7
15.5
16.5
9.0
-----------
--17.2
1.8
13.0
16.7
-----------
-----------
---12.8
27.8
18.4
18.4
--3.2
12.1
15.4
17.5
-----------
-----------
--13.2
16.0
5.9
5.9
1990
1991
1992
1993
1994
18.3
18.4
13.2
11.0
-1.9
17.9
14.6
9.0
21.0
11.6
14.0
10.1
16.1
11.6
14.1
-----------
18.2
18.0
12.9
11.7
-0.6
-----------
-----------
14.7
11.3
11.2
13.1
6.6
16.6
14.9
12.1
12.3
2.6
------10.0
11.6
------8.4
7.4
7.1
7.1
6.8
9.2
9.7
1995
1996
1997
1998
1999
3.0
8.6
10.3
9.4
12.6
12.9
9.1
2.6
9.2
9.6
5.7
-6.0
2.1
25.6
17.2
-----------
3.9
8.5
9.5
9.5
12.4
-----------
-----------
9.4
6.1
10.0
16.4
5.4
6.4
7.3
9.7
12.7
9.0
1.4
3.3
2.3
6.1
8.6
4.4
1.5
3.9
7.1
6.3
2.7
2.5
3.0
6.6
7.5
2000
2001
2002
2003
2004
15.5
10.7
1.7
-1.9
6.5
7.3
12.7
15.8
15.8
5.1
15.1
8.3
-3.0
6.4
17.9
-----------
14.7
10.9
2.9
0.0
6.4
-----------
-----------
12.7
12.4
18.5
16.1
14.5
13.8
11.6
10.2
8.1
10.8
4.1
4.0
5.1
8.1
6.2
1.5
5.0
5.1
2.3
2.7
2.9
4.5
5.1
5.4
4.7
2005
2006
2007
2008
2009
7.1
5.8
4.0
3.7
3.2
4.3
5.0
3.1
2.6
1.4
8.8
10.4
4.9
5.7
-4.3
-----------
6.8
5.8
3.9
3.6
2.9
-----------
-----------
2.6
18.2
0.7
11.6
5.0
4.4
12.6
2.1
8.1
4.1
1.2
3.0
-7.2
2.3
5.2
3.3
2.0
-9.4
1.3
3.2
2.1
2.6
-8.1
1.9
4.3
2010f
f
2011
5.1
4.0
0.1
1.9
20.8
8.5
-----
4.7
3.8
-----
-----
5.3
2.6
5.0
3.1
6.3
0.6
2.3
6.6
4.6
3.1
1985
1986
1987
1988
1989
30.9
34.0
30.3
30.1
30.8
1.9
1.9
1.8
2.5
2.8
0.3
0.3
0.3
0.3
0.3
-----------
33.1
36.2
32.5
32.9
34.0
-----------
-----------
29.1
23.7
26.6
28.3
29.6
62.1
59.9
59.1
61.2
63.6
-----------
-----------
37.9
40.1
40.9
38.8
36.4
1990
1991
1992
1993
1994
32.2
34.0
34.9
34.8
32.5
2.9
3.0
3.0
3.2
3.4
0.3
0.3
0.3
0.3
0.4
-----------
35.5
37.3
38.2
38.3
36.4
-----------
-----------
30.0
29.8
30.0
30.5
31.0
65.5
67.1
68.2
68.8
67.4
----16.7
16.5
17.6
----15.1
14.7
15.0
34.5
32.9
31.8
31.2
32.6
1995
1996
1997
1998
1999
31.8
32.7
33.5
33.0
34.3
3.7
3.8
3.6
3.6
3.6
0.4
0.3
0.3
0.4
0.4
-----------
35.9
36.8
37.5
37.0
38.3
-----------
-----------
32.2
32.3
33.0
34.6
33.6
68.1
69.1
70.5
71.6
71.9
16.9
16.6
15.7
15.0
15.0
14.9
14.3
13.8
13.4
13.1
31.9
30.9
29.5
28.4
28.1
2000
35.7
3.5
0.4
---
39.6
---
---
34.2
73.9
14.1
12.0
26.1
2001
2002
2003
2004
36.1
33.7
30.8
29.9
3.6
3.8
4.1
4.0
0.4
0.4
0.4
0.4
-------
40.1
37.8
35.2
34.3
---------
---------
35.1
38.1
41.2
43.2
75.1
76.0
76.4
77.5
13.4
12.9
13.0
12.6
11.5
11.1
10.5
9.9
24.9
24.0
23.6
22.5
2005
2006
2007
2008
2009
30.9
29.6
30.8
29.9
29.6
4.0
3.8
3.9
3.7
3.6
0.4
0.4
0.4
0.4
0.4
-----------
35.2
33.8
35.1
34.0
33.6
-----------
-----------
42.6
45.6
46.0
48.0
48.3
77.8
79.4
81.1
82.0
81.9
12.3
11.5
10.7
10.2
10.3
9.9
9.1
8.3
7.8
7.7
22.2
20.6
18.9
18.0
18.1
29.6
3.5
0.4
29.9
3.4
0.5
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
-----
33.5
33.8
-----
-----
48.5
48.2
82.0
82.0
10.4
10.2
7.6
7.8
18.0
18.0
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
2010f
f
2011
98
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B B.C.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, British Columbia, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Private
Total
Public
($ Millions)
Year
Total
(Percentage Share)
1985
1986
1987
1988
1989
137.7
161.5
164.4
185.7
216.7
278.8
284.1
341.9
378.9
421.2
416.5
445.6
506.3
564.6
637.9
3,410.8
3,666.9
3,896.4
4,242.0
4,736.8
1,227.1
1,317.2
1,444.9
1,597.1
1,773.0
4,637.9
4,984.1
5,341.3
5,839.1
6,509.7
4.0
4.4
4.2
4.4
4.6
22.7
21.6
23.7
23.7
23.8
9.0
8.9
9.5
9.7
9.8
1990
1991
1992
1993
1994
256.3
302.4
341.5
381.6
379.2
465.4
507.3
552.2
613.5
663.6
721.7
809.7
893.7
995.1
1,042.9
5,390.4
5,967.8
6,478.5
6,870.4
7,238.1
1,986.0
2,159.5
2,291.2
2,427.0
2,533.2
7,376.3
8,127.4
8,769.7
9,297.4
9,771.3
4.8
5.1
5.3
5.6
5.2
23.4
23.5
24.1
25.3
26.2
9.8
10.0
10.2
10.7
10.7
1995
1996
1997
1998
1999
394.1
427.5
468.0
512.4
575.7
703.2
733.3
781.4
873.5
928.8
1,097.3
1,160.9
1,249.4
1,385.9
1,504.6
7,538.9
7,688.7
7,942.6
8,304.5
8,969.4
2,574.3
2,689.4
2,889.4
3,109.8
3,310.3
10,113.2
10,378.1
10,832.0
11,414.3
12,279.7
5.2
5.6
5.9
6.2
6.4
27.3
27.3
27.0
28.1
28.1
10.9
11.2
11.5
12.1
12.3
2000
2001
2002
2003
2004
660.4
732.1
753.4
753.3
801.9
1,005.4
1,095.7
1,237.2
1,385.1
1,536.8
1,665.8
1,827.7
1,990.6
2,138.4
2,338.7
9,825.8
10,819.7
11,452.1
11,922.9
12,232.3
3,586.8
3,860.3
4,218.0
4,466.5
4,893.7
13,412.6
14,680.1
15,670.2
16,389.4
17,126.0
6.7
6.8
6.6
6.3
6.6
28.0
28.4
29.3
31.0
31.4
12.4
12.5
12.7
13.0
13.7
2005
2006
2007
2008
2009
856.3
906.0
941.4
975.2
1,003.3
1,574.0
1,776.3
1,739.7
1,892.2
1,983.0
2,430.3
2,682.3
2,681.2
2,867.4
2,986.3
13,000.8
13,541.2
14,361.9
15,681.3
16,309.1
5,098.4
5,902.5
5,915.1
6,611.5
6,662.4
18,099.2
19,443.8
20,277.0
22,292.8
22,971.5
6.6
6.7
6.6
6.2
6.2
30.9
30.1
29.4
28.6
29.8
13.4
13.8
13.2
12.9
13.0
2010f
f
2011
1,050.5
1,090.9
2,084.1
2,141.1
3,134.6
3,232.0
17,225.6
17,898.1
6,805.9
7,198.8
24,031.5
25,097.0
6.1
6.1
30.6
29.7
13.0
12.9
1985
1986
1987
1988
1989
--17.2
1.8
13.0
16.7
--1.9
20.3
10.8
11.2
--7.0
13.6
11.5
13.0
--7.5
6.3
8.9
11.7
--7.3
9.7
10.5
11.0
--7.5
7.2
9.3
11.5
1990
1991
1992
1993
1994
18.2
18.0
12.9
11.7
-0.6
10.5
9.0
8.9
11.1
8.2
13.1
12.2
10.4
11.3
4.8
13.8
10.7
8.6
6.0
5.4
12.0
8.7
6.1
5.9
4.4
13.3
10.2
7.9
6.0
5.1
1995
1996
1997
1998
1999
3.9
8.5
9.5
9.5
12.4
6.0
4.3
6.6
11.8
6.3
5.2
5.8
7.6
10.9
8.6
4.2
2.0
3.3
4.6
8.0
1.6
4.5
7.4
7.6
6.4
3.5
2.6
4.4
5.4
7.6
2000
2001
2002
2003
2004
14.7
10.9
2.9
0.0
6.4
8.2
9.0
12.9
12.0
11.0
10.7
9.7
8.9
7.4
9.4
9.5
10.1
5.8
4.1
2.6
8.4
7.6
9.3
5.9
9.6
9.2
9.4
6.7
4.6
4.5
2005
2006
2007
2008
2009
6.8
5.8
3.9
3.6
2.9
2.4
12.9
-2.1
8.8
4.8
3.9
10.4
0.0
6.9
4.1
6.3
4.2
6.1
9.2
4.0
4.2
15.8
0.2
11.8
0.8
5.7
7.4
4.3
9.9
3.0
2010 f
f
2011
4.7
3.8
5.1
2.7
5.0
3.1
5.6
3.9
2.2
5.8
4.6
4.4
B.C.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
33.1
36.2
32.5
32.9
34.0
66.9
63.8
67.5
67.1
66.0
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
35.5
37.3
38.2
38.3
36.4
64.5
62.7
61.8
61.7
63.6
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
35.9
36.8
37.5
37.0
38.3
64.1
63.2
62.5
63.0
61.7
100.0
100.0
100.0
100.0
100.0
2000
39.6
60.4
100.0
2001
2002
2003
2004
40.1
37.8
35.2
34.3
59.9
62.2
64.8
65.7
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009
35.2
33.8
35.1
34.0
33.6
64.8
66.2
64.9
66.0
66.4
100.0
100.0
100.0
100.0
100.0
2010f
f
2011
33.5
33.8
66.5
66.2
100.0
100.0
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
99
Drug Expenditure in Canada, 1985 to 2011
Table B B.C.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, British Columbia, 1985 to 2011
Provincial
Prescribed Drugs
Public
Private
Subtotal
Insurers*
Out of
Social Security Funds
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Federal
Year
B.C.
Subtotal
Private
Total
Prescribed
Drugs
OvertheCounter
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
Personal
Total
Health
Non-Presc.
Supplies
Drugs
1985
1986
1987
1988
1989
43.21
50.41
50.32
54.50
61.46
2.63
2.86
3.02
4.48
5.64
0.47
0.49
0.55
0.63
0.67
-----------
46.31
53.75
53.89
59.62
67.77
-----------
-----------
40.72
35.14
44.21
51.23
59.07
87.03
88.89
98.11
110.85
126.84
-----------
-----------
53.01
59.43
67.88
70.39
72.63
1990
1991
1992
1993
1994
70.67
81.63
89.90
96.98
92.34
6.46
7.22
7.65
9.01
9.75
0.74
0.79
0.90
0.97
1.08
-----------
77.87
89.64
98.45
106.96
103.18
-----------
-----------
65.87
71.48
77.29
84.97
87.94
143.74
161.12
175.73
191.93
191.11
----43.10
46.07
49.92
----38.83
40.93
42.69
75.56
78.90
81.93
87.01
92.60
1995
1996
1997
1998
1999
92.52
97.94
106.03
114.95
128.53
10.72
11.40
11.47
12.42
13.52
1.11
1.02
1.02
1.27
1.48
-----------
104.35
110.35
118.52
128.63
143.52
-----------
-----------
93.59
96.76
104.40
120.51
126.07
197.94
207.12
222.92
249.15
269.60
49.24
49.60
49.77
52.34
56.44
43.36
42.91
43.73
46.45
49.04
92.59
92.51
93.50
98.79
105.48
2000
2001
2002
2003
2004
147.40
161.60
162.87
158.27
166.60
14.41
16.09
18.47
21.19
22.02
1.69
1.81
1.74
1.83
2.14
-----------
163.50
179.50
183.07
181.29
190.76
-----------
-----------
141.14
157.17
184.53
212.11
240.15
304.64
336.66
367.60
393.40
430.91
58.34
60.09
62.57
66.96
70.31
49.42
51.39
53.53
54.26
55.10
107.76
111.48
116.10
121.22
125.41
2005
2006
2007
2008
2009
176.04
187.07
191.58
195.27
197.99
22.66
23.89
24.24
24.45
24.38
2.29
2.54
2.63
2.73
2.57
-----------
201.00
213.50
218.45
222.45
224.94
-----------
-----------
243.07
288.43
285.96
313.74
323.67
444.07
501.93
504.41
536.18
548.61
70.20
72.61
66.38
66.76
69.05
56.19
57.55
51.35
51.14
51.86
126.39
130.16
117.73
117.89
120.91
2010f
f
2011
204.76
209.53
24.03
24.09
3.05
3.26
-----
231.85
236.89
-----
-----
335.46
338.60
567.30
575.49
72.26
71.55
52.25
54.80
124.51
126.34
1985
1986
1987
1988
1989
--16.7
-0.2
8.3
12.8
--8.5
5.7
48.3
25.7
--3.7
13.7
14.1
6.2
-----------
--16.1
0.3
10.6
13.7
-----------
-----------
---13.7
25.8
15.9
15.3
--2.1
10.4
13.0
14.4
-----------
-----------
1990
1991
1992
1993
1994
15.0
15.5
10.1
7.9
-4.8
14.5
11.8
6.0
17.7
8.3
10.8
7.4
12.9
8.5
10.7
-----------
14.9
15.1
9.8
8.6
-3.5
-----------
-----------
11.5
8.5
8.1
9.9
3.5
13.3
12.1
9.1
9.2
-0.4
------6.9
8.3
------5.4
4.3
4.0
4.4
3.8
6.2
6.4
1995
1996
1997
1998
1999
0.2
5.9
8.3
8.4
11.8
9.9
6.4
0.6
8.2
8.9
2.8
-8.4
0.2
24.5
16.4
-----------
1.1
5.8
7.4
8.5
11.6
-----------
-----------
6.4
3.4
7.9
15.4
4.6
3.6
4.6
7.6
11.8
8.2
-1.4
0.7
0.3
5.2
7.8
1.6
-1.0
1.9
6.2
5.6
0.0
-0.1
1.1
5.7
6.8
2000
14.7
6.6
14.3
---
13.9
(Annual Percentage Change)
---
---
3.4
0.8
--12.1
14.2
3.7
3.2
11.9
13.0
2001
9.6
11.6
7.3
---
9.8
---
---
11.4
10.5
3.0
4.0
3.4
2002
0.8
14.8
-3.9
---
2.0
---
---
17.4
9.2
4.1
4.2
4.1
2.2
2003
-2.8
14.7
5.3
---
-1.0
---
---
14.9
7.0
7.0
1.3
4.4
2004
5.3
3.9
16.6
---
5.2
---
---
13.2
9.5
5.0
1.6
3.5
2005
2006
2007
2008
2009
5.7
6.3
2.4
1.9
1.4
2.9
5.4
1.5
0.9
-0.3
7.3
10.9
3.3
3.9
-5.9
-----------
5.4
6.2
2.3
1.8
1.1
-----------
-----------
1.2
18.7
-0.9
9.7
3.2
3.1
13.0
0.5
6.3
2.3
-0.2
3.4
-8.6
0.6
3.4
2.0
2.4
-10.8
-0.4
1.4
0.8
3.0
-9.6
0.1
2.6
2010f
f
2011
3.4
2.3
-1.4
0.3
18.9
6.8
-----
3.1
2.2
-----
-----
3.6
0.9
3.4
1.4
4.6
-1.0
0.7
4.9
3.0
1.5
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
100
1985
1986
1987
1988
1989
--13.9
-4.9
3.8
8.2
--5.7
1.0
43.8
21.2
--0.9
9.0
9.6
1.6
-----------
--13.3
-4.5
6.1
9.1
-----------
-----------
---16.5
21.1
11.4
10.7
---0.7
5.6
8.5
9.9
-----------
-----------
--9.3
9.5
-0.8
-1.4
1990
1991
1992
1993
1994
12.0
12.7
8.9
6.4
-5.9
11.5
9.0
4.8
16.3
7.2
7.8
4.6
11.6
7.0
9.6
-----------
11.9
12.4
8.6
7.2
-4.6
-----------
-----------
8.5
5.8
6.9
8.5
2.4
10.3
9.3
7.8
7.8
-1.5
------5.5
7.2
------4.0
3.2
1.0
1.7
2.6
4.8
5.3
1995
1996
1997
1998
1999
-2.1
4.2
7.3
8.8
10.0
7.6
4.7
-0.4
8.7
7.1
0.5
-10.1
-0.8
25.0
14.6
-----------
-1.2
4.1
6.4
9.0
9.8
-----------
-----------
4.1
1.7
6.9
15.9
2.8
1.2
3.0
6.6
12.2
6.4
-3.7
-0.9
-0.7
5.6
6.0
-0.8
-2.7
0.9
6.7
3.8
-2.3
-1.8
0.1
6.1
5.0
2000
10.6
2.5
10.2
---
9.8
---
---
7.8
8.9
-0.7
-3.3
-1.9
2001
2002
2003
2004
8.3
-0.3
-5.7
2.7
10.3
13.8
11.8
1.3
5.9
-4.9
2.4
14.0
---------
8.4
0.9
-3.9
2.6
---------
---------
10.0
16.4
12.1
10.6
9.2
8.1
4.1
6.9
1.6
3.1
4.1
2.4
2.6
3.1
-1.5
-1.0
2.1
3.1
1.5
0.9
2005
2006
2007
2008
2009
2.7
3.5
-1.3
-2.9
4.1
-0.1
2.6
-2.2
-4.0
2.4
4.3
8.1
-0.4
-0.9
-3.2
-----------
2.4
3.4
-1.4
-3.0
3.8
-----------
-----------
-1.8
15.9
-4.5
4.8
5.9
0.0
10.2
-3.2
1.4
5.0
-3.2
0.6
-12.3
-4.3
6.1
-1.0
-0.4
-14.4
-5.3
4.1
-2.2
0.2
-13.2
-4.7
5.3
2010f
0.5
-4.4
15.9
f
2011
-1.7
-3.7
2.8
f: forecast.
* Confidentiality precludes reporting provincial-level insurance data.
-----
0.1
-1.8
-----
-----
0.7
-3.1
0.5
-2.6
1.7
-5.0
-2.2
0.9
0.0
-2.5
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B B.C.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, British Columbia, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Year
Health Expenditure
Private
Public
GDP Implicit
Price Index—Canada
Total
(1997 = 100)
($ per Capita)
1985
1986
1987
1988
1989
46.31
53.75
53.89
59.62
67.77
93.73
94.57
112.09
121.62
131.70
140.04
148.32
165.99
181.24
199.47
1,146.76
1,220.62
1,277.43
1,361.65
1,481.22
412.58
438.48
473.72
512.66
554.42
1,559.34
1,659.09
1,751.15
1,874.31
2,035.64
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
77.87
89.64
98.45
106.96
103.18
141.42
150.38
159.22
171.97
180.54
219.29
240.03
257.66
278.93
283.72
1,638.00
1,769.05
1,867.85
1,925.89
1,969.18
603.48
640.15
660.58
680.33
689.18
2,241.49
2,409.20
2,528.43
2,606.22
2,658.36
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
104.35
110.35
118.52
128.63
143.52
186.18
189.28
197.90
219.30
231.55
290.53
299.63
316.42
347.94
375.08
1,996.01
1,984.56
2,011.53
2,084.94
2,236.02
681.57
694.17
731.75
780.76
825.22
2,677.58
2,678.72
2,743.29
2,865.71
3,061.24
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
163.50
179.50
183.07
181.29
190.76
248.90
268.64
300.63
333.33
365.57
412.40
448.14
483.70
514.61
556.32
2,432.62
2,652.91
2,782.74
2,869.28
2,909.81
887.99
946.52
1,024.93
1,074.87
1,164.12
3,320.61
3,599.43
3,807.68
3,944.15
4,073.93
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009
201.00
213.50
218.45
222.45
224.94
369.46
418.59
403.69
431.63
444.59
570.46
632.09
622.14
654.08
669.53
3,051.65
3,190.99
3,332.50
3,577.05
3,656.51
1,196.74
1,390.93
1,372.54
1,508.14
1,493.72
4,248.39
4,581.93
4,705.04
5,085.20
5,150.23
117.5
120.8
125.2
131.3
127.8
2010f
f
2011
231.85
236.89
459.97
464.95
691.82
701.83
3,801.76
3,886.60
1,502.08
1,563.24
5,303.84
5,449.84
131.5
136.8
1985
1986
1987
1988
1989
--16.1
0.3
10.6
13.7
--0.9
18.5
8.5
8.3
--5.9
11.9
9.2
10.1
--6.4
4.7
6.6
8.8
--6.3
8.0
8.2
8.1
--6.4
5.5
7.0
8.6
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
14.9
15.1
9.8
8.6
-3.5
7.4
6.3
5.9
8.0
5.0
9.9
9.5
7.3
8.3
1.7
10.6
8.0
5.6
3.1
2.2
8.8
6.1
3.2
3.0
1.3
10.1
7.5
4.9
3.1
2.0
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
1.1
5.8
7.4
8.5
11.6
3.1
1.7
4.6
10.8
5.6
2.4
3.1
5.6
10.0
7.8
1.4
-0.6
1.4
3.6
7.2
-1.1
1.8
5.4
6.7
5.7
0.7
0.0
2.4
4.5
6.8
2.3
1.7
1.0
-0.4
1.8
2000
13.9
B.C.
(Annual Percentage Change)
7.5
9.9
8.8
7.6
8.5
4.1
2001
9.8
7.9
8.7
9.1
6.6
8.4
1.4
2002
2.0
11.9
7.9
4.9
8.3
5.8
1.0
2003
-1.0
10.9
6.4
3.1
4.9
3.6
2.9
2004
5.2
9.7
8.1
1.4
8.3
3.3
2.6
2005
2006
2007
2008
2009
5.4
6.2
2.3
1.8
1.1
1.1
13.3
-3.6
6.9
3.0
2.5
10.8
-1.6
5.1
2.4
4.9
4.6
4.4
7.3
2.2
2.8
16.2
-1.3
9.9
-1.0
4.3
7.9
2.7
8.1
1.3
3.0
2.8
3.7
4.9
-2.7
2010 f
f
2011
3.1
2.2
3.5
1.1
3.3
1.4
4.0
2.2
0.6
4.1
3.0
2.8
2.9
4.0
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--13.3
-4.5
6.1
9.1
---1.9
13.8
4.0
3.7
--3.1
7.2
4.7
5.5
--3.6
-0.1
2.1
4.2
--3.5
3.3
3.7
3.6
--3.6
0.8
2.5
4.0
1990
1991
1992
1993
1994
11.9
12.4
8.6
7.2
-4.6
4.4
3.6
4.6
6.6
3.9
6.9
6.7
6.1
6.8
0.6
7.6
5.2
4.3
1.7
1.1
5.8
3.3
1.9
1.6
0.2
7.1
4.7
3.7
1.6
0.9
1995
1996
1997
1998
1999
-1.2
4.1
6.4
9.0
9.8
0.8
0.0
3.6
11.3
3.8
0.1
1.5
4.6
10.4
6.0
-1.0
-2.2
0.4
4.1
5.4
-3.4
0.2
4.4
7.1
3.9
-1.6
-1.6
1.4
4.9
5.0
2000
9.8
3.4
5.8
4.7
3.5
4.4
2001
2002
2003
2004
8.4
0.9
-3.9
2.6
6.6
10.9
8.0
7.1
7.3
6.9
3.5
5.5
7.7
3.8
0.2
-1.2
5.2
7.2
2.0
5.7
7.0
4.7
0.7
0.7
2005
2006
2007
2008
2009
2.4
3.4
-1.4
-3.0
3.8
-1.9
10.5
-7.2
2.1
5.7
-0.5
8.0
-5.3
0.3
5.1
1.9
1.8
0.8
2.5
4.9
-0.2
13.4
-5.0
5.0
1.8
1.3
5.1
-1.0
3.2
4.0
2010 f
f
2011
0.1
-1.8
0.5
-2.9
0.4
-2.5
1.0
-1.8
-2.4
0.1
0.0
-1.2
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
101
Drug Expenditure in Canada, 1985 to 2011
Table B Y.T.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Yukon, 1985 to 2011
Territorial
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out of
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Federal
Year
Y.T.
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter
Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
0.2
0.3
0.7
1.0
1.2
0.3
0.3
0.4
0.6
0.8
0.0
0.0
0.0
0.0
0.0
-----------
0.5
0.7
1.1
1.7
2.1
-----------
-----------
1.3
1.2
1.2
1.0
1.0
1.8
1.9
2.3
2.7
3.1
-----------
-----------
1.3
1.3
1.2
1.1
1.1
1990
1991
1992
1993
1994
1.3
1.6
2.0
2.3
2.1
1.0
1.2
1.3
1.5
1.7
0.0
0.0
0.0
0.0
0.0
-----------
2.3
2.8
3.4
3.8
3.8
-----------
-----------
1.0
1.2
1.2
2.3
1.6
3.3
4.0
4.5
6.1
5.4
----1.2
1.3
1.4
----1.1
1.1
1.1
1.0
1.3
2.3
2.4
2.4
1995
1996
1997
1998
1999
1.5
1.5
1.9
2.2
2.7
1.8
1.9
2.0
2.1
3.1
0.0
0.0
0.0
0.0
0.0
-----------
3.4
3.4
4.0
4.4
5.8
-----------
-----------
1.7
2.2
3.4
2.9
3.0
5.1
5.6
7.4
7.3
8.8
1.4
1.7
1.7
1.8
1.9
1.2
1.5
1.5
1.6
1.7
2.6
3.1
3.3
3.4
3.6
2000
2001
2002
2003
2004
3.3
3.9
4.5
5.1
5.9
3.0
3.0
3.5
3.8
3.8
0.1
0.1
0.1
0.1
0.1
-----------
6.4
7.0
8.1
9.0
9.8
-----------
-----------
3.2
3.6
3.9
4.8
4.9
9.6
10.5
12.1
13.8
14.7
1.9
2.0
2.0
2.2
2.4
2.1
2.1
2.1
1.9
2.0
3.9
4.0
4.1
4.1
4.3
2005
2006
2007
2008
2009
6.5
7.2
7.0
7.6
8.1
4.1
4.2
5.0
4.6
5.1
0.1
0.1
0.1
0.1
0.1
-----------
10.7
11.5
12.1
12.4
13.3
-----------
-----------
5.2
5.9
6.6
6.5
7.5
15.9
17.3
18.7
18.9
20.7
2.5
2.6
2.5
2.6
2.7
2.0
2.1
2.0
2.0
2.0
4.4
4.7
4.5
4.6
4.7
2010 f
f
2011
8.7
9.1
5.3
5.4
0.1
0.1
-----
14.1
14.6
-----
-----
8.2
9.1
22.3
23.7
2.7
2.5
2.1
2.1
4.8
4.6
1985
1986
1987
1988
1989
--53.7
126.4
41.8
15.4
--10.9
6.7
72.7
37.4
---18.3
32.5
32.5
-42.2
-----------
--27.7
65.5
51.6
23.0
-----------
-----------
---6.2
-2.6
-13.2
-0.3
--3.5
21.4
18.0
14.1
1990
1991
1992
1993
1994
5.9
26.2
23.5
13.2
-8.4
17.1
16.5
15.7
14.3
10.1
98.0
-54.9
303.9
-7.9
-5.0
-----------
10.8
21.5
21.0
13.5
-1.0
-----------
-----------
-6.5
25.0
-4.1
95.5
-29.3
1995
1996
1997
1998
1999
-26.3
-2.3
26.0
17.8
21.9
9.1
3.8
7.0
4.0
44.5
42.5
4.8
-2.3
-0.1
27.1
-----------
-10.1
1.1
15.2
10.5
32.9
-----------
-----------
2000
2001
2002
2003
2004
21.4
17.7
17.6
12.1
15.0
-0.9
0.4
14.9
10.0
-1.2
6.6
64.3
15.3
6.9
3.1
-----------
9.6
9.8
16.4
11.1
8.0
-----------
2005
2006
2007
2008
2009
11.1
10.2
-2.9
9.7
5.5
8.7
1.2
19.6
-7.2
9.7
-2.0
4.6
-2.9
42.9
-28.4
-----------
10.0
6.7
5.3
3.0
6.7
2010f
f
2011
7.8
4.4
4.2
1.9
-6.3
10.2
-----
6.3
3.5
1985
1986
1987
1988
1989
6.7
10.3
20.9
27.6
28.9
9.5
10.6
10.0
16.2
20.2
0.3
0.3
0.3
0.4
0.2
-----------
16.6
21.2
31.2
44.1
49.3
-----------
1990
1991
1992
1993
1994
30.0
30.7
29.4
26.7
26.5
23.1
21.9
19.6
18.0
21.5
0.4
0.1
0.4
0.3
0.3
-----------
53.5
52.7
49.4
45.1
48.3
1995
1996
1997
1998
1999
19.8
17.0
17.7
20.9
21.8
23.7
21.7
19.1
19.9
24.6
0.5
0.4
0.4
0.3
0.4
-----------
2000
24.3
22.4
0.4
2001
2002
2003
2004
26.5
28.0
28.5
30.9
20.8
21.6
21.5
20.0
0.6
0.6
0.6
0.6
2005
2006
2007
2008
2009
32.0
32.5
30.0
32.5
31.7
20.3
18.9
21.5
19.7
20.0
(Annual Percentage Change)
-----------
-----------
---5.0
-1.6
-12.6
0.2
5.1
22.5
13.4
34.5
-11.5
------6.7
4.3
------2.4
-0.1
-6.2
25.2
77.9
4.7
2.3
8.0
27.6
55.4
-15.7
4.8
-4.7
10.0
30.9
-1.6
21.7
2.1
19.9
3.3
3.3
7.5
13.0
20.2
3.9
4.6
4.7
7.0
20.0
3.6
3.9
6.2
-----------
6.0
10.7
10.8
20.7
3.0
8.3
10.1
14.5
14.2
6.3
-1.8
5.6
2.9
9.0
6.8
22.3
0.3
1.7
-10.4
4.3
9.5
2.8
2.3
-0.8
5.7
-----------
-----------
5.1
13.7
13.1
-2.7
15.8
8.4
9.0
7.9
1.0
9.8
3.4
6.7
-2.9
2.8
3.0
0.6
7.9
-5.8
1.9
-0.2
2.2
7.2
-4.2
2.4
1.6
-----
-----
10.3
10.2
7.8
6.0
2.2
-8.7
2.9
0.3
2.5
-4.8
-----------
41.3
38.8
33.6
27.2
24.6
57.8
59.9
64.9
71.4
73.9
-----------
-----------
42.2
40.1
35.1
28.6
26.1
-----------
-----------
22.6
22.9
17.0
26.7
20.5
76.1
75.7
66.5
71.8
68.8
----17.9
15.4
17.4
----15.6
12.8
13.9
23.9
24.3
33.5
28.2
31.2
43.9
39.1
37.2
41.1
46.7
-----------
-----------
22.3
25.1
32.3
27.2
24.4
66.2
64.3
69.4
68.3
71.1
17.9
18.9
16.2
16.7
15.4
15.9
16.8
14.4
15.1
13.5
33.8
35.7
30.6
31.7
28.9
---
47.1
---
---
23.8
70.9
13.9
15.2
29.1
---------
47.9
50.2
50.5
51.4
---------
---------
24.4
24.3
26.6
25.8
72.3
74.5
77.1
77.2
13.6
12.6
12.4
12.5
14.1
12.9
10.5
10.3
27.7
25.5
22.9
22.8
0.5
0.5
0.5
0.6
0.4
-----------
52.9
52.0
51.9
52.8
52.1
-----------
-----------
25.4
26.6
28.5
27.4
29.3
78.2
78.5
80.5
80.2
81.4
12.1
11.9
10.9
11.1
10.6
9.7
9.6
8.6
8.7
8.0
21.8
21.5
19.5
19.8
18.6
32.0
19.5
0.4
32.1
19.1
0.4
f: forecast.
* Confidentiality precludes reporting territorial-level insurance data.
-----
51.9
51.6
-----
-----
30.3
32.1
82.2
83.7
10.1
8.9
7.7
7.4
17.8
16.3
(Percentage Share of Total Drug Expenditure)
2010f
f
2011
102
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B Y.T.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Yukon, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Private
Total
Public
($ Millions)
Year
Total
(Percentage Share)
1985
1986
1987
1988
1989
0.5
0.7
1.1
1.7
2.1
2.6
2.5
2.4
2.1
2.1
3.2
3.2
3.5
3.8
4.2
32.9
37.0
39.1
40.6
44.2
6.8
5.6
5.6
5.2
5.3
39.7
42.6
44.7
45.8
49.5
1.6
1.8
2.8
4.1
4.7
38.9
44.4
43.3
40.8
40.3
8.0
7.4
7.9
8.3
8.5
1990
1991
1992
1993
1994
2.3
2.8
3.4
3.8
3.8
2.0
2.5
3.4
4.7
4.0
4.3
5.3
6.8
8.5
7.8
48.5
56.5
60.6
69.5
84.1
5.0
6.1
6.9
10.6
9.9
53.6
62.6
67.5
80.1
94.0
4.7
4.9
5.6
5.5
4.5
39.6
41.0
49.7
44.1
40.7
8.0
8.4
10.1
10.6
8.3
1995
1996
1997
1998
1999
3.4
3.4
4.0
4.4
5.8
4.3
5.3
6.7
6.3
6.6
7.7
8.8
10.6
10.6
12.4
85.2
92.0
86.0
87.8
92.4
10.5
18.2
17.3
16.3
16.9
95.8
110.2
103.3
104.1
109.2
4.0
3.7
4.6
5.0
6.3
41.2
29.3
38.7
38.4
39.2
8.1
8.0
10.3
10.2
11.4
2000
2001
2002
2003
2004
6.4
7.0
8.1
9.0
9.8
7.1
7.6
8.1
8.9
9.2
13.5
14.6
16.2
17.9
19.0
98.4
115.3
122.3
124.0
132.0
24.8
27.5
33.2
32.3
35.5
123.2
142.7
155.5
156.3
167.5
6.5
6.1
6.7
7.3
7.4
28.8
27.7
24.3
27.4
26.0
11.0
10.2
10.4
11.4
11.3
2005
2006
2007
2008
2009
10.7
11.5
12.1
12.4
13.3
9.6
10.6
11.2
11.1
12.2
20.3
22.1
23.2
23.5
25.4
151.1
177.5
179.1
191.0
222.1
36.6
39.4
51.9
50.3
56.0
187.6
216.9
231.0
241.3
278.1
7.1
6.5
6.7
6.5
6.0
26.2
26.9
21.5
22.1
21.8
10.8
10.2
10.1
9.8
9.1
2010f
f
2011
14.1
14.6
13.1
13.7
27.2
28.3
241.1
248.1
60.2
66.1
301.3
314.2
5.8
5.9
21.7
20.7
9.0
9.0
1985
1986
1987
1988
1989
--27.7
65.5
51.6
23.0
---5.6
-2.1
-12.9
-0.1
---0.1
12.2
7.3
10.1
--12.3
5.8
3.8
9.1
---17.3
0.4
-7.5
1.2
--7.2
5.1
2.3
8.2
1990
1991
1992
1993
1994
10.8
21.5
21.0
13.5
-1.0
-6.3
25.1
38.2
35.3
-13.1
2.1
23.2
29.1
24.5
-7.6
9.7
16.4
7.2
14.7
20.9
-4.8
20.9
14.1
52.5
-6.0
8.2
16.8
7.9
18.6
17.4
1995
1996
1997
1998
1999
-10.1
1.1
15.2
10.5
32.9
7.4
23.0
25.0
-6.1
5.5
-1.1
13.4
21.2
0.1
16.8
1.4
7.9
-6.5
2.0
5.2
6.1
73.0
-5.2
-5.4
3.3
1.9
15.1
-6.3
0.8
4.9
2000
2001
2002
2003
2004
9.6
9.8
16.4
11.1
8.0
7.9
6.4
6.3
9.7
4.2
8.7
8.0
11.1
10.4
6.1
6.5
17.1
6.1
1.4
6.4
46.7
10.9
20.8
-2.6
10.0
12.8
15.9
8.9
0.5
7.2
2005
2006
2007
2008
2009
10.0
6.7
5.3
3.0
6.7
3.7
10.7
5.4
-0.6
9.8
7.0
8.6
5.3
1.3
8.1
14.5
17.5
0.9
6.6
16.3
2.8
7.8
31.7
-3.1
11.4
12.0
15.6
6.5
4.4
15.3
2010f
f
2011
6.3
3.5
7.3
4.6
6.8
4.0
8.6
2.9
7.4
10.0
8.3
4.3
Y.T.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
16.6
21.2
31.2
44.1
49.3
83.4
78.8
68.8
55.9
50.7
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
53.5
52.7
49.4
45.1
48.3
46.5
47.3
50.6
54.9
51.7
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
43.9
39.1
37.2
41.1
46.7
56.1
60.9
62.8
58.9
53.3
100.0
100.0
100.0
100.0
100.0
2000
47.1
52.9
100.0
2001
2002
2003
2004
47.9
50.2
50.5
51.4
52.1
49.8
49.5
48.6
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009
52.9
52.0
51.9
52.8
52.1
47.1
48.0
48.1
47.2
47.9
100.0
100.0
100.0
100.0
100.0
2010f
f
2011
51.9
51.6
48.1
48.4
100.0
100.0
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
103
Drug Expenditure in Canada, 1985 to 2011
Table B Y.T.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Yukon, 1985 to 2011
Territorial
Prescribed Drugs
Public
Private
Subtotal
Insurers*
Out of
Social Security Funds
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Federal
Year
Y.T.
Subtotal
Private
Total
Prescribed
Drugs
OvertheCounter
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
Personal
Total
Health
Non-Presc.
Supplies
Drugs
1985
1986
1987
1988
1989
8.73
13.36
28.81
39.46
44.68
12.38
13.65
13.87
23.14
31.20
0.40
0.33
0.41
0.53
0.30
-----------
21.51
27.34
43.10
63.12
76.17
-----------
-----------
53.66
50.07
46.44
38.94
38.08
75.17
77.41
89.54
102.06
114.25
-----------
-----------
54.79
51.78
48.51
40.97
40.28
1990
1991
1992
1993
1994
46.19
56.02
66.44
74.64
69.86
35.65
39.91
44.31
50.24
56.56
0.58
0.25
0.97
0.88
0.86
-----------
82.41
96.18
111.72
125.76
127.27
-----------
-----------
34.77
41.78
38.47
74.59
53.92
117.18
137.95
150.19
200.35
181.20
----40.52
42.89
45.73
----35.28
35.83
36.58
36.89
44.38
75.80
78.72
82.32
1995
1996
1997
1998
1999
50.23
47.63
59.26
71.27
87.87
60.17
60.58
63.97
67.89
99.30
1.19
1.21
1.17
1.19
1.54
-----------
111.60
109.43
124.40
140.35
188.71
-----------
-----------
56.82
70.33
107.92
92.92
98.53
168.42
179.76
232.32
233.27
287.24
45.56
53.00
54.06
57.00
62.00
40.31
47.00
48.20
51.46
54.53
85.88
100.00
102.26
108.45
116.54
2000
2001
2002
2003
2004
107.91
128.25
150.84
166.67
189.79
99.59
100.91
115.93
125.70
122.99
1.66
2.75
3.17
3.34
3.41
-----------
209.16
231.91
269.94
295.72
316.19
-----------
-----------
105.64
118.12
130.84
155.61
158.79
314.79
350.03
400.78
451.33
474.98
61.61
65.69
67.55
72.57
76.78
67.49
68.33
69.46
61.37
63.36
129.10
134.02
137.01
133.94
140.14
2005
2006
2007
2008
2009
209.60
222.31
213.85
230.77
239.59
132.99
129.49
153.43
140.01
151.14
3.32
3.34
3.22
4.52
3.19
-----------
345.92
355.14
370.50
375.30
393.92
-----------
-----------
165.98
181.62
203.59
194.81
221.92
511.90
536.76
574.09
570.11
615.84
78.96
81.03
78.00
78.84
79.88
63.41
65.79
61.39
61.52
60.40
142.37
146.82
139.38
140.36
140.28
2010f
f
2011
251.83
259.87
153.53
154.62
2.91
3.17
-----
408.26
417.66
-----
-----
238.58
259.79
646.84
677.45
79.56
71.83
60.60
60.06
140.16
131.89
1985
1986
1987
1988
1989
--52.9
115.7
36.9
13.2
--10.3
1.6
66.8
34.8
---18.7
26.2
28.0
-43.3
-----------
--27.1
57.6
46.5
20.7
-----------
-----------
---6.7
-7.2
-16.2
-2.2
--3.0
15.7
14.0
12.0
-----------
-----------
1990
1991
1992
1993
1994
3.4
21.3
18.6
12.3
-6.4
14.3
11.9
11.0
13.4
12.6
93.3
-56.6
287.7
-8.6
-2.8
-----------
8.2
16.7
16.2
12.6
1.2
-----------
-----------
-8.7
20.1
-7.9
93.9
-27.7
2.6
17.7
8.9
33.4
-9.6
------5.8
6.6
------1.6
2.1
-8.4
20.3
70.8
3.9
4.6
1995
1996
1997
1998
1999
-28.1
-5.2
24.4
20.3
23.3
6.4
0.7
5.6
6.1
46.3
39.0
1.7
-3.5
2.0
28.6
-----------
-12.3
-1.9
13.7
12.8
34.5
-----------
-----------
5.4
23.8
53.5
-13.9
6.0
-7.1
6.7
29.2
0.4
23.1
-0.4
16.3
2.0
5.4
8.8
10.2
16.6
2.6
6.7
6.0
4.3
16.4
2.3
6.1
7.5
9.6
-0.6
23.8
10.8
(Annual Percentage Change)
0.3
7.8
---
10.8
---
---
7.2
---5.5
-6.3
-15.5
-1.7
2000
22.8
2001
18.9
1.3
65.9
---
10.9
---
---
11.8
11.2
6.6
1.2
3.8
2002
17.6
14.9
15.2
---
16.4
---
---
10.8
14.5
2.8
1.7
2.2
-2.2
2003
10.5
8.4
5.4
---
9.5
---
---
18.9
12.6
7.4
-11.6
2004
13.9
-2.2
2.1
---
6.9
---
---
2.0
5.2
5.8
3.2
4.6
2005
2006
2007
2008
2009
10.4
6.1
-3.8
7.9
3.8
8.1
-2.6
18.5
-8.7
8.0
-2.5
0.6
-3.7
40.5
-29.5
-----------
9.4
2.7
4.3
1.3
5.0
-----------
-----------
4.5
9.4
12.1
-4.3
13.9
7.8
4.9
7.0
-0.7
8.0
2.8
2.6
-3.7
1.1
1.3
0.1
3.8
-6.7
0.2
-1.8
1.6
3.1
-5.1
0.7
-0.1
2010f
f
2011
5.1
3.2
1.6
0.7
-8.7
8.9
-----
3.6
2.3
-----
-----
7.5
8.9
5.0
4.7
-0.4
-9.7
0.3
-0.9
-0.1
-5.9
-----------
-----------
---8.3
-11.1
-20.1
-6.2
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
104
1985
1986
1987
1988
1989
--50.1
110.9
32.4
8.7
--7.5
-3.2
62.3
30.3
---21.5
21.5
23.5
-47.9
-----------
--24.3
52.9
41.9
16.1
-----------
-----------
---9.5
-12.0
-20.7
-6.8
--0.2
10.9
9.5
7.4
1990
1991
1992
1993
1994
0.4
18.5
17.3
10.9
-7.5
11.2
9.2
9.8
11.9
11.5
90.3
-59.4
286.5
-10.1
-3.9
-----------
5.2
13.9
14.9
11.1
0.1
-----------
-----------
-11.7
17.4
-9.2
92.5
-28.8
-0.5
15.0
7.6
32.0
-10.7
------4.4
5.5
------0.1
1.0
-11.4
17.5
69.5
2.4
3.5
1995
1996
1997
1998
1999
-30.4
-6.9
23.4
20.7
21.5
4.1
-1.0
4.6
6.6
44.4
36.6
0.0
-4.5
2.4
26.8
-----------
-14.7
-3.6
12.7
13.3
32.6
-----------
-----------
3.0
22.1
52.5
-13.5
4.2
-9.4
5.1
28.2
0.8
21.3
-2.7
14.6
1.0
5.9
7.0
7.9
14.9
1.6
7.2
4.2
2.0
14.8
1.3
6.5
5.6
2000
18.7
-3.8
3.7
---
6.7
---
---
3.1
5.5
-4.7
19.7
6.7
2001
2002
2003
2004
17.5
16.6
7.6
11.3
0.0
13.8
5.5
-4.7
64.6
14.2
2.5
-0.5
---------
9.5
15.4
6.7
4.3
---------
---------
10.5
9.7
16.0
-0.6
9.8
13.5
9.7
2.7
5.3
1.8
4.5
3.2
-0.1
0.6
-14.5
0.6
2.5
1.2
-5.1
2.0
2005
2006
2007
2008
2009
7.4
3.3
-7.5
3.0
6.5
5.1
-5.4
14.8
-13.6
10.7
-5.6
-2.2
-7.4
35.6
-26.8
-----------
6.4
-0.1
0.6
-3.6
7.7
-----------
-----------
1.5
6.6
8.4
-9.2
16.6
4.8
2.1
3.3
-5.6
10.7
-0.2
-0.2
-7.4
-3.8
4.0
-2.9
1.0
-10.4
-4.7
0.9
-1.4
0.3
-8.7
-4.2
2.7
2010f
2.2
-1.4
-11.6
f
2011
-0.8
-3.3
4.9
f: forecast.
* Confidentiality precludes reporting territorial-level insurance data.
-----
0.7
-1.7
-----
-----
4.6
4.9
2.1
0.7
-3.3
-13.7
-2.6
-4.9
-3.0
-9.9
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B Y.T.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Yukon, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Year
Health Expenditure
Private
Public
GDP Implicit
Price Index—Canada
Total
(1997 = 100)
($ per Capita)
1985
1986
1987
1988
1989
21.51
27.34
43.10
63.12
76.17
108.45
101.85
94.95
79.90
78.36
129.96
129.19
138.05
143.03
154.53
1,351.18
1,510.29
1,521.49
1,524.93
1,632.10
278.89
229.51
219.52
196.03
194.61
1,630.07
1,739.80
1,741.02
1,720.95
1,826.71
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
82.41
96.18
111.72
125.76
127.27
71.66
86.16
114.27
153.32
136.24
154.07
182.33
225.99
279.07
263.51
1,747.95
1,954.71
2,011.98
2,290.11
2,831.14
180.81
210.04
230.03
347.90
334.47
1,928.76
2,164.74
2,242.01
2,638.01
3,165.61
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
111.60
109.43
124.40
140.35
188.71
142.69
170.33
210.18
201.37
215.07
254.29
279.76
334.58
341.73
403.77
2,799.51
2,930.96
2,705.48
2,818.35
3,000.99
346.09
580.94
543.38
524.56
548.37
3,145.60
3,511.90
3,248.86
3,342.91
3,549.36
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
209.16
231.91
269.94
295.72
316.19
234.73
252.14
267.85
289.56
298.92
443.89
484.05
537.79
585.28
615.12
3,234.92
3,826.04
4,058.32
4,055.76
4,274.60
813.89
911.33
1,100.78
1,056.96
1,151.06
4,048.81
4,737.37
5,159.10
5,112.71
5,425.66
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009
345.92
355.14
370.50
375.30
393.92
308.35
328.44
342.97
335.17
362.20
654.27
683.58
713.47
710.47
756.12
4,865.49
5,499.54
5,499.67
5,766.16
6,598.67
1,177.12
1,220.89
1,593.79
1,518.95
1,665.08
6,042.61
6,720.43
7,093.46
7,285.11
8,263.75
117.5
120.8
125.2
131.3
127.8
2010f
f
2011
408.26
417.66
378.74
391.68
787.00
809.34
6,984.49
7,101.88
1,742.29
1,893.76
8,726.79
8,995.64
131.5
136.8
1985
1986
1987
1988
1989
--27.1
57.6
46.5
20.7
---6.1
-6.8
-15.8
-1.9
---0.6
6.9
3.6
8.0
--11.8
0.7
0.2
7.0
---17.7
-4.4
-10.7
-0.7
--6.7
0.1
-1.2
6.1
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
8.2
16.7
16.2
12.6
1.2
-8.5
20.2
32.6
34.2
-11.1
-0.3
18.3
23.9
23.5
-5.6
7.1
11.8
2.9
13.8
23.6
-7.1
16.2
9.5
51.2
-3.9
5.6
12.2
3.6
17.7
20.0
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
-12.3
-1.9
13.7
12.8
34.5
4.7
19.4
23.4
-4.2
6.8
-3.5
10.0
19.6
2.1
18.2
-1.1
4.7
-7.7
4.2
6.5
3.5
67.9
-6.5
-3.5
4.5
-0.6
11.6
-7.5
2.9
6.2
2.3
1.7
1.0
-0.4
1.8
Y.T.
(Annual Percentage Change)
9.9
7.8
48.4
14.1
4.1
2001
10.9
7.4
9.0
18.3
12.0
17.0
1.4
2002
2000
16.4
10.8
6.2
9.1
11.1
6.1
20.8
8.9
1.0
2003
9.5
8.1
8.8
-0.1
-4.0
-0.9
2.9
2004
6.9
3.2
5.1
5.4
8.9
6.1
2.6
2005
2006
2007
2008
2009
9.4
2.7
4.3
1.3
5.0
3.2
6.5
4.4
-2.3
8.1
6.4
4.5
4.4
-0.4
6.4
13.8
13.0
0.0
4.8
14.4
2.3
3.7
30.5
-4.7
9.6
11.4
11.2
5.6
2.7
13.4
3.0
2.8
3.7
4.9
-2.7
2010f
f
2011
3.6
2.3
4.6
3.4
4.1
2.8
5.8
1.7
4.6
8.7
5.6
3.1
2.9
4.0
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--24.3
52.9
41.9
16.1
---8.9
-11.5
-20.4
-6.5
---3.4
2.1
-0.9
3.5
--9.0
-4.0
-4.3
2.5
---20.5
-9.1
-15.2
-5.3
--3.9
-4.7
-5.7
1.6
1990
1991
1992
1993
1994
5.2
13.9
14.9
11.1
0.1
-11.6
17.5
31.4
32.7
-12.2
-3.3
15.6
22.7
22.0
-6.7
4.1
9.1
1.7
12.4
22.5
-10.1
13.4
8.3
49.8
-5.0
2.6
9.5
2.3
16.2
18.9
1995
1996
1997
1998
1999
-14.7
-3.6
12.7
13.3
32.6
2.4
17.7
22.4
-3.8
5.0
-5.8
8.3
18.6
2.6
16.3
-3.5
3.0
-8.7
4.6
4.7
1.1
66.2
-7.5
-3.0
2.7
-3.0
10.0
-8.5
3.3
4.4
2000
6.7
5.0
5.8
3.7
44.3
10.0
2001
2002
2003
2004
9.5
15.4
6.7
4.3
6.1
5.2
5.2
0.6
7.7
10.1
5.9
2.5
16.9
5.0
-3.0
2.8
10.6
19.7
-6.9
6.3
15.7
7.9
-3.8
3.5
2005
2006
2007
2008
2009
6.4
-0.1
0.6
-3.6
7.7
0.1
3.7
0.7
-7.1
10.8
3.4
1.7
0.7
-5.3
9.1
10.8
10.2
-3.7
0.0
17.1
-0.7
0.9
26.9
-9.6
12.3
8.4
8.4
1.9
-2.2
16.1
2010f
f
2011
0.7
-1.7
1.6
-0.6
1.1
-1.2
2.9
-2.3
1.7
4.7
2.7
-0.9
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
105
Drug Expenditure in Canada, 1985 to 2011
Table B N.W.T.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Northwest Territories, 1985 to 2011
Territorial
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out of
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Federal
Year
N.W.T.
Subtotal
Private
Total
Prescribed
Drugs
1985
1986
1987
1988
1989
1.1
1.4
1.7
1.9
2.1
2.4
2.7
3.0
3.2
3.7
0.0
0.0
0.0
0.0
0.0
-----------
3.5
4.1
4.7
5.1
5.8
-----------
-----------
2.3
2.7
3.0
3.4
3.9
5.8
6.8
7.7
8.6
9.7
1990
1991
1992
1993
1994
2.4
3.0
3.6
2.5
1.2
4.3
4.9
5.7
6.4
7.1
0.0
0.0
0.0
0.0
0.1
-----------
6.6
7.9
9.3
8.9
8.3
-----------
-----------
3.9
5.0
4.9
4.7
3.5
1995
1996
1997
1998
1999
1.1
1.3
1.4
1.7
1.8
7.7
8.0
8.5
8.8
7.6
0.1
0.0
0.0
0.0
0.0
-----------
8.9
9.3
10.0
10.5
9.4
-----------
-----------
2000
2001
2002
2003
2004
1.9
2.2
2.4
3.2
3.6
7.6
8.8
10.7
9.0
8.1
0.0
0.0
0.0
0.0
0.1
-----------
9.5
11.0
13.1
12.3
11.8
-----------
2005
2006
2007
2008
2009
3.7
4.3
4.9
5.1
5.4
6.2
6.3
8.3
8.5
10.4
0.1
0.1
0.1
0.1
0.1
-----------
10.0
10.6
13.2
13.8
15.9
2010 f
f
2011
5.3
5.3
11.1
11.3
0.1
0.1
-----
16.5
16.6
1985
1986
1987
1988
1989
--30.3
22.0
12.6
7.6
--12.3
8.5
6.9
17.3
---5.7
6.9
67.7
-6.6
-----------
--17.7
13.1
9.2
13.5
-----------
1990
1991
1992
1993
1994
13.9
25.2
21.7
-31.8
-50.0
14.8
16.0
14.9
13.3
10.0
-0.9
13.9
1.0
27.0
32.1
-----------
14.4
19.2
17.4
-4.2
-6.5
1995
1996
1997
1998
1999
-8.1
15.1
9.9
16.1
9.8
9.1
3.3
6.5
3.3
-13.7
0.9
-15.9
-3.6
1.1
-14.2
-----------
2000
2001
2002
2003
2004
6.6
13.6
7.4
34.8
12.8
-0.1
16.2
21.8
-15.7
-9.6
0.1
22.9
4.0
1.7
56.6
2005
2006
2007
2008
2009
3.7
13.6
14.2
5.6
5.0
-24.4
2.4
31.2
3.2
21.9
2010f
f
2011
-1.1
-0.8
1985
1986
1987
1988
1989
Non-Prescribed Drugs
Private (Out of Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter
Supplies
Drugs
Drugs
-----------
-----------
4.1
4.4
4.7
5.1
5.4
10.6
12.9
14.2
13.6
11.8
----2.4
2.6
2.8
----2.1
2.2
2.3
5.1
6.0
4.5
4.7
5.1
3.8
3.5
4.4
4.5
3.3
12.6
12.8
14.4
15.0
12.7
2.9
2.7
3.1
3.2
2.3
2.5
2.4
2.8
2.9
2.1
5.4
5.1
5.9
6.2
4.4
-----------
3.4
3.6
4.0
5.3
5.4
13.0
14.7
17.2
17.5
17.2
2.3
2.2
2.3
2.2
2.2
1.4
1.4
1.5
1.5
1.4
3.7
3.6
3.7
3.7
3.5
-----------
-----------
7.0
7.9
8.6
8.4
8.9
17.0
18.5
21.8
22.2
24.8
2.0
1.9
2.5
2.5
2.8
1.4
1.4
1.9
1.9
2.1
3.4
3.3
4.4
4.4
4.9
-----
-----
9.0
9.3
25.4
25.9
2.9
2.8
2.2
2.3
5.0
5.1
-----------
--14.6
12.7
15.4
14.2
--16.5
12.9
11.6
13.8
-----------
-----------
0.2
25.8
-1.1
-4.2
-25.9
6.5
4.7
7.0
5.1
-10.0
-----------
-----------
-----------
1.2
15.7
18.9
-6.5
-3.5
-----------
-14.4
-2.7
13.3
16.1
9.2
-----------
-15.7
6.6
24.3
4.2
15.5
6.2
1.9
4.9
1.0
-----
3.7
1.0
10.9
12.6
13.9
14.2
13.7
24.5
24.3
23.9
23.2
24.4
0.2
0.1
0.1
0.2
0.2
-----------
35.6
37.1
38.0
37.6
38.3
-----------
1990
1991
1992
1993
1994
15.1
15.7
19.3
13.4
7.3
27.1
26.1
30.3
34.9
41.8
0.2
0.2
0.2
0.2
0.3
-----------
42.4
41.9
49.7
48.6
49.4
1995
1996
1997
1998
1999
6.3
7.3
7.1
7.9
10.7
42.7
44.5
41.8
41.4
44.2
0.3
0.2
0.2
0.2
0.2
-----------
2000
11.7
45.2
0.2
2001
2002
2003
2004
12.1
11.4
15.1
17.4
48.0
51.2
42.4
39.3
0.2
0.2
0.2
0.3
2005
2006
2007
2008
2009
18.4
19.5
18.5
19.3
18.1
30.2
28.9
31.5
32.1
35.0
(Annual Percentage Change)
-----------
-----------
--8.2
6.2
8.6
7.2
8.7
21.7
10.3
-4.2
-13.2
------7.3
9.0
------3.0
4.3
-6.0
17.8
-25.1
5.3
6.9
7.8
-6.7
27.0
1.7
-27.4
6.9
1.3
12.4
4.1
-15.2
1.5
-6.2
15.7
4.2
-27.8
12.3
-6.0
16.3
5.4
-29.6
6.3
-6.1
16.0
4.8
-28.7
-----------
5.1
5.8
11.0
30.7
1.7
2.2
13.1
16.9
2.2
-1.9
-0.9
-6.5
4.2
-2.3
-1.9
-32.0
2.7
3.0
1.4
-8.7
-15.5
-3.0
3.7
-0.8
-4.6
-----------
-----------
30.9
11.7
10.0
-2.8
6.3
-1.2
8.7
18.2
1.4
12.0
-7.8
-2.8
26.8
1.4
12.8
1.8
0.3
38.3
0.5
9.3
-4.1
-1.5
31.6
1.0
11.2
-----
-----
0.2
3.7
2.4
2.0
1.7
-2.5
2.4
6.5
2.0
1.4
-----------
23.4
23.7
24.2
25.3
25.9
59.0
60.7
62.2
62.8
64.2
-----------
-----------
41.0
39.3
37.8
37.2
35.8
-----------
-----------
25.1
26.2
26.2
25.6
20.6
67.5
68.2
75.9
74.1
70.0
----12.9
14.1
16.7
----11.2
11.8
13.3
32.5
31.8
24.1
25.9
30.0
49.3
52.1
49.1
49.5
55.1
-----------
-----------
20.8
19.6
21.9
21.4
19.2
70.1
71.6
71.0
70.9
74.3
15.9
15.0
15.3
15.3
13.7
14.0
13.3
13.7
13.8
12.0
29.9
28.4
29.0
29.1
25.7
---
57.1
---
---
20.6
77.8
13.9
8.4
22.2
---------
60.4
62.8
57.7
57.0
---------
---------
19.9
19.4
24.9
25.9
80.3
82.1
82.6
83.0
11.8
10.8
10.4
10.4
7.9
7.1
7.1
6.6
19.7
17.9
17.4
17.0
0.3
0.3
0.3
0.3
0.3
-----------
48.9
48.7
50.3
51.7
53.4
-----------
-----------
34.5
36.0
33.0
31.6
30.0
83.4
84.7
83.3
83.3
83.4
9.8
8.9
9.4
9.4
9.4
6.8
6.4
7.4
7.3
7.1
16.6
15.3
16.7
16.7
16.6
17.5
36.3
0.3
17.0
36.3
0.3
f: forecast.
* Confidentiality precludes reporting territorial-level insurance data.
-----
54.1
53.6
-----
-----
29.4
29.9
83.5
83.6
9.4
9.0
7.1
7.5
16.5
16.4
(Percentage Share of Total Drug Expenditure)
2010f
f
2011
106
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B N.W.T.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Northwest Territories, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Private
Total
Public
($ Millions)
Year
Total
(Percentage Share)
1985
1986
1987
1988
1989
3.5
4.1
4.7
5.1
5.8
6.4
7.0
7.7
8.5
9.4
9.9
11.2
12.3
13.6
15.2
118.9
145.2
157.4
183.9
203.6
19.6
21.7
23.9
27.3
29.3
138.5
166.9
181.3
211.2
232.9
3.0
2.9
3.0
2.8
2.9
32.4
32.5
32.1
31.2
31.9
7.1
6.7
6.8
6.5
6.5
1990
1991
1992
1993
1994
6.6
7.9
9.3
8.9
8.3
9.0
11.0
9.4
9.4
8.6
15.7
18.9
18.7
18.4
16.9
218.5
247.2
249.9
258.7
259.5
28.4
32.3
29.7
28.3
26.8
246.8
279.5
279.6
287.1
286.3
3.0
3.2
3.7
3.4
3.2
31.9
34.0
31.7
33.3
32.0
6.4
6.8
6.7
6.4
5.9
1995
1996
1997
1998
1999
8.9
9.3
10.0
10.5
9.4
9.1
8.6
10.3
10.7
7.7
18.0
17.9
20.3
21.1
17.1
270.3
250.9
262.6
283.8
201.9
24.7
26.7
26.4
26.0
21.1
295.0
277.7
289.0
309.8
223.1
3.3
3.7
3.8
3.7
4.7
37.0
32.0
39.1
41.0
36.3
6.1
6.4
7.0
6.8
7.7
2000
2001
2002
2003
2004
9.5
11.0
13.1
12.3
11.8
7.2
7.2
7.8
9.0
8.9
16.7
18.3
20.9
21.2
20.7
188.9
213.6
237.0
233.5
253.9
19.6
26.3
28.7
29.9
30.3
208.5
240.0
265.7
263.4
284.3
5.0
5.2
5.5
5.2
4.7
36.5
27.5
27.1
30.1
29.4
8.0
7.6
7.9
8.1
7.3
2005
2006
2007
2008
2009
10.0
10.6
13.2
13.8
15.9
10.4
11.2
13.0
12.8
13.9
20.4
21.8
26.2
26.6
29.8
268.4
286.1
316.3
344.9
364.3
50.4
58.2
68.9
62.1
67.5
318.8
344.3
385.2
407.0
431.8
3.7
3.7
4.2
4.0
4.4
20.7
19.2
18.9
20.7
20.5
6.4
6.3
6.8
6.5
6.9
2010f
f
2011
16.5
16.6
14.0
14.4
30.5
31.0
366.5
372.8
72.2
79.5
438.7
452.3
4.5
4.5
19.4
18.1
6.9
6.9
1985
1986
1987
1988
1989
--17.7
13.1
9.2
13.5
--10.5
8.7
11.3
10.0
--13.1
10.3
10.5
11.3
--22.2
8.4
16.8
10.7
--10.5
10.0
14.4
7.5
--20.5
8.6
16.5
10.3
1990
1991
1992
1993
1994
14.4
19.2
17.4
-4.2
-6.5
-3.4
21.3
-14.2
0.3
-9.4
3.4
20.4
-1.0
-1.9
-8.0
7.3
13.2
1.1
3.5
0.3
-3.3
13.7
-7.9
-4.7
-5.5
6.0
13.2
0.1
2.7
-0.3
1995
1996
1997
1998
1999
6.5
4.7
7.0
5.1
-10.0
6.9
-6.4
20.5
3.4
-28.1
6.7
-0.9
13.4
4.3
-19.2
4.1
-7.2
4.6
8.1
-28.9
-7.8
8.3
-1.4
-1.3
-18.8
3.0
-5.9
4.1
7.2
-28.0
2000
2001
2002
2003
2004
1.2
15.7
18.9
-6.5
-3.5
-6.7
1.2
7.4
15.6
-0.9
-2.3
9.5
14.3
1.7
-2.4
-6.5
13.1
10.9
-1.5
8.7
-7.0
34.1
9.0
4.1
1.4
-6.5
15.1
10.7
-0.9
7.9
2005
2006
2007
2008
2009
-15.7
6.6
24.3
4.2
15.5
17.0
7.4
16.4
-1.5
8.0
-1.7
7.0
20.2
1.4
11.9
5.7
6.6
10.6
9.0
5.6
66.2
15.4
18.5
-10.0
8.8
12.2
8.0
11.9
5.6
6.1
2010f
f
2011
3.7
1.0
0.9
2.9
2.4
1.9
0.6
1.7
6.9
10.2
1.6
3.1
N.W.T.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
35.6
37.1
38.0
37.6
38.3
64.4
62.9
62.0
62.4
61.7
100.0
100.0
100.0
100.0
100.0
1990
1991
1992
1993
1994
42.4
41.9
49.7
48.6
49.4
57.6
58.1
50.3
51.4
50.6
100.0
100.0
100.0
100.0
100.0
1995
1996
1997
1998
1999
49.3
52.1
49.1
49.5
55.1
50.7
47.9
50.9
50.5
44.9
100.0
100.0
100.0
100.0
100.0
2000
57.1
42.9
100.0
2001
2002
2003
2004
60.4
62.8
57.7
57.0
39.6
37.2
42.3
43.0
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009
48.9
48.7
50.3
51.7
53.4
51.1
51.3
49.7
48.3
46.6
100.0
100.0
100.0
100.0
100.0
2010f
f
2011
54.1
53.6
45.9
46.4
100.0
100.0
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
107
Drug Expenditure in Canada, 1985 to 2011
Table B N.W.T.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Northwest Territories, 1985 to 2011
Territorial
Prescribed Drugs
Public
Private
Subtotal
Insurers*
Out of
Social Security Funds
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Federal
Year
N.W.T.
Subtotal
Private
Total
Prescribed
Drugs
OvertheCounter
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
Personal
Total
Health
Non-Presc.
Supplies
Drugs
1985
1986
1987
1988
1989
19.87
25.75
31.22
34.75
36.51
44.58
49.79
53.68
56.71
64.93
0.30
0.29
0.30
0.50
0.46
-----------
64.76
75.83
85.21
91.96
101.90
-----------
-----------
42.52
48.45
54.27
61.91
69.02
107.28
124.28
139.47
153.87
170.93
-----------
-----------
74.63
80.32
84.79
91.01
95.30
1990
1991
1992
1993
1994
40.26
48.72
57.90
38.77
18.92
72.19
80.93
90.80
101.02
108.39
0.44
0.48
0.48
0.60
0.77
-----------
112.88
130.14
149.18
140.39
128.08
-----------
-----------
66.93
81.44
78.63
73.95
53.43
179.82
211.58
227.81
214.34
181.52
----38.63
40.71
43.27
----33.63
34.01
34.62
86.68
98.76
72.26
74.73
77.89
1995
1996
1997
1998
1999
17.01
19.28
21.15
24.75
44.90
115.69
117.78
125.16
130.34
185.89
0.76
0.63
0.60
0.62
0.87
-----------
133.46
137.69
146.92
155.70
231.66
-----------
-----------
56.36
51.79
65.59
67.25
80.64
189.82
189.48
212.51
222.95
312.30
43.00
39.74
45.87
48.16
57.48
38.04
35.24
40.90
43.48
50.56
81.04
74.98
86.77
91.64
108.04
2000
2001
2002
2003
2004
48.07
54.18
57.23
75.78
84.28
186.46
215.04
257.78
213.37
190.26
0.88
1.07
1.10
1.09
1.69
-----------
235.41
270.29
316.11
290.24
276.23
-----------
-----------
85.11
89.29
97.51
125.19
125.54
320.51
359.58
413.62
415.44
401.76
57.16
53.05
54.38
52.20
50.49
34.51
35.15
35.62
35.49
31.97
91.67
88.20
90.01
87.70
82.47
2005
2006
2007
2008
2009
87.63
98.49
111.54
117.42
123.31
144.25
146.08
190.07
195.53
238.42
1.45
1.39
1.57
1.81
1.98
-----------
233.33
245.96
303.18
314.77
363.71
-----------
-----------
164.70
181.98
198.54
192.36
204.68
398.02
427.94
501.71
507.12
568.39
46.65
44.84
56.41
56.98
64.29
32.61
32.35
44.40
44.46
48.61
79.27
77.19
100.81
101.44
112.90
2010f
f
2011
121.67
119.57
252.61
255.07
2.07
2.08
-----
376.36
376.72
-----
-----
204.76
210.40
581.12
587.12
65.24
63.00
49.69
52.46
114.93
115.46
1985
1986
1987
1988
1989
--29.6
21.2
11.3
5.1
--11.7
7.8
5.6
14.5
---6.3
6.3
65.8
-8.8
-----------
--17.1
12.4
7.9
10.8
-----------
-----------
--14.0
12.0
14.1
11.5
--15.8
12.2
10.3
11.1
-----------
-----------
1990
1991
1992
1993
1994
10.3
21.0
18.8
-33.0
-51.2
11.2
12.1
12.2
11.3
7.3
-4.0
10.2
-1.4
24.8
28.8
-----------
10.8
15.3
14.6
-5.9
-8.8
-----------
-----------
-3.0
21.7
-3.4
-6.0
-27.7
5.2
17.7
7.7
-5.9
-15.3
------5.4
6.3
------1.1
1.8
-9.1
13.9
-26.8
3.4
4.2
1995
1996
1997
1998
1999
-10.1
13.4
9.7
17.0
81.4
6.7
1.8
6.3
4.1
42.6
-1.3
-17.1
-3.8
1.9
41.8
-----------
4.2
3.2
6.7
6.0
48.8
-----------
-----------
5.5
-8.1
26.7
2.5
19.9
4.6
-0.2
12.2
4.9
40.1
-0.6
-7.6
15.4
5.0
19.3
9.9
-7.4
16.1
6.3
16.3
4.0
-7.5
15.7
5.6
17.9
(Annual Percentage Change)
--7.6
5.6
7.3
4.7
2000
7.1
0.3
0.5
---
1.6
---
---
5.5
2.6
-0.6
-31.7
-15.2
2001
12.7
15.3
22.0
---
14.8
---
---
4.9
12.2
-7.2
1.9
-3.8
2002
5.6
19.9
2.3
---
17.0
---
---
9.2
15.0
2.5
1.3
2003
32.4
-17.2
-0.1
---
-8.2
---
---
28.4
0.4
-4.0
-0.4
-2.6
2004
11.2
-10.8
54.5
---
-4.8
---
---
0.3
-3.3
-3.3
-9.9
-6.0
2005
2006
2007
2008
2009
4.0
12.4
13.3
5.3
5.0
-24.2
1.3
30.1
2.9
21.9
-14.3
-3.8
12.4
15.7
9.2
-----------
-15.5
5.4
23.3
3.8
15.5
-----------
-----------
31.2
10.5
9.1
-3.1
6.4
-0.9
7.5
17.2
1.1
12.1
-7.6
-3.9
25.8
1.0
12.8
2.0
-0.8
37.2
0.1
9.3
-3.9
-2.6
30.6
0.6
11.3
2010f
f
2011
-1.3
-1.7
6.0
1.0
4.7
0.1
-----
3.5
0.1
-----
-----
0.0
2.8
2.2
1.0
1.5
-3.4
2.2
5.6
1.8
0.5
2.0
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
108
1985
1986
1987
1988
1989
--26.8
16.5
6.8
0.5
--8.9
3.1
1.1
9.9
---9.1
1.5
61.2
-13.4
-----------
--14.3
7.6
3.4
6.2
-----------
-----------
--11.2
7.3
9.6
6.9
--13.0
7.5
5.8
6.5
-----------
-----------
1990
1991
1992
1993
1994
7.2
18.3
17.6
-34.5
-52.3
8.1
9.4
10.9
9.8
6.2
-7.1
7.4
-2.6
23.3
27.7
-----------
7.7
12.5
13.4
-7.3
-9.9
-----------
-----------
-6.1
18.9
-4.7
-7.4
-28.8
1995
1996
1997
1998
1999
-12.4
11.7
8.7
17.5
79.6
4.4
0.1
5.3
4.6
40.8
-3.6
-18.8
-4.8
2.3
40.0
-----------
1.9
1.5
5.7
6.4
47.0
-----------
-----------
3.1
-9.8
25.7
3.0
18.1
--4.8
0.8
2.8
0.1
2.2
14.9
6.4
-7.4
-16.4
------4.0
5.2
-------0.3
0.7
-12.1
11.2
-28.1
2.0
3.1
2.2
-1.9
11.2
5.4
38.3
-3.0
-9.3
14.4
5.4
17.5
7.6
-9.0
15.1
6.7
14.5
1.7
-9.1
14.7
6.1
16.1
2000
3.0
-3.8
-3.6
---
-2.5
---
---
1.4
-1.5
-4.7
-35.8
-19.3
2001
2002
2003
2004
11.4
4.6
29.5
8.6
14.0
18.8
-20.1
-13.4
20.6
1.2
-3.0
51.9
---------
13.5
15.9
-11.1
-7.4
---------
---------
3.6
8.2
25.5
-2.3
10.8
14.0
-2.5
-5.9
-8.5
1.5
-6.9
-5.9
0.5
0.3
-3.3
-12.5
-5.1
1.0
-5.5
-8.6
2005
2006
2007
2008
2009
1.0
9.6
9.6
0.4
7.7
-27.2
-1.5
26.4
-2.0
24.6
-17.3
-6.6
8.7
10.8
12.0
-----------
-18.5
2.6
19.6
-1.0
18.3
-----------
-----------
28.2
7.7
5.4
-8.0
9.1
-3.9
4.7
13.6
-3.8
14.8
-10.6
-6.7
22.1
-3.9
15.5
-1.0
-3.6
33.5
-4.7
12.0
-6.9
-5.4
26.9
-4.2
14.0
2010f
-4.3
3.0
1.7
f
2011
-5.7
-3.0
-3.9
f: forecast.
* Confidentiality precludes reporting territorial-level insurance data.
-----
0.5
-3.9
-----
-----
-2.9
-1.2
-0.7
-3.0
-1.5
-7.4
-0.7
1.6
-1.1
-3.5
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B N.W.T.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Northwest Territories, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Year
Health Expenditure
Private
Public
GDP Implicit
Price Index—Canada
Total
(1997 = 100)
($ per Capita)
1985
1986
1987
1988
1989
64.76
75.83
85.21
91.96
101.90
117.15
128.77
139.05
152.93
164.33
181.91
204.59
224.26
244.89
266.23
2,185.68
2,655.45
2,859.77
3,302.40
3,570.18
361.05
396.69
433.59
490.09
514.33
2,546.73
3,052.14
3,293.37
3,792.49
4,084.51
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
112.88
130.14
149.18
140.39
128.08
153.61
180.20
150.89
148.68
131.32
266.49
310.34
300.07
289.07
259.40
3,708.35
4,057.16
4,004.30
4,071.51
3,983.42
481.64
529.44
476.22
445.89
410.95
4,190.00
4,586.61
4,480.52
4,517.40
4,394.37
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
133.46
137.69
146.92
155.70
231.66
137.40
126.77
152.36
158.89
188.69
270.86
264.46
299.28
314.60
420.34
4,060.01
3,713.59
3,876.75
4,224.30
4,967.41
370.96
395.82
389.36
387.25
519.57
4,430.96
4,109.41
4,266.11
4,611.55
5,486.97
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
235.41
270.29
316.11
290.24
276.23
176.78
177.49
187.52
212.89
208.00
412.19
447.78
503.63
503.13
484.23
4,664.19
5,232.80
5,711.56
5,529.05
5,929.69
484.88
645.24
692.07
708.13
708.29
5,149.06
5,878.03
6,403.63
6,237.18
6,637.98
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009
233.33
245.96
303.18
314.77
363.71
243.96
259.17
299.34
293.80
317.58
477.29
505.13
602.52
608.57
681.29
6,282.52
6,623.07
7,264.10
7,893.52
8,340.98
1,179.97
1,346.79
1,582.85
1,420.18
1,545.93
7,462.49
7,969.85
8,846.95
9,313.70
9,886.91
117.5
120.8
125.2
131.3
127.8
2010f
f
2011
376.36
376.72
319.70
325.86
696.05
702.58
8,375.71
8,441.38
1,649.11
1,800.89
10,024.82
10,242.28
131.5
136.8
1985
1986
1987
1988
1989
--17.1
12.4
7.9
10.8
--9.9
8.0
10.0
7.5
--12.5
9.6
9.2
8.7
--21.5
7.7
15.5
8.1
--9.9
9.3
13.0
4.9
--19.8
7.9
15.2
7.7
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
10.8
15.3
14.6
-5.9
-8.8
-6.5
17.3
-16.3
-1.5
-11.7
0.1
16.5
-3.3
-3.7
-10.3
3.9
9.4
-1.3
1.7
-2.2
-6.4
9.9
-10.1
-6.4
-7.8
2.6
9.5
-2.3
0.8
-2.7
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
4.2
3.2
6.7
6.0
48.8
4.6
-7.7
20.2
4.3
18.8
4.4
-2.4
13.2
5.1
33.6
1.9
-8.5
4.4
9.0
17.6
-9.7
6.7
-1.6
-0.5
34.2
0.8
-7.3
3.8
8.1
19.0
2.3
1.7
1.0
-0.4
1.8
1.6
-6.3
N.W.T.
(Annual Percentage Change)
-1.9
-6.1
-6.7
-6.2
4.1
2001
14.8
0.4
8.6
12.2
33.1
14.2
1.4
2002
2000
17.0
5.6
12.5
9.1
7.3
8.9
1.0
2003
-8.2
13.5
-0.1
-3.2
2.3
-2.6
2.9
2004
-4.8
-2.3
-3.8
7.2
0.0
6.4
2.6
2005
2006
2007
2008
2009
-15.5
5.4
23.3
3.8
15.5
17.3
6.2
15.5
-1.9
8.1
-1.4
5.8
19.3
1.0
11.9
6.0
5.4
9.7
8.7
5.7
66.6
14.1
17.5
-10.3
8.9
12.4
6.8
11.0
5.3
6.2
3.0
2.8
3.7
4.9
-2.7
2010f
f
2011
3.5
0.1
0.7
1.9
2.2
0.9
0.4
0.8
6.7
9.2
1.4
2.2
2.9
4.0
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
--14.3
7.6
3.4
6.2
--7.1
3.2
5.5
2.9
--9.7
4.9
4.7
4.2
--18.7
3.0
11.0
3.5
--7.1
4.6
8.5
0.4
--17.0
3.2
10.6
3.1
1990
1991
1992
1993
1994
7.7
12.5
13.4
-7.3
-9.9
-9.5
14.5
-17.5
-2.9
-12.8
-2.9
13.7
-4.6
-5.1
-11.4
0.8
6.6
-2.6
0.2
-3.3
-9.4
7.2
-11.3
-7.8
-8.9
-0.4
6.7
-3.6
-0.6
-3.8
1995
1996
1997
1998
1999
1.9
1.5
5.7
6.4
47.0
2.3
-9.4
19.2
4.7
16.9
2.1
-4.0
12.2
5.6
31.8
-0.4
-10.2
3.4
9.4
15.8
-12.1
5.0
-2.6
-0.1
32.4
-1.5
-8.9
2.8
8.5
17.2
2000
-2.5
-10.4
-6.0
-10.2
-10.8
-10.3
2001
2002
2003
2004
13.5
15.9
-11.1
-7.4
-0.9
4.6
10.6
-4.9
7.3
11.4
-3.0
-6.3
10.8
8.1
-6.1
4.7
31.7
6.2
-0.6
-2.6
12.8
7.9
-5.5
3.8
2005
2006
2007
2008
2009
-18.5
2.6
19.6
-1.0
18.3
14.3
3.4
11.8
-6.7
10.8
-4.4
3.0
15.6
-3.9
14.7
2.9
2.6
6.0
3.8
8.4
63.6
11.3
13.8
-15.1
11.6
9.4
4.0
7.3
0.4
8.9
2010f
f
2011
0.5
-3.9
-2.3
-2.1
-0.8
-3.1
-2.5
-3.2
3.7
5.2
-1.5
-1.8
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
109
Drug Expenditure in Canada, 1985 to 2011
Table B Nun.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Nunavut, 1985 to 2011
Territorial
Prescribed Drugs
Public
Private
Social Security Funds
Subtotal
Insurers*
Out of
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ Millions)
Federal
Year
Nun.
Subtotal
Private
Total
Prescribed
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
OverPersonal
Total
theHealth
Non-Presc.
Counter
Supplies
Drugs
Drugs
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1995
1996
1997
1998
1999
--------1.0
--------0.0
--------0.0
-----------
--------1.1
-----------
-----------
--------1.3
--------2.4
--------1.5
--------1.3
--------2.9
2000
2001
2002
2003
2004
1.2
1.2
1.5
2.1
2.2
0.2
0.4
0.8
4.1
5.1
0.0
0.0
0.0
0.0
0.1
-----------
1.4
1.7
2.4
6.3
7.4
-----------
-----------
1.5
1.5
2.1
3.3
4.1
2.8
3.2
4.5
9.6
11.5
1.6
1.5
1.6
1.5
1.5
0.9
1.0
1.0
1.0
0.9
2.5
2.5
2.6
2.6
2.4
2005
2006
2007
2008
2009
2.4
2.8
2.9
2.1
2.5
7.7
8.9
7.7
8.8
8.6
0.0
0.0
0.0
0.1
0.1
-----------
10.2
11.7
10.7
11.0
11.2
-----------
-----------
3.7
4.3
5.1
4.9
6.1
14.0
16.1
15.8
15.9
17.4
1.4
1.4
1.8
1.8
2.1
1.0
1.0
1.4
1.4
1.6
2.4
2.5
3.2
3.2
3.7
2010f
f
2011
2.7
2.7
8.4
8.5
0.1
0.1
-----
11.1
11.3
-----
-----
6.9
8.0
18.0
19.3
2.1
1.9
1.6
1.5
3.7
3.4
(Annual Percentage Change)
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1995
1996
1997
1998
1999
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
2000
2001
2002
2003
2004
21.7
3.7
23.4
36.7
6.3
290.0
174.4
88.4
421.2
22.9
3.1
24.7
4.5
1.4
56.9
-----------
31.3
23.1
39.2
165.5
17.5
-----------
-----------
9.4
4.7
36.1
56.6
25.1
19.1
13.6
37.7
114.5
20.1
1.1
-4.8
6.0
-2.7
-1.6
-30.6
4.5
4.7
1.0
-8.4
-13.7
-1.3
5.5
-1.3
-4.4
2005
2006
2007
2008
2009
8.6
17.2
3.3
-27.0
18.1
52.0
14.3
-13.3
14.9
-2.4
-13.1
-1.2
14.1
16.9
11.3
-----------
38.4
14.9
-9.2
3.4
1.7
-----------
-----------
-8.5
15.4
19.1
-4.6
25.2
21.7
15.0
-1.6
0.8
8.9
-7.1
2.4
23.9
2.1
15.5
2.6
5.7
35.1
1.2
11.9
-3.4
3.8
28.6
1.7
13.9
2010f
f
2011
6.2
0.2
-3.0
1.9
8.0
0.0
-----
-0.8
1.5
-----
-----
11.5
16.3
3.6
7.1
2.1
-10.7
2.9
-10.1
2.5
-10.4
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1995
1996
1997
1998
1999
--------18.8
--------0.7
--------0.4
-----------
--------19.9
-----------
-----------
--------25.4
--------45.3
--------29.1
--------25.6
--------54.7
2000
22.6
2.9
0.5
---
25.9
---
---
27.4
53.3
29.1
17.6
46.7
2001
2002
2003
2004
21.9
21.9
17.4
16.1
7.4
11.3
34.2
36.6
0.5
0.4
0.3
0.4
---------
29.9
33.6
51.9
53.1
---------
---------
26.9
29.6
27.0
29.4
56.8
63.2
78.9
82.4
26.0
22.2
12.6
10.8
17.2
14.6
8.5
6.8
43.2
36.8
21.1
17.6
2005
2006
2007
2008
2009
14.9
15.4
15.5
11.2
12.1
47.5
47.8
40.5
46.1
41.0
0.3
0.2
0.3
0.3
0.3
-----------
62.6
63.4
56.3
57.6
53.4
-----------
-----------
22.9
23.3
27.1
25.6
29.2
85.5
86.8
83.4
83.2
82.6
8.5
7.7
9.3
9.4
9.9
6.0
5.5
7.3
7.3
7.5
14.5
13.2
16.6
16.8
17.4
12.4
38.5
0.3
11.9
37.7
0.3
f: forecast.
* Confidentiality precludes reporting territorial-level insurance data.
-----
51.2
49.9
-----
-----
31.6
35.3
82.8
85.2
9.8
8.4
7.5
6.4
17.2
14.8
2010f
f
2011
110
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B Nun.—Total
Expenditure on Drugs by Type, by Source of Finance and as a Share of Public, Private and
Total Health Expenditures, Nunavut, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Health Expenditure
Private
Public
Share of Drugs in Public, Private and
Total Health Expenditures
Private
Total
Public
($ Millions)
Year
Total
(Percentage Share)
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1995
1996
1997
1998
1999
--------1.1
--------4.2
--------5.3
--------133.6
--------9.1
--------142.6
--------0.8
--------46.5
--------3.7
2000
2001
2002
2003
2004
1.4
1.7
2.4
6.3
7.4
4.0
4.0
4.7
5.8
6.5
5.3
5.7
7.0
12.1
13.9
159.2
173.7
203.8
279.4
294.1
9.3
10.6
11.2
13.3
13.9
168.5
184.3
215.0
292.7
308.0
0.9
1.0
1.2
2.2
2.5
42.5
37.5
41.9
43.8
47.0
3.2
3.1
3.3
4.1
4.5
2005
2006
2007
2008
2009
10.2
11.7
10.7
11.0
11.2
6.1
6.8
8.3
8.1
9.8
16.3
18.5
19.0
19.1
21.0
288.0
317.8
333.1
346.6
339.9
16.7
17.6
21.0
21.0
24.8
304.6
335.4
354.1
367.6
364.7
3.6
3.7
3.2
3.2
3.3
36.6
38.4
39.6
38.6
39.5
5.4
5.5
5.4
5.2
5.8
2010f
f
2011
11.1
11.3
10.6
11.3
21.7
22.6
341.3
373.7
25.8
27.4
367.1
401.1
3.3
3.0
41.1
41.3
5.9
5.6
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
1995
1996
1997
1998
1999
-----------
-----------
-----------
-----------
-----------
-----------
2000
2001
2002
2003
2004
31.3
23.1
39.2
165.5
17.5
-6.4
0.9
17.2
24.6
12.1
1.1
6.6
23.8
71.9
14.9
19.2
9.1
17.4
37.1
5.3
2.5
14.4
4.9
19.1
4.5
18.1
9.4
16.6
36.1
5.3
2005
2006
2007
2008
2009
38.4
14.9
-9.2
3.4
1.7
-6.6
10.9
22.5
-2.2
20.7
17.3
13.4
2.4
0.9
9.8
-2.1
10.3
4.8
4.0
-1.9
20.0
5.7
18.9
0.3
18.0
-1.1
10.1
5.6
3.8
-0.8
2010f
f
2011
-0.8
1.5
8.2
6.9
3.4
4.1
0.4
9.5
3.8
6.4
0.7
9.3
Nun.
(Annual Percentage Change)
(Percentage Share of Total Drug Expenditure)
1985
1986
1987
1988
1989
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
1995
1996
1997
1998
1999
--------19.9
--------80.1
--------100.0
2000
25.9
74.1
100.0
2001
2002
2003
2004
29.9
33.6
51.9
53.1
70.1
66.4
48.1
46.9
100.0
100.0
100.0
100.0
2005
2006
2007
2008
2009
62.6
63.4
56.3
57.6
53.4
37.4
36.6
43.7
42.4
46.6
100.0
100.0
100.0
100.0
100.0
2010f
f
2011
51.2
49.9
48.8
50.1
100.0
100.0
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
111
Drug Expenditure in Canada, 1985 to 2011
Table B Nun.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Nunavut, 1985 to 2011
Territorial
Prescribed Drugs
Public
Private
Subtotal
Insurers*
Out of
Social Security Funds
WCBs
Drug Insurance
Public
Pocket
Funds
(Premium Component)
($ per Capita)
Federal
Year
Nun.
Subtotal
Private
Total
Prescribed
Drugs
OvertheCounter
Drugs
Non-Prescribed Drugs
Private (Out of Pocket)
Personal
Total
Health
Non-Presc.
Supplies
Drugs
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1995
1996
1997
1998
1999
--------36.87
--------1.47
--------0.87
-----------
--------39.22
-----------
-----------
--------49.87
--------89.09
--------57.22
--------50.33
--------107.55
2000
2001
2002
2003
2004
43.76
44.37
53.59
72.19
75.53
5.60
15.02
27.68
142.15
172.02
0.88
1.07
1.10
1.09
1.69
-----------
50.24
60.46
82.36
215.44
249.24
-----------
-----------
53.24
54.52
72.60
112.06
137.95
103.47
114.97
154.96
327.50
387.20
56.42
52.52
54.45
52.19
50.53
34.07
34.80
35.67
35.49
32.00
90.49
87.32
90.12
87.68
82.53
2005
2006
2007
2008
2009
80.98
92.52
94.11
67.98
78.81
258.19
287.53
245.41
279.16
267.41
1.45
1.39
1.57
1.81
1.98
-----------
340.62
381.44
341.09
348.95
348.20
-----------
-----------
124.68
140.20
164.43
155.30
190.79
465.30
521.65
505.51
504.25
538.99
46.34
46.24
56.41
57.01
64.61
32.40
33.37
44.40
44.48
48.85
78.74
79.61
100.81
101.48
113.46
2010f
f
2011
81.10
80.29
251.48
253.13
2.07
2.05
-----
334.66
335.48
-----
-----
206.25
237.03
540.90
572.50
63.96
56.42
48.72
43.26
112.68
99.69
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1995
1996
1997
1998
1999
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
2000
(Annual Percentage Change)
18.7
280.4
0.5
---
28.1
---
---
6.7
16.1
-1.4
-32.3
-15.9
2001
1.4
168.4
22.0
---
20.3
---
---
2.4
11.1
-6.9
2.2
-3.5
2002
20.8
84.3
2.3
---
36.2
---
---
33.2
34.8
3.7
2.5
3.2
2003
34.7
413.6
-0.1
---
161.6
---
---
54.4
111.3
-4.1
-0.5
-2.7
2004
4.6
21.0
54.5
---
15.7
---
---
23.1
18.2
-3.2
-9.8
-5.9
2005
2006
2007
2008
2009
7.2
14.2
1.7
-27.8
15.9
50.1
11.4
-14.6
13.8
-4.2
-14.3
-3.8
12.4
15.7
9.2
-----------
36.7
12.0
-10.6
2.3
-0.2
-----------
-----------
-9.6
12.5
17.3
-5.6
22.9
20.2
12.1
-3.1
-0.2
6.9
-8.3
-0.2
22.0
1.1
13.3
1.2
3.0
33.1
0.2
9.8
-4.6
1.1
26.6
0.7
11.8
2010f
f
2011
2.9
-1.0
-6.0
0.7
4.7
-1.2
-----
-3.9
0.2
-----
-----
8.1
14.9
0.4
5.8
-1.0
-11.8
-0.3
-11.2
-0.7
-11.5
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
112
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
1995
1996
1997
1998
1999
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
-----------
2000
14.6
276.3
-3.6
---
24.0
---
---
2.6
12.0
-5.5
-36.4
-20.0
2001
2002
2003
2004
0.0
19.7
31.8
2.0
167.0
83.3
410.7
18.4
20.6
1.2
-3.0
51.9
---------
19.0
35.2
158.7
13.1
---------
---------
1.0
32.1
51.5
20.5
9.8
33.7
108.4
15.6
-8.3
2.6
-7.0
-5.8
0.8
1.4
-3.4
-12.4
-4.9
2.2
-5.6
-8.5
2005
2006
2007
2008
2009
4.2
11.4
-2.0
-32.6
18.6
47.1
8.6
-18.3
8.9
-1.5
-17.3
-6.6
8.7
10.8
12.0
-----------
33.7
9.2
-14.3
-2.6
2.5
-----------
-----------
-12.6
9.7
13.6
-10.4
25.6
17.2
9.3
-6.8
-5.1
9.6
-11.3
-3.0
18.3
-3.8
16.1
-1.8
0.2
29.4
-4.7
12.5
-7.6
-1.7
23.0
-4.2
14.5
2010f
0.0
-8.9
1.7
f
2011
-5.0
-3.3
-5.2
f: forecast.
* Confidentiality precludes reporting territorial-level insurance data.
-----
-6.8
-3.7
-----
-----
5.2
10.9
-2.6
1.8
-4.0
-15.8
-3.2
-15.2
-3.6
-15.5
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
Drug Expenditure in Canada, 1985 to 2011
Table B Nun.—Per Capita
Expenditure on Drugs per Capita by Type, by Source of Finance and Public, Private and
Total Health Expenditures, Nunavut, 1985 to 2011 (cont’d)
All Drugs
Private
Public
Total
Year
Health Expenditure
Private
Public
GDP Implicit
Price Index—Canada
Total
(1997 = 100)
($ per Capita)
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
73.6
75.6
79.2
82.8
86.6
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
89.2
91.6
92.8
94.1
95.2
1995
1996
1997
1998
1999
--------39.22
--------157.43
--------196.64
--------4,979.28
--------338.43
--------5,317.71
97.4
99.0
100.0
99.6
101.4
2000
2001
2002
2003
2004
50.24
60.46
82.36
215.44
249.24
143.73
141.83
162.72
199.74
220.48
193.96
202.29
245.08
415.18
469.73
5,787.58
6,175.94
7,091.92
9,579.10
9,926.96
338.32
378.42
388.55
456.07
469.23
6,125.90
6,554.36
7,480.48
10,035.17
10,396.20
105.5
106.9
108.1
111.2
114.1
2005
2006
2007
2008
2009
340.62
381.44
341.09
348.95
348.20
203.41
219.81
265.24
256.78
304.26
544.04
601.26
606.33
605.74
652.46
9,594.32
10,316.90
10,651.83
10,969.71
10,556.54
556.13
572.83
670.53
665.81
771.17
10,150.45
10,889.73
11,322.35
11,635.53
11,327.71
117.5
120.8
125.2
131.3
127.8
2010f
f
2011
334.66
335.48
318.93
336.71
653.58
672.19
10,275.37
11,113.19
775.67
815.45
11,051.05
11,928.64
131.5
136.8
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
--2.8
4.7
4.5
4.6
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
3.0
2.8
1.3
1.4
1.1
1995
1996
1997
1998
1999
-----------
-----------
-----------
-----------
-----------
-----------
2.3
1.7
1.0
-0.4
1.8
Nun.
(Annual Percentage Change)
2000
28.1
16.2
0.0
2001
20.3
-1.3
4.3
6.7
11.9
7.0
1.4
2002
36.2
14.7
-8.7
21.2
-1.4
14.8
2.7
14.1
15.2
1.0
4.1
2003
161.6
22.7
69.4
35.1
17.4
34.2
2.9
2004
15.7
10.4
13.1
3.6
2.9
3.6
2.6
2005
2006
2007
2008
2009
36.7
12.0
-10.6
2.3
-0.2
-7.7
8.1
20.7
-3.2
18.5
15.8
10.5
0.8
-0.1
7.7
-3.4
7.5
3.2
3.0
-3.8
18.5
3.0
17.1
-0.7
15.8
-2.4
7.3
4.0
2.8
-2.6
3.0
2.8
3.7
4.9
-2.7
2010f
f
2011
-3.9
0.2
4.8
5.6
0.2
2.8
-2.7
8.2
0.6
5.1
-2.4
7.9
2.9
4.0
(Annual Percentage Change in Excess of Inflation in the Canadian Economy)
1985
1986
1987
1988
1989
-----------
-----------
-----------
-----------
-----------
-----------
1990
1991
1992
1993
1994
-----------
-----------
-----------
-----------
-----------
-----------
1995
1996
1997
1998
1999
-----------
-----------
-----------
-----------
-----------
-----------
2000
24.0
-12.8
-5.5
12.1
-4.1
11.1
2001
2002
2003
2004
19.0
35.2
158.7
13.1
-2.7
13.7
19.9
7.8
2.9
20.1
66.5
10.5
5.4
13.8
32.2
1.0
10.5
1.6
14.5
0.3
5.6
13.1
31.3
1.0
2005
2006
2007
2008
2009
33.7
9.2
-14.3
-2.6
2.5
-10.8
5.3
17.0
-8.1
21.2
12.8
7.7
-2.8
-5.0
10.4
-6.4
4.7
-0.4
-1.9
-1.1
15.5
0.2
13.4
-5.6
18.5
-5.4
4.5
0.3
-2.1
0.1
2010f
f
2011
-6.8
-3.7
1.9
1.6
-2.8
-1.1
-5.6
4.2
-2.4
1.1
-5.4
3.9
f: forecast.
National Health Expenditure Database, 2011, Canadian Institute for Health Information.
113
Series C—International Comparisons
Drug Expenditure in Canada, 1985 to 2011
Table C.1
The Share of Pharmaceutical Goods* in Total Expenditure on Health,
in Descending Order, OECD Reporting Countries, 1985, 2008, 2009
1985
Portugal
Korea
Spain
Japan
Iceland
France
Belgium
Luxembourg
United Kingdom
Germany
New Zealand
Turkey
Switzerland
Ireland
Finland
Canada
Netherlands
Norway
Australia
United States
Sweden
Denmark
2008
(%)
25.4
23.2
20.3
18.0
16.6
16.2
15.7
14.8
14.1
13.8
13.3
13.0
11.3
9.9
9.7
9.6
9.3
9.1
9.0
8.7
7.0
6.6
Hungary
Mexico
Slovak Republic
Korea
Poland
Estonia
Portugal
Czech Republic
Japan
Spain
Slovenia
Italy
Ireland
Canada
Belgium
France
Germany
Finland
Australia
Iceland
Austria
Sweden
United States
United Kingdom
Switzerland
New Zealand
Luxembourg
Denmark
Norway
2009
(%)
31.5
28.3
27.6
23.2
22.6
20.7
20.6
20.4
19.4
18.7
18.5
18.3
17.3
17.0
16.7
16.3
15.0
14.8
14.6
14.6
13.4
12.9
11.9
11.6
10.1
9.4
9.1
8.0
7.5
Hungary
Mexico
Slovak Republic
Estonia
Korea
Poland
Czech Republic
Spain
Slovenia
Italy
Ireland
Canada
Belgium
France
Iceland
Germany
Finland
Austria
Sweden
United States
Switzerland
Netherlands
New Zealand
Denmark
Norway
(%)
32.6
27.1
26.6
23.4
22.5
22.4
19.4
18.9
18.8
18.2
17.5
17.0
16.2
16.1
15.7
14.9
14.3
12.5
12.5
12.0
10.1
9.6
9.3
7.3
7.3
OECD
Notes
* The OECD proposes the following standard definition: Includes prescribed medicines and self-medication, often referred
to as over-the-counter (OTC) products. Also includes other medical non-durables comprising a wide range of items such as
bandages, elasticized stockings, incontinence articles, condoms and other mechanical contraceptive devices.
Excludes pharmaceutical consumption in hospitals.
Country-specific definitions differ from the OECD proposed standard definition as follows:
Greece:
Excludes other medical non-durables.
Hungary:
Excludes subsidies by local governments.
New Zealand:
Includes cost of care provided in prisons and military facilities; excludes subsidies from
charitable not-for-profit organizations and regional and local governments.
Switzerland:
Excludes other medical non-durables.
Turkey:
Includes pharmaceutical consumption in hospitals.
Source
Organisation for Economic Co-operation and Development, OECD Health Data 2011(Paris, France: OECD, June 2011).
117
Drug Expenditure in Canada, 1985 to 2011
Table C.2
The Share of Public Expenditure in Total Expenditure on Pharmaceutical
Goods and Other Medical Non-Durables,* OECD Reporting Countries,
1985, 2008, 2009
1985
OECD
Turkey
Luxembourg
New Zealand
Germany
Sweden
France
Portugal
United Kingdom
Netherlands
Spain
Iceland
Ireland
Japan
Belgium
Australia
Denmark
Finland
Norway
Canada
Korea
United States
2008
(%)
90.0
86.0
80.4
71.9
70.1
67.1
64.7
64.1
63.3
62.5
61.9
60.8
60.6
51.0
47.2
45.5
44.5
43.2
29.4
15.4
8.4
United Kingdom
Luxembourg
Germany
Ireland
Japan
Slovak Republic
Spain
Switzerland
Austria
France
New Zealand
Czech Republic
Sweden
Belgium
Slovenia
Korea
Hungary
Portugal
Norway
Finland
Denmark
Australia
Iceland
Italy
Estonia
Canada
Poland
United States
Mexico
2009
(%)
84.7
84.0
76.6
74.6
72.1
71.4
70.0
68.5
67.0
66.7
63.7
61.6
59.7
59.3
59.3
57.4
56.7
56.2
54.8
54.6
54.3
53.8
48.1
47.3
42.9
38.7
38.3
30.3
20.1
Netherlands
Germany
Ireland
Spain
Slovak Republic
Czech Republic
Switzerland
France
New Zealand
Austria
Belgium
Korea
Sweden
Slovenia
Hungary
Finland
Norway
Denmark
Iceland
Italy
Estonia
Canada
Poland
United States
Mexico
(%)
78.8
77.6
74.7
71.1
69.8
68.7
68.5
66.7
65.6
65.2
60.5
59.3
58.6
57.5
57.3
55.4
53.9
53.3
48.8
46.8
41.4
38.8
38.6
31.1
18.9
Notes
* The OECD proposes the following standard definition: Includes prescribed medicines and self-medication, often referred
to as over-the-counter (OTC) products. Also includes other medical non-durables comprising a wide range of items such as
bandages, elasticized stockings, incontinence articles, condoms and other mechanical contraceptive devices.
Excludes pharmaceutical consumption in hospitals.
Country-specific definitions differ from the OECD proposed standard definition as follows:
Greece:
Excludes other medical non-durables.
Hungary:
Excludes subsidies by local governments.
New Zealand:
Includes cost of care provided in prisons and military facilities; excludes subsidies from
charitable not-for-profit organizations and regional and local governments.
Norway:
Public expenditure includes expenditure by hospitals and the National Insurance Administration
(Rikstrygdeverket, RTV) only.
Switzerland:
Excludes other medical non-durables.
Turkey:
Includes pharmaceutical consumption in hospitals.
Source
Organisation for Economic Co-operation and Development, OECD Health Data 2011(Paris, France: OECD, June 2011).
118
Drug Expenditure in Canada, 1985 to 2011
Table C.3
The Share of Pharmaceutical Goods* in Public Expenditure on Health,
in Descending Order, OECD Reporting Countries, 1985, 2008, 2009
1985
Portugal
Turkey
Spain
Japan
Luxembourg
France
Germany
New Zealand
Iceland
Korea
United Kingdom
Netherlands
Ireland
Australia
Finland
Sweden
Norway
Canada
Denmark
United States
2008
(%)
30.1
23.1
15.7
15.4
14.2
13.8
12.8
12.3
11.8
11.3
10.5
8.3
7.9
6.0
5.5
5.4
4.6
3.8
3.5
1.8
Slovak Republic
Hungary
Korea
Spain
Portugal
Japan
Ireland
Czech Republic
Germany
Slovenia
France
Belgium
Mexico
Poland
United Kingdom
Switzerland
Austria
Australia
Estonia
Italy
Finland
Sweden
Canada
Luxembourg
Iceland
United States
New Zealand
Chile
Denmark
Norway
2009
(%)
29.1
25.2
23.8
18.0
17.8
17.3
16.8
15.2
15.0
15.0
14.0
13.2
12.1
12.0
12.0
11.7
11.7
11.6
11.4
11.2
10.8
9.4
9.3
9.1
8.5
7.8
7.4
6.1
5.1
4.8
Slovak Republic
Hungary
Korea
Spain
Ireland
Czech Republic
Germany
Slovenia
France
Belgium
Estonia
Poland
Switzerland
Italy
Finland
Mexico
Austria
Canada
Iceland
Sweden
United States
New Zealand
Chile
Norway
Denmark
(%)
28.2
26.8
22.9
18.2
17.4
15.8
15.0
14.7
13.8
13.0
12.9
12.0
11.6
11.0
10.6
10.6
10.5
9.4
9.3
9.0
7.8
7.5
6.0
4.7
4.6
OECD
Notes
* The OECD proposes the following standard definition: Includes prescribed medicines and self-medication, often referred
to as over-the-counter (OTC) products. Also includes other medical non-durables comprising a wide range of items such as
bandages, elasticized stockings, incontinence articles, condoms and other mechanical contraceptive devices.
Excludes pharmaceutical consumption in hospitals.
Country-specific definitions differ from the OECD proposed standard definition as follows:
Greece:
Excludes other medical non-durables.
Hungary:
Excludes subsidies by local governments.
New Zealand:
Includes cost of care provided in prisons and military facilities; excludes subsidies from
charitable not-for-profit organizations and regional and local governments.
Norway:
Public expenditure includes expenditure by hospitals and the National Insurance Administration
(Rikstrygdeverket, RTV) only.
Switzerland:
Excludes other medical non-durables.
Turkey:
Includes pharmaceutical consumption in hospitals.
Source
Organisation for Economic Co-operation and Development, OECD Health Data 2011(Paris, France: OECD, June 2011).
119
Drug Expenditure in Canada, 1985 to 2011
Appendix A—Comparison of Provincial and
Territorial Drug Subsidy Programs
Comparison of Provincial and Territorial Drug
Subsidy Programs
Table 7 gives an overview of provincial and territorial drug subsidy programs as of December 31,
2011. The table was verified for accuracy with provincial/territorial programs. Information is also
available from the following websites:
British Columbia Pharmacare
www.health.gov.bc.ca/pharmacare/
Alberta Prescription Drug Program
www.health.alberta.ca/AHCIP/prescription-program.html
Saskatchewan Drug Plan
www.health.gov.sk.ca/prescription-drugs
Manitoba Pharmacare Program
www.gov.mb.ca/health/pharmacare/index.html
Ontario Drug Benefits
www.health.gov.on.ca/en/public/programs/drugs/default.aspx
Régime général d’assurance médicaments du Québec (RGAM)
www.ramq.gouv.qc.ca/en/citoyens/assurancemedicaments/index.shtml
New Brunswick Prescription Drug Program
www.gnb.ca/0212/intro-e.asp
Nova Scotia Pharmacare
http://www.gov.ns.ca/health/pharmacare/
Prince Edward Island Pharmacy Services
www.healthpei.ca/index.php3?number=1026180&lang=E
Newfoundland and Labrador Prescription Drug Program
www.health.gov.nl.ca/health/prescription/nlpdp_plan_overview.html
Yukon Pharmacare
www.hss.gov.yk.ca/insured_services.php
Northwest Territories
www.hlthss.gov.nt.ca/english/services/health_care_plan/default.htm
Nunavut
www.drugcoverage.ca/p_benefit_nu.asp
121
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of December 2011
Province/
Territory
Program/
Plan
British
Columbia
Fair
PharmaCare
Enhanced
Assistance
Families in which
None
at least one family
member is born in
1939 or earlier and
is not covered by
other plans
Fair
PharmaCare
Families in
which all family
members are
born in 1940
or later and are
not covered by
other plans
None
PharmaCare
Plan B
Permanent
residents of
licensed residential
care facilities
Recipients of
B.C. Income
Assistance
Cystic fibrosis
patients registered
with a provincial
cystic fibrosis clinic
Severely
handicapped
children registered
in the At Home
Program
Clients of mental
health service
centres meeting
clinical and lowincome criteria
Palliative care
patients treated
at home
For prescription
smoking cessation
drugs: Residents
of British Columbia
must be registered
for Fair
PharmaCare or
covered by one
of the following
PharmaCare
plans: Plan B,
Plan C,
Plan G.
For nicotine
replacement
therapies (NRTs):
All British Columbia
residents.
PharmaCare
Plan C
PharmaCare
Plan D
PharmaCare
Plan F
PharmaCare
Plan G
PharmaCare
Plan P
Smoking
Cessation
Program
122
Beneficiary
Premium
Maximum
Annual
Copay
Deductible
Copay
PharmaCare
pays 75%
1.25%:
<$33K
2%: $33K
to $50K
3%: >$50K
PharmaCare
pays 70%
2%: <$15K
3%: $15K
to $30K
4%: >$30K
None
Based on
family net
income:
$0: <$33K
1%: $33K
to $50K
2%: >$50K
Based on
family net
income:
$0: <$15K
2%: $15K
to $30K
3%: >$30K
None
None
N/A
None
None
None
N/A
None
None
None
N/A
None
None
None
N/A
None
None
None
N/A
None
None
None
N/A
None
See applicable See applicable
PharmaCare PharmaCare
plans above
plans above
See
applicable
PharmaCare
plans above
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
Province/
Territory
Program/
Plan
Alberta
Seniors
Beneficiary
Premium
Maximum
Annual
Copay
Deductible
Copay
Seniors age 65
None
and older and their
eligible dependants
None
30% of
prescription
to a max.
of $25 per
prescription*
N/A
Widows
Residents age 55 to None
64 who qualify for
Alberta Widows’
Pension and
eligible dependants
None
30% of
prescription
to a max.
of $25 per
prescription*
N/A
Palliative
Palliative residents None
treated at home
None
30% of
prescription
to a max. of
$25 per
prescription*
The lifetime
maximum
amount
palliative
patients pay
out of pocket
is $1,000
Non-Group
A universal plan
available to all
residents under
the age of 65
Monthly rate
is $63.50 for
singles and
$118.00 for
families.
Subsidized
rates are
available at
$44.45 for
singles and
$82.60 for
families.
None
30% of
prescription
to a max.
of $25 per
prescription*
N/A
Province-Wide
Services
Residents
with specific
conditions may
be eligible for
high-cost drugs,
mostly transplant
and HIV drugs via
Alberta Health
Services
None
None
None
N/A
Income Support Residents receiving None
social assistance
and eligible
dependants
None
None
N/A
Note
* Costs incurred by the client choosing a high-cost product where cheaper alternatives are available are borne by the client.
123
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
Deductible
Copay
Maximum
Annual
Copay
Residents receiving None
AISH (an incomesupport program
for adults with
a permanent
disability that
severely impairs
their ability to earn
a living) and eligible
dependants
None
None
N/A
Alberta Adult
Health Benefit
Qualified clients
leaving Income
Support for work
None
None
None
N/A
Alberta Child
Health Benefit
Children in lowincome families
None
None
None
N/A
Rare Diseases
Drug Program
Residents with
None
extremely rare
genetic disorders
(Gaucher’s
disease, Fabry
disease, MPS-I,
Hunter disease and
Pompe disease)
may be eligible for
rare disease drugs
via Alberta Health
Services
None
None
N/A
All residents with
Saskatchewan
health coverage
(application
required)
Income-tested
(annual
threshold
based on 3.4%
of adjusted
family income)
Income-tested N/A
(based on
benefit drug
costs, to help
spread cost
out evenly over
the year)
None
Maximum
$15 per
prescription
Province/
Territory
Program/
Plan
Alberta
(cont’d)
Assured Income
for the Severely
Handicapped
(AISH)
Saskatchewan† Saskatchewan
Drug Plan—
Special Support
Program
Seniors’
Drug Plan
Beneficiary
Premium
None
Saskatchewan
None
residents 65 and
older. Individual
annual net income
must be below the
limit for the federal
age credit to be
eligible for the
cap of $15 per
prescription
(application
required to
determine
eligibility).
N/A
Note
† To be eligible for drug plan coverage, the resident must not be covered under another provincial or federal government program,
such as the Non-Insured Health Benefits Program. For all residents who are eligible for more than one drug plan program,
the best coverage for each prescription will be applied.
124
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
Province/
Territory
Program/
Plan
†
Beneficiary
Premium
Saskatchewan Seniors Income
(cont’d)
Supplement
Recipients
(Basic
Deductible
Programs)
Seniors receiving
None
the Seniors Income
Plan supplement
or receiving
the federal
Guaranteed Income
Supplement
Note: May also and residing in a
special care home
apply for the
Seniors’ Drug
Seniors receiving
None
Plan and the
the Guaranteed
Special Support Income
Program
Supplement
Maximum
Annual
Copay
Deductible
Copay
$100 semiannual family
deductible
35% consumer N/A
copayment after
deductible has
been paid
$200 semiannual family
deductible
35% consumer N/A
copayment after
deductible has
been paid
and living in
the community
Emergency
Assistance
Program
Residents who
None
require immediate
treatment with
covered
prescription drugs
and are unable to
cover their share of
the cost. This is a
one-time benefit,
and individuals are
encouraged to
apply for incometested coverage for
future assistance.
None
The level of
assistance
provided is
in accordance
with the
consumer’s
ability to pay
Family Health
Benefits
Eligibility is
None
established by the
Ministry of Social
Services, based on
the number of
children in the
family and the
family’s annual
income
$100 semiannual family
deductible
No charge
N/A
for benefit
prescriptions for
children; 35%
consumer
copayment after
deductible has
been paid for
adult benefit
prescriptions
N/A
Note
† To be eligible for drug plan coverage, the resident must not be covered under another provincial or federal government program,
such as the Non-Insured Health Benefits Program. For all residents who are eligible for more than one drug plan program,
the best coverage for each prescription will be applied.
125
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
Province/
Territory
Program/
Plan
Beneficiary
Premium
†
Saskatchewan Supplementary Persons nominated None
(cont’d)
Health
by Saskatchewan
Social Services for
special coverage,
including persons
on social
assistance, wards,
inmates, etc.
Maximum
Annual
Copay
Deductible
Copay
None
Up to $2 per
N/A
prescription
(some drugs
covered at
no charge;
individuals
younger than 18
and certain
other categories
receive benefit
prescriptions at
no charge)
Saskatchewan
Aids to
Independent
Living (SAIL)
Persons registered None
under the following
SAIL programs
receive formulary
and approved nonformulary drugs
at no charge:
Paraplegia
Program, Cystic
Fibrosis Program
and Chronic
End-Stage Renal
Disease Program
None
None
N/A
Palliative Care
Program
Residents who
are in the late
stages of a
terminal illness
None
None
None
N/A
Children’s
Insulin Pump
Program
Type 1 diabetic
None
children (younger
than 18) who
require pumps to
adequately stabilize
blood sugar levels
and are not eligible
for benefits
under a federal
government
program (such as
the Non-Insured
Health Benefits
Program)
None
No charge for
N/A
insulin pump.
Insulin pump
supplies subject
to coverage
(family
deductible/
copay).
None
Maximum $15 N/A
per prescription
Children’s Drug Children 14 and
Plan
younger
None
Note
† To be eligible for drug plan coverage, the resident must not be covered under another provincial or federal government program,
such as the Non-Insured Health Benefits Program. For all residents who are eligible for more than one drug plan program, the
best coverage for each prescription will be applied.
126
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
Maximum
Annual
Copay
Province/
Territory
Program/
Plan
Manitoba
Pharmacare
All provincial
None
residents who
are eligible for
benefits under The
Prescription Drug
Cost Assistance
Act
Ranging from None
2.73% to
6.17% based
on total
adjusted family
income. Credit
of $3,000 for
a spouse
and each
dependant
younger
than 18.
N/A
Employment
and Income
Assistance
Program
Individual
Manitobans who
are receiving
drug benefits
pursuant to the
Employment
and Income
Assistance
Program
None
None
None
N/A
Personal Care
Home/Nursing
Home
Manitoba residents None
of personal care
homes
None
None
N/A
Palliative Care
Drug Access
Program
Residents who are None
terminally ill and
wish to remain
at home
None
None
N/A
$100
per recipient
After deductible, N/A
up to $6.11 per
prescription and
$2.83 for
prescriptions
dispensed in
outpatient
hospital
pharmacies
None
Up to $2 per
prescription
Ontario
Beneficiary
Premium
Ontario Drug
Seniors (65 and
None
Benefit Program older). Single
seniors with annual
income ≥$16,018 or
seniors in couples
with combined
annual income
of ≥$24,175.
Seniors (65 and
None
older). Single
seniors with annual
income <$16,018 or
seniors in couples
with combined
annual income
of <$24,175.
Deductible
Copay
N/A
127
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
Province/
Territory
Program/
Plan
Ontario
(cont’d)
Trillium Drug
Program
Special Drugs
Program
128
Maximum
Annual
Copay
Beneficiary
Premium
Deductible
Copay
Residents of longterm care facilities
None
None
Up to $2 per
prescription
N/A
Residents of homes None
for special care
None
Up to $2 per
prescription
N/A
Residents receiving None
professional
services under
the home care
program
None
Up to $2 per
prescription
N/A
Residents receiving None
social assistance
(Ontario Disability
Support Program
or Ontario
Works Program)
None
Up to $2 per
prescription
N/A
Residents with high None
drug costs in
relation to income
Residents with valid None
Ontario health
insurance.
Coverage is
product-specific
for a limited number
of diseases or
conditions.
Income-based Up to $2 per
prescription
N/A
None
N/A
None
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
Province/
Territory
Program/
Plan
Quebec
Régime public
Deductible
Copay
Maximum
Annual
Copay
Employment
None
assistance
(welfare) recipients
(EAR) and other
holders of a
claim slip
None
None
None
Seniors (65 and
None
older) receiving
at least 94% of
the maximum
Guaranteed Income
Supplement (GIS)
None
None
None
Seniors (65 and
older) receiving
less than 94% of
the maximum GIS
Seniors (65 and
older) without GIS
$16.00
per month
32% of
prescription
costs
$49.97 per
month
$16.00
per month
32% of
prescription
costs
$80.25 per
month
$16.00
per month
32% of
prescription
costs
$80.25 per
month
Beneficiary
Premium
$0 to $563 per
adult per year,
depending on
income
$0 to $563
per adult
per year,
depending
on income
General clientele
$0 to $563 per
(residents younger adult per year,
than 65 without
depending on
access to a
income
group plan).
Adults are subject
to a premium, a
deductible and
a copayment. Their
children (including
students age 18 to
25, under certain
conditions) are
covered free
of charge.
129
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
Province/
Territory
Program/
Plan
New
Brunswick
Plan A
Plan B
130
Maximum
Annual
Copay
Beneficiary
Premium
Deductible
Copay
Seniors with
Guaranteed Income
Supplement (GIS)
Seniors without
GIS who qualify for
benefits based on
annual income as
follows: a single
senior with an
annual income of
$17,198 or less;
a senior couple
(both ≥65) with a
combined annual
income of $26,955
or less; a senior
couple with one
spouse younger
than 65, with a
combined annual
income of $32,390
or less
Cystic fibrosis
patients or patients
with juvenile or
infant sclerosis of
the pancreas
None
None
$9.05 for each
prescription
$250
None
None
$15 per
prescription
N/A
$50 yearly
registration
fee
None
20%
prescription
cost up to a
maximum
of $20
$500
per family
Plan E
Individuals residing None
in a licensed adult
residential facility
who hold a valid
health card for
prescription drugs
issued by the
Department
of Social
Development
None
$4 for each
prescription
$250
Plan F
Individuals holding None
a valid health card
for prescription
drugs issued by
the Department
of Social
Development
None
$4 per
prescription for
adults (18 and
older) and $2
for children
(younger
than 18)
$250
per family
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
Premium
Deductible
Copay
Maximum
Annual
Copay
Special-needs
children and
children in
the care of the
Minister of Social
Development
None
None
None
N/A
Plan H
Individuals
diagnosed with
multiple sclerosis
and in possession
of a prescription
written by a
neurologist for
the medications
Avonex, Rebif,
Betaseron or
Copaxone are
eligible to apply
for assistance
$50 yearly
registration
fee
None
Income-tested
(ranges from
0% to 100%)
N/A
Plan R
Recipients of an
$50 yearly
organ or bone
registration
marrow transplant fee
who are registered
and qualify with
the NBPDP
None
$500
20%
prescription cost per family
up to a
maximum
of $20
Plan T
$50 yearly
Individuals with
registration
growth hormone
fee
deficiency or
hypopituitarism
who are registered
and qualify with
the NBPDP
None
20%
prescription
cost up to
a maximum
of $20
Plan U
Individuals who are $50 yearly
HIV positive and
registration
are registered with fee
the NBPDP
None
20%
$500
prescription
per family
cost up to a
maximum of $20
Plan V
Individuals
who reside in
a registered
nursing home
None
None
Province/
Territory
Program/
Plan
New
Brunswick
(cont’d)
Plan G
Beneficiary
None
$500
per family
N/A
131
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
Province/
Territory
Program/
Plan
Nova Scotia
Seniors
Pharmacare
Program
Department
of Community
Services
Programs
132
Beneficiary
Premium
Maximum
Annual
Copay
Deductible
Copay
Residents (65 and None
older) who are
receiving the
Guaranteed Income
Supplement (GIS),
are covered by
Medical Services
Insurance (MSI)
and do not have
prescription drug
coverage through
Veterans Affairs
Canada, NonInsured Health
Benefits, Nova
Scotia Family
Pharmacare or
any other public
or private plan
None
30%
$382
prescription cost
Residents (65 and Up to $424
older) who are not per year
receiving the GIS,
are covered by MSI
and do not have
prescription drug
coverage through
Veterans Affairs
Canada,
Non-Insured Health
Benefits, Nova
Scotia Family
Pharmacare
or any other public
or private plan
None
30%
$382
prescription cost
Eligible clients and None
their dependants in
receipt of income
assistance; any
client and/or
dependant having
access to another
drug plan, be it
from a public or
private entity, will
be required to use
that plan and will
not be eligible for
the Pharmacare
Program
None
All incomeN/A
assistance
clients and
dependants are
required to
copay a flat fee
of $5 per
prescription
unless the client
or dependant
is eligible
for copay
exemption
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
Deductible
Copay
Maximum
Annual
Copay
Drug Assistance Residents with a
None
for Cancer
valid Nova Scotia
Patients
health card who
are not eligible for
any other drug
coverage, except
Nova Scotia Family
Pharmacare; have
a diagnosis of
cancer; have a
gross family income
of no more than
$15,720; provide a
copy of their most
recent Income
Tax Notice of
Assessment or
Reassessment
from the Canada
Revenue Agency
(CRA) for the
cancer patient, his
or her parent(s) or
guardian(s), spouse
or common-law
partner; and agree
to family income
verification from the
CRA Notice of
Assessment or
Reassessment
None
None
N/A
Family
Pharmacare
Program
Income-based 20% of the total Incomeprescription cost based
Province/
Territory
Program/
Plan
Nova Scotia
(cont’d)
Beneficiary
Premium
Residents with a
None
valid Nova Scotia
health card who
agree to provide
family size
verification and also
agree to family
income verification
through the CRA
133
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
Province/
Territory
Program/
Plan
Nova Scotia
(cont’d)
Nova Scotia
Diabetes
Assistance
Program
(NSDAP)
Beneficiary
Premium
Residents younger None
than 65 with a
valid Nova Scotia
health card who
do not have
drug coverage
Effective April 1, through Veterans
Affairs Canada,
2010, the
First Nations and
NSDAP will
Inuit Health or any
no longer be
accepting new private drug plans
that cover diabetes
beneficiaries.
medications and
Existing
supplies: have
beneficiaries
of the NSDAP a confirmed
are required to diagnosis
of diabetes; agree
re-register by
to provide family
April 1 each
year to remain size verification;
in the program. and agree to family
Anyone newly income verification
diagnosed with through the CRA
diabetes who is
a member of a
family currently
enrolled in the
NSDAP will
be covered.
Prince Edward Seniors Drug
Seniors 65 or older None
Island
Cost Assistance and eligible for
Plan
P.E.I. Medicare
Children-inCare
134
Persons eligible
under the Social
Assistance Act
and persons in
the temporary or
permanent care
of the Director of
Child Welfare
None
Deductible
Copay
Maximum
Annual
Copay
Income-based 20% of the total N/A
prescription cost
None
First $8.25
of the
medication
cost plus the
pharmacy
professional
fee for each
prescription
N/A
None
None
N/A
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
Province/
Territory
Program/
Plan
Beneficiary
Premium
Prince Edward Family Health Families (parents, None
Island (cont’d) Benefit Program guardians and
children younger
than 18 or younger
than 25 and in fulltime attendance at
a post-secondary
education
institution), eligible
for P.E.I. Medicare
with a total net
family income less
than the threshold.
Families must apply
for coverage on an
annual basis and
provide income
information to
the program.
Maximum
Annual
Copay
Deductible
Copay
None
The pharmacy
professional
fee for each
prescription
N/A
Financial
Assistance
Program
Persons eligible
under the Social
Assistance Act
None
None
None
N/A
Erythropoietin
Program
Persons eligible
None
for P.E.I. Medicare
who have been
diagnosed with
chronic renal failure
or are receiving
kidney dialysis and
registered with
the program
None
None
N/A
135
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
Province/
Territory
Program/
Plan
Prince Edward Diabetes
Island (cont’d) Control
Program
Beneficiary
Premium
Persons eligible
None
for P.E.I. Medicare
who are registered
with the diabetes
program and are
insulin-dependent
Maximum
Annual
Copay
Deductible
Copay
None
Blood glucose
N/A
test strips: $11
per prescription
to a maximum of
100 strips every
30 days
Oral
medications and
urine testing
materials: $11
per prescription
High-cost
diabetes
medications:
an incomebased portion
of the
medication plus
the professional
fee for each
high-cost
medication
obtained
136
High Cost
Persons eligible
None
Drugs Program for P.E.I. Medicare
and approved for
coverage of one
or more of the
medications
included in
the program.
Patients must apply
for coverage on an
annual basis and
provide income
information to
the program.
None
Income-based
portion of the
drug cost plus
the pharmacy
professional
fee for each
prescription
N/A
Community
Mental Health
Program
Approved long-term None
psychiatric patients
living in the
community
None
None
N/A
Sexually
Transmitted
Diseases (STD)
Program
Persons diagnosed None
with sexually
transmitted disease
or identified
contacts of
a person with
a sexually
transmitted disease
None
None
N/A
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
Province/
Territory
Deductible
Copay
Maximum
Annual
Copay
Residents in
None
government
manors or private
nursing homes
eligible for
coverage under the
Long-Term Care
Subsidization Act
None
None
N/A
Disease-Specific
Programs
(AIDS/HIV,
cystic fibrosis,
growth
hormone,
hepatitis,
tuberculosis,
hairy cell
leukemia,
AIDS-related
Kaposi’s
sarcoma, basal
cell carcinoma,
meningitis,
phenylketonuria,
transplant drug
programs
delivered
through the
government-run
provincial
pharmacy,
Crohn’s disease
and rheumatic
fever)
Persons eligible for None
P.E.I. Medicare and
registered with the
program who are
diagnosed with
specific medical
conditions or at risk
for exposure to
communicable
diseases
None
None
N/A
Quit-Smoking
Program
Persons eligible
None
for P.E.I. Medicare
and who have
registered with
the program
None
Patients are
N/A
responsible for
all medication
costs approved,
except for the
first $75, which
will be paid by
the program
Nutrition
Program
Children and
high-risk pregnant
women diagnosed
with a nutritional
deficiency
None
None
None
N/A
Immunization
Program
Children and
None
persons at risk for
exposure to various
communicable
diseases
None
None
N/A
Program/
Plan
Prince Edward Nursing Home
Island (cont’d) Program
Beneficiary
Premium
137
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
Province/
Territory
Deductible
Copay
Maximum
Annual
Copay
None
None
N/A
Persons eligible for None
P.E.I. Medicare and
prescribed oxygen
by a specialist and
who meet clinical
criteria
None
P.E.I. Medicare N/A
will pay 50%
of the cost
of eligible
expenses up to
a maximum of
$200 per month
Seniors (65 and
None
older) who are
in receipt of the
Guaranteed Income
Supplement and
who are registered
for Old Age
Security benefits
None
Markup and
N/A
professional fee
for identified
benefits
The Foundation Residents of the
None
Plan
province who
qualify for full
benefit coverage
under the
Department
of Human
Resources,
Labour and
Employment, and
certain individuals
receiving services
through the
regional health
authorities,
including children in
the care of Child,
Youth and Family
Services and
individuals in
supervised care
None
None
Program/
Plan
Beneficiary
Premium
Prince Edward Rabies Program Persons with
None
Island (cont’d)
exposure to or at
risk for exposure to
rabies through an
animal bite
Home Oxygen
Program
Newfoundland The 65Plus
and Labrador Plan
138
N/A
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
Province/
Territory
Program/
Plan
Newfoundland The Access
and Labrador Plan
(cont’d)
Maximum
Annual
Copay
Beneficiary
Premium
Deductible
Copay
Residents with
low incomes who
access eligible
prescription
medications.
The amount
of coverage
is determined
by family net
income level and
family status.
None
None
Based on family
net income:
Family (with
children)
Income
Copay
<$30,009
20.0%
$31,000
23.9%
$32,000
27.7%
$33,000
31.6%
$34,000
35.5%
$35,000
39.4%
$36,000
43.3%
$37,000
47.2%
$38,000
51.1%
$39,000
55.0%
$40,000
58.8%
$41,000
62.7%
$42,000
66.6%
$42,870
70.0%
Between 20%
and 70%,
depending
on family net
income and
family status
(single,
couple or
family)
Couple (with
no children)
Income
Copay
<$21,435
20.0%
$22,000
23.3%
$23,000
29.1%
$24,000
35.0%
$25,000
40.8%
$26,000
46.6%
$27,000
52.4%
$28,000
58.3%
$29,000
64.1%
$30,000
69.9%
$30,009
70.0%
Single
individuals
Income
Copay
<$18,577
20.0%
$19,000
22.5%
$20,000
28.3%
$21,000
34.1%
$22,000
40.0%
$23,000
45.8%
$24,000
51.6%
$25,000
57.5%
$26,000
63.3%
$27,000
69.1%
$27,151
70.0%
139
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
Province/
Territory
Program/
Plan
Beneficiary
Premium
Newfoundland The Assurance Residents who
None
and Labrador Plan
experience the
(cont’d)
financial burden of
eligible high drug
costs, whether it be
from the cost of
one extremely
high-cost drug or
the combined cost
of different drugs
Yukon
Copay
None
Based on a
combination
of family net
income and
eligible family
drug costs
Based on
family net
income:
Income
<$40,000
Max.
5.0%
≥$40,000 to 7.5%
<$75,000
≥$75,000 to 10.0%
<$150,000
The Select
Needs Plan
Residents with
cystic fibrosis or
growth hormone
deficiency
None
None
None, for
identified
benefits
N/A
Pharmacare
Seniors 65 or older None
(and seniors’
spouses age 60 and
older) registered
with Yukon Health
Care Insurance Plan
and not having
coverage through
First Nations
and Inuit Health.
Residents with
another third-party
or group insurance
must use that plan
first. Program
includes clients
receiving
palliative care.
None
Residents who
have a chronic
disease or a
serious functional
disability as
provided under the
Chronic Disease
and Disability
Benefits
Regulations and
not having
coverage through
First Nations and
Inuit Health.
Residents with
another third-party
or group insurance
must use that plan
first. Program
includes clients
receiving
palliative care.
None
None
N/A
Maximum
None
$250 per year
per individual
and $500
per year per
family
(deductible
may be
waived,
depending
on income)
N/A
Chronic
Disease
Program
140
Deductible
Maximum
Annual
Copay
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
Province/
Territory
Program/
Plan
Yukon
(cont’d)
Children’s Drug Children younger
and Optical
than 19 from lowProgram
income families
and not having
coverage through
First Nations and
Inuit Health
Northwest
Territories
Extended
Health Benefits
Program for
Specified
Diseases
Premium
Deductible
None
Maximum
None
$250 per child
and $500 per
year per
family
(deductible
may be
waived,
depending
on income)
N/A
Resident, nonNone
native or Métis and
have a specified
disease condition
None
None
N/A
Seniors’ Benefit Resident and non- None
Program
native residents
who are 60 years
and older
None
None
N/A
Resident,
None
registered with
territorial health
care plan,
descendant of
Chipewyan,
Slavey, Gwich’in,
Dogrib, Hare or
Cree people; and
resided in or used
and occupied the
Mackenzie Basin
on or before
January 1, 1921,
or is a Community
Acceptance
Member, or was
adopted as
a minor
None
None
N/A
Indigent
Indigent individuals None
Health Benefits or families resident
Program
of the Northwest
Territories,
who meet
the eligibility
requirements
according to the
Indigent Health
Benefits Policy
None
None
N/A
Métis Health
Benefits
Program
Beneficiary
Copay
Maximum
Annual
Copay
141
Drug Expenditure in Canada, 1985 to 2011
Table 7: Comparison of Provincial and Territorial Drug Subsidy Programs as of
December 2011 (cont’d)
142
Deductible
Copay
Maximum
Annual
Copay
Extended
Non-Aboriginal
None
Health Benefits residents, including
Program
seniors, who have
a specific chronic
condition or have
reached the age
of 65
None
None
N/A
Residents
Indigent
Health Benefits receiving
income support
Program
None
None
N/A
Province/
Territory
Program/
Plan
Nunavut
Beneficiary
Premium
None
Drug Expenditure in Canada, 1985 to 2011
References
1.
Canadian Institute for Health Information, National Health Expenditure Trends, 1975 to
2011 (Ottawa, Ont.: CIHI, 2011).
2.
S. Morgan, “Sources of Variation in Provincial Drug Spending,” CMAJ 170, 3 (2004):
pp. 329–330.
3.
Organisation for Economic Co-operation and Development, OECD.Stat Extracts,
accessed November 2011, from <http://www.oecd.org>.
4.
Canadian Institute for Health Information, Drug Use Among Seniors on Public Drug
Programs in Canada, 2002 to 2008 (Ottawa, Ont.: CIHI, 2010).
5.
M. Aaserud et al., “Pharmaceutical Policies: Effects of Reference Pricing, Other Pricing
and Purchasing Policies (Review),” The Cochrane Collaboration 4 (The Cochrane Library:
John Wiley & Sons, Ltd., 2006): pp. 1–66, Cochrane Library Number CD005979.
6.
Canadian Institute for Health Information, Health Care Cost Drivers: The Facts.
(Ottawa, Ont.: CIHI, 2011).
7.
Health Council of Canada, Generic Drug Pricing and Access in Canada: What Are the
Implications? (Toronto, Ont.: Health Council of Canada, June 2010), accessed on
February 10, 2011, from <http://healthcouncilcanada.ca>.
8.
Alberta Health and Wellness, “Alberta Pharmaceutical Strategy Phase Two,” (fact sheet)
(Edmonton, Alta.: Alberta Health and Wellness, January 2010), accessed on
February 14, 2011, from <http://www.health.alberta.ca>.
9.
S. Morgan et al., “‘Breakthrough’ Drugs and Growth in Expenditure on Prescription Drugs in
Canada,” BMJ 331, 7520 (October 8, 2005): pp. 815–816, accessed on February 8, 2007,
from <http://www.pubmedcentral.nih.gov>, catalogue no. 38582.703866.
10.
Z. Karaca and S. Wiggins, The Impacts of Breakthrough Drug Classes on Total Health
Expenditures: Empirical Evidence From the 1996–2001 Medical Expenditure Panel Surveys,
eds. Z. Karaca and S. Wiggins (Texas: A&M University, November 11, 2006), pp. 1–40,
accessed on February 14, 2007, from <http://ssrn.com>, catalogue no. 947603.
11.
F. R. Lichtenberg, “Are the Benefits of Newer Drugs Worth Their Cost? Evidence From the
1996 MEPS,” Health Affairs 20, 5 (September/October 2001): pp. 241–251.
12.
Canadian Cancer Society, A National Home Care Program, accessed on February 9, 2007,
from <http://www.cancer.ca>.
13.
B. Mintzes et al., “Volume IV: Pills, Persuasion and Public Health Policies,” in An Assessment
of the Health System Impacts of Direct-to-Consumer Advertising of Prescription Medicines
(DTCA), eds. B. Mintzes, A. Kazanjian, K. Bassett and J. Lexchin (Report of an Expert Survey
on Direct-to-Consumer Advertising of Prescription Drugs in Canada, the United States and
New Zealand) (Vancouver, B.C.: Health Policy and Research Unit, Centre for Health Services
and Policy Research, August 2001), pp. 1–48, accessed on February 14, 2007, from
<http://www.chspr.ubc.ca>, catalogue no. HPRU 02:4D.
143
Drug Expenditure in Canada, 1985 to 2011
144
14.
Statistics Canada, Guide to the Income and Expenditure Accounts (Ottawa, Ont.:
Statistics Canada, 2008), p. 23, catalogue no. 13-017.
15.
Organisation for Economic Co-operation and Development, OECD Health Data 2011
(Paris, France: OECD, 2011).
16.
Statistics Canada, Family Expenditure in Canada (Ottawa, Ont.: Statistics Canada),
catalogue no. 65-555-XPB.
17.
Statistics Canada, Your Guide to the Consumer Price Index (Ottawa, Ont.: Statistics Canada,
1996), pp. 7–9, accessed on February 9, 2007, from <http://www.statcan.gc.ca>, catalogue
no. 62-557-XPB.
Production of this report is made possible by financial contributions from Health
Canada and provincial and territorial governments. The views expressed herein
do not necessarily represent the views of Health Canada or any provincial
or territorial government.
All rights reserved.
The contents of this publication may be reproduced unaltered, in whole or in part
and by any means, solely for non-commercial purposes, provided that the Canadian
Institute for Health Information is properly and fully acknowledged as the copyright
owner. Any reproduction or use of this publication or its contents for any commercial
purpose requires the prior written authorization of the Canadian Institute for Health
Information. Reproduction or use that suggests endorsement by, or affiliation with,
the Canadian Institute for Health Information is prohibited.
For permission or information, please contact CIHI:
Canadian Institute for Health Information
495 Richmond Road, Suite 600
Ottawa, Ontario K2A 4H6
Phone: 613-241-7860
Fax: 613-241-8120
www.cihi.ca
[email protected]
ISBN 978-1-77109-032-2 (PDF)
© 2012 Canadian Institute for Health Information
How to cite this document:
Canadian Institute for Health Information, Drug Expenditure in Canada, 1985 to 2011
(Ottawa, Ont.: CIHI, 2012).
Cette publication est aussi disponible en français sous le titre Dépenses en
médicaments au Canada, de 1985 à 2011.
ISBN 978-1-77109-033-9 (PDF)
Talk to Us
CIHI Ottawa
495 Richmond Road, Suite 600
Ottawa, Ontario K2A 4H6
Phone: 613-241-7860
CIHI Montréal
1010 Sherbrooke Street West, Suite 300
Montréal, Quebec H3A 2R7
Phone: 514-842-2226
CIHI Toronto
4110 Yonge Street, Suite 300
Toronto, Ontario M2P 2B7
Phone: 416-481-2002
CIHI St. John’s
140 Water Street, Suite 701
St. John’s, Newfoundland and Labrador A1C 6H6
Phone: 709-576-7006
CIHI Victoria
880 Douglas Street, Suite 600
Victoria, British Columbia V8W 2B7
Phone: 250-220-4100
www.cihi.ca
At the heart of data
Was this manual useful for you? yes no
Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Download PDF

advertisement